<SEC-DOCUMENT>0001171843-20-000105.txt : 20200107
<SEC-HEADER>0001171843-20-000105.hdr.sgml : 20200107
<ACCEPTANCE-DATETIME>20200107160515
ACCESSION NUMBER:		0001171843-20-000105
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20200104
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200107
DATE AS OF CHANGE:		20200107

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Anika Therapeutics, Inc.
		CENTRAL INDEX KEY:			0000898437
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				043145961
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14027
		FILM NUMBER:		20513375

	BUSINESS ADDRESS:	
		STREET 1:		32 WIGGINS AVENUE
		CITY:			BEDFORD
		STATE:			MA
		ZIP:			01730
		BUSINESS PHONE:		(781) 457-9000

	MAIL ADDRESS:	
		STREET 1:		32 WIGGINS AVENUE
		CITY:			BEDFORD
		STATE:			MA
		ZIP:			01730

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANIKA THERAPEUTICS INC
		DATE OF NAME CHANGE:	19970114

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANIKA RESEARCH INC
		DATE OF NAME CHANGE:	19930309
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k_010720.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 1pt -22.5pt 1pt 0in; width: 100%"><DIV STYLE="font-size: 0.75pt; border-top: Black 0.75pt solid; border-bottom: Black 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center">UNITED STATES</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">Washington, D.C. 20549</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">FORM 8-K</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">CURRENT REPORT</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">PURSUANT TO SECTION 13 OR 15(d)</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">OF THE SECURITIES EXCHANGE ACT OF 1934</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">Date of Report (Date of earliest event reported): January 4, 2020</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">Anika Therapeutics, Inc.</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><I>(Exact name of registrant as specified in its charter)</I></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">____________________</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"></P>



<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center"></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap; text-align: center; width: 33%">Delaware</TD>
    <TD STYLE="white-space: nowrap; text-align: center; width: 34%">000-21326</TD>
    <TD STYLE="white-space: nowrap; text-align: center; width: 33%">04-3145961</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap; text-align: center"><I>(State or other jurisdiction of</I></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><I>Commission file number</I></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><I>(I.R.S. Employer</I></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap; text-align: center"><I>incorporation or organization)</I></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><I>&nbsp;</I></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><I>Identification No.)</I></TD></TR>
</TABLE>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center"></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">32 Wiggins Avenue, Bedford, MA 01730</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><I>(Address of principal executive offices) (Zip code)</I></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">(781)-457-9000</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><I>Registrant&rsquo;s telephone number, including area code: </I></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><I></I></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">Not applicable</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><I>(Former name or former address, if changed since last report)</I><BR>
____________________</P>



<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center"></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"> &#9744;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)</FONT></P>

<P STYLE="font-size: 10pt; text-indent: 4.5pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&#9744;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)</FONT></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&#9744;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&#9744;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))</FONT></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt">
<TR>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; width: 44%; border-bottom: black 1pt solid; text-align: center"><B>Title of each class</B></TD>
    <TD STYLE="white-space: nowrap; width: 1%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; width: 18%; border-bottom: black 1pt solid; text-align: center"><B>Trading Symbol(s)</B></TD>
    <TD STYLE="white-space: nowrap; width: 1%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; width: 36%; border-bottom: black 1pt solid; text-align: center"><B>Name of each exchange on which registered</B></TD></TR>
<TR>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center">Common Stock, par value $0.01 per share</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center">ANIK</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center">NASDAQ Global Select Market</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging growth company as defined
in Rule 405 of the Securities Act of 1933 (17 CFR &sect;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &sect;240.12b-2).</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Emerging growth company &#9744;</FONT></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><FONT STYLE="font-size: 10pt">If an emerging growth company, indicate by check mark
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</FONT></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 1pt -22.5pt 1pt 0in; width: 100%"><DIV STYLE="font-size: 0.75pt; border-top: Black 0.75pt solid; border-bottom: Black 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.75in"><B>Item 1.01</B></TD><TD><B>Entry into a Material Definitive Agreement</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><U>Arthrosurface, Inc. Merger Agreement</U></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">On January 4, 2020, Anika Therapeutics, Inc. (the &ldquo;<U>Company</U>&rdquo;)
entered into an Agreement and Plan of Merger (the &ldquo;<U>ArthroSurface Merger Agreemen</U>t&rdquo;) with Button Merger Sub,
Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (&ldquo;<U>ArthroSurface Merger Sub</U>&rdquo;), ArthroSurface
Incorporated, a Delaware corporation (&ldquo;<U>ArthroSurface</U>&rdquo;) and Boston Millennia Partners Button Shareholder Representation,
Inc., a Delaware corporation, solely in its capacity as the representative, agent and attorney-in-fact of the Equityholders (as
defined in the ArthroSurface Merger Agreement).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">The ArthroSurface Merger Agreement provides that, among other things
and subject to the terms and conditions of the ArthroSurface Merger Agreement, (1) ArthroSurface Merger Sub will merge with and
into ArthroSurface, with ArthroSurface surviving such merger as a direct, wholly owned subsidiary of the Company (the &ldquo;<U>ArthroSurface
Merger</U>&rdquo;), and (2) at the effective time of the ArthroSurface Merger (the &ldquo;<U>ArthroSurface Closing</U>&rdquo;),
all of the o<FONT STYLE="background-color: white">utstanding </FONT>shares <FONT STYLE="background-color: white">of common stock
and preferred stock of ArthroSurface </FONT>issued and outstanding immediately prior to the ArthroSurface Closing (other than certain
stock owned by the Company, the Company&rsquo;s wholly owned subsidiaries or ArthroSurface and certain dissenting shares, if any)
will no longer be outstanding and will automatically be cancelled and will retired and cease to exist, and each holder thereof
will cease to have any rights with respect thereto, except the right to receive the applicable consideration calculated as set
forth in the ArthroSurface Merger Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">In addition, each option to purchase shares of common stock of ArthroSurface
that is outstanding and vested as of the ArthroSurface Closing will automatically be cancelled and only entitle the holder of such
option to receive an amount of cash calculated as set forth in the ArthroSurface Merger Agreement, without interest. Each option
that is unvested will automatically be cancelled for no consideration or payment. Each warrant that is validly exercised prior
to the ArthroSurface Closing will be entitled to receive an aggregate amount calculated as set forth in the ArthroSurface Merger
Agreement. Each warrant that is not so exercised prior to the ArthroSurface Closing will expire and be deemed to be extinguished
and cancelled immediately prior to the ArthroSurface Closing. The ArthroSurface Merger Agreement contains representations, warranties
and covenants by the parties, conditions in favor of the parties and indemnification rights in favor of the Company that are customary
for a transaction of this nature.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">Pursuant to the terms and conditions of the ArthroSurface Merger
Agreement, the purchase price payable by the Company at the ArthroSurface Closing is $60,040,000 in cash, subject to adjustments
for cash, indebtedness, working capital and transaction expenses of ArthroSurface as of the ArthroSurface Closing. The ArthroSurface
Merger Agreement also provides for certain earn-out payments of up to an aggregate amount of $40,000,000 if certain financial and
regulatory targets are achieved in 2020 and 2021, payable in cash.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">The ArthroSurface Closing is expected to occur in the first quarter
of 2019 and is subject to <FONT STYLE="background-color: white">the satisfaction or waiver of certain customary mutual closing
conditions.</FONT></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">The ArthroSurface Merger Agreement contains representations, warranties
and covenants by the parties and indemnification rights in favor of the Company that are customary for a transaction of this nature.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">The ArthroSurface Merger Agreement also contains certain termination
rights, including, among others, the right of either party to terminate the ArthroSurface Merger Agreement if the ArthroSurface
Merger has not occurred by April 3, 2020, and the failure to consummate is not caused by a breach of the ArthroSurface Merger Agreement
by the terminating party.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><U>Parcus Medical, LLC Merger Agreement</U></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">On January 4, 2020, the Company also entered into an Agreement and
Plan of Merger (the &ldquo;<U>Parcus Merger Agreement</U>&rdquo;) with Sunshine Merger Sub, LLC, a Wisconsin limited liability
company and a wholly-owned subsidiary of the Company (&ldquo;<U>Parcus Merger Sub</U>&rdquo;), Parcus, LLC, a Wisconsin limited
liability company (&ldquo;<U>Parcus</U>&rdquo;) and Philip Mundy, an individual, solely in his capacity as the representative,
agent and attorney-in-fact of the Equityholders (as defined in the Parcus Merger Agreement).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">The Parcus Merger Agreement provides that, among other things and
subject to the terms and conditions of the Parcus Merger Agreement, (1) Parcus Merger Sub will merge with and into Parcus, with
Parcus surviving such merger as a direct, wholly owned subsidiary of the Company (the &ldquo;<U>Parcus Merger</U>&rdquo;), (2)
at the effective time of the Parcus Merger (the &ldquo;<U>Parcus Closing</U>&rdquo;), all of the membership units of Parcus issued
and outstanding immediately prior to the Parcus Closing (other than certain membership units owned by the Company, the Company&rsquo;s
wholly owned subsidiaries or Parcus, if any) will no longer be outstanding and will automatically be cancelled and retired and
will cease to exist, and each holder thereof will cease to have any rights with respect thereto, except the right to receive the
applicable consideration calculated as set forth in the Parcus Merger Agreement and (3) at the Parcus Closing, all of the rights
to receive membership units of Parcus will, automatically accelerate in full and will automatically be cancelled and only entitle
the holder of such Company RSU to receive an amount of cash calculated as set forth in the Parcus Merger Agreement, without interest.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">Pursuant to the Parcus Merger Agreement, the purchase price payable
by the Company at closing is $35,000,000 in cash, subject to adjustments for cash, indebtedness, working capital and transaction
expenses of Parcus as of the Parcus Closing. The Parcus Merger Agreement also provides for certain potential earn-out payments
of up to an aggregate amount of $60,000,000 if certain financial targets are achieved in 2020, 2021 and 2022, payable in cash.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">The Parcus Closing is expected to occur in the first quarter of 2019
and is subject to <FONT STYLE="background-color: white">the satisfaction or waiver of certain customary mutual closing conditions.</FONT></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">The Parcus Merger Agreement contains representations, warranties
and covenants by the parties and indemnification rights in favor of the Company that are customary for a transaction of this nature.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">The Parcus Merger Agreement also contains certain termination rights,
including, among others, the right of either party to terminate the Parcus Merger Agreement if the Parcus Merger has not occurred
by April 3, 2020, and the failure to consummate is not caused by a breach of the Parcus Merger Agreement by the terminating party.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">The ArthroSurface Merger Agreement is attached hereto as Exhibit
2.1, with certain terms redacted, and is incorporated herein by reference. The Parcus Merger Agreement is also attached hereto
as Exhibit 2.2, with certain terms redacted, and is incorporated herein by reference. The foregoing descriptions of the ArthroSurface
Merger Agreement and the Parcus Merger Agreement (together, the &ldquo;<U>Merger Agreements</U>&rdquo;) have been included to
provide investors with information regarding their terms, do not purport to be complete and are qualified in their entirety by
reference to the full text of either Merger Agreement. They are not intended to provide any other factual information about the
Company, ArthroSurface or Parcus. The <U>Merger Agreements</U> each contain representations and warranties by certain of the parties
to the respective Merger Agreement, which were made only for purposes of the applicable Merger Agreement and as of specified dates.
The representations, warranties and covenants in the Merger Agreements were the product of negotiations among the applicable parties
and made solely for the benefit of the parties to the respective Merger Agreement; may be subject to limitations agreed upon by
the contracting parties, including being qualified by confidential disclosures made for the purposes of allocating contractual
risk between the parties to the applicable Merger Agreement instead of establishing these matters as facts; and may be subject
to standards of materiality applicable to the contracting parties that differ from those applicable to investors. Investors should
not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the actual state
of facts or condition of the Company, ArthroSurface, Parcus or any of their respective subsidiaries or affiliates. Moreover, information
concerning the subject matter of the representations, warranties and covenants may change after the date of each Merger Agreement,
which subsequent information may or may not be fully reflected in the Company&rsquo;s public disclosures.</P>



<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in"></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><U>Forward-Looking Statements </U></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">This Current Report includes forward-looking statements within the meaning of Section
27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, concerning, but not limited
to, the acquisition of ArthroSurface and Parcus and the effects of the ArthroSurface Merger and the Parcus Merger. The Securities
and Exchange Commission (&quot;<U>SEC</U>&quot;) encourages companies to disclose forward-looking statements so that investors
can better understand a company&rsquo;s future prospects and make informed investment decisions. Forward-looking statements are
subject to risks and uncertainties, many of which are outside our control, which could cause actual results to differ materially
from these statements. Therefore, you should not rely on any of these forward-looking statements. Forward-looking statements can
be identified by such words as &quot;will,&quot; &quot;likely,&quot; &quot;may,&quot; &quot;believe,&quot; &quot;expect,&quot;
&quot;anticipate,&quot; &quot;intend,&quot; &quot;seek,&quot; &quot;designed,&quot; &quot;develop,&quot; &quot;would,&quot; &quot;future,&quot;
&quot;can,&quot; &quot;could,&quot; and other expressions that are predictions of or indicate future events and trends and that
do not relate to historical matters. All statements other than statements of historical facts included in this Current Report regarding
our strategies, prospects, financial condition, operations, costs, plans, and objectives are forward-looking statements. Factors
that could cause or contribute to changes in such forward-looking statements include, but are not limited to (i) failure to realize
the anticipated benefits of the acquisitions, (ii) unexpected expenditures or assumed liabilities that may be incurred as a result
of the acquisitions, (iii) loss of key employees or customers following the acquisitions, (iv) unanticipated difficulties in conforming
business practices, including accounting policies, procedures, internal controls, and financial records of ArthroSurface and Parcus
with the Company, (v) inability to accurately forecast the performance of ArthroSurface and Parcus resulting in unforeseen adverse
effects on the Company&rsquo;s operating results, (vi) failure to satisfy the conditions to the completion of the acquisitions
on the anticipated schedule, or at all, and (vii) synergies between ArthroSurface or Parcus and the Company being estimates which
may be materially different from actual results.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">Please refer to the factors set forth under the heading &quot;Risk Factors&quot; in the
Company&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2018, filed with the SEC, as may be amended or supplemented
in subsequently filed Quarterly Reports on Form 10-Q for important factors that we believe could cause actual results to differ
materially from those in our forward-looking statements. Any forward-looking statement made by us in this Current Report is based
only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to
publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result
of new information, future developments, or otherwise.</P>

<P STYLE="margin: 0pt 0 0pt 0.75in; font-size: 10pt; text-indent: -0.75in"><B>&nbsp;</B></P>

<P STYLE="margin: 0pt 0 0pt 0.75in; font-size: 10pt; text-indent: -0.75in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.75in"><B>Item 9.01.</B></TD><TD><B>Financial Statements and Exhibits.</B></TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">(d) Exhibits.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center; width: 7%"><B>Exhibit </B><BR>
<B>Number</B></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: center; width: 92%"><B>Description</B></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center"><A HREF="exh_21.htm">2.1+</A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="exh_21.htm">Agreement and Plan of Merger, dated January 4, 2020, by and between Anika Therapeutics, Inc., Arthrosurface, Inc., Button Merger Sub, Inc. and Boston Millennia Partners Button Shareholder Representation, Inc.</A></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center"><A HREF="exh_22.htm">2.2+</A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="exh_22.htm">Agreement and Plan of Merger, dated January 4, 2020, by and between Anika Therapeutics, Inc., Parcus Medical, LLC, Sunshine Merger Sub, LLC and Philip Mundy</A></TD>
    </TR>
</TABLE>
<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">+ Portions of this exhibit have been redacted in compliance with Regulation S-K Item
601(b)(2). The omitted information is not material and would likely cause competitive harm to the Company if publicly disclosed.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0"><B>SIGNATURE</B></P>

<P STYLE="color: #000033; font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font-size: 10pt; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>Anika Therapeutics, Inc.</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 33%">Date: January 7, 2020</TD>
    <TD STYLE="width: 34%">&nbsp;</TD>
    <TD STYLE="width: 4%">By:&nbsp;&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 29%">/s/ <FONT STYLE="font-variant: small-caps">Sylvia Cheung</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Chief Financial Officer</TD></TR>
</TABLE>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0in">&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>exh_21.htm
<DESCRIPTION>EXHIBIT 2.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0"><B>Exhibit 2.1</B></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: right">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0; border: Black 1pt solid">Portions of this agreement have been redacted
in compliance with Regulation S-K Item 601(b)(2). The omitted information is not material and would likely cause competitive harm
to the Company if publicly disclosed.</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0; border: Black 0pt solid"></P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: right">EXECUTION COPY<BR>
CONFIDENTIAL</P>



<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center"></P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">AGREEMENT AND PLAN OF MERGER</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">by and among</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">Anika
Therapeutics, Inc.</FONT>,</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">BUTTON MERGER SUB, INC.,</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">ARTHROSURFACE INCORPORATED</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">AND</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">BOSTON MILLENNIA PARTNERS</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">BUTTON SHAREHOLDER REPRESENTATION, INC.,<BR>
as the Stockholder Representative</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">Dated as of January 4, 2020</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center"></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">TABLE OF CONTENTS</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: right"><U>Page</U></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: right">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="width: 90%; text-align: left; text-indent: -0.8in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.8in">Article I DEFINITIONS</TD>
    <TD STYLE="width: 10%; text-align: right; padding-top: 12pt; padding-bottom: 0pt">2</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">1.01&nbsp;&nbsp;&nbsp;Definitions</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">2</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">1.02&nbsp;&nbsp;&nbsp;Rules of Construction</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">2</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -0.8in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.8in">Article II THE MERGER</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">3</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.01&nbsp;&nbsp;&nbsp;The Merger</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">3</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.02&nbsp;&nbsp;&nbsp;Closing</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">3</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.03&nbsp;&nbsp;&nbsp;Effective Time</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">3</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.04&nbsp;&nbsp;&nbsp;Effects</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">3</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.05&nbsp;&nbsp;&nbsp;Governing Documents; Directors and Officers</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">3</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.06&nbsp;&nbsp;&nbsp;Additional Action</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">3</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -0.8in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.8in">Article III PURCHASE PRICE; EFFECT ON SHARES</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">4</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.01&nbsp;&nbsp;&nbsp;Effects of Merger</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">4</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.02&nbsp;&nbsp;&nbsp;Treatment of Company Preferred Stock</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">4</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.03&nbsp;&nbsp;&nbsp;Treatment of Company Options and Company Warrants</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">5</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.04&nbsp;&nbsp;&nbsp;Payment Procedures</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">6</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.05&nbsp;&nbsp;&nbsp;Holdback</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">9</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.06&nbsp;&nbsp;&nbsp;Aggregate Closing Payment Schedule</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">10</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.07&nbsp;&nbsp;&nbsp;Post-Closing Determination of the Closing Statement</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">10</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.08&nbsp;&nbsp;&nbsp;Earn-Out Consideration</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">12</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.09&nbsp;&nbsp;&nbsp;Lost, Stolen or Destroyed Certificates</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">15</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.10&nbsp;&nbsp;&nbsp;No Interest</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">16</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.11&nbsp;&nbsp;&nbsp;Withholding Rights</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">16</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -0.8in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.8in">Article IV REPRESENTATIONS AND WARRANTIES REGARDING THE COMPANY</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">16</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.01&nbsp;&nbsp;&nbsp;Organization; Qualification</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">16</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.02&nbsp;&nbsp;&nbsp;Capitalization</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">17</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.03&nbsp;&nbsp;&nbsp;Authority; Enforceability</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">18</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.04&nbsp;&nbsp;&nbsp;No Conflicts; Consents and Approvals</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">19</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.05&nbsp;&nbsp;&nbsp;No Subsidiaries; No Repurchase Obligations</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">19</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.06&nbsp;&nbsp;&nbsp;Financial Statements</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">20</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.07&nbsp;&nbsp;&nbsp;Liabilities</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">20</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.08&nbsp;&nbsp;&nbsp;Absence of Certain Changes</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">21</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.09&nbsp;&nbsp;&nbsp;Legal Proceedings</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">22</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.10&nbsp;&nbsp;&nbsp;Compliance with Applicable Laws</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">22</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.11&nbsp;&nbsp;&nbsp;Material Contracts</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">23</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.12&nbsp;&nbsp;&nbsp;Taxes</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">25</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.13&nbsp;&nbsp;&nbsp;Employee Matters</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">27</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.14&nbsp;&nbsp;&nbsp;Labor Matters</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">29</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.15&nbsp;&nbsp;&nbsp;Insurance</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">30</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.16&nbsp;&nbsp;&nbsp;Intellectual Property</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">30</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in; width: 90%">4.17&nbsp;&nbsp;&nbsp;Privacy and Data Security</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; width: 10%">32</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.18&nbsp;&nbsp;&nbsp;Real Property</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">33</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.19&nbsp;&nbsp;&nbsp;Personal Property</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">34</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.20&nbsp;&nbsp;&nbsp;Related-Party Transactions</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">34</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.21&nbsp;&nbsp;&nbsp;Bank Accounts</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">34</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.22&nbsp;&nbsp;&nbsp;Customers, Distributors and Suppliers</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">34</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.23&nbsp;&nbsp;&nbsp;Key Revenue Agreements</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">35</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.24&nbsp;&nbsp;&nbsp;Condition and Sufficiency of Assets</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">35</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.25&nbsp;&nbsp;&nbsp;Compliance with Healthcare Laws</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">35</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.26&nbsp;&nbsp;&nbsp;Medical Device Compliance</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">36</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.27&nbsp;&nbsp;&nbsp;Brokers</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">38</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.28&nbsp;&nbsp;&nbsp;Stockholders&rsquo; Agreement</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">39</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.29&nbsp;&nbsp;&nbsp;No Other Representations or Warranties</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">39</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -0.8in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.8in">Article V REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">39</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.01&nbsp;&nbsp;&nbsp;Organization; Qualification</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">39</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.02&nbsp;&nbsp;&nbsp;Authority; Enforceability</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">39</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.03&nbsp;&nbsp;&nbsp;No Conflicts; Consents and Approvals</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">40</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.04&nbsp;&nbsp;&nbsp;Litigation</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">40</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.05&nbsp;&nbsp;&nbsp;Availability of Funds</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">40</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.06&nbsp;&nbsp;&nbsp;Merger Sub</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">40</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.07&nbsp;&nbsp;&nbsp;No Other Representations or Warranties</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">40</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.08&nbsp;&nbsp;&nbsp;Parent&rsquo;s Investigation and Reliance</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">41</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -0.8in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.8in">Article VI COVENANTS OF THE PARTIES</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">41</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.01&nbsp;&nbsp;&nbsp;Access by Parent</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">41</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.02&nbsp;&nbsp;&nbsp;Certain Restrictions</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">42</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.03&nbsp;&nbsp;&nbsp;Reasonable Best Efforts; Regulatory and Other Approvals</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">44</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.04&nbsp;&nbsp;&nbsp;No Solicitation or Negotiation of Alternative Proposals</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">46</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.05&nbsp;&nbsp;&nbsp;Required Stockholder Approval</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">47</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.06&nbsp;&nbsp;&nbsp;Additional Stockholder Consents</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">47</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.07&nbsp;&nbsp;&nbsp;Information Statement</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">47</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.08&nbsp;&nbsp;&nbsp;Employees; Employee Benefits</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">48</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.09&nbsp;&nbsp;&nbsp;Third-Party Consents</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">49</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.10&nbsp;&nbsp;&nbsp;Tax Matters</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">49</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.11&nbsp;&nbsp;&nbsp;Further Assurances; Post-Closing Cooperation</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">53</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.12&nbsp;&nbsp;&nbsp;Indemnification of Directors and Officers; Directors&rsquo; and Officers&rsquo; Insurance, etc</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">53</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.13&nbsp;&nbsp;&nbsp;R&amp;W Insurance</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">53</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.14&nbsp;&nbsp;&nbsp;Notification</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">54</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.15&nbsp;&nbsp;&nbsp;Company Audit; Disclosure of Acquisition</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">54</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.16&nbsp;&nbsp;&nbsp;Fixing Record Date</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">54</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -0.8in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.8in">Article VII CONDITIONS TO OBLIGATIONS OF PARENT AND MERGER SUB</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">55</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.01&nbsp;&nbsp;&nbsp;Representations and Warranties</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">55</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.02&nbsp;&nbsp;&nbsp;Performance</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">55</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in; width: 90%">7.03&nbsp;&nbsp;&nbsp;Payment of Transaction Expenses</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; width: 10%">55</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.04&nbsp;&nbsp;&nbsp;Officer&rsquo;s Certificates</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">55</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.05&nbsp;&nbsp;&nbsp;Orders and Applicable Laws</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">55</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.06&nbsp;&nbsp;&nbsp;No Material Adverse Effect</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">55</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.07&nbsp;&nbsp;&nbsp;Stockholder Approval</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">55</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.08&nbsp;&nbsp;&nbsp;Series B Preferred Support Agreement</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">56</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.09&nbsp;&nbsp;&nbsp;Payments Administrator Agreement</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">56</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.10&nbsp;&nbsp;&nbsp;Stockholder Representative NDA</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">56</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.11&nbsp;&nbsp;&nbsp;280G Stockholder Vote</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">56</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.12&nbsp;&nbsp;&nbsp;Letter Agreements</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">56</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.13&nbsp;&nbsp;&nbsp;Continued Employment</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">56</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.14&nbsp;&nbsp;&nbsp;FIRPTA Certificate</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">56</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.15&nbsp;&nbsp;&nbsp;Stockholders Agreement; Investor Rights Agreement</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">56</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.16&nbsp;&nbsp;&nbsp;[&hellip;] Agreements</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">56</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.17&nbsp;&nbsp;&nbsp;Consents and Notice</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">56</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.18&nbsp;&nbsp;&nbsp;Audit and Interim Financials</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">56</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -0.8in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.8in">Article VIII CONDITIONS TO OBLIGATIONS OF THE COMPANY</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">57</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">8.01&nbsp;&nbsp;&nbsp;Representations and Warranties</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">57</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">8.02&nbsp;&nbsp;&nbsp;Performance</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">57</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">8.03&nbsp;&nbsp;&nbsp;Officer&rsquo;s Certificate</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">57</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">8.04&nbsp;&nbsp;&nbsp;Orders and Applicable Laws</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">57</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">8.05&nbsp;&nbsp;&nbsp;Stockholder Approval</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">57</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">8.06&nbsp;&nbsp;&nbsp;Payments Administrator Agreement</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">58</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -0.8in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.8in">Article IX TERMINATION</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">58</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">9.01&nbsp;&nbsp;&nbsp;Termination</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">58</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">9.02&nbsp;&nbsp;&nbsp;Effect of Termination</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">58</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -0.8in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.8in">Article X INDEMNIFICATION</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">59</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">10.01&nbsp;&nbsp;&nbsp;Survival</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">59</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">10.02&nbsp;&nbsp;&nbsp;Indemnification</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">60</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">10.03&nbsp;&nbsp;&nbsp;Third-Party Claims</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">61</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">10.04&nbsp;&nbsp;&nbsp;Limitations on Indemnification</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">61</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">10.05&nbsp;&nbsp;&nbsp;No Contribution</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">63</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">10.06&nbsp;&nbsp;&nbsp;Remedies Exclusive</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">63</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">10.07&nbsp;&nbsp;&nbsp;Adjustment Characterization</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">64</TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in; width: 90%">10.08&nbsp;&nbsp;&nbsp;Damage Limitations</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; width: 10%">64</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -0.8in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.8in">Article XI MISCELLANEOUS</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">64</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.01&nbsp;&nbsp;&nbsp;Stockholder Representative</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">64</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.02&nbsp;&nbsp;&nbsp;Actions of the Stockholder Representative</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">66</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.03&nbsp;&nbsp;&nbsp;Entire Agreement</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">66</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.04&nbsp;&nbsp;&nbsp;Expenses</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">66</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.05&nbsp;&nbsp;&nbsp;Announcements</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">66</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.06&nbsp;&nbsp;&nbsp;No Waiver</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">67</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.07&nbsp;&nbsp;&nbsp;Amendments</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">67</TD></TR>
</TABLE>
<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in; width: 90%">11.08&nbsp;&nbsp;&nbsp;Addresses for Notices</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; width: 10%">67</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.09&nbsp;&nbsp;&nbsp;Captions</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">68</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.10&nbsp;&nbsp;&nbsp;Severability</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">68</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.11&nbsp;&nbsp;&nbsp;Assignment</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">68</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.12&nbsp;&nbsp;&nbsp;Counterparts</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">68</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.13&nbsp;&nbsp;&nbsp;Disclosure</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">69</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.14&nbsp;&nbsp;&nbsp;Specific Performance</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">69</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.15&nbsp;&nbsp;&nbsp;Governing Applicable Law</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">69</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.16&nbsp;&nbsp;&nbsp;Consent to Jurisdiction</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">70</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.17&nbsp;&nbsp;&nbsp;Waiver of Jury Trial</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">70</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.18&nbsp;&nbsp;&nbsp;Obligations of Merger Sub</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">70</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.19&nbsp;&nbsp;&nbsp;No Third-Party Beneficiaries</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">70</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.20&nbsp;&nbsp;&nbsp;Legal Representation</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">70</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">ANNEXES AND SCHEDULES</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"> <B><U>Annexes</U></B></P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></P>

<P STYLE="font-size: 10pt; text-indent: -1.5in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 5%; font-size: 10pt; text-align: left; text-indent: -1.5in; padding-left: 1.5in">Annex A</TD>
    <TD STYLE="width: 95%; font-size: 10pt">Definitions</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -1.5in; padding-left: 1.5in">Annex B</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Form of Support Agreement</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -1.5in; padding-left: 1.5in">Annex C</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Form of Written Consent</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -1.5in; padding-left: 1.5in">Annex D</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Form of FIRPTA Certificate</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -1.5in; padding-left: 1.5in">Annex E</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Form of Term Sheet for Amendment to [&hellip;]</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -1.5in; padding-left: 1.5in">Annex F</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Form of Stockholder Representative NDA</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-indent: -1.5in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: -1.5in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: -1.5in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0"><U>Schedules</U></P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 5%; font-size: 10pt; text-align: left; text-indent: -1.5in; padding-left: 1.5in">Schedule A</TD>
    <TD STYLE="width: 95%; font-size: 10pt; text-align: left">Key Employees, Key Individuals and Key Stockholders</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -1.5in; padding-left: 1.5in">Schedule B</TD>
    <TD STYLE="font-size: 10pt; text-align: left">List of Stockholders to Sign Support Agreements by Midnight on January 5, 2020</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -1.5in; padding-left: 1.5in">Schedule C</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Preliminary Schedule of Consideration to be Paid to Each Equityholder</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -1.5in; padding-left: 1.5in">Schedule D</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Knowledge Parties</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-indent: -1.5in; padding-left: 1.5in">Schedule E-1</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Illustrative Calculation of Working Capital</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-indent: -1.5in; padding-left: 1.5in">Schedule E-2</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Illustrative Calculation of Indebtedness</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-indent: -1.5in; padding-left: 1.5in">Schedule E-3</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Illustrative Calculation of Cash</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -1.5in; padding-left: 1.5in">Schedule F</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Regulatory and Sales Milestones</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -1.5in; padding-left: 1.5in">Schedule G</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Related Parties</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -1.5in; padding-left: 1.5in">Schedule H</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Illustrative Parent Earn-Out Statement</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-indent: -1.5in; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">AGREEMENT AND PLAN OF MERGER</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">This AGREEMENT AND PLAN OF MERGER is made as of
January 4, 2020 (this &ldquo;<U>Agreement</U>&rdquo;) by and among (i) Anika Therapeutics, Inc., a Delaware corporation (&ldquo;<U>Parent</U>&rdquo;),
(ii) Button Merger Sub, Inc. a Delaware corporation and wholly owned subsidiary of Parent (&ldquo;<U>Merger Sub</U>&rdquo;), (iii)
ArthroSurface Incorporated, a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and (iv) Boston Millennia Partners Button
Shareholder Representation, Inc., a Delaware corporation, solely in its capacity as the representative, agent and attorney-in-fact
of the Equityholders (the &ldquo;<U>Stockholder Representative</U>&rdquo;). Parent, Merger Sub, the Company and the Stockholder
Representative are each referred to herein as a &ldquo;<U>Party</U>&rdquo; or, collectively, as the &ldquo;<U>Parties</U>&rdquo;.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">WITNESSETH:</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">WHEREAS, the respective boards of directors of
each of the Company, Parent and Merger Sub have determined that this Agreement is advisable and have approved this Agreement and
the merger of Merger Sub with and into the Company upon the terms and subject to the conditions set forth in this Agreement (the
&ldquo;<U>Merger</U>&rdquo;);</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">WHEREAS, concurrent with the execution of this
Agreement, and as a condition and inducement to Parent&rsquo;s willingness to enter into this Agreement, the Key Individuals and
Key Stockholders have entered into letter agreements (collectively, the &ldquo;<U>Letter Agreements</U>&rdquo;) dated as of the
date hereof and which shall be effective as of the Effective Time;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">WHEREAS, as an inducement to Parent&rsquo;s and
Merger Sub&rsquo;s willingness to enter into this Agreement, (i) promptly after the execution and delivery of this Agreement and
in any event by midnight on January 5, 2020, any combination of the Stockholders of the Company listed on <U>Schedule B</U> holding
in the aggregate at least sixty percent (60%) of the issued and outstanding shares of Company Capital Stock will have executed
and delivered the applicable support agreements in the form attached hereto as <U>Annex B</U> (the &ldquo;<U>Support Agreements</U>&rdquo;)
and (ii) prior to the Closing Date, and as a condition to the obligations of Parent and Merger Sub hereunder, a majority of the
holders of the Series B Preferred Stock and Stockholders holding at least ninety-five percent (95%) of the issued and outstanding
shares of Company Capital Stock shall have executed and delivered a written consent in the form attached to this Agreement as <U>Annex
C</U> (the &ldquo;<U>Written Consent</U>&rdquo;);</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">WHEREAS, the Support Agreements will constitute
the applicable Stockholder&rsquo;s agreement to consent to, and vote to approve and adopt, this Agreement and the Merger, waive
any dissenters&rsquo; or approval rights under Applicable Law and appoint the Stockholder Representative to act on its behalf pursuant
to <U>Section&nbsp;11.01</U>;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">WHEREAS, the Written Consents will constitute
the applicable Stockholder&rsquo;s consent to, and vote to approve and adopt, this Agreement and the Merger, waiver of any dissenters&rsquo;
or approval rights under Applicable Law and appointment of the Stockholder Representative to act on its behalf pursuant to <U>Section&nbsp;11.01</U>;
and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">WHEREAS, concurrently with the execution and delivery
of this Agreement, and as a condition of, and inducement to, the Company&rsquo;s willingness to enter into this Agreement, Parent
has delivered to the Company a binder (the &ldquo;<U>Binder Agreement</U>&rdquo;), evidencing a commitment to issue and bind the
R&amp;W Policy at or prior to the Closing.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">NOW, THEREFORE, in consideration of the mutual
representations, warranties, covenants and agreements in this Agreement, and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0"><FONT STYLE="color: #010000">Article
I</FONT><BR>
DEFINITIONS</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">1.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Definitions</U>. As used in this Agreement, certain terms have the meanings set forth in <U>Annex A</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">1.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Rules of Construction</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>All article, section, subsection, schedule and annex references used in this Agreement are to articles, sections,
subsections, schedules and annexes to this Agreement unless otherwise specified. The annexes and schedules attached to this Agreement
constitute a part of this Agreement and are incorporated into this Agreement for all purposes.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>If a term is defined as one part of speech (such as a noun), it shall have a corresponding meaning when used as another
part of speech (such as a verb). Unless the context of this Agreement clearly requires otherwise, words importing one gender shall
include all other genders. The words &ldquo;includes&rdquo; or &ldquo;including&rdquo; shall mean &ldquo;including without limitation,&rdquo;
and the words &ldquo;hereof,&rdquo; &ldquo;hereby,&rdquo; &ldquo;herein,&rdquo; &ldquo;hereunder&rdquo; and similar terms in this
Agreement shall refer to this Agreement as a whole and not any particular section or article in which such words appear. Any reference
to a Law shall include any amendment thereof or any successor thereto and any rules and regulations promulgated thereunder; <U>provided</U>
that for purposes of any representations and warranties contained in this Agreement that are made as of a specific date, references
to any Law shall be deemed to refer to such Law as amended as of such date. References to &ldquo;written&rdquo; or &ldquo;in writing&rdquo;
include documents in electronic form or transmission by email. A reference to any Person includes such Person&rsquo;s successors
and permitted assigns. Currency amounts referenced in this Agreement are in U.S. Dollars.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Whenever this Agreement refers to a number of days, such number shall refer to calendar days unless Business Days
are specified. Whenever any action must be taken hereunder on or by a day that is not a Business Day, then such action may be validly
taken on or by the next day that is a Business Day.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each Party acknowledges that it and its attorneys have been given an equal opportunity to negotiate the terms and
conditions of this Agreement and that any rule of construction to the effect that ambiguities are to be resolved against the drafting
Party or any similar rule operating against the drafter of an agreement shall not be applicable to the construction or interpretation
of this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Except as otherwise specifically provided herein, all accounting terms used herein and not expressly defined herein
shall have the respective meanings given to such terms under GAAP.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0"><FONT STYLE="color: #010000">Article
II</FONT><BR>
THE MERGER</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>The Merger</U>. On the terms and subject to the conditions set forth in this Agreement, and in accordance with
the relevant provisions of the Delaware Law, Merger Sub shall be merged with and into the Company at the Effective Time, and at
the Effective Time the separate existence of Merger Sub shall cease and the Company shall continue as the surviving corporation
and a wholly owned subsidiary of Parent. The entity that survives the Merger is sometimes referred to in this Agreement as the
&ldquo;<U>Surviving Corporation</U>&rdquo;.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Closing</U>. The closing of the transactions contemplated by this Agreement (the &ldquo;<U>Closing</U>&rdquo;)
will take place at 10:00 a.m. prevailing Eastern Time on the Closing Date at the offices of Sullivan &amp; Cromwell LLP, at 125
Broad Street, New York, New York 10004, or at such other place, time and/or date as Parent and the Company shall mutually agree
in writing; <U>provided</U>, <U>however</U>, that in no event shall the Closing take place fewer than twenty (20) days after the
receipt of the Information Statement by the Stockholders. On the Closing Date, the Parties will cause the transactions described
in <U>Section&nbsp;2.01</U>, <U>Section&nbsp;2.03</U>, <U>Section&nbsp;3.01</U> and <U>Section&nbsp;3.04</U> to occur and will,
as applicable, deliver the other documents and instruments to be delivered under <U>Article VII</U> and <U>Article VIII</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Effective Time</U>. As soon as practicable following the Closing, the Parties (other than the Stockholder Representative)
shall file with the Secretary of State of the State of Delaware a certificate of merger (the &ldquo;<U>Certificate of Merger</U>&rdquo;)
executed in accordance with the relevant provisions of the Delaware Law, and shall make all other filings or recordings required
under the Delaware Law. The Merger shall become effective at such time as the Certificate of Merger has been duly filed with such
Secretary of State, or at such other time as Parent and the Company shall agree and specify in the Certificate of Merger (the time
the Merger becomes effective being the &ldquo;<U>Effective Time</U>&rdquo;).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.04<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Effects</U>. The Merger shall have the effects set forth in the Delaware Law.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.05<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Governing Documents; Directors and Officers</U>. At the Effective Time, the certificate of incorporation and bylaws
of the Surviving Corporation shall be amended to be identical to those of Merger Sub immediately prior to the Effective Time, except
that the name of the Surviving Corporation shall be &ldquo;ArthroSurface Incorporated&rdquo;. The Parties (other than the Stockholder
Representative) shall take all actions necessary so that the directors and officers of Merger Sub immediately prior to the Effective
Time shall be the directors and officers of the Surviving Corporation from and after the Effective Time, until their successors
have been duly elected or appointed and qualified or until their earlier death, removal or resignation in accordance with the certificate
of incorporation and the bylaws of the Surviving Corporation.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.06<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Additional Action</U>. The Surviving Corporation may, at any time after the Effective Time, take any action, including
executing and delivering any document, in the name and on behalf of either the Company or Merger Sub, in order to consummate the
transactions contemplated by this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0"><FONT STYLE="color: #010000">Article
III</FONT><BR>
PURCHASE PRICE; EFFECT ON SHARES</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Effects of Merger</U>. At the Effective Time, as a result of the Merger and without any action on the part of
any of Parent, Merger Sub, the Company or any holder of Company Capital Stock:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Merger Sub</U>. Each share of common stock of Merger Sub issued and outstanding immediately prior to the Effective
Time shall be converted into and become one (1) fully paid and nonassessable share of common stock of the Surviving Corporation.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Conversion of Company Capital Stock</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The amounts payable hereunder in respect of the Company Capital Stock shall be allocated among the holders of shares
of Company Capital Stock in accordance with the Charter.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Without limiting <U>Section&nbsp;3.01(b)(i)</U>, as of the Effective Time, all of the shares of Company Capital Stock
issued and outstanding immediately prior to the Effective Time (other than Excluded Shares, if any) shall no longer be outstanding
and shall automatically be cancelled and retired and shall cease to exist, and each holder thereof shall cease to have any rights
with respect thereto, except the right to receive (A) in the case of the Company Common Stock and shares of Series B Preferred
Stock that are deemed to convert into the right to receive the Per Common Share Merger Consideration, the Per Common Share Merger
Consideration and (B) in the case of the Company Preferred Stock, the amounts set forth under <U>Section 3.02</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Cancellation of Excluded Shares</U>. Any Excluded Share shall, by virtue of the Merger and without any action
on the part of the holder of such Excluded Share, cease to be outstanding, be cancelled without payment of any consideration therefor
and shall cease to exist, subject to any rights the holders of Dissenting Shares may have under <U>Section&nbsp;3.01(d)</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Appraisal Rights</U>. Notwithstanding any provisions of this Agreement to the contrary, any Dissenting Shares
shall not be converted into the right to receive the Per Share Merger Consideration but shall instead be converted into the right
to receive such consideration as may be determined to be due with respect to any such Dissenting Shares pursuant to Section&nbsp;262
of the Delaware Law. The Company shall provide to Parent (i) prompt notice of any demands for appraisal or purchase received by
the Company, withdrawals of such demands and any other instruments related to such demands served pursuant to Section&nbsp;262
of the Delaware Law and received by the Company and (ii) the right to direct all negotiations and proceedings with respect to such
demands under Section&nbsp;262 of the Delaware Law. The Company shall not, except with the prior written consent of Parent, or
as otherwise required under Section&nbsp;262 of the Delaware Law, voluntarily make any payment or offer to make any payment with
respect to, or settle or offer to settle, any claim or demand in respect of any Dissenting Shares. Parent shall be entitled to
retain any Per Share Merger Consideration not paid on account of such Dissenting Shares pending resolution, withdrawal or loss
of claims of such holders.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Treatment of Company Preferred Stock</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Series B Preferred Stock</U>. Immediately prior to the Effective Time, pursuant to, and in accordance with Section
3F of the Charter, all shares of Series B Preferred Stock shall be deemed to convert into the right to receive the Per Common Share
Merger Consideration.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Non-Converting Company Preferred Stock</U>. Immediately prior to the Effective Time, pursuant to, and in accordance
with, Section&nbsp;3B of the Charter (in the case of the Series A Preferred Stock) and Section&nbsp;3B of the applicable Certificate
of Designation (in the case of all other series of Company Preferred Stock), before any distribution or payment is made to the
holders of shares of Company Common Stock, all shares of Non-Converting Company Preferred Stock shall be converted into the right
to receive the applicable Preferred Share Liquidation Preference for all purposes herein and all shares of Non-Converting Company
Preferred Stock shall no longer be outstanding and shall automatically be cancelled and retired and shall cease to exist, and each
holder thereof shall cease to have any rights with respect thereto, except the right to receive such applicable Preferred Share
Liquidation Preference. If, as of the Effective Time, the Aggregate Purchase Price is insufficient to make payment in full to all
holders of the Non-Converting Company Preferred Stock as required pursuant to this <U>Section 3.02(b)</U>, then such Aggregate
Purchase Price shall be distributed among the holders of shares of Non-Converting Company Preferred Stock at the time outstanding,
ratably in proportion to the full amounts to which they would otherwise be respectively entitled if such amounts had been paid
in full.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Converting Company Preferred Stock</U>. Immediately prior to the Effective Time, pursuant to, and in accordance
with, Section&nbsp;5A of the Charter (in the case of the Series A Preferred Stock) and Section&nbsp;5A of the applicable Certificate
of Designation (in the case of all other series of Company Preferred Stock), all shares of Converting Company Preferred Stock shall
be converted into such number of shares of Company Common Stock as provided in the Charter or Certificate of Designation (as applicable)
and all shares of Converting Company Preferred Stock shall no longer be outstanding and shall automatically be cancelled and retired
and shall cease to exist, and each holder thereof shall cease to have any rights with respect thereto, except the rights afforded
to holders of Company Common Stock.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Treatment of Company Options and Company Warrants</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Company Options</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>As of the Effective Time, each outstanding vested option to purchase shares of Company Common Stock (a &ldquo;<U>Company
Option</U>&rdquo;) under the Stock Plans shall, automatically and without any required action on the part of the holder thereof,
be cancelled and shall only entitle the holder of such Company Option to receive (without interest), subject to <U>Section&nbsp;3.03(a)(iii)</U>,
an amount in cash (the &ldquo;<U>Option Cashout Amount</U>&rdquo;) equal to the applicable Per Option Post-Closing Payments, if
any.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>For the avoidance of doubt, as of the Effective Time, each Company Option that is unvested shall, automatically and
without any required action on the part of the holder thereof, be cancelled for no consideration or payment.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>With respect to each Company Option that is vested as of the Effective Time, upon the payment of any Post-Closing
Payment, the applicable Per Option Post-Closing Payment, if any, will be paid in accordance with the provisions that provide for
the payment of such Post-Closing Payment.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Any portion of the Special Indemnity Holdback that is payable in respect of the Company Options in accordance with
this <U>Article III</U> shall be paid by the Surviving Company through its payroll no later than the first regularly scheduled
payroll that is at least four (4) Business Days after such amounts become payable to the Stockholder Representative pursuant to
this <U>Article III</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Company Warrants</U>. Each of the Company Warrants that is validly exercised in accordance with its terms prior
to the Effective Time will be entitled to receive an aggregate amount equal to the product of (i) the Preferred Share Liquidation
Preference applicable to the Series E Preferred Stock multiplied by (ii) the number of shares of Series E Preferred Stock subject
to such Company Warrant. Each of the Company Warrants that is not so exercised prior to the Effective Time will expire and be deemed
to be extinguished and cancelled immediately prior to the Effective Time in accordance with its terms.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Company Actions</U>. At or prior to the Effective Time, the Company and the Company&rsquo;s board of directors
or compensation committee, as applicable, shall adopt any resolutions and take any actions, including provision of any required
notice, that are necessary to (x) effectuate the treatment of Company Options and Company Warrants pursuant to <U>Section&nbsp;3.03</U>
and (y) cause the Stock Plans to terminate at or prior to the Effective Time. The Company shall take all actions necessary to ensure
that, from and after the Effective Time, neither Parent nor the Surviving Corporation will be required to deliver shares of Company
Common Stock or other capital stock of the Company or any other Person to any Person pursuant to or in settlement of the Company
Options and the Company Warrants.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.04<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Payment Procedures</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>No later than seven (7) Business Days before the Closing Date and no more than ten (10) Business Days prior to the
Closing Date, the Company shall deliver to Parent the Company&rsquo;s good faith calculation of, and reasonable supporting detail
relating to, both the estimated Aggregate Purchase Price (the &ldquo;<U>Estimated Aggregate Purchase Price</U>&rdquo;) and each
component thereof (the &ldquo;<U>Estimated Closing Statement</U>&rdquo;), together with reasonable supporting detail relating to
such component (including bank statements dated as of the date that the Estimated Closing Statement is provided, a reconciliation
between any differences in the Company&rsquo;s cash position and the bank statement, debt payoff letters and invoices). The Estimated
Closing Statement shall be prepared in accordance with the terms (including the definitions) of this Agreement. Parent shall have
the right to object to the amounts contained in the Estimated Closing Statement no later than the third (3<SUP>rd</SUP>) Business
Day immediately prior to the Closing Date. The Company shall in good faith consider the objections, if any, of Parent to the Estimated
Closing Statement and, if Parent has made any objections or if there have been any changes to the Estimated Aggregate Purchase
Price, shall reissue the Estimated Closing Statement containing the Estimated Aggregate Purchase Price and each component thereof
no later than the Business Day immediately prior to the Closing Date with any such revisions that the Company has determined in
good faith are appropriate.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each share of Company Common Stock (including shares of Series B Preferred Stock that are deemed to convert into
the right to receive the Per Common Share Merger Consideration pursuant to <U>Section 3.02(a)</U>) will be allocated an amount
equal to the Per Common Share Closing Payment.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>All Post-Closing Payments will be allocated as follows:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>first, <I>pro rata</I> to each share of Company Common Stock (including shares of Series B Preferred Stock that are
deemed to convert into the right to receive the Per Common Share Merger Consideration pursuant to <U>Section 3.02(a)</U>) until
the aggregate Per Common Share Closing Payments and Per Common Share Post-Closing Payments paid with respect to each share of Company
Common Stock (including shares of Series B Preferred Stock that are deemed to convert into the right to receive the Per Common
Share Merger Consideration) equals [&hellip;];</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>second, <I>pro rata</I> to (A) each share of Company Common Stock (including shares of Series B Preferred Stock that
are deemed to convert into the right to receive the Per Common Share Merger Consideration pursuant to <U>Section 3.02(a)</U>) and
(B) each [&hellip;] Option (with respect to each share of Company Common Stock subject to such [&hellip;] Option immediately prior
to the Effective Time), until the aggregate Per Common Share Closing Payments and Per Common Share Post-Closing Payments paid with
respect to each share of Company Common Stock (including shares of Series B Preferred Stock that are deemed to convert into the
right to receive the Per Common Share Merger Consideration pursuant to <U>Section&nbsp;3.02(a)</U>) equals [&hellip;] and the aggregate
Per Option Post-Closing Payments paid with respect to each [&hellip;] Option (with respect to each share of Company Common Stock
subject to such [&hellip;] Option immediately prior to the Effective Time) equals [&hellip;], respectively; and</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>third, <I>pro rata</I> to (A) each share of Company Common Stock (including shares of Series B Preferred Stock that
are deemed to convert into the right to receive the Per Common Share Merger Consideration pursuant to <U>Section 3.02(a)</U>),
(B) each [&hellip;] Option (with respect to each share of Company Common Stock subject to such [&hellip;] Option immediately prior
to the Effective Time), and (C) each [&hellip;] Option (with respect to each share of Company Common Stock subject to such [&hellip;]
Option immediately prior to the Effective Time).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>On or prior to the Closing Date, Parent, the Stockholder Representative and the Payments Administrator shall enter
into the Payments Administrator Agreement, which agreement shall have customary terms and shall provide that on the Closing Date,
Parent shall deposit with the Payments Administrator, for the benefit of the applicable Equityholders, an amount in cash equal
to the sum of (i) the aggregate Per Common Share Closing Payment and (ii) the Aggregate Preferred Share Payment, by wire transfer
of immediately available funds to an account specified by the Payments Administrator in writing no later than four (4) Business
Days prior to the Closing Date. The Payments Administrator Agreement also shall provide that the amounts paid to the Payments Administrator
pursuant to this <U>Section&nbsp;3.04(d)</U> (the &ldquo;<U>Payments Administrator Fund</U>&rdquo;) shall be held and disbursed
by the Payments Administrator, and Parent shall cause the Payments Administrator to hold and disburse the Payments Administrator
Fund, in accordance with this <U>Section&nbsp;3.04</U>. Any portion of the amount deposited by Parent (or caused to be deposited
by Parent) that remains unclaimed by the applicable Equityholders six (6) months after the Effective Time will, to the extent permitted
by Applicable Law, be returned to Parent upon demand.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>As promptly as practicable on or after the Closing Date (and in any event within 10 days after the Closing Date)
and in accordance with the Payments Administrator Agreement, the Payments Administrator shall provide (i) to each Stockholder,
a letter of transmittal (&ldquo;<U>Letter of Transmittal</U>&rdquo;) (which shall include a waiver and release pursuant to which
each Stockholder executes a full and unconditional release regarding any and all claims as a Stockholder, including the calculation
of the Per Share Merger Consideration, as a condition to receiving the Per Share Merger Consideration, in favor of Parent, Merger
Sub and the Surviving Corporation and its subsidiaries and each of their directors, officers, managers, employees and Affiliates,
and which shall be in such form and have such other provisions as Parent and the Company may reasonably agree), (ii) to each Stockholder,
if required, instructions for use in effecting the surrender of the certificates (if any) representing such Stockholder&rsquo;s
shares of Company Common Stock or Company Preferred Stock (as applicable) (the &ldquo;<U>Certificates</U>&rdquo;) in exchange for
such holder&rsquo;s right to receive the Per Share Merger Consideration for each such share (or in the case of a lost, stolen or
destroyed Certificate, upon delivery of an affidavit, if required, in the manner provided in <U>Section&nbsp;3.09</U>) and (iii)
to each Stockholder that did not execute and deliver to the Company a Written Consent, a notice of the availability of appraisal
rights under Delaware Law. Upon delivery of such Letter of Transmittal to the Payments Administrator together with any such Certificates,
duly executed (or in the case of a lost, stolen or destroyed Certificate, upon delivery of an affidavit, if required, in the manner
provided in <U>Section&nbsp;3.09</U>), the holder shall be entitled to receive, upon the date such holder delivers such documents
to the Payments Administrator (subject to the terms of the Payments Administrator Agreement), in exchange for each of their shares
of Company Common Stock or Series B Preferred Stock an amount of cash equal to the Per Common Share Closing Payment and in exchange
for each of their shares of Non-Converting Company Preferred Stock an amount of cash equal to the applicable Preferred Share Liquidation
Preference, and the shares of Company Common Stock or Company Preferred Stock (as applicable) so surrendered shall forthwith be
cancelled. Until surrendered as contemplated by this <U>Section&nbsp;3.04(e)</U>, each share of Company Common Stock or Company
Preferred Stock (as applicable) shall be deemed at all times after the Effective Time to represent only the right to receive upon
such surrender the Per Share Merger Consideration as contemplated by this <U>Article III,</U> and no cash shall be paid to the
holder of any such share in respect thereof. If any Certificate shall not have been surrendered immediately prior to such time
as such amounts would otherwise escheat to or become property of any Governmental Authority, any amounts remaining unclaimed (whether
held by the Payments Administrator, Parent or otherwise) by holders of the Company&rsquo;s securities immediately prior to such
time shall, to the extent permitted by Law, become the property of the Surviving Corporation free and clear of any claims or interest
of any Person previously entitled thereto. No interest shall be paid or accrue on any cash payable upon surrender of any Company
Common Stock or Company Preferred Stock (as applicable).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The consideration to be paid in accordance with the terms of this <U>Article III</U> upon effectiveness of the Merger
shall constitute satisfaction in full of all rights pertaining to the Company Common Stock, Company Preferred Stock, Company Warrants
and Company Options (other than any Dissenting Shares), and after the Effective Time there shall be no further registration of
transfers on the transfer books of the Surviving Corporation of Company Common Stock or Company Preferred Stock that were outstanding
immediately prior to the Effective Time.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>For the avoidance of doubt, and notwithstanding anything to the contrary herein, in no event shall the aggregate
amount of consideration payable by Parent to any Equityholder or any other holders of any equity or debt securities of the Company
pursuant to this <U>Section&nbsp;3.04</U> exceed the Aggregate Purchase Price.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.05<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Holdback</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>At the Effective Time, Parent shall holdback up to [&hellip;] of the Aggregate Purchase Price, which shall constitute
a holdback used to satisfy any indemnification amounts owed Parent from the Company pursuant to <U>Section 10.02(a)(iv)</U> (the
&ldquo;<U>Special Indemnity Holdback</U>&rdquo;). The amount of the Special Indemnity Holdback set forth in the immediately preceding
sentence will be reduced to the extent that the Company has provided documentation at least five (5) Business Days prior to the
Closing, that, in the reasonable determination of Parent&rsquo;s tax advisors (as stated in writing) [&hellip;] shall be deemed
sufficient for such determination [&hellip;] reduces the amount of the potential Special Indemnity Losses. The Special Indemnity
Holdback shall be disbursed solely for the purposes and in accordance with the terms of this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Following the Closing, to the extent that the Company or the Stockholder Representative provides documentation that,
in the reasonable determination of Parent&rsquo;s tax advisors (as stated in writing) (it being understood that [&hellip;] shall
be deemed sufficient for such determination), the potential Special Indemnity Losses have been reduced, Parent shall release such
amounts from the Special Indemnity Holdback to the Payments Administrator and, with respect to Company Options, to the Company,
promptly following such determination and allocated in accordance with <U>Section 3.04(c)</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The amount remaining in the Special Indemnity Holdback, as of the date that is two (2) years after the Closing Date
(the &ldquo;<U>Special Indemnity Release Date</U>&rdquo;), shall be released to the Payments Administrator and, with respect to
Company Options, to the Company, no later than ten (10) Business Days following the Special Indemnity Release Date and allocated
in accordance with <U>Section 3.04(c)</U>; <U>provided</U> that if there are any claims for Losses under <U>Section 10.02(a)(iv)</U>
that are pending on the Special Indemnity Release Date, the applicable portion (and only the applicable portion) of the Special
Indemnity Holdback that is subject to any such Losses shall not be so released until such applicable Losses are finally resolved
and satisfied. The Payments Administrator shall distribute the portion of the Special Indemnity Holdback that is distributable
to the Equityholders in accordance with Section 3.04(c) and the Payments Administrator Agreement promptly after its release from
the Special Indemnity Holdback, as applicable, and the Surviving Company shall process the portion of the Special Indemnity Holdback
that is payable in respect of Company Options through its payroll. To the extent amounts of the Special Indemnity Holdback are
distributed to the Equityholders, the Stockholder Representative shall be entitled to be reimbursed from such distributed amounts
from the Special Indemnity Holdback for any out-of-pocket costs (including attorney fees) for administering claims relating to
Losses, to the extent there are not adequate funds available in the Expense Fund to cover the reimbursement of such out-of-pocket
costs.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.06<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Aggregate Closing Payment Schedule</U>. <U>Schedule C</U> attached hereto sets forth the Company&rsquo;s preliminary
calculation of the allocation of the Aggregate Closing Amount and the allocation of the Aggregate Cash Amount entitled to be received
in accordance with this Agreement by each Equityholder. No later than five (5) Business Days prior to the Closing Date (but subject
to updates based on revisions, if any, to the Estimated Closing Statement pursuant to <U>Section&nbsp;3.04(a)</U>), the Company
shall deliver to Parent a schedule (the &ldquo;<U>Aggregate Closing Payment Schedule</U>&rdquo;) setting forth (a) the final allocation
of the Aggregate Closing Amount to be paid in accordance with this Agreement to each Equityholder and (b) the final allocation
of the Aggregate Cash Amount to be paid in accordance with this Agreement to each Equityholder. Parent shall be entitled to rely
exclusively upon the Aggregate Closing Payment Schedule in paying the Aggregate Cash Amount pursuant to <U>Section&nbsp;3.04</U>
and shall have no obligation to investigate the entitlements of any Person to any portion of the Aggregate Cash Amount payable
at Closing.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.07<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Post-Closing Determination of the Closing Statement</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Within sixty (60) days after the Closing Date, Parent shall prepare and deliver to the Stockholder Representative
a good faith calculation of the Aggregate Purchase Price and each component thereof (the &ldquo;<U>Closing Statement</U>&rdquo;).
The Parties acknowledge and agree that the Closing Statement, and the component items and calculations therein, shall be prepared
in a manner consistent with the terms (including the definitions) of this Agreement. If Parent fails to deliver the Closing Statement
in accordance with the immediately preceding sentence, then the Estimated Closing Statement delivered by the Company to Parent
pursuant to <U>Section&nbsp;3.04(a)</U> shall be deemed to be the Final Closing Statement. The Closing Statement shall be conclusive,
final and binding on all Parties absent manifest error unless the Stockholder Representative gives Parent written notice (the &ldquo;<U>Dispute
Notice</U>&rdquo;) of any disputes or objections thereto (collectively, the &ldquo;<U>Disputed Items</U>&rdquo;), with its good
faith calculation of, and reasonable supporting detail relating to, such Disputed Items, within thirty (30) days of receipt of
the Closing Statement (such period, the &ldquo;<U>Review Period</U>&rdquo;). In the event the Stockholder Representative fails
to deliver to Parent a Dispute Notice prior to the expiration of the Review Period or otherwise earlier notifies Parent in writing
that the Stockholder Representative has no disputes or objections to the Closing Statement, the amounts set forth in the Closing
Statement shall be conclusive, final and binding on all Parties absent manifest error.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Parent and the Stockholder Representative shall, for a period of ten (10) Business Days (or such longer period as
Parent and the Stockholder Representative may agree in writing) following delivery of a Dispute Notice to Parent (the &ldquo;<U>Resolution
Period</U>&rdquo;), attempt in good faith to resolve their differences, and any such resolution by them as to any Disputed Items
shall be conclusive, final and binding on all Parties absent manifest error. Any Disputed Items agreed to by Parent and the Stockholder
Representative in writing, together with any items or calculations set forth in the Closing Statement not disputed or objected
to by the Stockholder Representative in the Dispute Notice, are collectively referred to herein as the &ldquo;<U>Resolved Matters</U>&rdquo;.
Any Resolved Matters shall be conclusive, final and binding on all Parties absent manifest error, except to the extent such component
could be affected by other components of the calculations set forth in the Closing Statement that are the subject of a Dispute
Notice.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>If at the end of the Resolution Period, Parent and the Stockholder Representative have been unable to resolve any
differences that they may have with respect to the matters specified in the Dispute Notice, either of Parent or the Stockholder
Representative may, upon written notice to the other, refer all matters that remain in dispute with respect to the Dispute Notice
(the &ldquo;<U>Unresolved Matters</U>&rdquo;) for resolution to the Independent Accountant who shall, acting as an expert in accounting
and not arbitrator, render its decision on the Unresolved Matters (and not on any other matter or calculation set forth in the
Closing Statement) in a manner consistent with the terms (including the definitions) of this Agreement. In resolving any Unresolved
Matter, the Independent Accountant may not assign a value to any Unresolved Matter greater than the maximum value for such matter
claimed by either party or less than the minimum value for such matter claimed by either party. The Independent Accountant&rsquo;s
determination as to each Unresolved Matter shall be set forth in a written statement delivered to each of Parent and the Stockholder
Representative within ten (10) Business Days after such items are submitted for determination, with such written statement including
(i) the Independent Accountant&rsquo;s determination as to the calculation of each of the Unresolved Matters and (ii) the corresponding
corrective calculations set forth in the Closing Statement that are derived from its determination as to the calculations of the
Unresolved Matters, all of which shall be conclusive, final and binding on all Parties absent manifest error. Parent and the Stockholder
Representative shall each pay the fees and expenses of the Independent Accountant based on the inverse of the percentage of the
amounts that the Independent Accountant determines in such party&rsquo;s favor bears to the aggregate amount of the total Unresolved
Matters as originally submitted to the Independent Accountant. By way of example only, should the aggregate Unresolved Matters
sum to $1,000, and the Independent Accountant awards $600 in favor of the Stockholder Representative&rsquo;s position, sixty percent
(60%) of the Independent Accountant&rsquo;s fees and expenses would be borne by Parent and forty percent (40%) would be borne by
the Stockholder Representative. The Independent Accountant&rsquo;s fees and expenses payable by Parent (if any) shall be paid to
the Independent Accountant directly by Parent, and the Independent Accountant&rsquo;s fees and expenses payable by the Stockholder
Representative (if any, solely on behalf of the Equityholders) shall be paid from the Expense Fund. To the extent the Expense Fund
is insufficient or unavailable to cover all of the Independent Accountant&rsquo;s fees and expenses payable by the Stockholder
Representative, Parent shall pay any such remaining fees and expenses and Parent shall be entitled to deduct such amounts from
any amounts payable to the applicable Equityholders (or to the Payments Administrator on their behalf) pursuant to this <U>Section
3.07</U> or <U>Section 3.08</U> of this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>For purposes of this Agreement, the &ldquo;<U>Final Closing Statement</U>&rdquo; shall be (i)&nbsp;in the event that
no Closing Statement is delivered by Parent to the Stockholder Representative within sixty (60) days after the Closing Date, the
Estimated Closing Statement, (ii) in the event that no Dispute Notice is delivered by the Stockholder Representative to Parent
prior to the expiration of the Review Period, the Closing Statement delivered by Parent to the Stockholder Representative pursuant
to <U>Section&nbsp;3.07(a)</U>, (iii) in the event that a Dispute Notice is delivered by the Stockholder Representative to Parent
prior to the expiration of the Review Period, the Closing Statement delivered by Parent to the Stockholder Representative pursuant
to <U>Section&nbsp;3.07(a)</U>, as adjusted pursuant to the agreement of Parent and the Stockholder Representative in writing,
or (iv) in the event that a Dispute Notice is delivered by the Stockholder Representative to Parent prior to the expiration of
the Review Period and Parent and the Stockholder Representative are unable to agree on all matters set forth in such Dispute Notice,
the Closing Statement delivered by Parent to the Stockholder Representative pursuant to <U>Section&nbsp;3.07(a)</U>, as adjusted
by the Independent Accountant to be consistent with (A) the Resolved Matters and (B) the Independent Accountant&rsquo;s determination
as to the calculation of the Unresolved Matters in accordance with <U>Section&nbsp;3.07(a)</U> and <U>Section&nbsp;3.07(c)</U>.
The &ldquo;<U>Final Aggregate Purchase Price</U>&rdquo; shall mean the Aggregate Purchase Price as derived from the Final Closing
Statement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>From and after the delivery of the Closing Statement by Parent until the determination of the Final Closing Statement
pursuant to this <U>Section&nbsp;3.07</U>, Parent and the Surviving Corporation shall, and shall cause their respective subsidiaries
to, permit the Stockholder Representative and its Representatives reasonable access to the personnel, accountants and properties
of the Surviving Corporation and its subsidiaries, and provide reasonable access (with the right to make copies), during business
hours upon reasonable advance notice, to all of the books, records, contracts and other documents (including auditor&rsquo;s work
papers) of the Surviving Corporation or its subsidiaries only to the extent necessary to evaluate the calculations set forth in
the Closing Statement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Payment in Respect of Final Aggregate Purchase Price</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>If the Final Aggregate Purchase Price exceeds or is equal to the Estimated Aggregate Purchase Price, then within
five (5) Business Days after the final determination of the Final Closing Statement, Parent or the Surviving Corporation shall
deposit, or cause to be deposited, in immediately available funds, with the Payments Administrator an amount in cash equal to the
full amount, if any, by which the Final Aggregate Purchase Price exceeds the Estimated Aggregate Purchase Price and, immediately
thereafter, Parent and the Stockholder Representative shall provide a joint written instruction to the Payments Administrator to
deliver the applicable portions of such amount to the applicable Equityholders (except that any amounts due to holders of Company
Options shall be remitted to Parent and paid to such holders through payroll less any applicable required Tax withholding).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>If the Estimated Aggregate Purchase Price exceeds the Final Aggregate Purchase Price (such excess, the &ldquo;<U>Overstatement</U>&rdquo;),
Parent shall be entitled to deduct the Overstatement from any amounts payable to the applicable Equityholders (or to the Payments
Administrator on their behalf) pursuant to <U>Section 3.08</U> of this Agreement and the Equityholders shall have no further liability
or obligations with respect to the Overstatement. Parent&rsquo;s right to deduct the Overstatement pursuant to this <U>Section
3.07(f)(ii)</U> shall be the sole and exclusive remedy available to Parent against the Equityholders, or otherwise, with respect
to any adjustment pursuant to this <U>Section 3.07</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>All payments pursuant to this <U>Section&nbsp;3.07</U> shall be treated as an adjustment to the Estimated Aggregate
Purchase Price for all foreign, federal, state and local income Tax purposes unless otherwise required by Law.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.08<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Earn-Out Consideration</U>. As additional consideration for the Merger, upon the achievement of certain milestones
as further described below, Parent shall, subject to the terms of this <U>Section&nbsp;3.08</U>, pay the Earn-Out Consideration
to the applicable Equityholders as set forth on <U>Schedule C</U> under the heading &ldquo;Earn-Out Consideration&rdquo;; <U>provided</U>,
<U>however</U>, that any amounts payable by Parent pursuant to this <U>Section 3.08</U> shall be offset and reduced by any amounts
deductible from payments to Equityholders (or to the Payments Administrator on their behalf) pursuant to this Agreement (including
pursuant to <U>Article X,</U> the Post-Closing Option Payroll Taxes Offset and the Post-Closing Payments Administrator Fees).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Within five (5) Business Days of receipt of a Regulatory Earn-Out Approval, Parent or the Surviving Corporation shall
deposit, or cause to be deposited, in immediately available funds, with the Payments Administrator the applicable Regulatory Earn-Out
Consideration and, immediately thereafter, Parent and the Stockholder Representative shall provide a joint written instruction
to the Payments Administrator to deliver such amounts promptly to the applicable Equityholders as a Post-Closing Payment in accordance
with this Agreement (except that any amounts due to holders of Company Options shall be remitted to Parent and paid to such holders
through payroll less any applicable required Tax withholding); <U>provided</U> that the applicable Regulatory Earn-Out Approval
has been duly obtained on or before the applicable Regulatory Approval Deadline. If a Regulatory Earn-Out Approval is not obtained
on or before the applicable Regulatory Approval Deadline, no amount will be payable in respect of such Regulatory Earn-Out Approval.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Within five (5) Business Days of the amount of Net Sales for each of the years ending December 31, 2020 and December
31, 2021 becoming conclusive, final and binding on all Parties, in accordance with this <U>Section 3.07</U>, Parent or the Surviving
Corporation shall deposit, or cause to be deposited, in immediately available funds, with the Payments Administrator the applicable
amount of the Net Sales Earn-Out Consideration, if any, and, immediately thereafter, Parent and the Stockholder Representative
shall provide a joint written instruction to the Payments Administrator to deliver such amount promptly to the applicable Equityholders
as a Post-Closing Payment in accordance with this Agreement (except that any amounts due to holders of Company Options shall be
remitted to Parent and paid to such holders through payroll less any applicable required Tax withholding).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Subject to the Stockholder Representative&rsquo;s ongoing compliance with the Stockholder Representative NDA attached
hereto as Annex G, until April 30, 2022, Parent shall, within thirty (30) days following the filing of its Form 10-Q or Form 10-K
with the Securities and Exchange Commission (the &ldquo;<U>SEC</U>&rdquo;) (as applicable), prepare and deliver to the Stockholder
Representative a good faith calculation of the total Net Sales of each class of Company Products in the applicable calendar quarter
in the form set forth on <U>Schedule&nbsp;H</U> (a &ldquo;<U>Parent Earn-Out Statement</U>&rdquo;), together with, for the Parent
Earn-Out Statements delivered immediately following the filing of its Form 10-K for fiscal years 2020 and 2021 only, a statement
as to whether any Net Sales Earn-Out Consideration is payable in connection therewith and if so, the amount thereof; provided that
the reports, schedules, forms, statements and other documents filed or furnished by Parent with or to the SEC shall be deemed to
satisfy this reporting obligation if such information is disclosed therein. The Parties acknowledge and agree that the Parent Earn-Out
Statement, and the component items and calculations therein, shall be prepared in a manner consistent with the terms (including
the definitions) of this Agreement. Following the filing of its Form 10-K in respect of both calendar year 2020 and 2021, if requested
by the Stockholder Representative, Parent agrees that at least one of the Parent Executives will meet with the Stockholder Representative
to discuss the Parent Earn-Out Statement and provide additional information that Parent, in its sole discretion, deems appropriate.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>If the Stockholder Representative disputes the calculation of Net Sales set forth in the Parent Earn-Out Statement,
then the Stockholder Representative shall deliver to Parent a written notice (an &ldquo;<U>Earn-Out Dispute Notice</U>&rdquo;)
of any disputes or objections thereto (collectively, the &ldquo;<U>Earn-Out Disputed Items</U>&rdquo;) with reasonable supporting
detail as to such Earn-Out Disputed Items within twenty (20) Business Days of receipt of the Parent Earn-Out Statement (such period,
the &ldquo;<U>Earn-Out Review Period</U>&rdquo;).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>If the Stockholder Representative fails to deliver to Parent an Earn-Out Dispute Notice prior to the expiration of
the Earn-Out Review Period or otherwise earlier notifies Parent in writing that the Stockholder Representative has no disputes
or objections to the Parent Earn-Out Statement, the amount of Net Sales set forth in the Parent Earn-Out Statement shall be conclusive,
final and binding on all Parties absent manifest error.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Parent and the Stockholder Representative shall, for a period of ten (10) Business Days (or such longer period as
Parent and the Stockholder Representative may agree in writing) following delivery of an Earn-Out Dispute Notice to Parent (the
&ldquo;<U>Earn-Out Resolution Period</U>&rdquo;), attempt in good faith to resolve their differences, and any such resolution by
them as to any Earn-Out Disputed Items shall be conclusive, final and binding on all Parties absent manifest error. Any Earn-Out
Disputed Items agreed to by Parent and the Stockholder Representative in writing, together with any items or calculations set forth
in the Parent Earn-Out Statement not disputed or objected to by the Stockholder Representative in the Earn-Out Dispute Notice,
are collectively referred to herein as the &ldquo;<U>Earn-Out Resolved Matters</U>&rdquo;. Any Earn-Out Resolved Matters shall
be conclusive, final and binding on all Parties absent manifest error, except to the extent such component could be affected by
other components of the calculations set forth in the Parent Earn-Out Statement that are the subject of an Earn-Out Dispute Notice.
If at the end of the Earn-Out Resolution Period, Parent and the Stockholder Representative have been unable to resolve any differences
that they may have with respect to the matters specified in the Earn-Out Dispute Notice, either of Parent or the Stockholder Representative
may, upon written notice to the other, refer all matters that remain in dispute with respect to the Dispute Notice to be exclusively
and definitively resolved, without any recourse to appeal, by final and binding arbitration pursuant to <U>Section 3.08(g)</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Any Earn-Out Arbitration shall be instituted and conducted in, and its seat shall be, the city of New York, New York,
where the arbitration award shall be rendered. The arbitration shall be administered by the International Court of Arbitration
of the International Chamber of Commerce (&ldquo;<U>ICC</U>&rdquo;) in accordance with the Rules of Arbitration of the ICC (&ldquo;<U>Arbitration
Rules</U>&rdquo;), as in effect as of the date of commencement of the arbitration, as modified by this Agreement or mutual agreement
of the Parties. The arbitration shall be conducted in the English language, though documents or testimony may be submitted in other
languages if a translation is provided. The arbitration panel shall be composed of three (3) arbitrators. The first (1st) arbitrator
shall be nominated by the claimant and the second (2nd) arbitrator shall be nominated by the respondent, each in accordance with
Article 12(4) of the Arbitration Rules. The third (3rd) arbitrator (who shall act as chairman) shall be appointed by the two (2)
party-appointed arbitrators, within fifteen (15) calendar days from the date of confirmation of the second (2nd) party-appointed
arbitrator. If any party fails to appoint an arbitrator within the required period, or if the two (2) arbitrators cannot reach
an agreement with respect to the third (3rd) arbitrator within the applicable period, the appointment shall be made by the ICC
International Court of Arbitration pursuant to the Arbitration Rules. To the extent that an Earn-Out Arbitration involves more
than one (1) party as claimant, such claimants shall jointly appoint the first (1st) arbitrator. To the extent that an Earn-Out
Arbitration involves more than one (1) respondent, such respondents shall jointly appoint the second (2nd) arbitrator. The Parties
consent to the consolidation of arbitrations commenced hereunder pursuant to the Arbitration Rules. Any award of the arbitration
panel must be in writing and state the grounds upon which it is based (in each case, a &ldquo;<U>Final Award</U>&rdquo;). The Final
Award shall be conclusive, final and binding on the Parties and their successors, and a judgment upon the Final Award may be recognized
and enforced in any court of competent jurisdiction. The fees and expenses of the arbitration and other reasonable and documented
costs of the party which has prevailed in such arbitration (the &ldquo;<U>Arbitration Fees</U>&rdquo;), including reasonable attorney&rsquo;s
fees, shall be borne as established by the arbitration panel. The Arbitration Fees payable by Parent (if any) shall be paid directly
by Parent, and the Arbitration Fees payable by the Stockholder Representative (if any, solely on behalf of the Equityholders) shall
be paid from the Expense Fund. To the extent the Expense Fund is insufficient or unavailable to cover all of the Arbitration Fees
payable by the Stockholder Representative, Parent shall pay any such remaining Arbitration Fees and Parent shall be entitled to
deduct such amounts from any amounts payable to the applicable Equityholders (or to the Payments Administrator on their behalf)
pursuant to <U>Section 3.07</U> or this <U>Section 3.08</U> of this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(h)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Parent Actions</U>. Until December 31, 2021, subject to Applicable Law, Parent shall, and shall cause the Surviving
Corporation to, use commercially reasonable efforts to obtain all Regulatory Earn-Out Approvals and not take any action that was
specifically intended by any Parent Executive to avoid the payment of any Net Sales Earn-Out Consideration or any Regulatory Earn-Out
Consideration; <U>provided</U>, <U>however</U>, that the foregoing is not intended to, and shall not, restrict in any manner Parent&rsquo;s
ability to, in its sole discretion, make decisions in the ordinary course with respect to the operation of the Company, including:
(i) decisions to hire, fire, replace, substitute or change the role of any employees, suppliers or distributors; combine office
locations and back office support functions; and comply with Parent&rsquo;s global compliance and human resource policies; (ii)
to comply with Applicable Law and (iii) to comply with any express requirements of this Agreement. Any dispute arising out of,
resulting from or in connection with this <U>Section&nbsp;3.08(h)</U> shall be exclusively and definitively resolved, without any
recourse to appeal, by final and binding arbitration pursuant to <U>Section&nbsp;3.08(g)</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Enforcement of Earn-Out Covenant</U>. The right and power to enforce this <U>Section&nbsp;3.08</U> against Parent
shall reside entirely with the Stockholder Representative (on behalf of the Equityholders), and none of the Equityholders shall
be entitled to bring, commence, continue or prosecute any claim, legal action or proceeding under, in relation to, arising out
of or in connection with a breach of this <U>Section&nbsp;3.08</U> or otherwise claiming that after the Effective Time Parent has
not complied with this <U>Section&nbsp;3.08</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(j)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>No Equityholder shall assign its interest in the Earn-Out Consideration to any Person without first notifying Parent
and the Stockholder Representative of such transfer and the Aggregate Closing Payment Schedule shall be revised to reflect such
permitted transfer and shall record the name of the transferee.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.09<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Lost, Stolen or Destroyed Certificates</U>. In the event any Certificates shall have been lost, stolen or destroyed,
the Payments Administrator shall transfer in exchange for such lost, stolen or destroyed Certificates, upon the making of an affidavit
of that fact by the holder thereof, such amount of cash constituting the portion of the Per Share Merger Consideration payable
to such holder with respect to such lost, stolen or destroyed Certificates, as provided for in the Payments Administrator Agreement;
<U>provided</U>, <U>however</U>, that the Payments Administrator may, in its discretion and as a condition precedent to the issuance
thereof, require the Person who is the owner of such lost, stolen or destroyed Certificates to provide an indemnification agreement
in a form and substance reasonably acceptable to the Payments Administrator against Parent or the Payments Administrator with respect
to the Certificates alleged to have been lost, stolen or destroyed and, if required by the Payments Administrator in its sole discretion,
the posting of a bond in customary amount and terms (including with respect to the surety for such bond).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.10<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>No Interest</U>. Notwithstanding anything to the contrary contained herein, no interest shall accumulate on any
Per Share Merger Consideration.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.11<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Withholding Rights</U>. Parent shall be entitled to deduct and withhold from any amounts payable to any Equityholder
under this Agreement such amounts as Parent is required to deduct and withhold with respect to the making of such payment under
the Code or any provision of applicable Tax Law. Other than with respect to any withholding requirement arising out of a change
in Law or facts occurring after the date that is five (5) Business Days prior to the Closing Date, Parent shall provide written
notice of intent to withhold to such Equityholder at least five (5) Business Days prior to such withholding and afford such Equityholder
the opportunity to reduce or eliminate such deduction or withholding. The Parties shall cooperate in good faith to reduce or eliminate
any such deduction or withholding. To the extent that such amounts are so withheld and timely paid over to or deposited with the
relevant Tax Authority by Parent in accordance with the foregoing, such withheld amounts shall be treated for all purposes of this
Agreement as having been paid to the applicable Equityholder in respect to which such deduction and withholding was made.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0"><FONT STYLE="color: #010000">Article
IV</FONT><BR>
REPRESENTATIONS AND WARRANTIES REGARDING THE COMPANY</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The Company hereby represents and warrants to
Parent and Merger Sub as of the date hereof (except for any representation or warranty that is expressly made as of a specified
date, in which case the Company hereby represents and warrants to Parent and Merger Sub as of such specified date), except as disclosed
in the corresponding sections or subsections of the Company Disclosure Schedule, as follows:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Organization; Qualification</U>. The Company (a) is a corporation, duly incorporated, validly existing and in
good standing under the Applicable Laws of the State of Delaware and (b) has all requisite corporate power and authority to conduct
its business as now being conducted and to own, lease and operate its Properties. The Company is duly qualified or licensed to
do business in each jurisdiction listed in <U>Section&nbsp;4.01</U> of the Company Disclosure Schedule, which constitute all jurisdictions
in which the ownership or operation of its Properties make such qualification or licensing necessary, except where the failure
to be so qualified or licensed, individually or in the aggregate, has not had, and would not be reasonably likely to have, a Material
Adverse Effect. The Company has Made Available to Parent true and complete copies of the Organizational Documents of the Company,
each of which are in full force and effect.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Capitalization</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>As of January 3, 2020, the authorized stock of the Company consists solely of (i) 22,000,000 shares of Company Common
Stock, of which 6,570,944 such shares are issued and outstanding; and (ii) 15,311,557 shares of Company Preferred Stock, of which
12,813,501 such shares are issued and outstanding, consisting of (i) 3,311,557 shares of Series A Preferred Stock, (ii) 2,000,000
shares of Series B Preferred Stock, (iii) 2,448,500 shares of Series C Preferred Stock, (iv) 3,057,724 shares of Series D Preferred
Stock, (v) 1,111,112 shares of Series E Preferred Stock and (vi) 884,608 shares of Series F Preferred Stock. All of the issued
and outstanding shares of Company Common Stock and Company Preferred Stock are duly authorized, validly issued, fully paid and
non-assessable and are not subject to preemptive or similar rights of any kind. As of January 3, 2020, other than 415,435 shares
of Company Common Stock reserved for issuance under the Stock Plans, with respect to which 280,295 shares of Company Common Stock
are issuable upon the exercise of outstanding Company Options, the Company has no shares of Company Common Stock reserved for issuance.
As of the date of this Agreement, the Company Common Stock and the Company Preferred Stock are held by the Persons with the addresses
and in the amounts set forth in <U>Section&nbsp;4.02(a)(i)</U> of the Company Disclosure Schedule. Except as permitted by <U>Section&nbsp;6.02</U>
or as provided in the Company&rsquo;s Organizational Documents, no Person has as of the date of this Agreement or will have as
of or following the Effective Time any right to acquire from the Company any shares of Company Common Stock, Company Preferred
Stock, Company Options, or other Equity Interests of the Company. The Aggregate Closing Payment Schedule, when delivered in accordance
with <U>Section&nbsp;3.06</U>, will contain a true and correct calculation of the respective amounts of the Aggregate Closing Amount
to be paid in accordance with this Agreement to each holder of shares of the Company&rsquo;s outstanding Company Common Stock,
Company Preferred Stock, Company Options, Company Warrants and any other equity securities of the Company and will set forth the
amounts required to be paid to each such holder in accordance with the Company&rsquo;s Organizational Documents (as applicable)
and the Stock Plans. Except as set forth in the Aggregate Closing Payment Schedule, no Person is entitled to receive any portion
of the Aggregate Closing Amount.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Except as described in <U>Section 4.02(a)</U>, as of the date of this Agreement, there are no other issued and outstanding
shares of Company Capital Stock and no outstanding subscriptions, options, warrants, calls, rights, convertible securities, proxy
or stockholder agreements or other Contracts or other understandings of any character obligating the Company to issue, transfer,
sell, repurchase or redeem any shares of Company Capital Stock other than pursuant to the exercise of Company Options under the
Stock Plans or pursuant to the Company Warrants. The Company has no treasury shares. All of the shares of Company Capital Stock
were offered and sold in compliance with Applicable Laws and the Organizational Documents of the Company, including agreements
in respect of the Company Warrants. The Company has no outstanding bonds, debentures, notes or other obligations the holders of
which have the right to vote (or which are convertible into or exercisable for securities having the right to vote) with the Stockholders
on any matter submitted to the Stockholders or as a separate class of holders of capital stock. There are no declared but unpaid
dividends in respect of the Company Capital Stock.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Section&nbsp;4.02(c)</U> of the Company Disclosure Schedule sets forth a correct and complete listing of all outstanding
Company Options and Company Warrants as of the date of this Agreement, setting forth the number of shares of Company Common Stock
subject to each Company Option and the holder, grant date, vesting schedule (including whether the vesting will be accelerated
by (i) the execution of this Agreement or consummation of the transactions contemplated by this Agreement or (ii)&nbsp;the termination
of employment following the Effective Time, or both (i) and (ii) together) with respect to each Company Option and Company Warrant
and the exercise price with respect to each Company Option, as applicable.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each Company Option (1) was granted in compliance in all material respects with all Applicable Laws and all of the
terms and conditions of the Stock Plans, (2) has an exercise price per share of Company Common Stock equal to or greater than the
fair market value of a share of Company Common Stock on the date of such grant, (3) has a grant date on or following the date on
which the Company&rsquo;s board of directors or compensation committee actually awarded such Company Option, (4) qualifies for
the Tax and accounting treatment afforded to such Company Option in the Company&rsquo;s Tax Returns and the Company&rsquo;s financial
reports, respectively and (5) does not trigger any liability for the holder thereof under Section&nbsp;409A of the Code.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company is not a party or subject to any agreement or understanding which affects or relates to the ownership,
voting, dividend rights or giving of support agreements with respect to any Equity Interest in the Company or by a director of
the Company.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each share of Company Preferred Stock is convertible into one share of Company Common Stock.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Stockholder Representative is wholly owned by, and the sole director and officer thereof is, Martin J. Hernon.
The Stockholder Representative does not have any employees.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Authority; Enforceability</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has all requisite corporate power and authority to execute and deliver this Agreement and the other Transaction
Documents to which the Company is a party, to perform its obligations hereunder and thereunder and to consummate the transactions
contemplated hereby and thereby. The execution and delivery by the Company of this Agreement and the other Transaction Documents
to which the Company is a party, and the performance by the Company of its obligations hereunder and thereunder, have been duly
and validly authorized by all necessary corporate action, subject only to obtaining the affirmative vote of (i) a majority&nbsp;of
the outstanding shares of Company Capital Stock, voting together as a single class, and (ii) a majority in interest of the outstanding
shares of the Series B Preferred Stock, voting separately as a single class, in each case, to adopt this Agreement (the &ldquo;<U>Required
Stockholder Approval</U>&rdquo;). This Agreement has been (and each other Transaction Document to be executed by the Company at
or prior to Closing will be) duly and validly executed and delivered by the Company and, assuming the Required Stockholder Approval
is obtained, constitutes (and each other Transaction Document to be executed by the Company at or prior to Closing will constitute)
the legal, valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except as
the same may be limited by bankruptcy, insolvency, reorganization, arrangement, moratorium or other similar Applicable Laws relating
to or affecting the rights of creditors generally, or by general equitable principles (the &ldquo;<U>Enforceability Exceptions</U>&rdquo;).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Required Stockholder Approval is the only approval of the holders of Company Capital Stock required to approve
this Agreement and the Merger under the Company&rsquo;s Organizational Documents and Applicable Laws, and no other corporate proceedings
by the Company are necessary to authorize this Agreement or the transactions contemplated hereby, other than the filing of the
Certificate of Merger. No &ldquo;fair price,&rdquo; &ldquo;moratorium,&rdquo; &ldquo;control share acquisition&rdquo; or other
anti-takeover statute or regulation or any provision in the Company&rsquo;s Organizational Documents is, or at the Effective Time
will be, applicable to the Company, the Merger or the other transactions contemplated by this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company&rsquo;s board of directors has (i) determined that the Merger, upon the terms and subject to the conditions
set forth herein, is in the best interests of the holders of the Company Capital Stock, (ii) approved this Agreement and the transactions
contemplated hereby, and declared their advisability and (iii) recommended the adoption of this Agreement to the Stockholders entitled
to vote thereon (the &ldquo;<U>Board Recommendation</U>&rdquo;) in accordance in all respects with the Company&rsquo;s Organizational
Documents, Applicable Law and its fiduciary duties.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.04<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>No Conflicts; Consents and Approvals</U>. The execution and delivery by the Company of this Agreement and the
other Transaction Documents to which the Company is a party do not, and the performance by the Company of its obligations under
this Agreement and the other Transaction Documents to which the Company is a party will not:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>conflict with or result in a violation or breach of any of the terms, conditions or provisions of the Organizational
Documents of the Company;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>require the consent, notice or other action by any Person under, or result in a violation of or result in a breach
of or default (or give rise to any right of termination, cancellation or acceleration) under (with or without the giving of notice,
the lapse of time or both) any Contract or other understandings to which the Company is a party, except for (i) any such violations
or defaults (or rights of termination, cancellation or acceleration) which would not reasonably be expected to be material to the
Company, individually or taken as a whole and (ii) approvals required as a result of the business activities of Parent and its
Affiliates;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>(i) conflict with, violate or breach any term or provision of any Applicable Laws applicable to the Company, except
as would not reasonably be expected to be material to the Company, taken as a whole, or (ii) require any consent or approval of
any Governmental Authority, or notice to, or declaration, filing or registration with, any Governmental Authority, under any Applicable
Laws, the Required Stockholder Approval and the filing of the Certificate of Merger; or</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>result in the creation or imposition of any material Lien other than Permitted Liens on any asset of the Company.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.05<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>No Subsidiaries; No Repurchase Obligations</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company does not have any Subsidiaries and does not, directly or indirectly, own any interest in any other Person.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Except as provided herein, there are no (i) outstanding obligations of the Company to repurchase, redeem or otherwise
acquire any securities of the Company or (ii) outstanding obligations of the Company to provide funds to or make any investment
(in the form of a loan, capital contribution or otherwise) in the Company or any other Person.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.06<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Financial Statements</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Set forth in <U>Section&nbsp;4.06(a)(i)</U> of the Company Disclosure Schedule are true and complete copies of the
following financial statements: balance sheets and statements of operations and cash flows of the Company as at September 30, 2019
on an unaudited basis (the &ldquo;<U>YTD Financial Statements</U>&rdquo;), and for each of the three years in the period ended
December 31, 2018 on an audited basis (the &ldquo;<U>Audited Financial Statements</U>&rdquo; and, together with the YTD Financial
Statements, the &ldquo;<U>Financial Statements</U>&rdquo;). Except as described in <U>Section&nbsp;4.06(a)</U> of the Company Disclosure
Schedule, the Financial Statements are correct and complete in all material respects, were prepared in accordance with GAAP and
fairly present in all material respects the financial condition, results of operations and cash flows of the Company as at the
respective dates thereof and for the respective periods covered thereby, except that the YTD Financial Statements may be subject
to normal year-end adjustments (the effect of which will not be material, whether individually or in the aggregate) and may not
contain the footnotes required by GAAP (which if presented would not differ materially from those presented in the Audited Financial
Statements of the year ended December 31, 2018).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>All accounts, books, ledgers and records of the Company are complete and correct in all material respects, have been
maintained in a consistent manner and have recorded therein the results of operations and the assets and liabilities of the Company
in all material respects. The Company maintains a system of accounting and internal controls that provides reasonable assurance
that financial transactions are executed in accordance with the authorization of management. There are no significant deficiencies
or material weaknesses in the design or operation of the internal controls over financial reporting of the Company that would reasonably
be expected to affect their ability to record, process, summarize and report financial information in all material respects, and
there has been no written, or, to the Knowledge of the Company, other complaint, allegation or claim with respect to the accounting
or auditing practices, procedures, methodologies or methods of internal controls over financial reporting of the Company.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Section&nbsp;4.06(c)</U> of the Company Disclosure Schedule sets forth a list of the Indebtedness of the Company
as of the date hereof, including, for each item of Indebtedness, the agreement governing the Indebtedness and the interest rate,
maturity date, any assets securing such Indebtedness and any prepayment or other penalties payable in connection with the repayment
of such Indebtedness at the Closing.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.07<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Liabilities</U>. Except for (a) liabilities specifically reflected and adequately reserved against in the YTD
Financial Statements, (b) liabilities incurred since the date of the YTD Financial Statements in the Ordinary Course of Business
(none of which is a liability resulting from breach of contract, breach of warranty, tort, infringement or misappropriation), (c)
Transaction Expenses or (d) liabilities reflected in the calculation of the Indebtedness or Working Capital Difference, there are
no liabilities or obligations of the Company of the type that would be required to be disclosed or reserved against in a balance
sheet prepared in accordance with GAAP.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.08<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Absence of Certain Changes</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Since December 31, 2018, there has not been:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any resignation or termination of any officer of the Company, and to the Company&rsquo;s Knowledge there are no impending
resignations or terminations of employment of any officer or Key Employee;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any labor organization activity related to the Company;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any sale, assignment, transfer, exclusive license or other exclusive grant of any Intellectual Property Rights or
other intangible assets;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any non-exclusive license or other non-exclusive grant of any Intellectual Property Rights or other intangible assets,
other than in the Ordinary Course of Business;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(v)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any modification to any Material Contract outside of the Ordinary Course of Business;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(vi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any material change, except in the Ordinary Course of Business or otherwise not reflected in the YTD Financial Statements,
in the contingent obligations of the Company by way of guaranty, endorsement, indemnity or warranty;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(vii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any waiver by the Company of a right or of a debt owed to it;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(viii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any change in any compensation arrangement or agreement with any employee, officer or director, other than in connection
with the Company&rsquo;s annual reviews in the Ordinary Course of Business;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ix)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any incurrence of any material indebtedness for borrowed money by the Company and the Company has not guaranteed
such indebtedness of another Person or issued or sold any debt securities or warrants or other rights to acquire any debt security
of the Company;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(x)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any material change in any method of accounting or accounting practices by the Company, except in so far as was required
by a change in GAAP;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any making, changing or rescinding of any material election in respect of Taxes by the Company or changing of any
method of Tax accounting by the Company; or</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any arrangement or commitment by the Company regarding any of the matters described in subsections (i) through (xi)
above that is not disclosed in response to subsections (i) through (xi).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Since December 31, 2018, there has not been any state of facts, changes, development, event, effect, condition or
occurrence that, individually or in the aggregate with all other facts, changes, developments, events, effects, conditions and
occurrences, has resulted in or would reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.09<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Legal Proceedings</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>As of the date hereof, (i) (A) there is no Action or Order and (B) the Company has not received in writing notice
of any investigation that is pending or threatened, in each case, against the Company that would affect or bind the Company or
any of its assets or Properties, and (ii) to the Company&rsquo;s Knowledge, there is no Action, Order, investigation or review
pending or threatened by a Governmental Authority with respect to the Company.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>To the Company&rsquo;s Knowledge, there is no material Action or investigation of any nature pending or threatened
in writing against any current or former director of the Company (in their capacities as such or relating to their employment,
services or relationship with the Company).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.10<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Compliance with Applicable Laws</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company is, and the business of the Company is being conducted, and during the past three (3) years has been
and, to the Company&rsquo;s Knowledge, during the three (3) year period preceding the date three (3) years prior to the date of
this Agreement, has been, in compliance in all material respects with all Applicable Laws. The Company holds all material Governmental
Approvals necessary for the Company to own, lease and operate its Properties and to carry on its business as currently conducted
in each of the jurisdictions where such business is conducted, and all such Governmental Approvals are in full force and effect.
During the past three (3) years there has not, and, to the Company&rsquo;s Knowledge, during the three (3) year period preceding
the date three (3) years prior to the date of this Agreement, there has not occurred any material breach of or material default
under (with or without notice, lapse of time or both) any such material Governmental Approval, and the Company has not received
any written notice (including through any Action or investigation) of any such breach or default.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has not, and no director, officer, employee or, to the Knowledge of the Company, agent or other Person
acting for or on behalf of the Company has,: (i) used any funds for unlawful contributions, gifts, entertainment or other unlawful
expenses relating to political activity, (ii)&nbsp;made any unlawful payment to foreign or domestic government officials or employees
or to foreign or domestic political parties or campaigns, or violated any provision of applicable Anti-Corruption Laws or (iii)
taken any action that would constitute a violation of applicable Anti-Corruption Laws. No director, officer, employee, agent or
other Person acting for or on behalf of the Company, to the Knowledge of the Company, has established or maintained any fund or
asset that has not been recorded in the books and records of the Company.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company does not maintain or conduct, and has not maintained or conducted, any business, investment, operation
or other activity in or with: (i)&nbsp;any country or person targeted by any of the economic sanctions of the United States of
America administered by the United States Treasury Department&rsquo;s Office of Foreign Assets Control; (ii)&nbsp;any person appearing
on the list of Specially Designated Nationals and Blocked Persons issued by United States Treasury Department&rsquo;s Office of
Foreign Assets Control; or (iii)&nbsp;any country or person designated by the United States Secretary of the Treasury pursuant
to the USA PATRIOT Act as being of &ldquo;primary money laundering concern&rdquo;.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.11<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Material Contracts</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Section&nbsp;4.11(a)</U> of the Company Disclosure Schedule sets forth a true, complete and accurate list of all
Material Contracts in effect as of the date hereof. &ldquo;<U>Material Contracts</U>&rdquo; means:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Contract pursuant to which the Company is liable for any Indebtedness, except for Company Plans;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Contract pursuant to which the Company is a lessor or lessee of any real property or any machinery, equipment,
motor vehicles, office furniture, fixtures or other personal property involving expenditures in excess of $10,000 per annum;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any partnership, joint venture or similar Contract relating to any Person that is not wholly owned by the Company;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>other than any Immaterial Revenue Agreement, any Contract that involves a sharing of revenues, profits, cash flows,
expenses or losses with other Persons or any Contract that involves the payment of royalties to any other Person, in each case
that (A) involves payments by the Company in excess of $10,000 in the twelve (12)-month period ended September 30, 2019, or (B)
expressly, or to the reasonable belief of those having Knowledge of the Company, requires payments by the Company in excess of
$10,000 during any twelve (12)-month period between September 30, 2019 and September 30, 2021;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(v)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Contract for the purchase or sale of real property or any option to purchase or sell real property by the Company;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(vi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Contract relating to the acquisition or disposition by the Company of any business, a material amount of stock
or assets of any Person or business having a fair value in excess of $50,000 or all or substantially all of the assets of any Person
or business (whether by merger, sale of stock, sale of assets, license or otherwise) or any Contract pursuant to which it has any
material ownership interest in another Person;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(vii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>other than any Immaterial Revenue Agreement, any Contract which (A) expressly, or to the reasonable belief of those
having Knowledge of the Company, requires payments by the Company in excess of $15,000 in any twelve (12) period between September
30, 2019 and September 30, 2021, or (B) or pursuant to which the Company made payments in excess of $15,000 in the twelve (12)-month
period ended September 30, 2019, other than purchase orders, Company Plans or other Contracts that are terminable by the Company
on thirty (30) days&rsquo; notice or less without obligation to make any material payment;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(viii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Contract that contains any (A) &ldquo;most favored nation&rdquo; or similar provision in favor of a Person other
than the Company, (B) provision expressly requiring the Company to purchase goods or services exclusively from, or distribute or
resell goods or services exclusively through, another Person, or (C) express restriction on the ability of the Company or any of
its Affiliates (whether before or after the Closing) to compete or undertake business in any business market or geographic area;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ix)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any employment agreement binding on the Company that is not terminable at will or that contains any severance or
termination pay or other compensatory obligations in connection with a termination of employment other than (A) accrued payment
obligations for services rendered prior to the Termination Date and (B) relocation expense reimbursement in amounts less than $25,000,
except as mandated by local law;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(x)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any contract, letter or other agreement providing for payment by the Company of more than $25,000 annually which
provides for any consulting or advising role of any Person in respect of the business of the Company;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Contract between the Company, on the one hand, and any of its Affiliates, on the other hand, that is material
to the operation of the business of the Company, as applicable, and is not listed in response to another item of this <U>Section&nbsp;4.11</U>
or as a Company Plan;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Contract that results in any Person holding a power of attorney from the Company (other than those granted to
payroll providers, tax filing professionals, lawyers or law firms for administrative matters in the Ordinary Course of Business);</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xiii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Contract that provides for the indemnification of any Person other than Contracts entered into in the Ordinary
Course of Business and Contracts the primary purpose of which do not relate to taxes or environmental liabilities of any Person;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xiv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Contract that relates principally to the advertising or promotion of the business or operations of the Company;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Contract that requires the consent of a Governmental Authority as a result of the transactions contemplated by
this Agreement;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xvi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any agreement with any Key International Distributor, any Key Domestic Distributor, any Key Customer or Key Supplier;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xvii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any dealer, distributor, referral or similar agreement, or any Contract providing for the grant of rights to market,
refer or sell the Company&rsquo;s products or services to any other Person that individually represented more than $100,000 in
total recognized revenue during the twelve (12) month period ended September 30, 2019 (the &ldquo;<U>Key Revenue Agreements</U>&rdquo;)
(provided that any Contract that is not listed on <U>Section 4.11(a)(xvii)</U> of the Company Disclosure Schedule shall not be
considered a Material Contract for any purposes under this Agreement and shall not be required to be listed on the Company Disclosure
Schedule);</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xviii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;
</FONT></FONT>any standstill or similar agreement containing provisions prohibiting a third party from purchasing Equity Interests
of the Company or assets of the Company or otherwise seeking to influence or exercise control over the Company;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xix)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any settlement agreement with respect to any Action or investigation;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xx)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Contract primarily related to privacy and data protection, including any Contract for the collection, use, disclosure,
storage, transfer or disposal of Personal Data, in respect of the business of the Company; and</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xxi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Contract pursuant to which the Company has (A) granted to any Person a license, covenant not to sue, option or
other right with respect to or under any Company IP, other than non-exclusive licenses granted in the Ordinary Course of Business
to the Company&rsquo;s customers, suppliers, distributors and contractors; or (B) been granted by any Person a license, covenant
not to sue, option or other right with respect to any Intellectual Property Rights, other than non-exclusive licenses to off-the-shelf,
unmodified, commercially available software with annual payments no greater than $15,000.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has Made Available to Parent true, complete and accurate copies of all Material Contracts.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each of the Material Contracts constitutes a legal, valid and binding obligation of the Company and, to the Company&rsquo;s
Knowledge, of the other parties thereto, except as limited by the Enforceability Exceptions. The Company is not in material breach
of or in material default under any Material Contract, and no event or circumstance has occurred which, with notice, lapse of time
or both, would constitute a material default or material breach by the Company under any Material Contract. Prior to the date of
this Agreement, the Company has not received any written notice of any such material default or material breach (other than notices
of matters that have been resolved prior to the date hereof without material liability to the Company), and, to the Company&rsquo;s
Knowledge, there does not exist any material default or material breach, and no event or circumstance has occurred which, with
notice, lapse of time or both, would constitute a material default or material breach under any Material Contract by any party
thereto other than the Company.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.12<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Taxes</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company (A) has duly and timely filed (taking into account any valid extension of time within which to file)
all income Tax and material other Tax Returns required to be filed by it with the appropriate Tax Authority and all such filed
Tax Returns are complete and accurate in all material respects; (B) has duly and timely paid all material Taxes that have become
due (whether or not shown on any Tax Returns) and, with respect to material Taxes not yet due, has accrued such Taxes as current
liabilities on the consolidated balance sheet included in the YTD Financial Statements if required by GAAP; and (C) has withheld
and timely paid to the appropriate Tax Authorities all material Taxes required to have been withheld and complied with related
reporting requirements in all material respects.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>No issues that have been raised by the relevant Tax Authority in connection with any examination of any Tax Return
referred to in clause (a) above are currently pending. No Tax Return of the Company is currently being examined by any Tax Authority,
nor has the Company received any written notice from a Tax Authority that it intends to conduct any such examinations. All deficiencies
asserted or assessments made, if any, as a result of any such Tax examinations have been paid in full, settled or withdrawn. There
are no Liens for Taxes (other than Permitted Liens) upon any of the assets of the Company. No written power of attorney has been
granted with respect to any matter relating to the Taxes of the Company which will be in force for any taxable period beginning
after the Closing Date or for any Straddle Period.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has Made Available to Parent true and complete copies of (A) all income and other material Tax Returns
filed by the Company with respect to taxable periods ending on and after December 31, 2016, and (B) all private letter ruling requests,
closing agreements or gain recognition agreements with a Tax Authority with respect to Taxes requested or executed.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company is not a party to any Contract providing for allocation, sharing or indemnification with respect to Taxes
(other than a Contract not primarily related to Taxes which was entered into in the Ordinary Course of Business, including without
limitation credit or loan agreements, vendor agreements, purchase and sale agreements and leases).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>No written claim has been made within the last three (3) years by a Tax Authority in a jurisdiction where the Company
does not file Tax Returns such that it is subject to taxation by, or required to file any Tax Return in, that jurisdiction.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company (A) has not engaged in any &ldquo;listed transaction&rdquo; as defined in Treasury Regulations Section
1.6011-4(b)(2) or any other transaction requiring disclosure under any similar provision of state, local or foreign Law, (B) has
not ever been a member of any consolidated, combined, unitary or similar Tax group, (C) has not been granted any extension, or
waived the statute of limitations, for the assessment or collection of Taxes (other than pursuant to extensions of time to file
Tax Returns obtained in the Ordinary Course of Business), which extension or waiver is still in force, or (D) is not subject to
any private letter ruling of the IRS or comparable rulings of other Tax Authorities.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company will not be required to include any material item of income in, or to exclude any material item of deduction
from, taxable income in any taxable period (or portion thereof) ending after the Closing as a result of any closing agreement entered
into prior to the Closing with any Tax Authority, installment sale or open transaction entered into prior to the Closing, any accounting
method change made prior to the Closing, any prepaid amount received on or prior to the Closing Date, the application of Section&nbsp;965
of the Code, any election pursuant to Section&nbsp;108(i) of the Code (or any similar provision of state, local or foreign Law)
made prior to the Closing with respect to any taxable period ending on or prior to the Closing Date, or any transferee or successor
liability for the Taxes of any other Person (other than the Company) under Treasury Regulations Section&nbsp;1.1502-6 (or any similar
provision of state, local or foreign Law), or otherwise.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(h)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has not constituted either a &ldquo;distributing corporation&rdquo; or a &ldquo;controlled corporation&rdquo;
in a distribution of stock intended to qualify for tax-deferred treatment under Section 355 of the Code.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company is not a &ldquo;United States shareholder&rdquo; of any foreign corporation, within the meaning of Section
951(b) of the Code.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.13<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Employee Matters</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Section&nbsp;4.13(a)</U> of the Company Disclosure Schedule sets forth an accurate and complete list of each Company
Plan. For purposes of this Agreement, &ldquo;<U>Company Plan</U>&rdquo; means any benefit or compensation plan, program, policy,
practice, agreement, contract, arrangement or other obligation, whether or not in writing and whether or not funded, in each case,
which is sponsored or maintained by, or required to be contributed to, or with respect to which any potential liability is borne
by the Company. Company Plans include, but are not limited to, &ldquo;employee benefit plans&rdquo; within the meaning of Section&nbsp;3(3)
of ERISA (&ldquo;<U>ERISA Plans</U>&rdquo;), employment, consulting, retirement, severance, termination or change in control agreements,
deferred compensation, equity-based, incentive, bonus, supplemental retirement, profit sharing, insurance, medical, welfare, fringe
or other benefits or remuneration of any kind. No Company Plan is maintained outside the jurisdiction of the United States or covers
any employees or other service providers of the Company who reside or work outside of the United States.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>With respect to each Company Plan, the Company has Made Available to Parent, to the extent applicable, accurate and
complete copies of (i) the Company Plan document, including any amendments thereto, and all related trust documents, insurance
contracts or other funding vehicles, (ii) a written description of such Company Plan if such plan is not set forth in a written
document, (iii) the most recently prepared actuarial report, and (iv) all material correspondence to or from any Governmental Authority
received in the last three (3) years with respect to any Company Plan. With respect to each Company Plan that is an ERISA Plan,
the Company has Made Available to Parent, to the extent applicable, accurate and complete copies of (1) the most recent summary
plan description together with any summaries of all material modifications thereto, (2) the most recent IRS determination or opinion
letter, and (3) the most recent annual report (Form 5500 or 990 series and all schedules and financial statements attached thereto).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>(i) Each Company Plan (including any related trusts), other than &ldquo;multiemployer plans&rdquo; within the meaning
of Section&nbsp;3(37) of ERISA (each, a &ldquo;<U>Multiemployer Plan</U>&rdquo;), has been established, operated and administered
in material compliance with its terms and Applicable Laws, including, without limitation, ERISA and the Code, (ii) all contributions
or other amounts payable by the Company with respect to each Company Plan in respect of current or prior plan years have been paid
or accrued in accordance with GAAP, and (iii) there are no pending or served, or, to the Company&rsquo;s Knowledge, threatened
claims (other than routine claims for benefits) or proceedings by a Governmental Authority by, on behalf of or against any Company
Plan or any trust related thereto which could reasonably be expected to result in any material liability to the Company.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each Company Plan that is an ERISA Plan that is intended to be qualified under Section&nbsp;401(a) of the Code has
received a favorable determination, opinion or advisory letter from the Internal Revenue Service as to its qualification under
Section 401(a) of the Code and, to the Company&rsquo;s Knowledge, nothing has occurred that would reasonably be expected to adversely
affect the qualification or tax exemption of any such Company Plan. With respect to any Company Plan that is an ERISA Plan, the
Company has not engaged in a transaction in connection with which the Company reasonably could be subject to either a civil penalty
assessed pursuant to Section&nbsp;409 or Section&nbsp;502(i) of ERISA or a tax imposed pursuant to Section&nbsp;4975 or 4976 of
the Code.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Neither the Company nor any ERISA Affiliate has contributed (or had any obligation of any sort) in the last six (6)
years to a plan that is subject to Section&nbsp;412 of the Code or Section&nbsp;302 or Title IV of ERISA. Neither the Company nor
any ERISA Affiliate has maintained, established, participated in or contributed to, or is or has been obligated to contribute to,
or has otherwise incurred any obligation or liability (including any contingent liability) under, any Multiemployer Plan within
the last six (6) years. No Company Plan is a &ldquo;multiple employer welfare arrangement&rdquo; (as defined in Section&nbsp;3(40)
of ERISA). For purposes of this Agreement, &ldquo;<U>ERISA Affiliate</U>&rdquo; means all employers (whether or not incorporated)
that would be treated together with the Company as a &ldquo;single employer&rdquo; within the meaning of Section&nbsp;414 of the
Code.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Except as required by Applicable Laws, no Company Plan provides retiree or post-employment medical, disability or
life insurance benefits to any Person (other than for continuation coverage required under Section 4980B(f) of the Code or similar
state Law).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each Company Plan that is a &ldquo;nonqualified deferred compensation plan&rdquo; (within the meaning of Section&nbsp;409A
of the Code) is in all material respects in documentary compliance with, and has been operated and administered in all material
respects in compliance with, Section&nbsp;409A of the Code and the guidance issued by the Internal Revenue Service provided thereunder.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(h)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Neither the execution and delivery of this Agreement, approval of this Agreement nor the consummation of the transactions
contemplated by this Agreement could, either alone or in combination with another event, (1) entitle any current or former employee,
director, officer or independent contractor of the Company to severance pay or any material increase in severance pay, (2) accelerate
the time of payment or vesting, or materially increase the amount of compensation due to any such employee, director, officer or
independent contractor, (3) directly or indirectly cause the Company to transfer or set aside any assets to fund any material benefits
under any Company Plan, or (4) limit or restrict the right to merge, materially amend, terminate or transfer the assets of any
Company Plan on or following the Effective Time.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Neither the execution and delivery of this Agreement, approval of this Agreement nor the consummation of the transactions
contemplated by this Agreement could, either alone or in combination with another event, result in the payment of any amount that
could, individually or in combination with any other such payment, constitute an &ldquo;excess parachute payment&rdquo; as defined
in Section&nbsp;280G(b)(1) of the Code.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(j)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has no obligation to provide, and no Company Plan or other agreement provides any individual with the
right to, a gross up, indemnification, reimbursement or other payment for any excise or additional taxes, interest or penalties
incurred pursuant to Section&nbsp;409A or Section&nbsp;4999 of the Code or due to the failure of any payment to be deductible under
Section&nbsp;280G of the Code.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.14<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Labor Matters</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Section&nbsp;4.14(a)</U> of the Company Disclosure Schedule sets forth, with respect to each current employee
of the Company, including any employee who is on a leave of absence of any nature, paid or unpaid, authorized or unauthorized,
including disability, sick, family or other leave: (i) the name of such employee and the date as of which such employee was originally
hired by the Company, and whether the employee is on an active or inactive status, (ii) such employee&rsquo;s title, (iii) such
employee&rsquo;s annualized compensation as of January 3, 2020, including base salary, vacation and paid time off accrual amounts,
and target bonus and commission amounts (if any), (iv)&nbsp;such employee&rsquo;s severance entitlement (if any), (v) whether such
employee is not fully available to perform work because of a qualified disability or other leave and, if applicable, the type of
leave (e.g., disability, workers&rsquo; compensation, family or other leave protected by Applicable Laws) and the anticipated date
of return to full service, (vi) the facility at which such employee is located and (vii) whether such employee is classified as
exempt or non-exempt under the Fair Labor Standards Act (as applicable).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>As of the date hereof, the Company is not a party to any collective bargaining agreement or other agreement with
a labor union or like organization, and, to the Company&rsquo;s Knowledge, there are no activities or proceedings by any individual
or group of individuals, including representatives of any labor unions or like organizations, to organize any employees of the
Company. As of the date hereof, (i) there is no strike, lockout, slowdown, work stoppage, job action, picketing, unfair labor practice
or other labor dispute pending or, to the Company&rsquo;s Knowledge, threatened, (ii) there is no unfair labor practice charge
against the Company pending before the National Labor Relations Board or comparable labor relations authority, and (iii) there
is no pending or, to the Company&rsquo;s Knowledge, threatened arbitration or grievance, charge, complaint, audit or investigation
by or before any Governmental Authority with respect to any current or former employees of the Company.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company is in compliance in all material respects with all Applicable Laws respecting labor, employment, fair
employment practices (including equal employment opportunity laws), terms and conditions of employment, workers&rsquo; compensation,
occupational safety and health, affirmative action, employee privacy, sexual harassment, plant closings, and wages and hours. The
Company has not incurred any liability or obligation under the Worker Adjustment and Retraining Notification Act and the regulations
promulgated thereunder or any similar state or local Law that remains unsatisfied.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>There are no proceedings pending or, to the Company&rsquo;s Knowledge, threatened against the Company in any forum
by or on behalf of any present or former employee of the Company, any applicant for employment or classes of employees or applicants
for employment alleging breach of any express or implied employment contract, violation of any Applicable Laws governing employment
or the termination thereof, or any other discriminatory, wrongful or tortious conduct on the part of the Company in connection
with the employment relationship.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has no direct or indirect liability, whether actual or contingent, with respect to any misclassification
of any person as an independent contractor rather than as an employee, with respect to any misclassification of any employee as
exempt versus non-exempt, or with respect to any employee leased from another employer, except as would not, when taken as a whole,
reasonably be expected to be material to the Company, and the Company has not received any written notice and has no Knowledge
of any pending or threatened claim by any Person who is performing or has performed services for the Company that he/she is or
was misclassified for such purposes.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.15<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Insurance</U>. <U>Section&nbsp;4.15(i)</U> of the Company Disclosure Schedule contains a true and complete list
of all material insurance policies (other than any insurance policies that are Company Plans) currently in effect as of the date
hereof that insure the business, operations, employees and Properties of the Company. Each such material insurance policy is in
full force and effect and is valid and binding, and no premiums due under any such insurance policies have not been paid. The Company
has not received any written notice of cancellation or termination in respect of any such policy or is in default under any such
policy in any material respect. <U>Section&nbsp;4.15(ii)</U> of the Company Disclosure Schedule sets forth a true and complete
description of (a) all current and open or known claims relating to the Company under such policies and (b) all claims made under
such policies with respect to any claims, individually, in excess of $25,000 relating to the Company with respect to its business
during the preceding three (3) years. During the preceding three (3) years, the Company has not settled any Action or investigation
for an amount in excess of insured limits.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.16<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Intellectual Property</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Section&nbsp;4.16(a)</U> of the Company Disclosure Schedule sets forth a true and complete list of all Company
IP that is issued by, registered with, or the subject of a pending application before any Governmental Authority or Internet domain
name registrar, as applicable (the &ldquo;<U>Scheduled Company IP</U>&rdquo;), indicating for each such item the record owner or
registrant, registration or application number, registration or application date and the applicable filing jurisdiction (or in
the case of an Internet domain name, the applicable domain name registrar). The Company IP is in existence and, to the Knowledge
of the Company, the issued patents, registered Copyrights and registered Trademarks that are included in the Scheduled Company
IP are valid and enforceable.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>There are no inventorship challenges, opposition or nullity proceedings or interferences declared, commenced or,
to the Knowledge of the Company, threatened with respect to any Company IP. The Company has complied in all material respects with
its duty of candor and disclosure to the United States Patent and Trademark Office and any relevant foreign patent office with
respect to all applications and other filings with respect to any Company IP, as applicable, filed by or on behalf of the Company,
and has made no material misrepresentation in such applications.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company is the sole and exclusive owner of all Company IP owned by or purported to be owned by the Company, free
and clear of all Liens other than Permitted Liens. The Company owns, or has valid and sufficient rights pursuant to a written and
enforceable agreement to use, all Intellectual Property Rights used in or necessary for the conduct of the business of the Company,
as currently conducted, all of which rights shall continue in effect unchanged immediately after the consummation of the transactions
contemplated by this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>None of (i) the conduct of the business of the Company or (ii) the development, use, import, sale, offer for sale,
commercialization or other exploitation of any Company Products Infringes or has Infringed the Intellectual Property Rights of
any Person in the prior six (6) years. To the Knowledge of the Company, no Person is Infringing, or has within the prior six (6)
years Infringed, any Company IP. The Company has not, within the prior six (6) years, asserted any claim, notice, invitation to
license or similar communication against any Person alleging any Infringement of any Company IP.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has not received in the prior six (6) years any written claim, notice, invitation to license or similar
written communication (i)&nbsp;contesting or challenging the use of any Intellectual Property Rights, or the scope, validity, enforceability
or ownership of any Company IP, or (ii) relating to the actual or alleged Infringement of any Intellectual Property Rights of any
third Person. The Company IP is not subject to any Order or any Contract adversely affecting, as applicable, the ownership, scope,
validity or enforceability of, or the Company&rsquo;s use of or rights to, such Company IP. There is no Action that affects or
binds the Company, the Company has not received in writing notice of any investigation that is pending or threatened and, to the
Company&rsquo;s Knowledge, there is no Action, Order or investigation pending or threatened against the Company that, in each case,
seeks to cancel, limit or challenge, as applicable, the ownership, use, scope, validity or enforceability of any Company IP.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Neither the execution of this Agreement nor the consummation of the transactions contemplated by this Agreement will,
under any Contract to which the Company is bound, result in (i) Parent or the Company being bound by or subject to any obligation
to grant any license, covenant not to assert, or other right with respect to its respective Intellectual Property Rights that Parent
or the Company would not have been bound by or subject to but for the execution of this Agreement or the consummation of the transactions
contemplated by this Agreement, or (ii) the Company being obligated to pay any royalties, honoraria, fees or other payments to
any Person, with respect to Intellectual Property Rights, at a rate in excess of the rate at which the Company is obligated to
pay such amounts prior to the Closing.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has obtained, from all Persons (including each current or former employee, officer, director, consultant
and contractor) that have contributed to the creation or development of any Intellectual Property Rights for or on behalf of the
Company, valid and enforceable written agreements containing irrevocable present assignments to the Company of all such Intellectual
Property Rights, and no such Person retains any right, title or interest in or to any such Intellectual Property Rights. No current
or former employee, consultant, contractor, officer or director of the Company has excluded any Intellectual Property Rights from
any written assignment executed by any such Person in connection with work performed for or on behalf of the Company.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(h)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has taken commercially reasonable measures (including executing written and enforceable non-disclosure
agreements with all Persons who have (i) created or developed any subject matter that would be considered a Trade Secret of the
Company if the Company had taken commercially reasonable measures to protect the confidentiality of the subject matter or (ii)
had access to any material Trade Secrets used by the Company) to protect the confidentiality and value of all Trade Secrets used
or held for use by the Company (including all Trade Secrets included in the Company IP).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The IT Assets (i) are sufficient for and operate and perform in all material respects as required by the Company
to conduct the business of the Company as currently conducted; (ii) have not materially malfunctioned or failed within the prior
six (6) years, and (iii) function materially in accordance with all applicable documentation and specifications. The Company has
used commercially reasonable efforts, including using commercially available scanning tools, to detect &ldquo;viruses,&rdquo; &ldquo;worms,&rdquo;
&ldquo;spyware&rdquo; or other malicious software that may be present in the IT Assets, and, to the Company&rsquo;s Knowledge,
the IT Assets are free of material bugs, &ldquo;viruses,&rdquo; &ldquo;worms,&rdquo; &ldquo;spyware&rdquo; or other malicious software.
To the Knowledge of the Company, no Person has gained unauthorized access to or use of any IT Assets or any data or other information
stored on or processed by any IT Asset.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="color: #010000">(j)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>No funding, facilities or personnel of any Governmental Authority or any university, college, research institute
or other educational institution has been used to create or otherwise develop any Company IP, except for any such funding or use
of facilities or personnel that has not resulted in such Governmental Authority or institution obtaining ownership rights in (or
options to obtain ownership rights in), licenses to (or options to receive licenses to) or other rights to use or exploit any Company
IP.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.17<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Privacy and Data Security</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company&rsquo;s data, privacy and security practices comply in all material respects, and during the past five
(5) years have complied in all material respects, with applicable Data Protection and Security Requirements. The Company has provided
all notices and obtained all consents required by Data Protection and Security Requirements and satisfied all other requirements
of Data Protection and Security Requirements for their Processing of Personal Data and that are necessary for the conduct of business
as currently conducted and in connection with the consummation of the transaction contemplated hereunder. Without limitation, the
transactions to be consummated hereunder as of the Closing Date will comply with all applicable Data Protection and Security Requirements.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has implemented and maintains reasonable and appropriate organizational, physical, administrative and
technical measures designed to protect the operation, confidentiality, integrity and security of all of the Company&rsquo;s confidential
and other data and information, in any format, generated or used in the conduct of the business (&ldquo;<U>Business Data</U>&rdquo;)
and the IT Assets, against unauthorized access, acquisition, interruption, alteration, modification or use. Without limiting the
generality of the foregoing, the Company has implemented policies and procedures (i) designed to identify internal and external
risks to the security of the Business Data or IT Assets and (ii) has implemented, reasonable and appropriate safeguards designed
to control those risks. The Company has not experienced (nor have any third parties acting on the Company&rsquo;s behalf) any actual
or alleged Security Incident, including, without limitation, any &ldquo;breach&rdquo; (as defined in 45 C.F.R. Part 164, Subpart
D) of unsecured Protected Health Information or of EU Personal Data. The Company has not (nor have any third parties acting on
the Company&rsquo;s behalf) notified, and the Company has not experienced any event resulting in any requirement that the Company
notify, any Person or Data Protection Authority of any Security Incident that has resulted in the loss or unauthorized access,
use or disclosure of Personal Data, including any loss or unauthorized access, use or disclosure, of EU Personal Data for which
notification is required under the GDPR or of Protected Health Information that would constitute a breach for which notification
to individuals, the media, or the United States Department of Health and Human Services (&ldquo;<U>HHS</U>&rdquo;) is required
under 45 C.F.R. Part 164, Subpart D.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>In addition, to the Company&rsquo;s Knowledge, the Company does not have any data security, information security
or other technological vulnerabilities that are materially more significant in number or potential for material impact on Company
business operations than are typically present in information technology assets of businesses of similar size in Company&rsquo;s
industry.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has obligated all third party service providers, outsourcers, and processors of confidential information
on their behalf and all third parties managing IT Assets on their behalf to appropriate contractual terms relating to the Processing
of Business Data (as applicable and as required by Data Protection and Security Requirements) and information security and have
taken reasonable measures to ensure that such third parties have complied with their contractual obligations. Without limiting
the generality of the foregoing, the Company has entered into business associate agreements with vendors and customers in all situations
where required by 45 C.F.R. &sect;&sect; 164.502(e) and 164.504(e) or Article 28 of the GDPR. The Company has taken reasonable
measures to ensure that all third parties acting on its behalf have complied with their contractual obligations.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has not received any notice of any claims, investigations (including investigations by any Governmental
Authorities, including the HHS Office for Civil Rights and any other Data Protection Authority), for alleged violations of Data
Protection and Security Requirements with respect to Personal Data Processed by, or under the control of, Company, and, to the
Company&rsquo;s Knowledge, there are no facts or circumstances that are likely to form the basis for any such claims, investigations
or allegations.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: left; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.18<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Real Property</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>As of the date hereof, the Company does not own any real property.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Section&nbsp;4.18(b)</U> of the Company Disclosure Schedule sets forth as of the date hereof a true and complete
list of all material lease and sublease agreements (&ldquo;<U>Lease Agreements</U>&rdquo;) for the leasing, use or occupancy of,
or otherwise granting a right in or relating to all real property currently leased or subleased by the Company or otherwise used
or occupied by the Company, including all amendments, terminations and modifications thereof (&ldquo;<U>Leased Real Property</U>&rdquo;).
The Company has Made Available to Parent true and complete copies of all Lease Agreements. Each of the Lease Agreements (other
than any Lease Agreement which will terminate or expire by its terms prior to the Closing) constitutes a legal, valid and binding
obligation of the Company party thereto and, to the Company&rsquo;s Knowledge, of the other parties thereto, except as limited
by the Enforceability Exceptions. There are no outstanding defaults or events of default under the Lease Agreements. Except for
Permitted Liens, there are no Liens with respect to the Company on the Leased Real Property. The Company&rsquo;s occupancy, use
and operation of the Leased Real Property by the Company materially complies with all Applicable Laws. To the Company&rsquo;s Knowledge,
there are no pending or threatened appropriation, condemnation, eminent domain or similar proceedings by any Governmental Authority
relating to the Leased Real Property. As of the date hereof, the Company is the tenant or subtenant named under the Lease Agreement
for the Leased Real Property and is in possession of the properties purported to be leased or subleased thereunder.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.19<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Personal Property</U>. Except as would not reasonably be expected to be material, the Company (a) owns, leases
or licenses from third parties all tangible personal property required to conduct its business in the Ordinary Course of Business,
(b) has good and valid title to all tangible personal property owned by it, free and clear of all Liens except for Permitted Liens,
and (c) immediately upon consummation of the transactions contemplated by this Agreement, will be entitled to continue to use all
material tangible personal property which is currently employed by it in the conduct of its business as presently conducted. Except
as would not reasonably be expected to be material, such tangible personal property is in reasonable operating condition and reasonably
fit for the particular purposes for which it is used (subject only to normal maintenance requirements and reasonable wear and tear).
Other than with respect to any Intellectual Property Rights, the representations and warranties related to which are contained
solely in <U>Section&nbsp;4.16</U>, at the Closing, the Company will own, or has a valid and legal right to use, sufficient property,
assets and other rights (whether tangible or intangible) to be able to operate and conduct, and to continue to operate and conduct,
the business and operations of the Company in the Ordinary Course of Business, without the need for Parent or the Surviving Corporation
to acquire or license any other property, assets or other rights, and the Company will have good and valid title to such property,
assets and other rights, free and clear of any Liens except Permitted Liens.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.20<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Related-Party Transactions</U>. (a) No Affiliate of the Company (other than the Company) has any Indebtedness
for borrowed money owed by it to the Company and (b) the Company has no Indebtedness for borrowed money owed by it to any such
Affiliate. Except as expressly required by this Agreement, no Affiliate of the Company is a party to any Contract or other understanding
with the Company. Each Contract required to be listed in <U>Section&nbsp;4.20</U> of the Company Disclosure Schedule was entered
into upon fair and reasonable terms no less favorable to the Company, as the case may be, than it would obtain in a comparable
arm&rsquo;s-length transaction with a Person not an Affiliate.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.21<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Bank Accounts</U>. <U>Section&nbsp;4.21</U> of the Company Disclosure Schedule sets forth a true, complete and
correct list of each of the bank accounts in the name of the Company, including the title and number of the account, the individuals
with signatory authority over such account and the financial institution at which such account is located.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.22<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Customers, Distributors and Suppliers</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Section&nbsp;4.22(a)</U> of the Company Disclosure Schedule sets forth the top ten (10) international distributors
of the Company (in terms of total transfer pricing), during the twelve (12) month period ended September 30, 2019 (each, a &ldquo;<U>Key
International Distributor</U>&rdquo;) along with the amount of transfer pricing attributable to each Key International Distributor
within such period. None of the other international distributors of the Company individually represented more than $24,134 in total
recognized revenue during the twelve (12) month period ended September 30, 2019.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Section&nbsp;4.22(b)</U> of the Company Disclosure Schedule sets forth the top thirty-five (35) domestic distributors
of the Company (in terms of total commission), during the twelve (12) month period ended September 30, 2019 (each, a &ldquo;<U>Key
Domestic Distributor</U>&rdquo;) along with the amount of commission attributable to each Key Domestic Distributor within such
period. None of the other domestic distributors of the Company individually represented more than $55,363 in total recognized revenue
during the twelve (12) month period ended September 30, 2019.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Section&nbsp;4.22(c)</U> of the Company Disclosure Schedule sets forth the top twenty-five (25) domestic customers
of the Company (in terms of total recognized revenue), during the twelve (12) month period ended September 30, 2019 (each, a &ldquo;<U>Key
Customer</U>&rdquo;) along with the amount of recognized revenue attributable to each Key Customer within such period. None of
the other domestic customers of the Company individually represented more than $89,500 in total recognized revenue during the twelve
(12) month period ended September 30, 2019.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Section&nbsp;4.22(d)</U> of the Company Disclosure Schedule sets forth the top fifteen (15) suppliers of the Company
(in terms of total dollars spent), during the twelve (12) month period ended September 30, 2019 (each, a &ldquo;<U>Key Supplier</U>&rdquo;)
along with the amount of dollars spent with each Key Supplier within such period.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>As of the date of this Agreement, no Key International Distributor, Key Domestic Distributor, Key Customer or Key
Supplier has canceled or otherwise terminated, or, to the Knowledge of the Company, threatened to cancel or otherwise terminate,
its relationship with the Company. As of the date of this Agreement, the Company has not received written notice that any Key International
Distributor, Key Domestic Distributor, Key Customer or Key Supplier is considering or intends to cancel or otherwise materially
and adversely modify its relationship (including, without limitation, by seeking to renegotiate contractual terms) with the Company
or limit its purchases from or reduce its sales to, as applicable, the Company.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.23<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Key Revenue Agreements</U>. The amount of total revenue recognized pursuant to the Key Revenue Agreements during
the twelve (12) month period ended September&nbsp;30, 2019 was greater than eighty-five percent (85%) of the amount of total revenue
recognized by the Company during such period.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.24<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Condition and Sufficiency of Assets</U>. The Company owns or has the valid right to use under a lease or license
of, all the material assets and rights used in the operation of the Company&rsquo;s business as currently conducted. Such assets
and rights constitute all of the material assets, tangible and intangible, of any nature whatsoever, used in the operation of such
business as currently conducted.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.25<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Compliance with Healthcare Laws</U></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>For the past five (5) years, the Company, and to the Company&rsquo;s Knowledge, its officers, directors, employees
and independent contractors, in their capacity as such, are and have been, in material compliance with all Applicable Laws relating
to healthcare regulatory matters (collectively, the &ldquo;<U>Healthcare Laws</U>&rdquo;) that are applicable to the business of
the Company, including: (i) Laws governing participation in Medicare (Title XVIII of the Social Security Act), Medicaid (Title
XIX of the Social Security Act), and other federal and state healthcare programs defined in 42&nbsp;U.S.C.&nbsp;&sect;&nbsp;1320a-7b(f)
(collectively, &ldquo;<U>Federal Healthcare Programs</U>&rdquo;); (ii) HIPAA; (iii) Laws governing the corporate practice of medicine;
(iv) Laws relating to kickbacks and self-referrals, including (A) the federal Anti-Kickback Statute (42 U.S.C. &sect; 1320a-7b(b)),
(B) the False Claims Act (31&nbsp;U.S.C.&nbsp;&sect;&sect;&nbsp;3729 et seq.), (C) the Beneficiary Inducement Law (42 U.S.C. &sect;
1320a-7a(a)(5)), (D) the administrative False Claims Law (42 U.S.C. &sect; 1320a-7b(a)), (E) the exclusion Laws (42 U.S.C.&nbsp;&sect;&nbsp;1320a-7),
(F) the civil monetary penalty Laws (42 U.S.C. &sect; 1320a-7a), (G) the Stark Law (42&nbsp;U.S.C.&nbsp;&sect; 1395nn), (H) the
federal Sunshine Act (42 U.S.C. &sect; 1320a-7h) and (I) any other Applicable Laws imposed or enforced by HHS; and (v) any similar
federal, state or local Laws.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Without limiting the generality of the foregoing, for the past five (5) years, none of the Company, or, to the Knowledge
of the Company, any officer, director, managing employee, agent (as those terms are defined in 42&nbsp;C.F.R.&nbsp;&sect;&nbsp;1001.1001)
or healthcare professional of the Company: (i)&nbsp;is or has been a party to a corporate integrity agreement or Certificate of
Compliance Agreement with the Office of Inspector General (&ldquo;<U>OIG</U>&rdquo;) or similar government-mandated compliance
program; (ii)&nbsp;has any continuing material reporting obligations pursuant to a settlement agreement or other remedial measure
entered into with any Governmental Authority; (iii)&nbsp;has been served with or received any search warrants, subpoenas or civil
investigative demands of which the Company is the subject of such search warrants, subpoenas or civil investigative demands from
any Governmental Authority; (iv)&nbsp;has been debarred, excluded or suspended from participation, has received a written notice
of their exclusion, suspension or debarment from participation or has been threatened with exclusion, suspension or debarment from
participation in any federal or state healthcare program or subject to a formal disciplinary action by any payor or Governmental
Authority; (v)&nbsp;has had a civil monetary penalty assessed against it, him or her under Section 1128A of the Social Security
Act; (vi)&nbsp;is currently or has been listed on the United States General Services Administration published list of parties excluded
from federal procurement programs and non-procurement programs; or (vii)&nbsp;has been convicted of, or entered into any settlement
or reformation agreement with any Governmental Authority to avoid conviction of, any criminal offense relating to the delivery
of any item or service under a Federal Healthcare Program or had a civil monetary penalty assessed against them under Section 1128A
of the Social Security Act or any regulations promulgated thereunder.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has adopted a code of ethics and has an operational healthcare compliance program, materially covering
and implementing the seven elements of an effective compliance program described in the Compliance Program Guidance published by
the HHS OIG, which governs all employees and contractors, including sales representatives and their interactions with healthcare
providers.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>As required by applicable Healthcare Laws, the Company has (i)&nbsp;verified that all employees providing clinical
services, if any, have valid and current licenses, permits and credentials, (ii)&nbsp;conducted criminal background checks on all
applicable employees and independent contractors and&nbsp;(iii) screened all officers, directors, employees and independent contractors
using the HHS/OIG List of Excluded Individuals/Entities.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.26<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Medical Device Compliance</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company is currently conducting, and has conducted, its business and operations in compliance in all material
respects with all applicable requirements of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. &sect;&sect; 301 et seq., all
applicable regulations promulgated by the United States Food and Drug Administration (&ldquo;<U>FDA</U>&rdquo;) and all similar
laws and regulations issued by any other similar Governmental Authority including those relating to nonclinical research, clinical
research, good clinical practices, good laboratory practices, investigational use, premarket notification, premarket approval,
establishment registration, device listing, clinical trial registration and reporting, Quality System Regulation, record keeping,
labeling, advertising, device importation and exportation, adverse event reporting, recalls, and reporting of corrections and removals,
as applicable (collectively, &ldquo;<U>Medical Device Laws</U>&rdquo;).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has not received in the past five (5) years any written notice, Form FDA-483, FDA warning letters or
&ldquo;untitled letters,&rdquo; from the FDA or any similar notice or letter from any other Governmental Authority alleging or
asserting non-compliance with any applicable Medical Device Law or any other communication alleging actual or potential violations
of any applicable Medical Device Law. The Company has not entered into any consent decree or order pursuant to any Medical Device
Law, and the Company is not a party to any judgment, decree or judicial or administrative order pursuant to any Medical Device
Law. There is no Action or, to the Knowledge of the Company, investigation or complaint pending against the Company and the Company
has no material liability (whether actual or contingent) for failure to comply with any Medical Device Law. There is no act, omission,
event or circumstance that would reasonably be expected to give rise to or lead to any Action, or liability or, to the Knowledge
of the Company, any investigation or complaint.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each of the Company Products has been and is being designed, researched, developed, investigated, manufactured, tested,
packaged, labeled, stored, distributed, promoted, marketed, imported, exported and/or sold in compliance with all applicable requirements
under Medical Device Laws. Each of the Company Products is the subject of an appropriate Regulatory Authorization, as required
under Medical Device Laws, and duly held by the Company. The Company has obtained and maintained in full force and effect, all
necessary Regulatory Authorizations needed for the continuing operation of the Company, as listed in <U>Section 4.26(c)</U> of
the Company Disclosure Schedule.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company is and has been for the past five (5) years, in compliance with, and each Company Product has been designed,
manufactured, prepared, assembled, packaged, labeled, stored, and processed in compliance with applicable Quality System Regulation.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has made all notifications, submissions and reports to the FDA and other Governmental Authorities required
by applicable Medical Device Law, and all such notifications, submissions and reports were true, complete and correct as of the
date of submission to the FDA or other Governmental Authority (or were corrected or supplemented by a subsequent notification,
submission or report). The Company has not made any untrue statement of a fact or fraudulent statement to the FDA or other Governmental
Authority; failed to disclose a fact required to be disclosed to the FDA or other Governmental Authority; or committed an act,
made a statement, or failed to make a statement that, at the time such disclosure was made, would reasonably be expected to provide
a basis for the FDA to invoke its policy respecting &ldquo;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities,&rdquo;
set forth in 56 Fed. Reg. 46191 (September 10, 1991) or any other Governmental Authority to invoke any similar policy.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>With the exception of those items identified in <U>Section&nbsp;4.26(f)</U> of the Company Disclosure Schedule, none
of the Company, or, to the Company&rsquo;s Knowledge, any of its customers, has undertaken a recall, field correction, removal
or withdrawal of any Company Products, nor have any such products been seized, detained, subject to suspension of manufacturing
or termination or suspension of marketing. To the Company&rsquo;s Knowledge, there are no facts or circumstances reasonably likely
to cause such recall, field correction, removal, withdrawal, seizure, detention, suspension of manufacturing or termination or
suspension of marketing of any Company Product.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The studies, non-clinical laboratory studies, animal studies, tests, preclinical trials, and clinical trials, if
any, conducted by or on behalf of, or (if applicable) sponsored by, the Company were and, to the extent still pending, are being
conducted in accordance with experimental protocols, procedures and controls pursuant to, where applicable, standard medical and
accepted professional scientific research procedures and standards, and Medical Device Laws (including the applicable requirements
of good laboratory practices or good clinical practices, International Conference on Harmonization E6-Good Clinical Practices Consolidated
Guideline, FDA regulations, including 21 C.F.R. Parts 50, 54, 56, 58 and 812, and equivalent regulations of other Governmental
Authorities). The Company has not received any oral or written notices or correspondence or other communication from an institutional
review board, an ethics committee, a data monitoring committee, similar organization overseeing the conduct of clinical or other
studies, the FDA, any other Governmental Authority exercising comparable authority, that has ordered or commenced any Action or,
to the Company&rsquo;s Knowledge, investigation to place a clinical hold order on, or otherwise terminate, materially delay, limit,
modify or suspend, any proposed or ongoing clinical trial conducted by or on behalf of the Company, or, to the Company&rsquo;s
Knowledge, alleged any violation of any Medical Device Laws in connection with any preclinical or clinical studies, trials or tests.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(h)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has Made Available to Parent complete and accurate copies of (i)&nbsp;all material filings, commitments
and agreements with the FDA, any EU competent authority or equivalent Governmental Authority relating to any Company Product, (ii)&nbsp;all
material correspondence with the FDA, any EU competent authority or equivalent Governmental Authority relating to any Company Product
and (iii)&nbsp; all design history files and technical documentation relating to each Company Product, (iv) all material data,
information, results, analyses, publications, and reports relating to any Company Product, including all material information as
to the safety and efficacy of the Company Products and all clinical trial protocols, trial statistical analysis plans and published
trial results (collectively, the &ldquo;<U>Material Product and Trial Information</U>&rdquo;).&nbsp; The Material Product and Trial
Information is a true and correct representation in all material respects of the matters reflected therein. The registration and
regulatory files, Regulatory Authorizations, and supporting materials of the Company with respect to the Company Products have
been maintained in all material respects in accordance with all Applicable Laws, reasonable industry standards, and the standard
operating procedures of the Company.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.27<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Brokers</U>. The Company does not have any liability to pay fees or commissions to any broker, finder or agent
with respect to the transactions contemplated by this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.28<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Stockholders&rsquo; Agreement</U>. As of the Effective Time, the Stockholders&rsquo; Agreement, dated as of September
5, 2003, has been terminated and is of no further force or effect.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.29<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>No Other Representations or Warranties</U>. Except for the representations and warranties of the Company expressly
set forth in this <U>Article IV</U>, neither the Company nor any other Person makes any other express or implied representation
or warranty on behalf of the Company with respect to the Company or the transactions contemplated by this Agreement, and the Company
hereby disclaims any such other representations or warranties. Without limiting the generality of the foregoing, neither the Company
nor any other Person has made or makes any representation or warranty with respect to any financial projections, estimates or budgets
of future revenues, future results of operations, future cash flows or future financial condition (or any component of any of the
foregoing) of the Company.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0"><FONT STYLE="color: #010000">Article
V</FONT><BR>
REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Parent and Merger Sub hereby, jointly and severally,
represent and warrant to the Company as of the date hereof (except for any representation or warranty that is expressly made as
of a specified date, in which case Parent and Merger Sub hereby represent and warrant to the Company as of such specified date),
as follows:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">5.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Organization; Qualification</U>. Parent (a) is a corporation duly formed, validly existing and in good standing
under the Applicable Laws of its jurisdiction of organization, (b) has all requisite corporate power and authority to conduct its
business as it is now being conducted and to own, lease and operate its Properties and (c) holds all material Governmental Approvals
required to carry on its business as now being conducted. Merger Sub (i) is a corporation duly formed, validly existing and in
good standing under the Applicable Laws of its jurisdiction of organization, (ii) has all requisite corporate power and authority
to conduct its business as it is now being conducted and to own, lease and operate its Properties and (iii) holds all material
Governmental Approvals required to carry on its business as now being conducted.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">5.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Authority; Enforceability</U>. Each of Parent and Merger Sub has all requisite corporate power and authority to
execute and deliver this Agreement and the other Transaction Documents to which they are a party, to perform their obligations
hereunder and thereunder and to consummate the transactions contemplated hereby and thereby. The execution and delivery by Parent
and Merger Sub of this Agreement and the other Transaction Documents to which they are a party, and the performance by Parent and
Merger Sub of their obligations hereunder and thereunder, have been duly and validly authorized by all necessary corporate action
by each such party, except for adoption of this Agreement by Parent, as the sole stockholder of Merger Sub, which will be effected
by written consent immediately following the execution of this Agreement. This Agreement and each other Transaction Document to
which Parent or Merger Sub is a party has been duly and validly executed and delivered by Parent and Merger Sub and constitutes
the legal, valid and binding obligation of Parent and Merger Sub enforceable against Parent and Merger Sub in accordance with its
terms, except as the same may be limited by the Enforceability Exceptions.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">5.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>No Conflicts; Consents and Approvals</U>. The execution and delivery by Parent and Merger Sub of this Agreement
and the other Transaction Documents to which Parent and/or Merger Sub are a party do not, and the performance by Parent and Merger
Sub of their obligations under this Agreement and the other Transaction Documents to which Parent or Merger Sub are a party will
not:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>conflict with or result in a violation or breach of (i) any of the terms, conditions or provisions of the Organizational
Documents of Parent and Merger Sub or (ii) any Order to which Parent or Merger Sub is subject;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>require the consent, notice or other action by any Person under, or result in a violation of or result in a breach
of or default (or give rise to any right of termination, cancellation or acceleration) under (with or without the giving of notice,
the lapse of time or both) any Material Contract to which Parent or Merger Sub is a party; or</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>(i) conflict with, violate or breach any term or provision of any Applicable Law applicable to Parent or Merger Sub,
or (ii) require any consent or approval of any Governmental Authority, or notice to, or declaration, filing or registration with,
any Governmental Authority, under any Applicable Law and the filing of the Certificate of Merger.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">5.04<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Litigation</U>. As of the date hereof, (i) (A) there are no Actions or Orders that affect or bind Parent, Merger
Sub or any of their Properties and (B) Parent and Merger Sub has not received in writing notice of any investigation that is pending
or threatened, and (ii) to the knowledge of Parent or Merger Sub, there is no Action, Order or investigation pending or threatened,
against Parent or Merger Sub, that, for each of clauses (i) and (ii), would reasonably be expected to (x) result in the issuance
of an Order restraining, enjoining or otherwise prohibiting or making illegal the Merger or (y) adversely affect the performance
by Parent or Merger Sub of their obligations under this Agreement and the other Transaction Documents to which Parent or Merger
Sub is a party</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">5.05<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Availability of Funds</U>. Parent will have at Closing sufficient funds available for Parent and Merger Sub to
consummate the Closing and Parent will, at the applicable times, have sufficient funds available to consummate the other transactions
and make the other payments contemplated by this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">5.06<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Merger Sub</U>. Merger Sub is a wholly owned subsidiary of Parent. Merger Sub was formed specifically to consummate
the transactions contemplated by this Agreement and has conducted no operations and incurred no obligation or liabilities other
than in connection with its formation and the transactions contemplated hereby.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">5.07<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>No Other Representations or Warranties</U>. Except for the representations and warranties of Parent and Merger
Sub expressly set forth in this <U>Article V</U>, neither Parent, Merger Sub or any other Person makes any other express or implied
representation or warranty on behalf of Parent or Merger Sub with respect to Parent or Merger Sub or the transactions contemplated
by this Agreement, and Parent and Merger Sub each hereby disclaims any such other representations or warranties.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">5.08<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Parent&rsquo;s Investigation and Reliance</U>. Parent is a sophisticated purchaser and has made its own independent
investigation, review and analysis regarding the Company and the transactions contemplated hereby, which investigation, review
and analysis were conducted by Parent together with expert advisors, including legal counsel, that it has engaged for such purpose.&nbsp;
Parent acknowledges that neither the Company nor any other Person has made any representation or warranty, express or implied,
with respect to the Company or the transactions contemplated by this Agreement, or as to the accuracy or completeness of any information
concerning the Company contained herein or made available in connection with Parent&rsquo;s investigation of the Company (including
any information, documents or materials Made Available to Parent, whether orally or in writing, in any confidential information
memoranda, &ldquo;data rooms,&rdquo; management presentations, due diligence discussions or in any other form in expectation of,
or in connection with, the transactions contemplated by this Agreement) or otherwise, except as expressly set forth in <U>Article
IV</U>, and Parent and its Affiliates and Representatives expressly disclaim any and all liability that may be based on such information
or errors therein or omissions therefrom.&nbsp; Parent also disclaims any obligation or duty of the Company to make any disclosures
of fact not required to be disclosed pursuant to terms of this Agreement.&nbsp; Parent has not relied and is not relying on, and
specifically disclaims that it is relying upon or has relied upon, any statement, representation or warranty, oral or written,
express or implied, made or alleged to have been made by the Company or any other Person, except as expressly set forth in <U>Article
IV</U> and the Company Disclosure Schedule and by Stockholders in the Support Agreements and Letters of Transmittal. &nbsp;Parent
specifically acknowledges and agrees that the Company has specifically disclaimed and does hereby specifically disclaim any such
other statement, representation or warranty made or alleged to have been made by it or any other Person.&nbsp; Parent acknowledges
and agrees that the representations and warranties in <U>Article IV</U> are the result of arm&rsquo;s length negotiations between
sophisticated parties.&nbsp; Nothing in this <U>Section&nbsp;5.08</U> is intended to modify or limit any of the representations
or warranties of the Company set forth in <U>Article IV</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0"><FONT STYLE="color: #010000">Article
VI</FONT><BR>
COVENANTS OF THE PARTIES</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Access by Parent</U>. From and after the date hereof until the earlier of the Closing Date and the termination
of this Agreement (the &ldquo;<U>Interim Period</U>&rdquo;), the Company will provide Parent and its Representatives with reasonable
access, upon reasonable prior notice and during normal business hours, to all officers, employees, agents and accountants of the
Company and its Properties, books, Contracts and records relating to the Company, but, in each case, only to the extent that such
access does not unreasonably interfere with the business and operations of the Company; <U>provided</U>, <U>however</U>, the Company
shall not be required to provide any of the foregoing (a) with respect to any information that is subject to attorney-client privilege,
to the extent doing so would reasonably be expected to cause such privilege to be waived, or (b) if the Company reasonably determines,
after consulting with outside counsel, that such cooperation or access is prohibited by any federal, state or local Applicable
Laws. All such access and information obtained as a result of such access shall be subject to the terms and conditions of the Non-Disclosure
Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Certain Restrictions</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>During the Interim Period, except as set forth in <U>Section&nbsp;6.02(a)</U> of the Company Disclosure Schedule
or unless otherwise contemplated by this Agreement, the Company (w) will operate and maintain its business in the Ordinary Course
of Business, (x) will use commercially reasonable efforts to maintain the ordinary and customary relationships of the Company with
its suppliers, customers, key employees and others having material business relationships with it, and (y) except as required by
Applicable Law, will not take any of the following actions unless either (i) expressly required by this Agreement or (ii) as set
forth in <U>Section&nbsp;6.02(a)</U> of the Company Disclosure Schedule, without Parent&rsquo;s consent (which consent shall not
be unreasonably withheld, conditioned or delayed):</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>declare, set aside, make or pay any dividend or other distribution in respect of the capital stock of the Company
or repurchase, redeem or otherwise acquire any outstanding shares of the Company Capital Stock or other securities of, or other
ownership interests in, the Company (other than the withholding of shares to satisfy Tax obligations with respect to, or to pay
the warrant price or exercise price of, the Company Warrants or the Company Options outstanding as of the date of this Agreement
in accordance with the applicable Company Warrant or the Stock Plans and applicable employee award agreements as in effect on the
date of this Agreement or the repurchase of shares of capital stock from existing stockholders of the Company pursuant to the Company&rsquo;s
right of first refusal);</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>transfer, issue, sell or dispose of any shares of Company Capital Stock or other Equity Interests of the Company
(other than the issuance of shares in connection with the exercise of Company Warrants or Company Options or the conversion of
Company Preferred Stock outstanding as of the date of this Agreement in accordance with, as applicable, the Charter, the applicable
Company Warrant or Stock Plans and applicable employee award agreements as in effect on the date of this Agreement) or grant Equity
Interests of the Company;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>amend its Organizational Documents or undertake, declare or effect any recapitalization, reclassification, reorganization,
stock split, liquidation, dissolution or winding up;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>take any action that would result in the Company having any Subsidiaries;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(v)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>acquire, dispose, exchange or lease to any other Person any real property or other material Properties of the Company
or incur any Liens or permit any Liens to be imposed on any Property of the Company other than Permitted Liens, other than entry
into non-exclusive licenses in the Ordinary Course of Business;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(vi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>enter into, amend, modify or terminate (partially or completely) any (A) Material Contract, (B) Contract that would
constitute a Material Contract if entered into prior to the date of this Agreement, or (C) Contract with a Key Customer or material
supplier, except, in each case of (A), (B) and (C), in the Ordinary Course of Business;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(vii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>incur any Indebtedness other than Current Income Tax Liability;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(viii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>make any loans or advances to, or any investments in or capital contributions to, any Person, or forgive or discharge
in whole or in part any outstanding loans or advances, or prepay any indebtedness for borrowed money (other than routine advancement
of expenses or commissions to directors, officers, consultants or employees in the Ordinary Course of Business);</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ix)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>merge, fail to maintain its legal existence or consolidate with any other Person, or acquire capital stock or assets
of any other Person or enter into any Contract with respect to a joint venture, strategic alliance or partnership;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(x)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>change the Company&rsquo;s methods of accounting, except to the extent required by changes in GAAP;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>(A) make (outside the Ordinary Course of Business), change or rescind any material Tax election; (B) settle or compromise
any claim, audit, assessment or dispute relating to Taxes in excess of the amount reserved with respect thereto in the YTD Financial
Statements; (C) file any material amended Tax Return; (D) make any change in any material method of Tax accounting or material
Tax accounting periods; (E) knowingly surrender any claim for a refund of Taxes; (F) enter into any closing agreement with a Tax
Authority relating to any Tax; (G) file any material Tax Return except as in accordance with past practice; or (H) consent to any
extension or waiver of the limitation period applicable to any material Tax claim or assessment (other than pursuant to extensions
of time to file Tax Returns obtained in the Ordinary Course of Business);</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>make or enter into any commitment for any capital expenditures outside the Ordinary Course of Business;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xiii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>commence any lawsuit or legal proceedings or pay or agree to pay in settlement or compromise of any suits or claims
of liability against the Company;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xiv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>grant, extend, waive or modify any material rights in or to, or sell, assign, lease, license, transfer, let lapse,
abandon or otherwise dispose of, any material Properties of the Company (including any Company IP), other than grant non-exclusive
licenses in the Ordinary Course of Business;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>disclose to any third party, other than representatives of Parent or under a written and enforceable confidentiality
agreement, any Trade Secrets included in the Company IP in a way that results in the loss of protection for such Trade Secrets;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xvi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>except (A) as required under Applicable Laws or (B) to the extent required by any Company Plan, (1) materially increase
the compensation or consulting fees, bonus opportunity, pension, welfare, fringe or other benefits, severance or termination pay
of any of the current or former directors, officers, employees or consultants of the Company, (2)&nbsp;become a party to, establish,
adopt, amend (other than immaterial amendments in the Ordinary Course of Business that would not increase benefits or costs with
respect to such Company Plans by more than a <I>de minimis</I> amount), commence participation in or terminate any Company Plan
or any arrangement that would have been a Company Plan had it been entered into prior to this Agreement, (3) hire any employee
or engage any independent contractor (who is a natural person), except to fill a vacant position in each case with an annual salary
or wage rate or consulting fees and target cash bonus opportunity not in excess of $75,000, (4) terminate the employment of any
executive officer other than for cause, (5) grant any new equity awards, or amend or modify the terms of any outstanding equity
awards under the Stock Plans or any Company Plans, (6) take any action to accelerate the vesting or lapsing of restrictions or
payment, or fund or in any other way secure the payment of, compensation or benefits under any Company Plan (other than as otherwise
contemplated by this Agreement) or (7) forgive any loans or issue any loans (other than routine advances of expenses or commissions
issued in the Ordinary Course of Business) to any of its directors, officers, consultants or employees;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xvii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>become a party to, establish, adopt, amend, commence participation in or terminate any collective bargaining agreement
or other agreement with a labor union, works council or similar organization;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xviii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;
</FONT></FONT>cancel or terminate any material insurance policy or cause any of the coverage thereunder to lapse (unless simultaneously
with such termination, cancellation or lapse, replacement policies providing coverage equal to or greater than the coverage under
the canceled, terminated or lapsed policies, for premiums at not more than current market rates, are in full force and effect);</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xix)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>accelerate the collection of receivables or delay the payment of payables of the Company in a manner inconsistent
with the Ordinary Course of Business; or</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xx)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>agree or commit to do or engage in any of the foregoing.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Nothing contained in this Agreement shall give Parent, directly or indirectly, the right to control or direct the
Company&rsquo;s operations prior to the Closing. Prior to the Closing, the management of the Company shall exercise, consistent
with and in accordance with the terms and conditions of this Agreement, complete control and supervision over the operations of
the Company.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Reasonable Best Efforts; Regulatory and Other Approvals</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each of Parent, Merger Sub and the Company will, in order to consummate the Merger and the transactions contemplated
hereby, (i) take all steps reasonably necessary, and proceed diligently and in good faith and use its reasonable best efforts,
as promptly as practicable, to make all required filings required to be made by it with, and to give all required notices to, all
applicable Governmental Authorities, (ii) provide such other information and communications to such Governmental Authorities or
other Persons as such Governmental Authorities or other Persons may reasonably request in connection therewith and (iii) use its
reasonable best efforts and cooperate with each other Party, to take, or cause to be taken, all actions, and to do, or cause to
be done, all things reasonably necessary, appropriate or desirable to consummate and make effective, as promptly as practicable,
the Merger and the other transactions contemplated by this Agreement, including the satisfaction of the respective conditions set
forth in <U>Article VII</U> and <U>Article VIII</U>, and including to execute and deliver such other instruments and to do and
perform such other acts and things as may be reasonably necessary or reasonably desirable for effecting completely the consummation
of the Merger and the other transactions contemplated hereby.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Parent and the Company will provide prompt notification to each other when any such approval referred to in <U>Section&nbsp;6.03(a)</U>
is obtained, taken, made, given or denied, as applicable, and will advise each other of any material communications with any Governmental
Authority or other Person regarding any of the transactions contemplated by this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>In furtherance of the foregoing covenants in this <U>Section&nbsp;6.03</U>:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each of Parent, Merger Sub and the Company shall prepare, as soon as is practical following the execution of this
Agreement, any necessary filings in connection with the transactions contemplated by this Agreement that may be required to be
filed by such Party under any other federal, state or local Applicable Laws. Each such Party shall submit such filings as soon
as practicable, but in no event later than ten (10)&nbsp;days (subject to extension by mutual agreement)&nbsp;after the date hereof.
The Parties shall request expedited treatment of any such filings, shall promptly furnish each other with copies of any notices,
correspondence or other written communication from the relevant Governmental Authority, shall promptly make any appropriate or
necessary subsequent or supplemental filings and shall cooperate in the preparation of such filings.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>In connection with their obligations pursuant to this <U>Section&nbsp;6.03(c)</U>, Parent and the Company shall,
to the extent permitted by Applicable Laws, (w)&nbsp;keep each other informed in all material respects and on a reasonably timely
basis of any material communication received by such party from, or given by such party to, any Governmental Authority and of any
material communication received or given in connection with any proceeding by a private party, in each case with respect to this
Agreement or the transactions contemplated hereby, (x)&nbsp;notify each other of all documents filed with, submitted to or received
from any Governmental Authority with respect to this Agreement or the transactions contemplated hereby, (y)&nbsp;furnish each other
with such information and assistance as the other may reasonably request in connection with their preparation of any such governmental
filing or submission hereunder and (z)&nbsp;reasonably cooperate with each other in connection with and in advance of any such
filing or submission with a Governmental Authority in connection with the transactions contemplated by this Agreement and in connection
with any investigation or other inquiry by or before any Governmental Authority relating to this Agreement or the transactions
contemplated hereby, including any Action initiated by a private party. Subject to Applicable Laws relating to the exchange of
information, each of Parent and the Company (A)&nbsp;shall have the right to review in advance, and to the extent practicable each
will consult with each other with respect to, all information that appears in any filing made with, or written materials submitted
to, any Governmental Authority with respect to this Agreement, and (B)&nbsp;shall give the other a reasonable opportunity to attend
and participate in meetings and telephone conferences with any such Governmental Authority relating to the foregoing. To the extent
permitted by Applicable Law, the Company will not, nor will it permit any of its Representatives to, make any material communications
with, or proposals relating to, or enter into, any material understanding, undertaking or agreement with, any Governmental Authority
relating to the transactions contemplated by this Agreement without Parent&rsquo;s prior review and approval.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 51; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each Party shall cooperate in good faith with all Governmental Authorities, and undertake promptly any and all actions,
consistent with its obligation under this <U>Section&nbsp;6.03</U>, that are required to complete lawfully the transactions contemplated
by this Agreement prior to the Termination Date. Notwithstanding the foregoing, nothing in this Agreement shall require, or be
construed to require, either Party or any of its Affiliates, before or after the Closing Date, to agree to (x) sell, hold, divest,
license, discontinue or limit any of its or its Affiliates&rsquo; assets, businesses, contracts or interests; (y) subject to <U>Section
3.08(h)</U>, any conditions relating to, changes in, or restrictions on the operation of any of its or its Affiliates&rsquo; assets,
businesses, contracts or interests; or (z) any material modification or waiver of the terms and conditions of this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.04<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>No Solicitation or Negotiation of Alternative Proposals</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company agrees that neither it nor any of the officers and directors of it shall, and that none of its Representatives
shall, directly or indirectly: (i) initiate, solicit or knowingly encourage any inquiries or the making of any proposal or offer
that constitutes, or could reasonably be expected to lead to, any Acquisition Proposal; (ii) engage in, continue or otherwise participate
in any discussions or negotiations regarding, or provide any non-public information or data to any Person relating to, any Acquisition
Proposal; (iii) agree to, approve, endorse, recommend or consummate any Acquisition Proposal; (iv) enter into any letter of intent,
memorandum of understanding, agreement in principle, merger agreement, acquisition agreement or other agreement (an &ldquo;<U>Alternative
Acquisition Agreement</U>&rdquo;); or (v) otherwise knowingly facilitate any effort or attempt to make an Acquisition Proposal.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>No Change in Recommendation or Alternative Acquisition Agreement</U>. Except to the extent required by the directors&rsquo;
fiduciary duties prior to the time Written Consents constituting the Required Stockholder Approval have been delivered to Parent,
the Company&rsquo;s board of directors and each committee of the board shall not withhold, withdraw, qualify or modify (or propose
or resolve to withhold, withdraw, qualify or modify), in a manner adverse to Parent, the Board Recommendation.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Existing Discussions</U>. The Company agrees that it will immediately cease and cause to be terminated any existing
activities, discussions or negotiations with any parties conducted heretofore with respect to any Acquisition Proposal or any fundraising
effort, including exploration of or preparation for an initial public offering. The Company also agrees that it will promptly after
announcement of this Agreement request each Person that has heretofore executed a confidentiality agreement in connection with
its consideration of an existing Acquisition Proposal or any fundraising effort to return or destroy all confidential information
heretofore furnished to such Person by or on behalf of the Company.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Notice</U>. The Company agrees that it will promptly (and, in any event, within twenty-four (24) hours) notify
Parent if any inquiries, proposals or offers with respect to an Acquisition Proposal are received by, or any such information is
requested from, or any such discussions or negotiation are sought to be initiated or continued with, it or any of its Representatives
indicating, in connection with such notice, the material financial terms and conditions of any proposals or offers (including,
if applicable, copies of any written requests, proposals or offers, including proposed agreements) and thereafter shall keep Parent
informed, on a current basis, of the status and material financial terms of any such proposals or offers (including any amendments
thereto) and the status of any such discussions or negotiations, including any change in the Company&rsquo;s intentions as previously
notified.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 52; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.05<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Required Stockholder Approval</U>. In accordance with Applicable Laws, including Section&nbsp;228, Section&nbsp;251(c)
and Section&nbsp;262 of the Delaware Law, and the Company&rsquo;s Organizational Documents, immediately following the execution
of this Agreement and the mailing of the Information Statement, the Company shall seek and shall use its reasonable best efforts
to obtain as promptly as practicable, and in any event, by midnight on January 5, 2020, (the &ldquo;<U>Initial Stockholder Support
Delivery Period</U>&rdquo;) Support Agreements from the Stockholders holding a number of shares of Company Capital Stock sufficient
to satisfy the Required Stockholder Approval in lieu of a meeting pursuant to Section&nbsp;228 of the Delaware Law for the purposes
of (a) adopting this Agreement and approving the Merger and (b) acknowledging that the adoption and approvals are irrevocable and
result in the waiver of any right of such stockholders to demand appraisal in connection with the Merger pursuant to the Delaware
Law. As promptly as practicable and, in any event, prior to the expiration of the Initial Stockholder Support Delivery Period,
if Support Agreements sufficient to constitute the Required Stockholder Approval are duly executed and delivered to the Company,
the Company shall deliver to Parent a copy thereof (including by facsimile or other electronic image scan transmission), certified
as correct and complete by an executive officer of the Company.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.06<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Additional Stockholder Consents</U>. After the date of this Agreement and prior to the Effective Time, the Company
shall use reasonable best efforts to have Written Consents executed and delivered by Stockholders such that Stockholders holding
at least ninety-five percent (95%) of the issued and outstanding shares of Company Capital Stock shall have executed and delivered
Written Consents prior to the Closing Date.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.07<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Information Statement</U>. Within five (5) days of the date of this Agreement, the Company shall prepare (with
the cooperation of Parent) and mail to each holder of Company Capital Stock an information statement regarding the transactions
contemplated by this Agreement, which shall be in a form reasonably acceptable to Parent (as it may be amended or supplemented
from time to time, the &ldquo;<U>Information Statement</U>&rdquo;). The Information Statement shall constitute an information statement
for the Company&rsquo;s solicitation of consent of the holders of Company Capital Stock with respect to the adoption of this Agreement
and the approval of the Merger and a notice of the availability of appraisal rights under Delaware Law and shall include (a) a
statement to the effect that the Company&rsquo;s board of directors had unanimously recommended that the holders of Company Capital
Stock vote in favor of the adoption of this Agreement and the approval of the Merger, (b) a statement that adoption of this Agreement
shall constitute, among other things, approval by the holders of Company Capital Stock of the Expense Fund by the Stockholder Representative
and the withholding of the Special Indemnity Holdback and (c) such other information as Parent and the Company reasonably agree
is required or advisable under Applicable Laws to be included therein. The Company shall, with the cooperation of Parent (to the
extent reasonably required), prepare any other necessary documentation required or advisable to be provided to holders of Company
Capital Stock pursuant to the Delaware Law. None of the information supplied or to be supplied by Parent or the Company for inclusion
in the Information Statement or any amendment or supplement thereto will contain, as of the date of the delivery of such document,
any untrue statement of a material fact, or will omit to state any material fact necessary in order to make the statements therein,
in light of the circumstances under which they are made, not misleading.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 53; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.08<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Employees; Employee Benefits</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>For a period of one (1) year following the Effective Time (the &ldquo;<U>Continuation Period</U>&rdquo;), Parent
will, or will cause an Affiliate to, provide to each Continuing Employee for so long as such Continuing Employee remains an employee
of Parent or its Affiliates during the Continuation Period (i) base salary or regular hourly wage and target annual cash bonus
opportunities that are each no less favorable than the base salary or regular hourly wage and target annual cash bonus opportunities,
respectively, provided to such Continuing Employee as of immediately prior to the Effective Time and (ii) retirement and welfare
benefits (excluding any defined benefit plan benefits) that are, in the aggregate, substantially comparable to those provided to
such Continuing Employee as of immediately prior to the Effective Time. Parent shall honor each Continuing Employee&rsquo;s accrued,
unused vacation balances as of the Closing Date, and allow the Continuing Employees to use such vacation after the Closing Date,
in accordance with Parent&rsquo;s applicable policies.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Parent shall use commercially reasonable efforts to (i) cause any pre-existing conditions or limitations and eligibility
waiting periods under any group health plans of Parent or its Affiliates to be waived with respect to the Continuing Employees
and their eligible dependents, and (ii) give each Continuing Employee credit for the plan year in which the Effective Time occurs
towards applicable deductibles and annual out-of-pocket limits for medical expenses incurred prior to the Effective Time for which
payment has been made. Parent shall give each Continuing Employee service credit for such Continuing Employee&rsquo;s employment
with the Company for purposes of vesting, benefit accrual, level of benefits and eligibility to participate under each applicable
Parent benefit plan (which, for the avoidance of doubt, does not include any equity incentive plan), as if such service had been
performed with Parent, except for benefit accrual under defined benefit pension plans, for purposes of qualifying for subsidized
early retirement benefits or to the extent it would result in a duplication of benefits.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Prior to the Effective Time, if requested by Parent in writing at least ten (10) Business Days prior to the Effective
Time, the Company shall cause the Company&rsquo;s 401(k) plan to be terminated effective no later than the day immediately prior
to the Effective Time. In the event that Parent requests that the Company&rsquo;s 401(k) plan be terminated, the Company shall
provide Parent with evidence that such plan has been terminated (the form and substance of which shall be subject to reasonable
review and comment by Parent) no later than the day immediately preceding the Effective Time.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Prior to delivering or making any written or oral communications to the directors, officers or employees of the Company
pertaining to compensation or benefit matters that are affected by the transactions contemplated by this Agreement, the Company
shall provide Parent with a copy summarizing the intended communications for Parent&rsquo;s approval (which shall not be unreasonably
withheld, conditioned or delayed).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 54; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>(i) If required, within seven (7) Business Days prior to the Effective Time (and provided that within nine (9) Business
Days prior to the Effective Time, Parent has fully and timely disclosed any potential &ldquo;parachute payment&rdquo; (as defined
below) to any disqualified individual (as defined below) pursuant to any agreement or arrangement between any such disqualified
individual and Parent (or its applicable Affiliate)), the Company shall use its commercially reasonable efforts to cause to be
irrevocably waived by each of the applicable &ldquo;disqualified individuals&rdquo; (as defined under Section 280G of the Code
and the regulations promulgated thereunder) the right to any payments that would reasonably be expected to constitute a &ldquo;parachute
payment&rdquo; pursuant to Section 280G of the Code (each, a &ldquo;<U>Parachute Payment</U>&rdquo;) and (ii) at least five (5)
Business Days prior to the Effective Time, the Company shall submit for approval by holders of Company Capital Stock, in conformance
with Section 280G of the Code and the regulations thereunder (the &ldquo;<U>280G Stockholder Vote</U>&rdquo;), any Parachute Payments.
The disclosure and documents that comprise the 280G Stockholder Vote shall be prepared by the Company and Parent shall have a reasonable
period of time to review and provide reasonable comment, which the Company shall consider in good faith.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Prior to the Effective Time, the Company shall take the actions set forth on <U>Section 6.08(f)</U> of the Company
Disclosure Schedule.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Nothing contained in this Agreement is intended to (i) be treated as an amendment of any particular Company Plan,
(ii) prevent Parent, the Surviving Corporation or any of their Affiliates from amending or terminating any of their benefit plans
or, after the Effective Time, any Company Plan in accordance with its terms, (iii) prevent Parent, the Surviving Corporation or
any of their Affiliates, after the Effective Time, from terminating the employment of any Continuing Employee, or (iv) create any
third-party beneficiary rights in any employee of the Company, any beneficiary or dependent thereof, with respect to the compensation,
terms and conditions of employment and/or benefits that may be provided to any Continuing Employee by Parent, the Surviving Corporation
or any of their Affiliates or under any benefit plan which Parent, the Surviving Corporation or any of their Affiliates may maintain.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.09<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Third-Party Consents</U>. The Company shall use commercially reasonable efforts to (i) obtain prior to the Closing,
and (ii) deliver to Parent at or prior to the Closing, all consents, waivers and approvals under each Contract listed or described
in <U>Section&nbsp;6.09</U> of the Company Disclosure Schedule.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.10<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Tax Matters</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Tax Returns</U>. The Stockholder Representative shall prepare, or cause to be prepared, and Parent shall file
or cause to be filed, all Tax Returns that reflect any Pre-Closing Tax Period (including, for the avoidance of doubt, Tax Returns
for Straddle Periods) required to be filed by or on behalf of the Company after the Closing Date that have an initial due date
after the Closing Date (assuming for such purpose that, if a valid extension is obtained, the initial due date is the extended
due date) to the extent not already filed prior to the Closing Date (each, a &ldquo;<U>Pre-Closing Tax Return</U>&rdquo;). Such
Pre-Closing Tax Returns shall be prepared in a manner consistent with past practices of the Company unless otherwise required by
Applicable Laws and, if applicable, shall reflect the provisions of <U>Section 6.10(h)</U>. The Stockholder Representative shall
provide Parent with a copy of each such proposed Pre-Closing Tax Return (and such additional information regarding such Pre-Closing
Tax Return as may reasonably be requested by Parent) at least thirty (30) days before filing for Parent&rsquo;s review and comment.
Parent shall have fifteen (15) days following receipt of any such Pre-Closing Tax Return to provide to the Stockholder Representative
any written comments to such Pre-Closing Tax Return, and Parent and the Stockholder Representative shall attempt in good faith
to resolve any dispute regarding any such comments. If Parent and the Stockholder Representative are unable to resolve any such
dispute within a five (5) day period, such dispute shall be referred to the Independent Accountant for resolution. Each Party shall
use its reasonable efforts to furnish to the Independent Accountant such work papers and other documents and information pertaining
to the unresolved items as the Independent Accountant may request. All communications between Parent and Stockholder Representative,
on the one hand, and the Independent Accountant, on the other hand, will be in writing with copies simultaneously delivered to
the non-communicating Party. The Independent Accountant shall make a written determination as to the dispute within a reasonable
time after the same is submitted to the Independent Accountant (taking into account the due date of the applicable Pre-Closing
Tax Return), which determination shall be conclusive, final and binding on the parties for all purposes hereunder. If during the
process of resolving a dispute concerning a Pre-Closing Tax Return such Pre-Closing Tax Return becomes due (taking into account
valid extensions, which shall be obtained if available), then the Surviving Corporation may file such Pre-Closing Tax Return or
cause such Pre-Closing Tax Return to be filed reflecting any changes that were agreed upon prior to filing. If as a result of the
resolution of the dispute by the Independent Accountant it is determined that such Pre-Closing Tax Return should have been prepared
differently, such Pre-Closing Tax Return shall be amended and refiled accordingly. The costs and expenses of the Independent Accountant
shall be borne by the Stockholder Representative (solely on behalf of the Equityholders) and the Parent in a manner consistent
with <U>Section 3.07</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 55; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Audits and Contests Regarding Taxes for Pre-Closing Tax Periods</U>. Any Party who receives, or whose Affiliate
receives, any notice of a pending or threatened Tax audit, assessment or adjustment or other proceeding related to Taxes against
or with respect to the Company that relates to any Pre-Closing Tax Return or Taxes with respect to a Pre-Closing Tax Period shall
promptly notify the other Parties in writing within five (5) Business Days after receipt of such notice. Parent and the Stockholder
Representative each agree to consult with and to keep the other informed on a regular basis regarding the status of any such proceeding.
The Stockholder Representative shall have the right to conduct and control any such proceeding and to employ counsel of its choice
at the Equityholders&rsquo; sole expense in such proceeding, and to control the disposition of any issue involved in such proceeding
to the extent such proceeding relates to or affects Pre-Closing Tax Returns or Taxes of the Company for a Pre-Closing Tax Period
(including, for the avoidance of doubt, a Straddle Period); provided that Parent shall have the right to participate in such proceeding
through counsel of its choice at its own expense. To the extent inconsistent therewith, the provisions of this <U>Section&nbsp;6.10(b)</U>
shall supersede the provisions of <U>Section&nbsp;10.03</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Tax Cooperation</U>. Parent, the Surviving Corporation and the Stockholder Representative shall, and shall cause
their Affiliates to, cooperate following the Closing, as and to the extent reasonably requested by the other party, in connection
with any Tax matters relating to the Company for any Pre-Closing Tax Period (including, for the avoidance of doubt, a Straddle
Period), including filing Tax Returns and in resolving Tax-related disputes. Such cooperation shall include the retention and (upon
the other party&rsquo;s request) the prompt provision of records and information relating to Taxes of the Company (and the right
to make copies thereof), making employees available on a mutually convenient basis to provide additional information and explanation
of any material provided hereunder. Parent and the Surviving Corporation (and each of their respective Affiliates) agree to retain
all books and records with respect to Tax matters pertinent to the Company relating to any Pre-Closing Tax Period until the later
of (i) seven years and (ii) 120 days after the expiration of the statute of limitations of the respective taxable periods, and
to abide by all record retention agreements entered into with any Tax Authority.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 56; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Transfer Taxes</U>. Notwithstanding anything herein to the contrary, all transfer, documentary, sales, use, stamp,
registration and other similar Taxes (including penalties and interest) incurred solely as a result of the Merger (&ldquo;<U>Transfer
Taxes</U>&rdquo;) shall be borne by Parent. Parent shall prepare and file any returns with respect to such Transfer Taxes. The
Parties agree to cooperate in such preparation and filing of Tax Returns, including by promptly supplying any information in its
possession that is reasonably necessary to complete such returns.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Tax Sharing Agreements</U>. All written Contracts providing for allocation, sharing or indemnification with respect
to Taxes (other than Contracts not primarily related to Taxes which were entered into in the Ordinary Course of Business, including
without limitation credit or loan agreements, vendor agreements, purchase and sale agreements and leases) to which the Company
is a party and pursuant to which the Company may have any obligations or responsibilities with respect to Taxes shall be terminated
prior to the Closing, and the Company shall have no further obligations or responsibilities thereunder following the Closing.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Amended Tax Returns</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Except pursuant to <U>Section 6.10(a)</U> or <U>Section 6.10(f)(ii)</U>, neither Parent nor the Surviving Corporation
shall, and neither shall cause or permit any of their Affiliates to, amend, file, re-file, make, revoke or otherwise modify any
Tax Return or Tax election (including changing a method of accounting) of the Company with respect to any Pre-Closing Tax Period
(including, for the avoidance of doubt, any Straddle Period). Neither Parent nor the Surviving Corporation nor any of their Affiliates
shall initiate or enter into any voluntary disclosure program or similar process, or voluntarily initiate discussion with a Tax
Authority, with respect to Taxes or Tax Returns of the Company with respect to any Pre-Closing Tax Period or file any Tax Return
of the Company with respect to any Pre-Closing Tax Period in a jurisdiction in which the Company had not previously filed Tax Returns.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Notwithstanding <U>Section 6.10(f)(i)</U>, Parent or the Surviving Corporation may take an action described in <U>Section
6.10(f)(i)</U> if Parent satisfies the requirements of this <U>Section 6.10(f)(ii)</U>. If Parent determines that authority exists
to support taking an action described in <U>Section 6.10(f)(i)</U> that satisfies a &ldquo;more likely than not&rdquo; standard
(or higher standard), Parent may prepare draft documentation or memoranda with respect to or to effectuate such action (and which
documentation or memoranda, for the avoidance of doubt, support such standard) and shall submit such to the Stockholder Representative
for review and comment.&nbsp; Parent shall not take any such action if the Stockholder Representative asserts in writing with documentation
that reasonably supports such assertion within fifteen (15) days of receipt of Parent&rsquo;s materials that there does not exist
authority that satisfies a &ldquo;more likely than not&rdquo; standard (or higher standard) with respect to such action.&nbsp;
In the event of such disagreement, Parent and the Stockholder Representative shall attempt in good faith to resolve such disagreement.&nbsp;
If Parent and the Stockholder Representative are unable to resolve any such disagreement within a five (5) day period, such dispute
shall be referred to the Independent Accountant for resolution. &nbsp;Each Party shall use its reasonable efforts to furnish to
the Independent Accountant such work papers and other documents and information pertaining to the dispute as the Independent Accountant
may request.&nbsp; All communications between Parent and the Stockholder Representative, on the one hand, and the Independent Accountant,
on the other hand, will be in writing with copies simultaneously delivered to the non-communicating Party.&nbsp; The Independent
Accountant shall make a written determination as to the dispute within a reasonable time after the same is submitted to the Independent
Accountant, which determination shall be conclusive, final and binding on the Parties for all purposes hereunder. The costs and
expenses of the Independent Accountant shall be borne by the Stockholder Representative (solely on behalf of the Equityholders)
and the Parent in a manner consistent with <U>Section 3.07</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 57; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Refunds</U>. Any Tax refunds (and interest, if any, received thereon) or benefit of crediting an overpayment (and
interest, if any, received thereon) of Taxes that are received by or credited to Parent, its Affiliates or the Surviving Corporation
with respect to Taxes with respect to a Pre-Closing Tax Period shall be paid by Parent to the Stockholder Representative within
fifteen (15) Business Days after actual receipt or benefit thereof. Parent and the Surviving Corporation shall cause any losses,
deductions and credits of the Company relating to a Pre-Closing Tax Period to first offset income and gain in the period or portion
thereof to which they relate and thereafter carry them back to prior periods to the maximum extent permitted by Law prior to being
carried forward.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(h)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Deductions for Expenses</U>. The Parties agree that payments made with respect to Closing Indebtedness, Transaction
Expenses, and consideration paid pursuant to this Agreement with respect to Company Options, to the extent such payments give rise
to Tax deductions, Tax losses and Tax credits or otherwise may offset taxable income or Tax under Applicable Law, shall, to the
maximum extent permitted by Applicable Law, be considered to arise in a Pre-Closing Tax Period and the provisions of this Agreement
shall be interpreted and applied in a manner consistent therewith (including the preparation and filing of Tax Returns pursuant
to <U>Section 6.10(a)</U>). The Surviving Corporation shall make the election described in Section 4 of Revenue Procedure 2011-29,
2011-18 IRB 746 with respect to any success-based fees incurred in connection with the transactions contemplated by this Agreement
(including for purposes of filing Tax Returns pursuant to <U>Section 6.10(a)</U>).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Closing Date Items/No Section 338 Election</U>. None of Parent, the Surviving Corporation or any of their Affiliates
shall make or permit or cause to be made any extraordinary transactions or events on the Closing Date with respect to the Company
that would result in any increased liability with respect to Taxes for which any Equityholder would be responsible or would economically
bear (through payment, indemnification, reduction in consideration to be received, or otherwise). None of Parent, the Surviving
Corporation or any of their Affiliates shall file or permit or cause to be filed any election under Section 338 or Section 336
of the Code (or comparable provision of other Law) with respect to transactions described pursuant to this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 58; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.11<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Further Assurances; Post-Closing Cooperation</U>. Upon the terms and subject to the conditions of this Agreement,
at any time or from time to time after the Closing, each of the Parties hereto shall execute and deliver such other documents and
instruments, provide such materials and information and take such other actions as may reasonably be necessary, proper or advisable,
to the extent permitted by Applicable Law, to fulfill its obligations under this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.12<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Indemnification of Directors and Officers; Directors&rsquo; and Officers&rsquo; Insurance, etc</U>. Parent agrees
that, subject to Applicable Laws, all rights to indemnification and all limitations of liability existing in favor of the Indemnified
Directors and Officers (as provided in (i) the Company&rsquo;s Organizational Documents and (ii) any other indemnification agreements
(as applicable) as in effect as of the date of this Agreement) with respect to matters occurring on or prior to the Effective Time
shall survive the Merger and shall continue in full force and effect thereafter, without any amendment thereto.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>If Parent or the Surviving Corporation or any of its successors or assigns shall (i) consolidate with or merge into
any other Person and shall not be the continuing or surviving Person of such consolidation or merger or (ii) transfer all or substantially
all of its properties and assets to any Person, then, in each such case, proper provisions shall be made so that the successors
and assigns of Parent and the Surviving Corporation, as the case may be, assume all of the obligations of Parent and the Surviving
Corporation set forth in this <U>Section&nbsp;6.12</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Prior to, but effective as of, the Closing, the Company shall, at the Company&rsquo;s expense, obtain a directors&rsquo;
and officers&rsquo; liability, employment practices liability and fiduciary liability insurance policy providing each individual
currently covered by the Company&rsquo;s directors&rsquo; and officers&rsquo; liability, employment practices liability and fiduciary
liability insurance coverage for events occurring at or prior to the Effective Time (including acts or omissions relating to the
approval of this Agreement and consummation of the transactions contemplated hereby) that is no less favorable than the Company&rsquo;s
existing policy and has a claims period of six (6) years after the Closing Date.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The provisions of this <U>Section&nbsp;6.12</U> shall survive the consummation of the Merger and are intended to
be for the benefit of, and shall be enforceable by, each individual who served as a director or officer of the Company prior to
the Effective Time (each, an &ldquo;<U>Indemnified Director or Officer</U>&rdquo;), each of whom is an express third-party beneficiary
of this <U>Section&nbsp;6.12</U>. The obligations of Parent and the Surviving Corporation under this <U>Section&nbsp;6.12</U> shall
not be terminated or modified in such a manner as to adversely affect the rights of any Indemnified Director or Officer under this
<U>Section&nbsp;6.12</U> without the consent of such affected Indemnified Director or Officer.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.13<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>R&amp;W Insurance</U>. At or prior to the Closing, Parent shall obtain and bind the R&amp;W Policy. The Company
shall cooperate with Parent&rsquo;s efforts at Parent&rsquo;s request and provide such assistance as may be reasonably necessary
or appropriate in order to enable Parent to obtain and bind the R&amp;W Policy. The Parties acknowledge and agree that, other than
in the case of Fraud by any Stockholder, neither the Equityholders, the Stockholder Representative nor any of their respective
Representatives shall be liable to the insurer under the R&amp;W Policy for subrogation claims pursuant to the R&amp;W Policy,
and Parent covenants and agrees that the R&amp;W Policy will include a waiver of such subrogation claims (other than in the case
of Fraud by any Stockholder) for the benefit of the Equityholders, the Stockholder Representative and their respective Representatives.
From and after the issuance and binding of the R&amp;W Policy, Parent shall not (and shall cause its Affiliates to not) terminate
the R&amp;W Policy or amend, modify, supplement, terminate or waive any provision of the R&amp;W Policy, including regarding waiver
of subrogation, without the prior written consent of the Stockholder Representative. Parent shall cause the R&amp;W Policy, when
issued and bound, to be consistent in all material respects with the Binder Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 59; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.14<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Notification</U>. During the Interim Period, the Company shall give prompt notice to Parent, and Parent shall
give prompt notice to the Company, (a) of any notice or other communication received by such Party from any Governmental Authority
in connection with the transactions contemplated by this Agreement or from any Person alleging that the consent of such Person
is or may be required in connection with the transactions contemplated by this Agreement, and (b) any material communications (written
or oral) received from any Person relating to the Company IP and (c) any matter (including a breach of any representation, warranty,
covenant or agreement contained in this Agreement) that would reasonably be expected to lead to the failure to satisfy any of the
conditions to Closing in <U>Article VII</U> or <U>Article VIII</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.15<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Company Audit; Disclosure of Acquisition</U>. The Company will use its reasonable best efforts to (a) engage and
cause an independent registered auditor to conduct and complete an audit of its respective financial statements for the year ended
December 31, 2019; (b) obtain BDO&rsquo;s consent for the use of the Financial Statements in Parent&rsquo;s SEC filings and (c)
cooperate with Parent to (i) prepare pro forma financial statements that comply with the rules and regulations of the SEC to the
extent required for any SEC filings to be made by Parent, including the requirements of Regulation S-X; and (ii) provide and make
reasonably available upon reasonable notice the senior management employees of the Company to discuss the materials prepared and
delivered pursuant to this <U>Section 6.15</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.16<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Fixing Record Date</U>. Immediately after the date hereof, the Company will set the record date, which date shall
be twenty-five (25) days following the date of this Agreement, and at the time of mailing of the Information Statement, provide
written notice of such date as required by the Charter, for purposes of determining the holders of Company Capital Stock entitled
to vote in respect of the Merger, with such date being at least twenty (20) days&rsquo; following the date on which such prior
written notice is provided.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 60; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0"><FONT STYLE="color: #010000">Article
VII</FONT><BR>
CONDITIONS TO OBLIGATIONS OF PARENT AND MERGER SUB</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The obligations of Parent and Merger Sub to consummate
the Closing are subject to the satisfaction, at or before the Closing, of each of the following conditions (all or any of which
may be waived in whole or in part by Parent in its sole discretion):</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Representations and Warranties</U>. (a) The representations and warranties made by the Company set forth in <U>Article
IV</U>, other than the Company Fundamental Representations, shall be true and correct in all respects as of the date hereof and
on and as of and as though made on the Closing Date (except for any such representation or warranty that is expressly made as of
a specified date, which need only be true and correct as of such specified date), disregarding in each case any qualifications
regarding materiality or Material Adverse Effect, except for any failures in such representations and warranties to be so true
and correct that, individually or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse
Effect, and (b) the Company Fundamental Representations shall be true and correct in all respects as of the date hereof and as
of and as though made on the Closing Date (except for any such representation or warranty that is expressly made as of a specified
date, which need only be so true and correct as of such specified date, and with respect to the representations and warranties
made by the Company in <U>Section&nbsp;4.02(a)</U>, the first sentence of <U>Section&nbsp;4.02(b)</U>, and <U>Section&nbsp;4.02(c)</U>,
except where the failure to be so true and correct is to a <I>de minimis</I> extent).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Performance</U>. The Company shall have performed and complied in all material respects with the agreements, covenants
and obligations required by this Agreement to be so performed or complied with by it at or before the Closing.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Payment of Transaction Expenses</U>. The Company shall have provided copies of customary payoff letters in connection
with the repayment of Transaction Expenses from the Persons listed on <U>Schedule 7.03</U> hereto.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.04<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Officer&rsquo;s Certificates</U>. The Company shall have delivered to Parent and Merger Sub at the Closing a certificate
of the chief executive officer of the Company, dated as of the Closing Date, certifying that the conditions in <U>Section&nbsp;7.01</U>,
<U>Section&nbsp;7.02</U> and <U>Section 7.03</U> have been satisfied.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.05<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Orders and Applicable Laws</U>. There shall not be in effect on the Closing Date any Order or Applicable Law restraining,
enjoining or otherwise prohibiting or making illegal the consummation of any of the transactions contemplated by this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.06<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>No Material Adverse Effect</U>. Since the date of this Agreement, there shall not have occurred and be continuing
a Material Adverse Effect.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.07<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Stockholder Approval</U>. The Company shall have obtained the Required Stockholder Approval, and Stockholders
holding at least ninety-five percent (95%) of the issued and outstanding shares of Company Capital Stock shall have executed Written
Consents, certified copies of which shall have been provided to Parent, and have validly waived all appraisal rights under the
Delaware Law.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 61; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.08<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Series B Preferred Support Agreement</U>. All holders of the Series B Preferred Stock shall have executed a Support
Agreement in the form attached to this Agreement as Part 2 to Annex B.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.09<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Payments Administrator Agreement</U>. Parent shall have received the Payments Administrator Agreement duly executed
by the Stockholder Representative and the Payments Administrator.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.10<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Stockholder Representative NDA</U>. Parent shall have received the Stockholder Representative NDA duly executed
by the Stockholder Representative.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.11<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>280G Stockholder Vote</U>. If required, the 280G Stockholder Vote shall have occurred and the Company shall have
used its commercially reasonable efforts to ensure that any payments that could reasonably be expected to be non-deductible under
Section&nbsp;280G of the Code shall have been irrevocably waived by each of the applicable &ldquo;disqualified individuals&rdquo;
(as defined under Section&nbsp;280G of the Code and the regulations promulgated thereunder) and either approved or disapproved
in the 280G Stockholder Vote.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.12<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Letter Agreements</U>. The Key Individuals and Key Stockholders shall have executed Letter Agreements, which shall
remain in full force and effect.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.13<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Continued Employment</U>. The Key Employees shall be employed by the Company (except to the extent such employment
is terminated by death of a Key Employee) and shall not have served any resignations or be subject to pending termination.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.14<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>FIRPTA Certificate</U>. The Company shall have delivered to Parent a certificate pursuant to Treasury Regulations
Section&nbsp;1.1445-2(c)(3), duly executed and acknowledged, certifying that interests in the Company are not &ldquo;U.S. real
property interests,&rdquo; together with the notice required to be mailed to the IRS under Treasury Regulations Section&nbsp;1.897-2(h),
each substantially in the form on <U>Annex&nbsp;D</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.15<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Stockholders Agreement; Investor Rights Agreement</U>. The Stockholders&rsquo; Agreement, dated as of September
5, 2003, by and among the Company and certain of the Company&rsquo;s Equityholders, shall be terminated and be of no further force
or effect as of the Effective Time. The Investor Rights Agreement, dated as of September&nbsp;5,&nbsp;2003, by and among the Company
and certain of the Company&rsquo;s Equityholders, shall be terminated and be of no further force or effect as of the Effective
Time.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.16<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>[&hellip;] Agreements</U>. The Company and [&hellip;] shall have entered into an agreement containing the terms
set forth on <U>Annex E</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.17<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Consents and Notice</U>. The consents and notices listed on <U>Section 4.04(b)</U> of the Company Disclosure Schedule
shall have been obtained or provided (respectively) each in form and substance reasonably satisfactory to Parent.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.18<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Audit and Interim Financials</U>. The Company shall have (a) delivered to Parent either (i) annual financial statements
audited by the Company&rsquo;s independent registered auditor for the period ending December&nbsp;31, 2018 and interim financial
statements for the period through September 30, 2019 conducted in accordance with SAS 100 review procedures or (ii) annual financial
statements audited by the Company&rsquo;s independent registered auditor for both the periods ending December 31, 2018 and December&nbsp;31,
2019 and interim financial statements for the period through September 30, 2019 conducted in accordance with SAS 100 review procedures,
(b) delivered to Parent a copy of an executed engagement letter(s) (including the audit plan) with the Company&rsquo;s independent
registered auditor and (c) completed a physical inventory of the Company Products that are located at the Company&rsquo;s offices
in [&hellip;], the offices of [&hellip;] and the offices of [&hellip;] consistent with the Ordinary Course of Business following
the date of this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 62; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0"><FONT STYLE="color: #010000">Article
VIII</FONT><BR>
CONDITIONS TO OBLIGATIONS OF THE COMPANY</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The obligation of the Company to consummate the
Closing is subject to the satisfaction, at or before the Closing, of each of the following conditions (all or any of which may
be waived in whole or in part by the Company in its sole discretion):</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">8.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Representations and Warranties</U>. (a) The representations and warranties made by Parent and Merger Sub set forth
in <U>Article V</U>, other than the Parent Fundamental Representations, shall be true and correct in all respects as of the date
hereof and on and as of and as though made on the Closing Date (except for any such representation or warranty that is expressly
made as of a specified date, which need only be true and correct as of such specified date), disregarding in each case any qualifications
regarding materiality, except for any failures in such representations and warranties to be so true and correct that, individually
or in the aggregate, have not had and would not reasonably be expected to have a material adverse effect on the ability of Parent
and Merger Sub to consummate the transactions contemplated hereby, and (b) the Parent Fundamental Representations shall be true
and correct in all respects as of the date hereof and as of and as though made on the Closing Date (except for any such representation
or warranty that is expressly made as of a specified date, which need only be so true and correct as of such specified date).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">8.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Performance</U>. Parent and Merger Sub shall have performed and complied in all material respects with the agreements,
covenants and obligations required by this Agreement to be so performed or complied with by them at or before the Closing.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">8.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Officer&rsquo;s Certificate</U>. Parent and Merger Sub shall have delivered to the Company at the Closing a certificate
of an executive officer of Parent and Merger Sub, dated as of the Closing Date, certifying that the conditions in <U>Section&nbsp;8.01</U>
and <U>Section&nbsp;8.02</U> have been satisfied.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">8.04<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Orders and Applicable Laws</U>. There shall not be in effect on the Closing Date any Order or Applicable Law restraining,
enjoining or otherwise prohibiting or making illegal the consummation of any of the transactions contemplated by this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">8.05<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Stockholder Approval</U>. The Company shall have obtained the Required Stockholder Approval.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 63; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">8.06<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Payments Administrator Agreement</U>. The Company shall have received the Payments Administrator Agreement duly
executed by the Stockholder Representative and Parent.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0"><FONT STYLE="color: #010000">Article
IX</FONT><BR>
TERMINATION</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">9.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Termination</U>. This Agreement may be terminated, and the transactions contemplated by this Agreement may be
abandoned, at any time prior to the Closing by mutual written consent of Parent and the Company or by notice from Parent or the
Company, as applicable, to such other Party:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>by either Parent or the Company:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>if the Closing has not occurred on or before April 3, 2020 (the &ldquo;<U>Termination Date</U>&rdquo;) and the failure
to consummate is not caused by a breach of this Agreement by the terminating Party; or</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>if any Governmental Authority shall have issued an Order permanently restraining or enjoining or otherwise prohibiting
the consummation of the transactions contemplated by this Agreement and such Order or other action is or shall have become final
and nonappealable; or</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>by Parent if (i) the Support Agreements of Stockholders holding at least sixty percent (60%) of the issued and outstanding
shares of Company Capital Stock and (ii) the Series B Preferred Stock Consent have not been obtained and certified by the chief
executive officer of the Company prior to the end of the Initial Stockholder Support Delivery Period; or</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>by Parent if there has been a breach by the Company of any representation, warranty, covenant or agreement contained
in this Agreement that (x) would result in a failure of a condition set forth in <U>Section&nbsp;7.01</U> or <U>Section&nbsp;7.02</U>
and (y) if curable, is not cured prior to the earlier of (A) the Termination Date and (B) the date that is thirty (30) days after
written notice thereof is given by Parent to the Company; or</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>by the Company if there has been a breach by Parent or Merger Sub of any representation, warranty, covenant or agreement
contained in this Agreement that (x) would result in a failure of a condition set forth in <U>Section&nbsp;8.01</U> or <U>Section&nbsp;8.02</U>
and (y) if curable, is not cured prior to the earlier of (A) the Termination Date and (B) the date that is thirty (30) days after
written notice thereof is given by the Company to Parent.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">9.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Effect of Termination</U>. If this Agreement is terminated pursuant to <U>Section&nbsp;9.01</U>, this Agreement
will forthwith become null and void, and there will be no liability on the part of any Party (or any of their respective Representatives
or Affiliates) in respect of this Agreement, except as provided in this <U>Section&nbsp;9.02</U>, and except that the provisions
with respect to indemnification of the Stockholder Representative in <U>Section&nbsp;11.01(c)</U>, expenses in <U>Section&nbsp;11.04</U>
and confidentiality in <U>Section&nbsp;6.01</U> and <U>Section&nbsp;11.05</U> will continue to apply following any termination;
<U>provided</U>, <U>however</U>, that nothing in this <U>Section&nbsp;9.02</U> shall release any Party from liability for any willful
and material breach of this Agreement by such Party prior to the termination of this Agreement. If (a) either Parent or the Company
terminates this Agreement pursuant to <U>Section&nbsp;9.01(a)</U> or (b) the Company terminates this Agreement pursuant to <U>Section&nbsp;9.01(d)</U>,
the Company shall, promptly following such termination, provide Parent with the amount of bona fide and reasonably documented fees
and expenses charged by BDO to the Company in respect of the BDO Expenses and Parent shall pay to the Company, within fourteen
(14) days following such provision of information, a fee equal to the BDO Expenses.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 64; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0"><FONT STYLE="color: #010000">Article
X</FONT><BR>
INDEMNIFICATION</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">10.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Survival</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The representations and warranties of the Parties contained in or made pursuant to <U>Article IV</U> and <U>Article
V</U> shall survive in full force and effect until the date that is twelve&nbsp;(12) months from the Closing Date; <U>provided</U>,
<U>however</U>, that the Company Fundamental Representations and the Parent Fundamental Representations and the representations
and warranties contained in or made pursuant to <U>Section 4.16</U> shall survive in full force and effect until the date that
is six (6) years from the Closing Date and the representations and warranties contained in or made pursuant to <U>Section&nbsp;4.12</U>
shall survive in full force and effect until the expiration of the applicable statute of limitations, taking into account any tolling
periods and other extensions; <U>provided</U>, <U>further</U>, that Parent shall not, nor shall it permit any of its Affiliates
(including the Company) to waive or extend any such statute of limitations without the consent of the Stockholder Representative
(each such survival period, a &ldquo;<U>Representations Survival Period</U>&rdquo;). All covenants of the Parties shall survive
until performed. For the avoidance of doubt, the Parties hereby agree and acknowledge that a Representations Survival Period is
a contractual statute of limitations that may be shorter than the statute of limitations otherwise available under Applicable Law
and any claim brought by any Indemnified Party pursuant to this <U>Article X</U> must be brought or filed prior to the expiration
of the applicable Representations Survival Period. Notwithstanding the foregoing, if written notice of a claim has been given pursuant
to and in accordance with this <U>Article X</U> prior to the expiration of the applicable Representations Survival Period by the
Person seeking indemnification for such claim, then the representations, warranties, covenants or agreements with respect to which
such claim alleges a breach shall survive solely as and to the extent of such claim and only until such claim has been finally
resolved pursuant to this <U>Article X</U> and only for purposes of such resolution. Nothing contained in this <U>Section&nbsp;10.01</U>
shall affect the rights of Parent under the R&amp;W Policy.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>This <U>Article X</U> shall survive the Closing and shall remain in effect (i) with respect to <U>Section&nbsp;10.02(a)(i)</U>
and <U>Section&nbsp;10.02(b)(i)</U>, only so long as and until the relevant representations and warranties survive, (ii) with respect
to <U>Section&nbsp;10.02(a)(ii)</U> and <U>Section&nbsp;10.02(b)(ii)</U>, only so long as and until the relevant covenants are
fully performed, and (iii) with respect to <U>Section&nbsp;10.02(a)(iii)</U> only until sixty (60) days after the expiration of
the statute of limitations (including all applicable periods of extension) with respect to any claim arising thereunder.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Notice of any assertion by any Indemnified Party that the Indemnifying Party is liable to it pursuant to <U>Section&nbsp;10.02</U>
must be given to the Indemnifying Party in writing on or prior to the time of expiration of the relevant representation, warranty
or covenant as set forth in this <U>Section&nbsp;10.01</U> or such claim will be forever barred. Any Indemnified Party seeking
indemnification hereunder shall state the facts known to the asserting Indemnified Party that give rise to such notice in sufficient
detail to allow the Indemnifying Party to evaluate the assertion, along with the amount of Losses to the extent known, or a good
faith reasonable estimate of the Losses, and method of computation thereof. With respect to any recovery or indemnification sought
by an Indemnified Party from an Indemnifying Party, if the Indemnifying Party disputes such claim, it shall so notify the Indemnified
Party (the &ldquo;<U>Indemnity Dispute Notice</U>&rdquo;), and the Indemnifying Party and the Indemnified Party shall proceed in
good faith to negotiate a resolution to such dispute. If the Indemnifying Party and the Indemnified Party cannot resolve such dispute
within thirty (30) days after delivery of the Indemnity Dispute Notice, such dispute may be resolved by litigation in any court
of competent jurisdiction in accordance with <U>Section&nbsp;11.16</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 65; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">10.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Indemnification</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Subject to the limitations set forth in this <U>Article X</U>, subsequent to the Closing Date, the Stockholders shall
(severally but not jointly, according to their Indemnification Pro Rata Share) indemnify and hold harmless Parent, Merger Sub and
their Affiliates and Representatives, successors and permitted assigns (the &ldquo;<U>Parent Indemnified Parties</U>&rdquo;) against
any liabilities, losses, Actions, investigations, judgments, orders, damages, expenses or costs, including reasonable out of pocket
attorneys&rsquo; fees and expenses (collectively, &ldquo;<U>Losses</U>&rdquo; and, individually, a &ldquo;<U>Loss</U>&rdquo;),
that any of the foregoing suffers as a result of:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any breach of the representations and warranties of the Company set forth in <U>Article IV</U> of this Agreement
or any failure of any such representation or warranty to be true and correct as of and as though made on the Closing Date (other
than those expressly given as of a specified date prior to the date of this Agreement, for which the breach shall be determined
as of such specified date);</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any breach by the Company of any of the covenants or agreements of the Company set forth in this Agreement required
by this Agreement to be performed or complied with by the Company at or before the Closing;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Indemnified Taxes; and</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>the matters set forth on <U>Section 10.02</U> of the Company Disclosure Schedule (the &ldquo;<U>Special Indemnity
Losses</U>&rdquo;).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Subject to the limitations set forth in this <U>Article X</U>, subsequent to the Closing Date, Parent shall indemnify
and hold harmless each Stockholder and their respective estate, heirs, Affiliates, Representatives, successors and permitted assigns
against any Loss that any of the foregoing suffers as a result of:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any breach of the representations and warranties of Parent and Merger Sub set forth in <U>Article V</U> of this Agreement
or any failure of any such representation or warranty to be true and correct as of and as though made on the Closing Date (other
than those expressly given as of a specified date prior to the date of this Agreement, for which the breach shall be determined
as of such specified date); and</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 66; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any breach by Parent, Merger Sub or the Surviving Corporation of any of the covenants or agreements of Parent, Merger
Sub or the Surviving Corporation set forth in this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">10.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Third-Party Claims</U>. Except as provided otherwise in <U>Section 6.10(b)</U>, the obligations and liabilities
of an Indemnifying Party with respect to Losses resulting from the assertion of liability by third parties resulting from breaches
or failures pursuant to <U>Section&nbsp;10.02</U> (other than <U>Section 10.02(a)(iii)</U> and <U>Section 10.02(a)(i)</U> with
respect to breaches of <U>Section 4.12</U>) (each, a &ldquo;<U>Third-Party Claim</U>&rdquo;) shall be subject to the following
terms and conditions:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Indemnified Parties shall promptly give written notice to the Indemnifying Parties of any Third-Party Claim that
might give rise to any Loss by the Indemnified Parties, stating the nature and basis of such Third-Party Claim, and the amount
thereof to the extent known, or a good-faith reasonable estimate of the Losses, and the method of computation of such Losses; <U>provided</U>,
<U>however</U>, that, so long as such written notice is given on or prior to the time of expiration of the relevant representation,
warranty or covenant as set forth in <U>Section 10.01</U>, no delay on the part of the Indemnified Party in so notifying the Indemnifying
Party shall relieve the Indemnifying Party from any obligation hereunder unless the Indemnifying Party is materially prejudiced
thereby. Such notice shall be accompanied by copies of all relevant documentation with respect to such Third-Party Claim, including
any summons, complaint or other pleading that may have been served, any written demand or any other document or instrument.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>From and after receipt of notice of a Third-Party Claim pursuant to <U>Section&nbsp;10.03(a)</U>, the Indemnifying
Parties shall have the right to assume and conduct, at their own expense, the defense against the Third-Party Claim in their own
names or in the names of the Indemnified Parties. Any Indemnified Parties shall have the right to employ separate counsel in any
such Third-Party Claim and/or to participate in the defense thereof, but the fees and expenses of such counsel shall not be included
as part of any Loss incurred by the Indemnified Party and shall not be payable by the Indemnifying Parties. The Party or Parties
conducting the defense of any Third-Party Claim shall keep the other Parties apprised of all significant developments with respect
thereto and shall not enter into any settlement, compromise or consent to judgment with respect to such Third-Party Claim without
the prior written consent of the other Parties hereto, such consent not to be unreasonably withheld, conditioned or delayed; <U>provided</U>,
<U>however</U>, that the Indemnifying Party shall be entitled to settle, compromise or consent to a judgment without the consent
of the Indemnified Party with respect to a Third-Party Claim that only imposes monetary obligations that are paid by the Indemnifying
Party and contains a release of the Indemnified Party from all liability thereunder. The Indemnified Party shall make available
all information and assistance reasonably available and necessary for the defense of the Third-Party Claim as the Indemnifying
Party may reasonably request and shall cooperate with the Indemnifying Party in such defense. The Stockholder Representative shall
be the sole party entitled to exercise any rights of the Stockholders with respect to Third-Party Claims under this <U>Section&nbsp;10.03</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">10.04<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Limitations on Indemnification</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The sole and exclusive source of recovery for indemnification available to any Parent Indemnified Parties shall be
(i) first, by making deductions from any amounts payable to Stockholders (or to the Payments Administrator on their behalf) pursuant
to <U>Section 3.07</U> or <U>Section 3.08</U> of this Agreement, with such deduction not being greater, in the aggregate, than
the R&amp;W Retention Amount (the &ldquo;<U>Earn-Out Indemnification Deduction</U>&rdquo;), (ii) second (for the avoidance of doubt,
only after having reached the amount available pursuant to clause (i) of this sentence), the R&amp;W Policy to the extent covered
thereby, (iii) third, (A) solely in respect of any claims for breaches of Company Fundamental Representations or claims resulting
from Fraud by or on behalf of the Company (collectively, the &ldquo;<U>Special Losses</U>&rdquo;) (and for the avoidance of doubt,
only after having reached the amount available pursuant to clause (ii) of this sentence), either, at Parent&rsquo;s option, (1)
from each Stockholder for their Indemnification Pro Rata Share of the Special Losses or (2) by making deductions from any amounts
payable to Stockholders (or to the Payments Administrator on their behalf) pursuant to <U>Section&nbsp;3.07</U> or <U>Section&nbsp;3.08;</U>
(B) solely in respect of any claims for breaches of the representations and warranties of the Company set forth in <U>Section&nbsp;4.12</U>
or claims pursuant to <U>Section&nbsp;10.02(a)(iii)</U> (and for the avoidance of doubt, only after having reached the amount available
pursuant to clause (ii) of this sentence) by making deductions from any amounts payable to Stockholders (or to the Payments Administrator
on their behalf) pursuant to <U>Section&nbsp;3.07</U> or <U>Section&nbsp;3.08</U>; <U>provided</U> that in no event shall such
Stockholder be liable for any amount in excess of the Per Share Merger Consideration actually received by such Stockholder as of
the time of such indemnifiable claim; <U>provided</U>, <U>further</U>, that any limitation of liability in this <U>Section&nbsp;10.04(a)</U>
with respect to a Stockholder shall not apply in the case of Fraud committed by such Stockholder; <U>provided</U>, <U>further</U>,
that the Earn-Out Indemnification Deduction will not be decreased by any other deductions made to amounts paid to Stockholders
(or to the Payments Administrator on their behalf). For the avoidance of doubt, other than in the cases of Special Losses, in no
event will any Parent Indemnified Party be entitled to recover for any indemnification claim from any Stockholder.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 67; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Notwithstanding anything to the contrary in this Agreement, in no event will (i) the Stockholders be liable for any
amounts taken into account in the calculation of Final Aggregate Purchase Price (including any amounts included in Closing Indebtedness),
(ii) the Stockholders be liable more than once in respect of the same Loss (notwithstanding that such Loss may result from more
than one of the occurrences specified in <U>Section 10.02</U>) or (iii) any Stockholder be liable hereunder for any amount in excess
of the Per Share Merger Consideration actually received by such Stockholder, except with respect to Fraud committed by such Stockholder.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Notwithstanding anything to the contrary in this Agreement, other than in the case of any claims resulting from Fraud
by or on behalf of the Company (which shall be considered Special Losses for purposes of this <U>Section 10.04</U>), with respect
to any Special Indemnity Losses, the sole and exclusive source of recovery for indemnification shall be the then-remaining balance
of the Special Indemnity Holdback.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each Person entitled to indemnification hereunder or otherwise to reimbursement for Losses in connection with the
transactions contemplated by this Agreement shall use all reasonable efforts to mitigate all Losses upon becoming aware of any
event or circumstance that would reasonably be expected to give rise to any Losses that are indemnifiable or recoverable hereunder
or in connection herewith; <U>provided</U>, <U>however</U>, any and all such direct and indirect costs and expenses related to
such mitigation may be included with the Losses for which indemnification may be sought under this <U>Article X</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 68; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The right to indemnification, payment of Losses or other remedies based on any representations, warranties, covenants
or agreements set forth in this Agreement or in any certificate delivered with respect hereto will not be affected by any investigation
conducted with respect to, or any knowledge or information acquired (or capable of being acquired) by any Party at any time (other
than, for the avoidance of doubt, any disclosures set forth in the Company Disclosure Schedule), whether before or after the execution
and delivery of this Agreement or the Closing Date, with respect to the accuracy or inaccuracy of or compliance with, any such
representation, warranty, covenant or agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>With respect to the Parent Indemnified Parties, Losses shall not include (1) in respect of <U>Section&nbsp;10.02(a)(i)</U>
Taxes with respect to taxable periods or portions thereof beginning after the Closing Date, except Taxes attributable to a breach
of the representations set forth in <U>Section 4.12(d)</U>, <U>Section 4.12(g)</U>, <U>Section 4.12(h)</U> and <U>Section 4.12(i)</U>
and (2) Taxes that are due to the unavailability in any taxable period or portion thereof beginning after the Closing Date of any
net operating losses or other Tax attributes from a Pre-Closing Tax Period.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>For purposes of this <U>Article X</U>, any breach of any representation, warranty, covenant or agreement shall be
determined, and the resulting determination of any Losses shall be calculated, without regard to any &ldquo;materiality,&rdquo;
&ldquo;material,&rdquo; &ldquo;Material Adverse Effect&rdquo; or similar materiality qualification with respect thereto; provided
that the foregoing shall not apply to <U>Section 4.08(b)</U> or the terms &ldquo;Material Contract&rdquo;, &ldquo;Material Contracts&rdquo;,
and &ldquo;Material Product and Trial Information&rdquo;.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(h)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The amount of any and all Losses under this <U>Article X</U> will be determined net of any amounts actually recovered
by the Indemnified Party under indemnification agreements or arrangements with third parties or under insurance policies with respect
to such Losses. If any Indemnified Party shall recover any duplicate Losses pursuant to indemnification agreements or arrangements
with third parties or under insurance policies or otherwise subsequent to recovering corresponding Losses from the Stockholders
pursuant to this <U>Article X</U>, such Indemnified Party shall promptly reimburse and deliver the amount of such duplicate recovery
to the Payments Administrator, and, immediately thereafter, Parent and the Stockholder Representative shall provide a joint written
instruction to the Payments Administrator to deliver such amount promptly to the applicable Stockholders in accordance with this
Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">10.05<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>No Contribution</U>. No Indemnifying Party or any of its employees or agents shall have any right of contribution,
right of indemnity or other right or remedy against the Company in connection with any indemnification obligation or any other
liability to which they may become subject under or in connection with this Agreement in their capacity as a Stockholder.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">10.06<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Remedies Exclusive</U>. The indemnification rights of the Indemnified Parties under this <U>Article X</U> are
the sole and exclusive remedies after the Closing available to the Indemnified Parties with respect to any claims or disputes arising
between the Indemnified Parties and Indemnifying Parties with respect to the transactions contemplated by this Agreement or the
business of the Company, except as specified in this <U>Article X</U> with respect to Fraud; <U>provided</U>, <U>however</U>, that
nothing contained herein shall affect the rights of the Parties under (a) <U>Section&nbsp;11.14</U> with respect to any covenants
to be performed by the Parties, (b) <U>Section 3.07</U> or (c) <U>Section 3.08</U>; <U>provided</U>, <U>further</U>, that nothing
contained in this <U>Section&nbsp;10.06</U> shall affect the rights of Parent under the R&amp;W Policy.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 69; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">10.07<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Adjustment Characterization</U>. The Parties agree to treat any payment made pursuant to this <U>Article X</U>
after the Closing as an adjustment to the Aggregate Purchase Price for all Tax purposes, unless otherwise required by Applicable
Laws.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">10.08<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Damage Limitations</U>. Notwithstanding anything to the contrary contained in this Agreement, no Person shall
be liable under this <U>Article X</U> for any punitive or exemplary damages other than any such damages that are recovered by a
third party that is not an Affiliate of the applicable Indemnified Party in connection with a Third-Party Claim.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0"><FONT STYLE="color: #010000">Article
XI</FONT><BR>
MISCELLANEOUS</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Stockholder Representative</U>&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The adoption of this Agreement by the Required Stockholder Approval, and the receipt of the benefits hereof, including
the right to receive consideration payable in connection with the Merger, shall automatically and without any further action on
the part of any Equityholder constitute the irrevocable appointment of Boston Millennia Partners Button Shareholder Representation,
Inc. as the representative, agent, proxy and attorney-in-fact for each of the Equityholders with respect to matters arising after
the effectiveness of the Merger and for all purposes in connection with this Agreement and the agreements ancillary hereto to be
performed by the Stockholder Representative. The Stockholder Representative hereby represents and warrants to Parent, Merger Sub
and the Company that, as of the date hereof and as of the Closing Date, Martin J. Hernon is the sole stockholder, director and
officer of the Stockholder Representative, and the Stockholder Representative does not have any employees.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Without limiting <U>Section&nbsp;11.01(a)</U>, the Stockholder Representative is hereby irrevocably appointed the
representative, agent, proxy and attorney-in-fact for each of the Equityholders for all purposes of this Agreement and the Payments
Administrator Agreement, including full and sole power and authority on such Equityholders&rsquo; behalf, and in lieu of each Equityholder
having the ability to take any of the following actions directly, to, after the Closing, (i)&nbsp;give and receive notices and
communications, (ii) object to such deliveries, (iii) make and settle claims on behalf of the Stockholders pursuant to <U>Article
X</U> and Equityholders pursuant to <U>Section 3.07</U> and <U>Section 3.08</U>, (iv) agree to, negotiate, enter into settlements
and compromises of, and demand arbitration and comply with orders of, courts and awards of arbitrators with respect to such claims,
(v) take all actions necessary under <U>Section&nbsp;6.10</U>, (vi)&nbsp;execute any instrument or document that the Stockholder
Representative may determine is necessary or desirable in the exercise of its authority under this <U>Section&nbsp;11.01</U> and
the Payments Administrator Agreement, and (vii) take all actions necessary or appropriate in the judgment of the Stockholder Representative
for the accomplishment of the foregoing; <U>provided</U>, <U>however</U>, that the Stockholder Representative will have no obligation
to act on behalf of the Equityholders, except as expressly provided herein. In connection with the carrying out of its duties,
the Stockholder Representative shall have the full and complete authority to incur reasonable expenses and engage counsel, advisors
and experts. The Stockholder Representative may resign at any time with ten (10) days&rsquo; prior written notice. A vacancy in
the position of Stockholder Representative may be filled by the holders of a majority of the outstanding shares of Company Capital
Stock immediately prior to the Effective Time, with the appointment effective upon the written acceptance thereof by the new Stockholder
Representative. No bond shall be required of the Stockholder Representative. Notices or communications to or from the Stockholder
Representative after the Closing shall constitute notice to or from each of the Equityholders.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 70; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Stockholder Representative will incur no liability of any kind with respect to any action or omission by the
Stockholder Representative in connection with the Stockholder Representative&rsquo;s services pursuant to this Agreement and any
agreements ancillary hereto, except in the event of liability directly resulting from the Stockholder Representative&rsquo;s gross
negligence or willful misconduct. The Stockholder Representative shall not be liable for any action or omission pursuant to the
advice of counsel. The Equityholders will indemnify, defend and hold harmless the Stockholder Representative from and against any
and all Losses, liabilities, damages, claims, penalties, fines, forfeitures, actions, fees, costs and expenses (including the fees
and expenses of counsel, advisors and experts and their staffs and all expense of document location, duplication and shipment)
(collectively, &ldquo;<U>Representative Losses</U>&rdquo;) arising out of or in connection with the Stockholder Representative&rsquo;s
execution and performance of this Agreement and any agreements ancillary hereto, in each case as such Representative Loss is suffered
or incurred; <U>provided</U> that in the event that any such Representative Loss is finally adjudicated to have been directly caused
by the gross negligence or willful misconduct of the Stockholder Representative, the Stockholder Representative will reimburse
the Equityholders the amount of such indemnified Representative Loss to the extent attributable to such gross negligence or willful
misconduct. If not paid directly to the Stockholder Representative by the Equityholders, any such Representative Losses may be
recovered by the Stockholder Representative from the funds in (i) the Expense Fund and (ii) the amounts in the Special Indemnity
Holdback, each at such time as remaining amounts would otherwise be distributable to the applicable Equityholders; <U>provided</U>
that while this <U>Section&nbsp;11.01</U> allows the Stockholder Representative to be paid from the aforementioned sources of funds,
this does not relieve the Equityholders from their obligation to promptly pay such Representative Losses as they are suffered or
incurred, nor does it prevent the Stockholder Representative from seeking any remedies available to it at Law or otherwise. In
no event will the Stockholder Representative be required to advance its own funds on behalf of the Equityholders or otherwise.
Notwithstanding anything in this Agreement to the contrary, any restrictions or limitations on liability or indemnification obligations
of, or provisions limiting the recourse against non-parties otherwise applicable to, the Equityholders set forth elsewhere in this
Agreement are not intended to be applicable to the indemnities provided to the Stockholder Representative under this <U>Section&nbsp;11.01</U>.
The foregoing indemnities will survive the Closing, the resignation or removal of the Stockholder Representative or the termination
of this Agreement. Upon the Closing, Parent will wire to the Stockholder Representative an aggregate cash amount of $200,000 (the
&ldquo;<U>Expense Fund Amount</U>&rdquo;), such amount to constitute an expense fund (the &ldquo;<U>Expense Fund</U>&rdquo;), which
will be used for the purposes of paying directly, or reimbursing the Stockholder Representative for, any third-party expenses pursuant
to this Agreement and the Payments Administrator Agreement. The Equityholders will not receive any interest or earnings on the
Expense Fund and irrevocably transfer and assign to the Stockholder Representative any ownership right that they may otherwise
have had in any such interest or earnings. The Stockholder Representative will not be liable for any loss of principal of the Expense
Fund other than as a result of its gross negligence or willful misconduct. The Stockholder Representative shall have sole control
of withdrawals from, or other decisions with respect to, the Expense Fund but acknowledges that it will hold these funds separate
from its corporate funds, will not use these funds for its operating expenses or any other corporate purposes and will not voluntarily
make these funds available to its creditors in the event of bankruptcy. Contemporaneous with or as soon as practicable following
the completion of the Stockholder Representative&rsquo;s responsibilities, the Stockholder Representative will deliver any remaining
balance of the Expense Fund to the Payments Administrator, for further payment of such balance as a Post-Closing Payment (except
that any amounts due to holders of Company Options shall be remitted to Parent and paid to such holders through payroll less any
applicable required Tax withholding). For tax purposes, the Expense Fund will be treated as having been received and voluntarily
set aside by the applicable Equityholders at the time of Closing.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 71; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Actions of the Stockholder Representative</U>. A decision, act, consent or instruction of the Stockholder Representative
shall constitute a decision of all Equityholders and shall be final, binding and conclusive upon each such Equityholder, and Parent
may rely upon any decision, act, consent or instruction of the Stockholder Representative as being the decision, act, consent or
instruction of each and every such Equityholder. Parent is hereby relieved from any liability to any Person for any acts done by
them in accordance with such decision, act, consent or instruction of the Stockholder Representative.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Entire Agreement</U>. This Agreement supersedes all prior discussions and agreements among the Parties with respect
to the subject matter hereof, excluding the Non-Disclosure Agreement, and, together with the Non-Disclosure Agreement, contains
the sole and entire agreement among the Parties hereto with respect to the subject matter hereof. The Non-Disclosure Agreement
shall survive any termination of this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.04<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Expenses</U>. Except as otherwise provided in this Agreement, whether or not the transactions contemplated by
this Agreement are consummated, each Party will pay its own costs and expenses incurred in connection with the negotiation, execution
and consummation of the transactions contemplated by this Agreement, including the Merger.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.05<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Announcements</U>. No press or other public announcement, or public statement or comment in response to any inquiry,
relating to the transactions contemplated by this Agreement or the terms hereof shall be issued or made by any Party without the
prior review and joint approval of the other Parties (other than the Stockholder Representative); <U>provided</U> that a press
release or other public announcement, regulatory filing, statement or comment made without such prior review and joint approval
shall not be in violation of this <U>Section&nbsp;11.05</U> if it is made in order for the disclosing Party or any of its Affiliates
to comply with Applicable Laws or stock exchange rules and in the reasonable judgment of the Party making such release or announcement,
based upon advice of outside counsel, prior review and joint approval, despite reasonable efforts to obtain the same, would prevent
dissemination of such release or announcement in a sufficiently timely fashion to comply with such Applicable Laws or rules; <U>provided</U>,
<U>further</U>, that in all instances prompt notice from one Party to the others shall be given with respect to any such release,
announcement, statement or comment. Each Party shall inform its Affiliates that may be involved in the transactions contemplated
by this Agreement of the requirements set forth in this <U>Section&nbsp;11.05</U> and shall make reasonable efforts to obtain compliance
with the provisions of this <U>Section&nbsp;11.05</U> from such Affiliates.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 72; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.06<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>No Waiver</U>. No failure on the part of any Party to exercise and no delay in exercising, and no course of dealing
with respect to, any right, remedy, power or privilege under this Agreement shall operate as a waiver of such right, remedy, power
or privilege, nor shall any single or partial exercise of any right, remedy, power or privilege under this Agreement preclude any
other or further exercise of any such right, remedy, power or privilege or the exercise of any other right, remedy, power or privilege.
The rights, remedies, powers and privileges provided in this Agreement are cumulative and not exclusive of any rights, remedies,
powers and privileges provided by Applicable Law.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.07<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Amendments</U>. Any provision of this Agreement may be amended, modified, supplemented or waived only by an instrument
in writing duly executed by, if executed prior to the Effective Time, Parent, the Company, Merger Sub and the Stockholder Representative,
and if executed after the Effective Time, Parent and the Stockholder Representative. Any such amendment, modification, supplement
or waiver shall be for such period and subject to such conditions as shall be specified in the instrument effecting the same and
shall be binding upon the Parties, and any such waiver shall be effective only in the specific instance and for the purposes for
which given.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.08<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Addresses for Notices</U>. All notices and other communications given or made pursuant hereto shall be in writing
and shall be deemed to have been duly given or made (i) as of the date delivered or sent if delivered personally, (ii) on the next
Business Day if sent by prepaid overnight carrier (providing proof of delivery), (iii) on the fifth (5<SUP>th</SUP>) Business Day
following the date of mailing if delivered by registered or certified mail (postage prepaid, return receipt requested) or (iv)
on the date delivered if sent by email (providing confirmation of receipt) to the Parties at the following addresses or email addresses
(or at such other addresses or email addresses as shall be specified by the Parties by like notice):</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1in">if to the Company (prior to the Closing):</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1.5in">ArthroSurface Incorporated<BR>
28 Forge Parkway, Franklin,</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1.5in">MA 02038</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1.5in">Attn: Francis Fedorowicz</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1.5in">Email: ffedorowicz@arthrosurface.com</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1in">with a copy to (which shall not constitute notice):</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1.5in">Pepper Hamilton LLP<BR>
125 High Street, 19<SUP>th</SUP> Floor<BR>
Boston, Massachusetts 02110<BR>
Attn: Steve London; Nicholas Stawasz<BR>
Email: londons@pepperlaw.com; stawaszn@pepperlaw.com</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1in">if to Parent, Merger Sub or the Surviving Corporation:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1.5in">Anika Therapeutics, Inc.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1.5in">32 Wiggins Ave</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1.5in">Bedford, MA 01730</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1.5in">Attn: Charles Sherwood III</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1.5in">Email: ChSherwoodIII@AnikaTherapeutics.com</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 1.5in; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 73; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0 0pt 1.5in; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1in">with a copy to (which shall not constitute notice):</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1.5in">Sullivan &amp; Cromwell LLP<BR>
125 Broad Street<BR>
New York, New York 10004<BR>
Attn: Keith Pagnani; Melissa Sawyer<BR>
Email: pagnanik@sullcrom.com; sawyerm@sullcrom.com</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1in">if to the Stockholder Representative, or to the Equityholders after the Closing:</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1.5in">Boston Millennia Partners Button Shareholder Representation, Inc.<BR>
c/o Boston Millennia Partners</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1.5in">30 Rowes Wharf, Suite 400, Boston, MA 02110</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1.5in">Attn: Martin J. Hernon</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1.5in">Email: marty@bmpvc.com</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1.5in"></P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1in">with a copy to (which shall not constitute notice):</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1.5in">Pepper Hamilton LLP<BR>
125 High Street, 19<SUP>th</SUP> Floor<BR>
Boston, Massachusetts 02110<BR>
Attn: Steve London; Nicholas Stawasz<BR>
Email: londons@pepperlaw.com; stawaszn@pepperlaw.com</P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.09<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Captions</U>. The captions and Section&nbsp;headings appearing in this Agreement are included solely for convenience
of reference and are not intended to affect the interpretation of any provision of this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.10<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Severability</U>. Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall,
as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining
provisions of this Agreement, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable
such provision in any other jurisdiction, and in lieu of such prohibited or unenforceable provision, there will be added automatically
as a part of this Agreement a legal, valid and enforceable provision as similar in terms to such prohibited or unenforceable provision
as may be possible.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.11<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Assignment</U>. The obligations of the Parties under this Agreement are not assignable without the prior written
consent of the other Parties, which such Parties may withhold in their discretion.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.12<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Counterparts</U>. This Agreement may be executed in any number of counterparts, all of which taken together shall
constitute one and the same instrument and any of the Parties may execute this Agreement by signing any such counterpart. Delivery
of an executed counterpart of a signature page to this Agreement may be made by electronic or digital delivery such as in Adobe
Portable Document Format or using generally recognized e-signature technology (e.g., DocuSign or Adobe Sign).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 74; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.13<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Disclosure</U>. The Company Disclosure Schedule is hereby incorporated in and made a part of this Agreement as
if set forth in full herein. The Company may, at its option, include in the Company Disclosure Schedule, any items that are not
material in order to avoid any misunderstanding, and any such inclusion, or any references to dollar amounts, shall not be deemed
to be an acknowledgment or representation that such items are material to establish any standard of materiality or to define further
the meaning of such terms for purposes of this Agreement. In no event shall the inclusion of any matter in the Company Disclosure
Schedule be deemed or interpreted to broaden the Company&rsquo;s representations, warranties, covenants or agreements contained
in this Agreement. The mere inclusion of an item in the Company Disclosure Schedule shall not be deemed an admission by the Company
that such item represents a material exception or fact, event, or circumstance or that such item would be reasonably likely to
result in a Material Adverse Effect. The information contained in the Company Disclosure Schedule is disclosed solely for the purposes
of this Agreement, and no information contained therein shall be deemed to be an admission by any Party hereto to any third party
of any matter whatsoever, including of any violation of Law or breach of any agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.14<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Specific Performance</U>. The Parties agree that if any of the provisions of this Agreement were not performed
in accordance with their specific terms or were otherwise breached, irreparable damage would occur, money damages may not be a
sufficient remedy and that the Parties shall be entitled to specific performance of the terms of this Agreement and immediate injunctive
relief, without the necessity of proving the inadequacy of money damages as a remedy, in addition to any other remedy at Law or
in equity.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.15<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Governing Applicable Law</U>. THIS AGREEMENT SHALL BE DEEMED TO BE MADE IN AND IN ALL RESPECTS SHALL BE INTERPRETED,
CONSTRUED AND GOVERNED BY AND IN ACCORDANCE WITH THE LAW OF THE STATE OF DELAWARE WITHOUT REGARD TO THE CONFLICTS OF LAW PRINCIPLES
THEREOF TO THE EXTENT THAT SUCH PRINCIPLES WOULD DIRECT A MATTER TO ANOTHER JURISDICTION. Subject to <U>Sections 3.07(c)</U> and
<U>3.08(f)</U> to <U>3.08(h)</U>, the Parties hereby irrevocably submit to the personal jurisdiction of the Chancery Court of the
State of Delaware (and, if the Chancery Court of the State of Delaware declines to accept jurisdiction over a particular matter,
the state courts or the Federal courts of the United States of America located in the State of Delaware) solely in respect of the
interpretation and enforcement of the provisions of this Agreement and of the documents referred to in this Agreement, and in respect
of the transactions contemplated by this Agreement, and hereby waive, and agree not to assert, as a defense in any action, suit
or proceeding for the interpretation or enforcement hereof or of any such document, that it is not subject thereto or that such
action, suit or proceeding may not be brought or is not maintainable in said courts or that the venue thereof may not be appropriate
or that this Agreement or any such document may not be enforced in or by such courts, and the parties hereto irrevocably agree
that all claims with respect to such shall be heard and determined in such a Delaware State or Federal court.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 75; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.16<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Consent to Jurisdiction</U>. Each Party irrevocably consents to service of process by registered mail, return
receipt requested, as provided in <U>Section&nbsp;11.08</U>. Nothing in this Agreement will affect the right of any Party to serve
process in any other manner permitted by Applicable Law.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.17<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Waiver of Jury Trial</U>. TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, EACH PARTY HEREBY WAIVES ALL RIGHTS
TO A TRIAL BY JURY IN ANY LEGAL ACTION TO ENFORCE OR INTERPRET THE PROVISIONS OF THIS AGREEMENT OR THAT OTHERWISE RELATES TO THIS
AGREEMENT.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.18<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Obligations of Merger Sub</U>. Parent hereby guarantees the due and punctual performance and payment (not merely
collection) in full of all obligations and liabilities of Merger Sub under this Agreement, as and when due and payable or required
to be performed pursuant to any provision of this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.19<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>No Third-Party Beneficiaries</U>. Nothing in this Agreement, express or implied, is intended to confer upon any
Person (other than the Parties, an Indemnified Party, an Indemnified Director or Officer (solely with respect to <U>Section 6.12</U>)
or Company Counsel (solely with respect to <U>Section 11.20</U>)) any rights or remedies under or by reason of this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.20<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Legal Representation</U>.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Parent, on behalf of itself and its Affiliates (including, after the Closing, the Surviving Corporation), acknowledges
and agrees that each of Pepper Hamilton LLP, Grossman, Tucker, Perreault &amp; Pfleger, PLLC and Norton Rose Fulbright US LLP (each,
&ldquo;<U>Company Counsel</U>&rdquo;) has acted as counsel for the Company in connection with this Agreement and the transactions
contemplated hereby (the &ldquo;<U>Acquisition Engagement</U>&rdquo;), and in connection with this Agreement and the transactions
contemplated hereby, each Company Counsel has not acted as counsel for any other Person, including Parent.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Only the Company and its Affiliates shall be considered clients of each Company Counsel in the Acquisition Engagement.
Parent, on behalf of itself and its Affiliates (including, after the Closing, the Surviving Corporation), acknowledges and agrees
that, upon and after the Closing, all confidential communications between the Company and its Affiliates, on the one hand, and
each Company Counsel, on the other hand, in the course of the Acquisition Engagement, and any attendant attorney-client privilege,
attorney work product protection, and expectation of client confidentiality applicable thereto, shall survive the Closing and be
deemed to belong solely to the Equityholders and their respective Affiliates (other than the Company), and not the Company, and
shall not pass to or be claimed, held, or used by Parent or the Company (or, after the Closing, the Surviving Corporation) or any
insurance carrier providing the R&amp;W Policy upon or after the Closing. Accordingly, Parent shall not have access to any such
communications, or to the files of any Company Counsel relating to the Acquisition Engagement, whether or not the Closing occurs.
Without limiting the generality of the foregoing, upon and after the Closing, (i)&nbsp;to the extent that files of any Company
Counsel in respect of the Acquisition Engagement constitute property of the client, only the Equityholders and their respective
Affiliates shall hold such property rights and (ii) each Company Counsel shall have no duty whatsoever to reveal or disclose any
such attorney-client communications or files to the Company (or, after the Closing, the Surviving Corporation) or Parent or any
insurance carrier providing the R&amp;W Policy by reason of any attorney-client relationship between each Company Counsel and the
Company or otherwise; <U>provided</U>, <U>however</U>, that notwithstanding the foregoing, each Company Counsel shall not disclose
any such attorney-client communications or files to any third parties (other than representatives, accountants and advisors of
the Equityholders and their respective Affiliates; <U>provided</U> that such representatives, accounts and advisors are instructed
to maintain the confidence of such attorney-client communications). Parent, on behalf of itself and its Affiliates (including,
after the Closing, the Surviving Corporation), irrevocably waives any right it may have arising out of its ownership of the Company
(including, after Closing, the Surviving Corporation) or the Merger to discover or obtain (or use, if discovered or obtained) information
or documentation relating to the Acquisition Engagement, to the extent that such information or documentation was subject to an
attorney-client privilege, work product protection or other expectation of confidentiality owed to the Company and/or its Affiliates.
If and to the extent that, at any time subsequent to Closing, Parent or any of its Affiliates (including, after the Closing, the
Surviving Corporation) shall have the right to assert or waive any attorney-client privilege with respect to any communication
between the Company or its Affiliates and any Person representing them that occurred at any time prior to the Closing, Parent,
on behalf of itself and its Affiliates (including, after the Closing, the Surviving Corporation), shall be entitled to waive such
privilege only with the prior written consent of the Stockholder Representative, on behalf of the Equityholders, (such consent
not to be unreasonably withheld). Parent, on behalf of itself and its Affiliates (including, after the Closing, the Surviving Corporation),
acknowledges and agrees that each Company Counsel has acted as counsel for the Company and its respective Affiliates and that each
Company Counsel may represent the Equityholders, the Stockholder Representative and/or their respective Affiliates in future matters.
Accordingly, Parent, on behalf of itself and its Affiliates (including, after the Closing, the Surviving Corporation), expressly
consents to each Company Counsel&rsquo;s representation of the Equityholders, the Stockholder Representative and/or their respective
Affiliates and/or any of their respective agents (if any of the foregoing Persons so desire) in any matter, including, without
limitation, any post-Closing matter in which the interests of Parent and the Surviving Corporation, on the one hand, and the Equityholders,
the Stockholder Representative or any of their respective Affiliates, on the other hand, are adverse, including any matter relating
to the transactions contemplated by this Agreement, and whether or not such matter is one in which any Company Counsel may have
previously advised the Company or its Affiliates.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 76; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>From and after the Closing, the Surviving Corporation shall cease to have any attorney-client relationship with any
Company Counsel, unless and to the extent a Company Counsel is expressly engaged in writing by the Surviving Corporation to represent
the Surviving Corporation after the Closing. Any such representation of the Surviving Corporation by a Company Counsel after the
Closing shall not affect the foregoing provisions hereof. Furthermore, each Company Counsel, in its sole discretion, shall be permitted
to withdraw from representing the Surviving Corporation in order to represent the Equityholders.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each of the Parties to this Agreement consents to the arrangements in this <U>Section&nbsp;11.20</U> and waives any
actual or potential conflict of interest that may be involved in connection with any representation by any Company Counsel permitted
hereunder.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">[THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK]</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center"></P>

<!-- Field: Page; Sequence: 77; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">IN WITNESS WHEREOF, this Agreement has been duly
executed and delivered by the duly authorized officer of each Party as of the date first above written.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="white-space: nowrap"><FONT STYLE="text-transform: uppercase">Anika Therapeutics,
Inc.</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="white-space: nowrap">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">By:&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid">/s/ Joseph G. Darling</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap; width: 33%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 34%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 5%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 5%">Name:&nbsp;&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 23%">Joseph G. Darling</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">Title:&nbsp;&nbsp;</TD>
    <TD STYLE="white-space: nowrap">President and Chief Executive Officer</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="white-space: nowrap">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="white-space: nowrap">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0 0pt 3in"></P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0 0pt 3in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 3in; font-size: 10pt; font-weight: bold">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 3in; font-size: 10pt; font-weight: bold">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 3.3in; font-size: 10pt; text-indent: -0.3in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 3.3in; font-size: 10pt; text-indent: -0.3in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 3.3in; font-size: 10pt; text-indent: -0.3in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 3.3in; font-size: 10pt; text-indent: -0.3in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 3.3in; font-size: 10pt; text-indent: -0.3in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 3.3in; font-size: 10pt; text-indent: -0.3in">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">[<I>Signature Page to Agreement and Plan of Merger</I>]</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 3.3in; font-size: 10pt; text-indent: -0.3in"></P>

<!-- Field: Page; Sequence: 78; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0 0pt 3.3in; font-size: 10pt; text-indent: -0.3in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="white-space: nowrap"><B>BUTTON MERGER SUB, INC.</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="white-space: nowrap">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">By:&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid">/s/ Charles Sherwood
III</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap; width: 33%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 34%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 5%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 5%">Name:&nbsp;&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 23%">Charles H. Sherwood III</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="white-space: nowrap">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="white-space: nowrap">&nbsp;</TD></TR>
</TABLE>
<P STYLE="margin: 0pt 0; font-size: 10pt"><B>&nbsp;</B></P>

<P STYLE="margin: 0pt 0; font-size: 10pt"><B>&nbsp;</B></P>

<P STYLE="margin: 0pt 0; font-size: 10pt"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0 0pt 3in"></P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0 0pt 3in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">[<I>Signature Page to Agreement and Plan of Merger</I>]</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 79; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="white-space: nowrap"><B>ARTHROSURFACE INCORPORATED</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="white-space: nowrap">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">By:&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid">/s/ Steven W. Ek</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap; width: 33%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 34%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 5%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 5%">Name:&nbsp;&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 23%">Steven W. Ek</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">Title:&nbsp;</TD>
    <TD STYLE="white-space: nowrap">President and Chief Executive Officer</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="white-space: nowrap">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="white-space: nowrap">&nbsp;</TD></TR>
</TABLE>
<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0 0pt 3in"></P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0 0pt 3in">&nbsp;<BR></P>

<P STYLE="margin: 0pt 0 0pt 3in; font-size: 10pt; font-weight: bold">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"><B>&nbsp;</B></P>

<P STYLE="margin: 0pt 0; font-size: 10pt"><B>&nbsp;</B></P>

<P STYLE="margin: 0pt 0; font-size: 10pt"><B>&nbsp;</B></P>

<P STYLE="margin: 0pt 0; font-size: 10pt"><B>&nbsp;</B></P>

<P STYLE="margin: 0pt 0; font-size: 10pt"><B>&nbsp;</B></P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">[<I>Signature Page to Agreement and Plan of
Merger</I>]</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"><B></B></P>

<!-- Field: Page; Sequence: 80; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt"><B>&nbsp;</B></P>

<P STYLE="margin: 0pt 0; font-size: 10pt"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="white-space: nowrap"><B>BOSTON MILLENNIA PARTNERS BUTTON<BR>
    SHAREHOLDER REPRESENTATION, INC.,<BR>
    </B>solely in its capacity as Stockholder Representative</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="white-space: nowrap">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">By:&nbsp;&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid">/s/ Martin J. Hernon</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap; width: 33%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 34%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 5%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 5%">Name:&nbsp;&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 23%">Martin J. Hernon</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">Title:&nbsp;</TD>
    <TD STYLE="white-space: nowrap">President</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="white-space: nowrap">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="white-space: nowrap">&nbsp;</TD></TR>
</TABLE>
<P STYLE="margin: 0pt 0; font-size: 10pt"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0 0pt 3in"></P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0 0pt 3in"></P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">[<I>Signature Page to Agreement and Plan of Merger</I>]</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 81; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">Annex A</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Unless otherwise defined in this Agreement, the
following terms have the meanings specified in this <U>Annex A</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>280G Stockholder Vote</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;6.08(e)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;[<U>&hellip;] Option</U>&rdquo; means each
Company Option with a per share exercise price equal to [&hellip;].</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;[<U>&hellip;] Option</U>&rdquo; means each
Company Option with a per share exercise price equal to [&hellip;].</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Acquisition Engagement</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;11.20(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Acquisition Proposal</U>&rdquo; means
(i) any proposal or offer with respect to a merger, joint venture, partnership, consolidation, dissolution, liquidation, tender
offer, recapitalization, reorganization, share exchange, business combination or similar transaction involving the Company pursuant
to which the Stockholders immediately preceding such transaction would hold, directly or indirectly, less than eighty percent (80%)
of the Equity Interests in the surviving or resulting entity of such transaction and (ii) any acquisition by any Person resulting
in, or proposal or offer, which if consummated would result in, any Person becoming the beneficial owner of, directly or indirectly,
in one or a series of related transactions, twenty percent (20%) or more of the total voting power or of any class of equity securities
of the Company, or twenty percent (20%) or more of the consolidated total assets of the Company, in each case other than the transactions
contemplated by this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Action</U>&rdquo; means any action,
demand, claim, suit, proceeding, hearing, or arbitration by or before any Governmental Authority or arbitration tribunal.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Affiliate</U>&rdquo; means any Person
that directly or indirectly through one or more intermediaries, controls, is controlled by or is under common control with, the
Person specified. For purposes of this definition, &ldquo;<U>control</U>&rdquo; of a Person means the power to direct or cause
the direction of the management and policies of such Person whether through the ownership of voting securities or ownership interests,
by Contract or otherwise.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Aggregate Cash Amount</U>&rdquo; means
(i) the aggregate amount of the Per Common Share Closing Payment payable at Closing pursuant to <U>Section&nbsp;3.01, Section&nbsp;3.03</U>
and <U>Section&nbsp;3.04</U>, <I>plus</I> (ii) the Aggregate Preferred Share Payment.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Aggregate Closing Amount</U>&rdquo;
means an amount equal to (i) the Estimated Aggregate Purchase Price, <I>minus</I> (ii) the Expense Fund Amount <I>minus </I>(iii)
the Special Indemnity Holdback.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Aggregate Closing Payment Schedule</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;3.06</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 82; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Aggregate Preferred Share Payment</U>&rdquo;
means the aggregate amount of the Preferred Share Liquidation Preference payable at Closing pursuant to <U>Section&nbsp;3.02(b)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Aggregate Purchase Price</U>&rdquo;
means (i) $60,040,000, <I>plus </I>(ii) Cash on Hand, <I>minus </I>(iii) Closing Indebtedness, <I>plus </I>(iv) the Working Capital
Difference, <I>minus</I> (v) Transaction Expenses <I>plus </I>(vi) the BDO Expenses.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Agreement</U>&rdquo; has the meaning
given to that term in the Preamble to this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Alternative Acquisition Agreement</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;6.04(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Anti-Corruption Law</U>&rdquo; means
any Law governing financial recordkeeping and reporting requirements or for the prevention or punishment of public or commercial
corruption and bribery, including the U.S. Currency and Foreign Transactions Reporting Act of 1970, the U.S. Money Laundering Control
Act of 1986, the U.S. Foreign Corrupt Practices Act of 1977, the UK Bribery Act 2010 and any applicable money laundering-related,
anti-corruption or anti-bribery Laws of any other jurisdiction.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Applicable Laws</U>&rdquo; means all
laws (including common law), statutes, codes, rules, regulations, ordinances, orders, writs, judgments, injunctions, decrees and
other pronouncements having the effect of Law of the United States, any foreign country or any state, county, city or other political
subdivision thereof or of any Governmental Authority, in each case as applicable to the Company, Parent, Merger Sub, or the Stockholder
Representative, as the case may be.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Arbitration Fees</U>&rdquo; has the
meaning given to that term in <U>Section 3.08(g)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Arbitration Rules</U>&rdquo; has the
meaning given to that term in <U>Section 3.08(g)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Audited Financial Statements</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;4.06(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>BDO</U>&rdquo; means BDO USA, LLP.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>BDO Expenses</U>&rdquo; means the amount
of bona fide and reasonably documented fees and expenses charged by BDO to the Company in connection with (i) an accelerated audit
of the Company&rsquo;s annual financial statements for the year ended December 31, 2019, (ii) the review of the Company&rsquo;s
interim financial statements for the period through September 30, 2019 conducted in accordance with SAS 100 review procedures,
(iii) a physical inventory of the Company&rsquo;s offices in [&hellip;], the offices of [&hellip;] and the offices of [&hellip;]
(conducted in a manner consistent with the prior practices, policies and procedures of the Company), to be completed by January
17, 2020 and (iv) obtaining BDO&rsquo;s consent for the use of the Financial Statements in Parent&rsquo;s SEC filings.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Binder Agreement</U>&rdquo; has the
meaning given to that term in the Recitals to this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Board Recommendation</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;4.03(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 83; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Business Data</U>&rdquo; has the meaning
given to that term in <U>Section&nbsp;4.17(b)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Business Day</U>&rdquo; means a day
other than Saturday, Sunday or any day on which (a)&nbsp;banks located in New York, New York or (b) solely for purposes of determining
the Closing Date, the Department of State of the State of Delaware, is authorized or required by Law to close.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Calendar Year</U>&rdquo; means a period
of twelve (12) consecutive months commencing on January 1 and ending on the following December 31.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Cash on Hand</U>&rdquo; means, with
respect to the Company, all cash, cash equivalents and marketable securities (convertible to cash within 30 days) other than Restricted
Cash as of 12:01 a.m. Eastern Standard Time on the Closing Date. For the avoidance of doubt, Cash on Hand shall (i) be calculated
net of uncleared checks and drafts issued by the Company and (ii) include uncleared checks and drafts received or deposited for
the account of the Company, including deposits in transit.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Certificates</U>&rdquo; has the meaning
given to that term in <U>Section&nbsp;3.04(e)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Certificate of Merger</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;2.03</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Certificates of Designation</U>&rdquo;
means, collectively, the Series C Certificate of Designation, the Series D Certificate of Designation, the Series E Certificate
of Designation and the Series F Certificate of Designation.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Change in Control Payments</U>&rdquo;
means any change in control, transaction, retention, or bonus payments to any Person and any fees, costs or expenses related thereto,
which are or may become payable by or on behalf of the Company in connection with the execution and delivery of this Agreement
or the consummation of the Merger or any of the other transactions contemplated by this Agreement, either alone or in combination
with another event that occurs at or prior to the Closing, whether payable hereunder, under any Contract or Company Plan, or under
any other plan, policy, agreement or arrangement, and whether payable prior to or following the Closing, and, for the avoidance
of doubt, excluding any payments made to any Equityholder pursuant to <U>Article III</U> of this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Charter</U>&rdquo; means the Company&rsquo;s
Amended and Restated Certificate of Incorporation, dated September 3, 2003, including the terms of the Certificates of Designation.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Closing</U>&rdquo; has the meaning given
to that term in <U>Section&nbsp;2.02</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Closing Date</U>&rdquo; means (i) the
first (1<SUP>st</SUP>) Business Day following the date on which the last of the conditions set forth in <U>Article VII</U> and
<U>Article VIII</U> (other than those that by their nature are intended to be satisfied at the Closing, but subject to the satisfaction
or waiver thereof at the Closing) are satisfied or waived by the applicable Parties or (ii) such other date as Parent and the Company
mutually agreed upon in writing, in each case, subject to the proviso in the first sentence of <U>Section&nbsp;2.02</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Closing Indebtedness</U>&rdquo; means
the Indebtedness of the Company as of 12:01 a.m. Eastern Standard Time on the Closing Date. For the avoidance of doubt, Closing
Indebtedness shall not include any Transaction Expenses or any amounts included in the Working Capital Difference.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 84; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Closing Statement</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;3.07(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Code</U>&rdquo; means the Internal Revenue
Code of 1986, as amended.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Company</U>&rdquo; has the meaning given
to that term in the Preamble to this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Company Capital Stock</U>&rdquo; means
the Company Common Stock and the Company Preferred Stock, collectively.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Company Common Stock</U>&rdquo; means
the common stock, par value $0.001 per share, of the Company.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Company Counsel</U>&rdquo; has the meaning
given to that term in <U>Section&nbsp;11.20(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Company Disclosure Schedule</U>&rdquo;
means the disclosure schedule dated the date hereof regarding this Agreement that has been prepared by the Company and delivered
to Parent with this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Company Fundamental Representations</U>&rdquo;
means the representations and warranties made pursuant to <U>Section&nbsp;4.01</U>, <U>Section&nbsp;4.02</U> (except with respect
to addresses of Equityholders), <U>Section&nbsp;4.03</U>, <U>Section&nbsp;4.04(a), Section&nbsp;4.27</U> and <U>Section 4.28</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Company IP</U>&rdquo; means all Intellectual
Property Rights that are owned by, purported to be owned by or exclusively licensed to the Company.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Company Option</U>&rdquo; has the meaning
given to that term in <U>Section&nbsp;3.03(a)(i)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Company Plan</U>&rdquo; has the meaning
given to that term in <U>Section&nbsp;4.13(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Company Preferred Stock</U>&rdquo; means
the preferred stock, par value $.001 per share, of the Company.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Company Products</U>&rdquo; means all
products, services or other offerings currently provided or under development by the Company (including, for the avoidance of doubt,
the Regulatory Approval Products).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Company Tax Liability</U>&rdquo; means
any unpaid liability of the Company for Taxes based on taxable net income, such liability accrued in accordance with GAAP.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Company Warrants</U>&rdquo; means the
warrant to purchase shares of Series E Convertible Preferred Stock, dated as of August 24, 2007, issued by the Company to Silicon
Valley Bank, as amended.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Continuation Period</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;6.08(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 85; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Continuing Employees</U>&rdquo; means
the employees who continue to be employed with the Company at the Effective Time.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Contract</U>&rdquo; means any legally
binding contract, agreement, instrument, lease, license, evidence of indebtedness, mortgage, indenture, security agreement or other
legally binding arrangement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Converting Company Preferred Stock</U>&rdquo;
means the shares of Company Preferred Stock which are to be converted into Company Common Stock as of the Effective Time pursuant
to, and in accordance with, the Charter or applicable Certificate of Designations (which, for the avoidance of doubt, does not
include any shares of Series B Preferred Stock).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Copyrights</U>&rdquo; has the meaning
given to that term in the definition of Intellectual Property Rights.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Current Income Tax Liability</U>&rdquo;
means the unpaid liability of the Company for taxes based on net income for the taxable year of the Company ending on the Closing
Date (or, with respect to any such taxable year that does not end on the Closing Date, for the portion of the Straddle Period ending
on the Closing Date determined as provided in the second sentence of the defined term &ldquo;<U>Indemnified Taxes</U>&rdquo;).
For the avoidance of doubt, and notwithstanding anything to the contrary, the amount of the Current Income Tax Liability, if any,
shall take into account any estimated payments made prior to the Closing.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Data Protection and Security Requirements</U>&rdquo;
means (i) all Laws relating to the Processing of Personal Data, data privacy, data or cyber security, breach notification, or data
localization, including but not limited to HIPAA and the GDPR; (ii) all regulatory and self-regulatory guidelines and published
interpretations by Governmental Authorities of such Laws; (iii) all provisions of Contracts to which the Company is a party or
is otherwise bound that relate to the Processing of Personal Data; and (iv) all policies and notices of the Company relating to
the Processing of Personal Data.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Data Protection Authority</U>&rdquo;
means the Governmental Authority charged with supervising and enforcing compliance with Data Protection and Security Requirements.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Delaware Law</U>&rdquo; means the Delaware
General Corporation Law.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Dispute Notice</U>&rdquo; has the meaning
given to that term in <U>Section&nbsp;3.07(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Disputed Items</U>&rdquo; has the meaning
given to that term in <U>Section&nbsp;3.07(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Dissenting Shares</U>&rdquo; means any
shares of Company Capital Stock that are issued and outstanding immediately prior to the Effective Time and in respect of which
appraisal rights shall have been perfected and not waived, withdrawn or lost, in accordance with Section&nbsp;262 of the Delaware
Law, in connection with the Merger.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Earn-Out Arbitration</U>&rdquo; means
any arbitration commenced pursuant to <U>Section&nbsp;3.08(f)</U> or <U>3.08(h)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 86; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Earn-Out Consideration</U>&rdquo; means
the Regulatory Earn-Out Consideration and the Net Sales Earn-Out Consideration.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Earn-Out Dispute Notice</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;3.08(d)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Earn-Out Disputed Items</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;3.08(d)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Earn-Out Indemnification Deduction</U>&rdquo;
has the meaning given to that term in <U>Section 10.04(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Earn-Out Resolution Period</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;3.08(f)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Earn-Out Resolved Matters</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;3.08(f)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Earn-Out Review Period</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;3.08(d)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Effective Time</U>&rdquo; has the meaning
given to that term in <U>Section&nbsp;2.03</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Enforceability Exceptions</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;4.03(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Equityholder</U>&rdquo; means a holder
of any shares of Company Common Stock or Company Preferred Stock or any Company Option or Company Warrants immediately prior to
the Effective Time.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Equity Interests</U>&rdquo; means capital
stock, partnership or membership interests or units (whether general or limited), options, warrants, calls, phantom stock, profit
participation (other than any cash bonus tied to Company profit or performance and not to the value of the Company Capital Stock),
restricted stock, stock appreciation rights and any other interest or participation that confers on a Person the right to receive
a share of the profits and losses of the issuing entity.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>ERISA</U>&rdquo; means the Employee
Retirement Income Security Act of 1974, as amended.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>ERISA Affiliate</U>&rdquo; has the meaning
given to that term in <U>Section&nbsp;4.13(e)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>ERISA Plans</U>&rdquo; has the meaning
given to that term in <U>Section&nbsp;4.13(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Estimated Aggregate Purchase Price</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;3.04(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Estimated Closing Statement</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;3.04(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>EU</U>&rdquo; means the European Union.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Excluded Shares</U>&rdquo; means (i)
shares of Company Capital Stock owned by Parent, Merger Sub or any other direct or indirect wholly owned subsidiary of Parent and
shares of Company Capital Stock owned by the Company or any direct or indirect wholly owned subsidiary of the Company, and in each
case not held on behalf of third parties, and (ii) Dissenting Shares.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 87; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Expense Fund</U>&rdquo; has the meaning
given to that term in <U>Section&nbsp;11.01(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Expense Fund Amount</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;11.01(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>FDA</U>&rdquo; has the meaning given
to that term in <U>Section&nbsp;4.26(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Federal Healthcare Programs</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;4.25(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Final Aggregate Purchase Price</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;3.07(d)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Final Award</U>&rdquo; has the meaning
given to that term in <U>Section 3.08(g)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Final Closing Statement</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;3.07(d)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Financial Statements</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;4.06(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Fraud</U>&rdquo; means any fraud causes
of action that require as an element an intent to deceive, malice, scienter or similar intent (and not any type of fraud cause
of action based solely on recklessness, negligence, misrepresentation or omission or any similar constructive intent or knowledge
element) by the Company with respect to the making of the representations and warranties set forth in <U>Article IV</U> of this
Agreement, by Parent or Merger Sub with respect to the making of the representations and warranties set forth in <U>Article V</U>
of this Agreement or by a Stockholder with respect to the making of the representations and warranties set forth in such Stockholder&rsquo;s
Letter of Transmittal or Support Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Fully Diluted Shares</U>&rdquo; means
the sum of (x) the aggregate number of shares of Company Common Stock (other than Excluded Shares, if any) and Series B Preferred
Stock issued and outstanding immediately prior to the Effective Time; <I>plus</I> (y) the aggregate number of shares of Company
Common Stock underlying Company Options outstanding immediately prior to the Effective Time (other than any Company Options cancelled
for no consideration or payment pursuant to <U>Section&nbsp; 3.03(a)(ii)</U>).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>GAAP</U>&rdquo; means Generally Accepted
Accounting Principles in the United States.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>GDPR</U>&rdquo; means Regulation (EU)
2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the
processing of personal data and on the free movement of such data.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Good Manufacturing Practices</U>&rdquo;
means with respect to the Company, the standards for the manufacture, processing, packaging, testing, transportation, handling
and holding of Company Products, as set forth in Applicable Law and FDA guidance documents.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Governmental Approval</U>&rdquo; means
any authorization, consent, approval, license, permit, franchise, tariff, rate, certification, agreement, directive, waiver, exemption,
variance or Order of any Governmental Authority.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 88; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Governmental Authority</U>&rdquo; means
any entity exercising executive, legislative, judicial, regulatory or administrative functions of or pertaining to government,
including any governmental authority, agency, department, board, commission or instrumentality of the United States or any foreign
country, any state or local body of the United States or any foreign country or any political subdivision of any of the foregoing,
and any tribunal, court or arbitrator, including any Notified Body.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Government Shutdown</U>&rdquo; means
any shutdown of certain United States federal government services provided by the FDA to approve the Regulatory Earn-Out Approvals.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Healthcare Laws</U>&rdquo; has the meaning
given to that term in <U>Section&nbsp;4.25(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>HHS</U>&rdquo; has the meaning given
to that term in <U>Section 4.17(b)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>HIPAA</U>&rdquo; means, collectively,
the Health Insurance Portability and Accountability Act of 1996, Public Law 104-191, as amended by the Health Information Technology
for Economic and Clinical Health Act, enacted as Title XIII of the American Recovery and Reinvestment Act of 2009, Public Law 111-5,
and their implementing regulations, including but not limited to, the Standards for Privacy of Individually Identifiable Health
Information at 45 C.F.R. Parts 160 and 164, Subparts A and E, the Security Standards for the Protection of Electronic Protected
Health Information at 45 C.F.R. Parts 160 and 164, Subparts A and C, and the Notification of Breach of Unsecured Protected Health
Information requirements at 45 C.F.R. Part 164, Subpart D.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>ICC</U>&rdquo; has the meaning given
to that term in <U>Section 3.08(g)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Immaterial Revenue Agreement</U>&rdquo;
means any dealer, distributor, referral or similar agreement, or any Contract providing for the grant of rights to market, refer
or sell the Company&rsquo;s products or services to any other Person that individually represented $100,000 or less in total recognized
revenue during the twelve (12) month period ended September 30, 2019.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Indebtedness</U>&rdquo; means all obligations,
contingent or otherwise, of the Company, including accrued and unpaid interest, and any prepayment fees, breakage costs, premiums,
expenses or penalties in respect of (i) borrowed money, other than intercompany loans; (ii)&nbsp;bonds, debentures, notes (including,
for the avoidance of doubt, any convertible notes) or similar instruments; (iii)&nbsp;capitalized leases on the Financial Statements
or required to be capitalized in accordance with GAAP; (iv)&nbsp;all Indebtedness of others secured by a Lien on Property of the
Company, whether or not the Indebtedness secured thereby has been assumed; (v)&nbsp;interest rate, currency or commodity derivatives
or hedging transactions or similar arrangements (valued at the termination thereof); (vi)&nbsp;all letters of credit or performance
bonds not collateralized by cash issued for the account of the Company, only to the extent drawn upon; (vii)&nbsp;all guarantees
of the Company of any Indebtedness of any Person other than a wholly owned Subsidiary of the Company; (viii) deferred purchase
price with respect to the acquisition of any business, asset, or securities, whether contingent or otherwise, including all Tax-related
payments and amounts owed under any earn-out or similar performance payment, at the maximum value, whether contingent or not, or
any seller notes or post-closing true-up obligations (provided, however, that any amounts payable or that may be payable to [&hellip;]
pursuant to that certain [&hellip;] by and between the Company and [&hellip;], dated [&hellip;] shall not be considered Indebtedness]);
(ix) Company Tax Liability, if any, and (x)&nbsp;any payables to any Equityholders or any Persons listed on <U>Schedule G</U> that
are outside of the Ordinary Course of Business (and, for the avoidance of doubt, (A) amounts payable to any of them in their capacity
as a director, officer, employee or consultant of the Company and (B) amounts payable to [&hellip;] for goods and services it provides
to the Company shall not be considered Indebtedness).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 89; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Indemnification Pro Rata Share</U>&rdquo;
means, with respect to any Stockholder and expressed as a percentage, the quotient obtained by <I>dividing</I> (i) the aggregate
amount of the Per Share Merger Consideration payable to such Stockholder pursuant to <U>Article III</U> (assuming release in full
of the Expense Fund, Earn-Out Consideration and Special Indemnity Holdback) <I>by</I> (ii) the sum of the Per Share Merger Consideration
paid to all Stockholders pursuant to <U>Article III</U> (assuming release in full of the Expense Fund, Earn-Out Consideration and
Special Indemnity Holdback).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Indemnified Director or Officer</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;6.12(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Indemnified Party</U>&rdquo; means,
in the case of an indemnification claim pursuant to <U>Section&nbsp;10.02(a)</U>, Parent, the Surviving Corporation, Merger Sub
and their Affiliates and Representatives, successors and permitted assignees, and in the case of an indemnification claim pursuant
to <U>Section&nbsp;10.02(b)</U>, each Stockholder and their respective estate, heirs, Affiliates, Representatives, successors and
permitted assignees.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Indemnified Taxes</U>&rdquo; means,
except to the extent taken into account in determining the Final Aggregate Purchase Price as finally determined pursuant to <U>Section
3.07</U>, (a) any and all Taxes imposed on or with respect to the Company with respect to a Pre-Closing Tax Period, (b) Taxes of
any member of an affiliated, consolidated, combined or unitary group of which the Company is or was a member on or prior to the
Closing Date, including pursuant to Treasury Regulations Section 1.1502-6 or any analogous or similar state, local or non-U.S.
Law and (c) Taxes with respect to a Pre-Closing Tax Period of any Person imposed on the Company as a transferee or successor, by
Contract, indemnification agreement or pursuant to any Applicable Law, which Taxes relate to an event, agreement or transaction
occurring before the Closing. With respect to any Straddle Period: (a) in the case of any Taxes that are imposed on or with respect
to income, gains, receipts, sales, payroll or payments (or any subset or combination thereof) and are payable for a Straddle Period,
the portion of such Taxes related to the Pre-Closing Tax Period shall be deemed equal to the amount which would be payable if the
relevant Tax period ended on and included the Closing Date (and for such purpose, the taxable period of any partnership or other
pass-through entity or non-U.S. entity in which the Company holds a beneficial interest shall be deemed to terminate at such time),
(b) in the case of any other Taxes for a Straddle Period, the portion of such Taxes related to the Pre-Closing Tax Period shall
be deemed to be the amount of such Tax for the entire taxable period, <I>multiplied</I> by a fraction, the numerator of which is
the number of days in the taxable period prior to and including the Closing Date and the denominator of which is the number of
days in such Straddle Period, and (c) <U>Section 6.10(h)</U> shall apply. The Parties agree that the taxable year of the Company
for federal income Tax purposes shall end as of the close of business on the Closing Date and the Company shall join the federal
income Tax consolidated group of which Parent is a member on the beginning of the day following the Closing Date.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 90; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Indemnifying Party</U>&rdquo; means,
in the case of an indemnification claim pursuant to <U>Section&nbsp;10.02(a)</U>, the Stockholders and their respective successors
and permitted assigns and in the case of an indemnification claim pursuant to <U>Section&nbsp;10.02(b)</U>, Parent and its successors
and permitted assigns.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Indemnity Dispute Notice</U>&rdquo;
has the meaning given to that term in <U>Section 10.01(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Independent Accountant</U>&rdquo; means
a certified public firm of independent accountants of national standing satisfactory to Parent and the Stockholder Representative.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Information Statement</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;6.07</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Infringe</U>&rdquo; means, with respect
to any Intellectual Property Rights, to directly or indirectly infringe, misappropriate or make unauthorized use of such Intellectual
Property Rights.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Initial Stockholder Support Delivery
Period</U>&rdquo; has the meaning given to that term in <U>Section&nbsp;6.05</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Intellectual Property Rights</U>&rdquo;
means all intellectual property and the rights appurtenant thereto, in any and all jurisdictions worldwide, including the following:
(i) patents, patent applications, inventions, and utility models, whether or not patented or patentable, including provisionals,
statutory invention registrations, invention disclosures, registrations, design patents, divisions, continuations and continuations-in-part,
and any reexaminations, substitutions, renewals, extensions, reexaminations and reissues thereof; (ii) copyrights in works of authorship,
including software, firmware, applications, files, databases and compilations, the registrations and applications therefor, and
all renewals, extensions, restorations and reversions thereof, together with all moral rights and common law rights thereto (collectively,
&ldquo;<U>Copyrights</U>&rdquo;); (iii) trademarks, service marks, trade names, brand names, corporate names, logos, trade dress,
slogans, and other source indicators, applications and registrations for the foregoing, including all renewals of the same, and
the common law rights and goodwill associated therewith and symbolized thereby (collectively, &ldquo;<U>Trademarks</U>&rdquo;);
(iv) Internet domain names, all applications and registrations for the foregoing, including all renewals of same; (v) trade secrets,
know-how, and all non-public, confidential or proprietary information, documents and materials (collectively, &ldquo;<U>Trade Secrets</U>&rdquo;);
and (vi) all other intellectual property, industrial or proprietary rights.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Interim Period</U>&rdquo; has the meaning
given to that term in <U>Section&nbsp;6.01</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>IRS</U>&rdquo; means the Internal Revenue
Service.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>IT Assets</U>&rdquo; means all information
technology and computer systems (including the computers, computer software, databases, firmware, middleware, servers, workstations,
routers, hubs, switches, data communications lines and all other information technology equipment, and all associated documentation)
used by or on behalf of the Company.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Key Customer</U>&rdquo; has the meaning
given to that term in <U>Section&nbsp;4.22(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Key Domestic Distributor</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;4.22(b)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 91; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Key Employees</U>&rdquo; means those
employees of the Company listed on Part 1 of <U>Schedule A</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Key Individuals</U>&rdquo; means those
individuals listed on Part 2 of <U>Schedule A</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Key International Distributor</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;4.22(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Key Revenue Agreements</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;4.11(a)(xvii)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Key Stockholders</U>&rdquo; means those
stockholders of the Company listed on Part 3 of <U>Schedule&nbsp;A</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Key Supplier</U>&rdquo; has the meaning
given to that term in <U>Section&nbsp;4.22(d)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Knowledge</U>&rdquo; means, when used
with respect to the Company, the actual knowledge after reasonable inquiry, of the individuals listed on <U>Schedule D</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Law</U>&rdquo; means any U.S. or non-U.S.
federal, state or local law, statute, treaty, ordinance, rule, regulation, judgment, order, injunction or decree of any Governmental
Authority.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Lease Agreements</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;4.18(b)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Leased Real Property</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;4.18(b)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Letter Agreements</U>&rdquo; has the
meaning given to that term in the Recitals to this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Letter of Transmittal</U>&rdquo; has
the meaning given to that term in <U>Section 3.04(e)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Liens</U>&rdquo; means any lien, charge,
pledge, security interest or other encumbrance.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Loss</U>&rdquo; or &ldquo;<U>Losses</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;10.02(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Made Available to Parent</U>&rdquo;
means made available in the virtual data room supported by Donnelley Financial Solutions with respect to &ldquo;Project Button&rdquo;
no later than 5:00 p.m. (prevailing Eastern Standard Time) on the second (2<SUP>nd</SUP>) Business Day prior to the date of this
Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Material Adverse Effect</U>&rdquo; means
any state of facts, change, development, event, effect, condition or occurrence that, individually or in the aggregate with all
other facts, changes, developments, events, effects, conditions and occurrences, (i) would reasonably be expected to prevent, materially
delay, materially impair or have a material adverse effect on the ability of the Company to perform its obligations under this
Agreement or the other Transaction Documents to which it is a party or to otherwise consummate the transactions contemplated by
this Agreement, or (ii) is or would reasonably be expected to be materially adverse to the assets, business, financial condition
or results of operations of the Company, taken as a whole; <U>provided</U>, <U>however</U>, that none of the following, either
alone or in combination, shall be considered or taken into account in determining whether a Material Adverse Effect has occurred
or would reasonably be expected to occur: (a) any change in Applicable Law after the date of this Agreement; (b) any change in
general regulatory, economic, or political conditions, or in the economy or financial markets generally or in the particular industry
or industries in which the Company participates; (c) any engagement of hostilities, act of war (whether or not declared) or terrorist
activity; (d) any effect of weather, geological or meteorological events; (e) any change in GAAP (including the rules and principles
related to accelerated depreciation) after the date of this Agreement; (f) any change or development in any financial, banking
or securities market in the U.S. in general; (g) any effect of the announcement or pendency of this Agreement and the transactions
contemplated hereby; (h)&nbsp;any failure to meet financial projections, estimates or forecasts (except that the underlying causes
of such failure may be taken into account in determining whether there has been a Material Adverse Effect); or (i)&nbsp;any actions
taken (or omitted to be taken) at the request of Parent or Merger Sub or required to be taken or omitted, as applicable, by the
express terms of this Agreement; <U>provided further</U> that the effects described in clauses (b), (c), (d) or (f) do not disproportionately
affect the Company in any material respect as compared to other similarly situated companies in the industry in which the Company
operates.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 92; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Material Contracts</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;4.11(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Material Product and Trial Information</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;4.26(h)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Medical Device Laws</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;4.26(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Merger</U>&rdquo; has the meaning given
to that term in the Recitals to this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Merger Sub</U>&rdquo; has the meaning
given to that term in the Preamble to this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>MSRP</U>&rdquo; means manufacturer suggested
retail price.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Multiemployer Plan</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;4.13(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Net Sales</U>&rdquo; means total revenue
attributable to the Company Products, <I>minus</I> the aggregate amount of sales returns, allowances, and discounts attributable
to the Company Products, calculated in accordance with GAAP, and only to the extent in accordance with GAAP, using the accounting
methods, policies, practices and procedures as were used in the preparation of the Audited Financial Statements for the period
ended December 31, 2018. As used herein, &ldquo;total revenue&rdquo; includes, without limitation, all invoiced sales and unbilled
earned revenue that is supported by a completed Delivered Order Form indicating: the part number and lot number of each Company
Product implanted along with disposables consumed (if any), quantity, pricing (subject to review of the applicable Contract), the
date of the applicable surgery, and the name and address of the applicable hospital or surgical center. If any Company Product
is combined or bundled with any product (<I>i.e.</I>, the invoice or Delivered Order Form provides an aggregate price that covers
both a Company Product and a non-Company Product but does not have a separate itemized price for the Company Product), the revenue
attributable to such Company Product in respect of such combination or bundle will be equal to: (1) the standalone MSRP (or equivalent)
of that Company Product in the bundle <I>divided by</I> the standalone MSRP (or equivalent) of all products in the bundle; <I>multiplied
by</I> (2) the revenue generated by the bundle.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 93; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Net Sales Earn-Out Consideration</U>&rdquo;
means the additional consideration as set forth on Part 2 of <U>Schedule F</U> as it may be adjusted pursuant to <U>Section&nbsp;3.08</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Non-Converting Company Preferred Stock</U>&rdquo;
means all shares of Company Preferred Stock other than the Series B Preferred Stock and Converting Company Preferred Stock.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Non-Disclosure Agreement</U>&rdquo;
means the Confidential Disclosure Agreement, dated as of November 28, 2018, between Parent and the Company.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Notified Body</U>&rdquo; means an entity
licensed, authorized or approved by the applicable government agency, department or other authority to assess and certify the conformity
of a medical device with the requirements of the EU legislation governing medical devices and with applicable harmonized standards.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>OFAC</U>&rdquo; has the meaning given
to that term in <U>Section 4.10(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>OIG</U>&rdquo; has the meaning given
to that term in <U>Section 4.25(b)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Option Cashout Amount</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;3.03(a)(i)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Order</U>&rdquo; means any writ, judgment,
decree, injunction or similar order of any Governmental Authority (in each such case whether preliminary or final).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Ordinary Course of Business</U>&rdquo;
means the conduct of the business of the Company in all material respects in accordance with its customary and normal practices,
policies and procedures prior to the date of this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Organizational Documents</U>&rdquo;
means, with respect to any Person, the articles or certificate of incorporation or organization and by-laws, or such other organizational
documents of such Person, including those that are required to be registered or kept in the place of incorporation, organization
or formation of such Person and which establish the legal existence of such Person.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Out of the Money Option</U>&rdquo; means
any vested Company Option that has a per-share exercise price that is equal to or greater than the Per Common Share Closing Payment.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Overstatement</U>&rdquo; has the meaning
given to that term in <U>Section 3.07(f)(iii)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Parachute Payment</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;6.08(e)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Parent</U>&rdquo; has the meaning given
to that term in the Preamble to this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Parent Earn-Out Statement</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;3.08(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Parent Executive</U>&rdquo; means each
of the chief executive officer, chief financial officer, executive vice president of Business Development &amp; Strategic Planning,
vice president of international sales and vice president of U.S. sales of Parent from time to time (or any individual filling a
role with similar seniority and responsibilities).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 94; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Parent Fundamental Representations</U>&rdquo;
means the representations and warranties made pursuant to <U>Section&nbsp;5.01</U>, <U>Section&nbsp;5.02</U>, <U>Section&nbsp;5.03(a)</U>
and <U>Section&nbsp;5.05</U> of this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Parent Indemnified Parties</U>&rdquo;
has the meaning given in <U>Section&nbsp;10.02(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Party</U>&rdquo; and &ldquo;<U>Parties</U>&rdquo;
have the meanings given to those terms in the Preamble to this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Payments Administrator</U>&rdquo; means
<FONT STYLE="font-size: 10pt">Acquiom Financial LLC.</FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Payments Administrator Agreement</U>&rdquo;
means the agreement among the Stockholder Representative, Parent and the Payments Administrator for purposes of distributing the
Per Share Merger Consideration and other applicable amounts to the applicable Equityholders pursuant to the terms of this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Payments Administrator Fund</U>&rdquo;
has the meaning given in <U>Section&nbsp;3.04(d)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Per Common Share Closing Payment</U>&rdquo;
means, in respect of any share of Company Common Stock and each share of Series B Preferred Stock, an amount equal to the quotient
of (i) (a) the Aggregate Closing Amount <I>minus</I> (b) the Aggregate Preferred Share Payment, <I>plus</I> (c) the aggregate exercise
price of all Company Warrants and Company Options outstanding immediately prior to the Effective Time (other than any Company Options
cancelled for no consideration or payment pursuant to <U>Section&nbsp; 3.03(a)(ii)</U> and any Company Warrants extinguished and
cancelled pursuant to <U>Section 3.03(b))</U>, <I>divided by </I>(ii) the total number of Fully Diluted Shares; provided, however,
that for purposes of this definition, to the extent any vested Company Options are <U>Out of the Money Options</U>, then the Per
Common Share Closing Payment shall be recalculated such that (x) clause (i)(c) above shall be reduced by the aggregate exercise
price of the Out of the Money Options, and (y) clause (ii) above shall be reduced by the aggregate number of shares of Company
Common Stock underlying the Out of the Money Options.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Per Common Share Merger Consideration</U>&rdquo;
means, with respect to each share of Company Common Stock and each share of Series B Preferred Stock, an amount equal to the Per
Common Share Closing Payment, <I>plus</I> any Per Common Share Post-Closing Payment.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Per Common Share Post-Closing Payment</U>&rdquo;
means, in respect of each share of Company Common Stock and each share of Series B Preferred Stock, the aggregate amount of any
Post-Closing Payment allocated thereto pursuant to <U>Section 3.04(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Per Option Post-Closing Payment</U>&rdquo;
means, in respect of any Company Option, the aggregate amount of any Post-Closing Payment allocated thereto pursuant to <U>Section
3.04(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Per Share Merger Consideration</U>&rdquo;
means, as applicable, (i) with respect to shares of Company Common Stock and shares of Series B Preferred Stock, the Per Common
Share Merger Consideration, (ii)&nbsp;with respect to shares of Non-Converting Company Preferred Stock, the applicable Preferred
Share Liquidation Preference, and (iii) with respect to Company Options, the Option Cashout Amount.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 95; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Permitted Lien</U>&rdquo; means any
of the following: (i) any Lien (x) for Taxes not yet due or delinquent or (y) for Taxes being contested in good faith by appropriate
proceedings for which adequate reserves have been maintained to the extent required by GAAP; (ii) zoning, planning and similar
limitations and restrictions on, and all rights of any Governmental Authority to regulate any real property that would not reasonably
be expected to impair the continued use and operation of the assets to which they relate in the conduct of the business of the
Company as presently conducted; (iii) statutory or common law Liens in favor of carriers, warehousemen, mechanics and materialmen,
and statutory or common law Liens to secure claims for labor, materials or supplies for amounts not yet due or that are being contested
in good faith by appropriate proceedings for which adequate reserves have been maintained in accordance with GAAP; (iv) pledges
and deposits made in the Ordinary Course of Business in compliance with workers&rsquo; compensation, unemployment insurance and
other Applicable Laws regarding social security; (v) any Lien that is released on or prior to the Closing; (vi) any Lien arising
in the Ordinary Course of Business by operation of Applicable Law with respect to a liability that is not yet due or delinquent
or that is being contested in good faith by the Company; (vii) any Lien reflected in the Financial Statements; and (viii) any purchase
money Lien arising in the Ordinary Course of Business.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Person</U>&rdquo; means any individual,
corporation, company, voluntary association, partnership, joint venture, trust, limited liability company, unincorporated organization,
Governmental Authority or other entity.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Personal Data</U>&rdquo; means any data
or information in any medium relating to an identified or identifiable individual and any other data or information that constitutes
personal information or personally identifiable information under any Applicable Law, and includes, but is not limited to, a natural
person&rsquo;s first and last name, home or other physical address, telephone number, e-mail address, photograph, social security
number, driver&rsquo;s license number, passport number or other government-issued identification number, biometric information,
credit card or other financial information, or customer or account number, IP address, cookie information, or other unique identifiers.
An identifiable individual is one who can be identified, directly or indirectly, in particular by reference to an identification
number or to one or more factors specific to his/her physical, physiological, mental, economic, cultural or social identity. Personal
Data shall include Protected Health Information.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Post-Closing Option Payroll Taxes Offset</U>&rdquo;
means any employer-level employment or payroll Taxes payable as a result of the payment of the Per Option Post-Closing Payments.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Post-Closing Payment</U>&rdquo; means
any amount (i) payable by Parent (or on its behalf or at its direction) pursuant to <U>Section 3.05</U>, <U>Section 3.07(f)</U>
or <U>Section 3.08</U> or (ii) of the Expense Fund delivered by the Stockholder Representative to the Payments Administrator as
provided in <U>Section 11.01(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 96; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Post-Closing Payments Administrator
Fees</U>&rdquo; means any fees or expenses incurred under the Payments Administrator Agreement that are due and payable following
the Closing Date.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Pre-Closing Tax Period</U>&rdquo; means
any taxable year or other taxable period ending on or before the Closing Date, and that portion of any Straddle Period ending on
the Closing Date.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Pre-Closing Tax Return</U>&rdquo; has
the meaning given to that term in <U>Section 6.10(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Preferred Share Liquidation Preference</U>&rdquo;
means (a) for each share of Series A Preferred Stock, $1.00 per share; (b) for each share of Series B Preferred Stock, $1.00 per
share; (c) for each share of Series C Preferred Stock, $2.50 per share; (d) for each share of Series D Preferred Stock, $3.50 per
share; (e) for each share of Series E Preferred Stock, $4.50 per share; and (f) for each share of Series F Preferred Stock, $4.75
per share, <I>plus</I>, in each case, an amount equal to any dividends declared but unpaid thereon.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;[<U>&hellip;] Agreements</U>&rdquo; means
the [&hellip;], dated [&hellip;], by and between the Company and [&hellip;] and the [&hellip;], dated [&hellip;], by and between
Company and [&hellip;].</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Process&rdquo; or &ldquo;Processing</U>&rdquo;
means the collection, use, storage, processing, recording, distribution, transfer, import, export, protection (including security
measures), disposal, disclosure or other activity regarding data (whether electronically or in any other form or medium).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Properties</U>&rdquo; means, as to any
Person, all assets and properties of every kind, nature, character and description (whether real, personal or mixed, whether tangible
or intangible, and wherever situated) operated, owned or leased by such Person.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Protected Health Information</U>&rdquo;
means protected health information as that term is defined at 45 C.F.R. &sect; 160.103 for purposes of HIPAA.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Quality System Regulation</U>&rdquo;
means design control, Good Manufacturing Practices, and quality system management requirements governing the standards and methods
to be used in, and the facilities or controls to be used for, the design, manufacture, processing, packaging, testing or holding
of medical devices to assure their quality, safety, performance, and efficacy, including the FDA Quality System Regulation at 21
C.F.R. Part 820 and associated FDA guidance, international standards for quality management systems as adopted by the International
Organization for Standardization such as ISO 13485:2016, and similar requirements of any Governmental Authority.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>R&amp;W Policy</U>&rdquo; means the
general representations and warranties insurance policy that is being obtained by Parent relating to the transactions contemplated
by this Agreement with a face value of $[&hellip;].</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>R&amp;W Retention Amount</U>&rdquo;
means $[&hellip;].</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Regulatory Approval Deadline</U>&rdquo;
means the deadline set forth opposite each Regulatory Approval Product on Part 1 of <U>Schedule&nbsp;F</U>; <U>provided</U>, <U>however</U>,
that if a Government Shutdown directly causes a delay in the achievement of any such deadline, that deadline shall be automatically
extended one (1) day for each day of delay suffered by the Surviving Corporation as a direct result of the occurrence of any such
Government Shutdown.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 97; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Regulatory Approval Products</U>&rdquo;
means the products set forth on Part 1 of <U>Schedule&nbsp;F</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Regulatory Authorization</U>&rdquo;
means, with respect to a particular jurisdiction, any and all approvals, licenses, registrations, certificates, permits, consents,
notifications, clearances or authorizations of any Governmental Authority as are necessary to manufacture, commercially distribute,
import, export, sell and market a Company Product in such jurisdiction, which shall include where applicable: 510(k) or premarket
notification clearances, de novo classifications, pre-market approvals, investigational device exemptions, product recertifications,
manufacturing approvals and authorizations, CE Mark certifications, pricing and reimbursement approvals, labeling approvals, registration
notifications or their foreign equivalents.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Regulatory Earn-Out Approval</U>&rdquo;
means the receipt of all Regulatory Authorizations required for the commercial sale of the applicable Regulatory Approval Product
in the United States of America.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Regulatory Earn-Out Consideration</U>&rdquo;
means the additional consideration based on the achievement of each Regulatory Milestone, as set forth on Part 1 of <U>Schedule&nbsp;F</U>
as it may be adjusted pursuant to <U>Section&nbsp;3.08</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Representations Survival Period</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;10.01(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Representative Losses</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;11.01(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Representatives</U>&rdquo; means, as
to any Person, its officers, directors, employees, partners, members, stockholders, counsel, accountants, financial advisors, engineers,
agents and consultants (other than the Stockholder Representative).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Required Stockholder Approval</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;4.03(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Resolution Period</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp; 3.07(b)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Resolved Matters</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp; 3.07(b)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Restricted Cash</U>&rdquo; means any
cash which is not freely usable by the Company because it is subject to restrictions, limitations or Taxes on use or distribution
by Law, contract or otherwise, including without limitation, restrictions on dividends and repatriations or any other form of restriction.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Review Period</U>&rdquo; has the meaning
given to that term in <U>Section&nbsp;3.07(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Scheduled Company IP</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;4.16(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 98; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>SEC</U>&rdquo; has the meaning given
to that term in <U>Section 3.08(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Security Incident</U>&rdquo; means any
unauthorized access, acquisition, use, disclosure, modification, deletion or destruction of information (including Personal Data)
or interference with system operations of IT Assets.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Series A Preferred Stock</U>&rdquo;
means the Company Preferred Stock designated Series&nbsp;A Convertible Preferred Stock, par value $.001 per share.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Series B Preferred Stock</U>&rdquo;
means the Company Preferred Stock designated Series&nbsp;B Convertible Preferred Stock, par value $.001 per share.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Series C Certificate of Designation</U>&rdquo;
means the Certificate of Designation for the Series C Convertible Preferred Stock of the Company, as filed January 28, 2004.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Series C Preferred Stock</U>&rdquo;
means the Company Preferred Stock designated Series&nbsp;C Convertible Preferred Stock, par value $.001 per share.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Series D Certificate of Designation</U>&rdquo;
means the Certificate of Designation for the Series D Convertible Preferred Stock of the Company, as filed November 4, 2004, as
amended.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Series D Preferred Stock</U>&rdquo;
means the Company Preferred Stock designated Series&nbsp;D Convertible Preferred Stock, par value $.001 per share.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Series E Certificate of Designation</U>&rdquo;
means the Certificate of Designation for the Series E Convertible Preferred Stock of the Company, as filed May 25, 2006, as amended.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Series E Preferred Stock</U>&rdquo;
means the Company Preferred Stock designated Series&nbsp;E Convertible Preferred Stock, par value $.001 per share.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Series F Certificate of Designation</U>&rdquo;
means the Certificate of Designation for the Series F Convertible Preferred Stock of the Company, as filed November 5, 2007, as
amended.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Series F Preferred Stock</U>&rdquo;
means the Company Preferred Stock designated Series&nbsp;F Convertible Preferred Stock, par value $.001 per share.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Severance Costs</U>&rdquo; means the
aggregate amount of severance due and payable in connection with any termination of employment prior to the Closing Date of any
employee of the Company that is outstanding as of the Closing Date.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Special Indemnity Holdback</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;3.05(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Special Indemnity Release Date</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;3.05(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Special Indemnity Losses</U>&rdquo;
has the meaning given to that term in <U>Section 10.02(a)(iv)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 99; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Special Losses</U>&rdquo; has the meaning
given to that term in <U>Section&nbsp;10.04(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Stock Plans</U>&rdquo; means the 2002
Stock Incentive Plan, as amended, of the Company and the 2013 Stock Incentive Plan of the Company.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Stockholder</U>&rdquo; means any holder
of shares of Company Common Stock or Company Preferred Stock immediately prior to the Effective Time.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Stockholder Representative</U>&rdquo;
has the meaning given to that term in the Preamble to this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Straddle Period</U>&rdquo; means any
taxable period that begins on or before and ends after the Closing Date.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Subsidiary</U>&rdquo; means, with respect
to any Person, any other Person of which such Person (either alone or through or together with any other subsidiary) owns, directly
or indirectly, fifty percent (50%) or more of the outstanding equity securities or securities carrying the voting power in the
election of the board of directors or other governing body of such Person.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Support Agreements</U>&rdquo; has the
meaning given to that term in the Recitals to this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Surviving Corporation</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;2.01</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Tax</U>&rdquo; means any and all federal,
state, local or foreign taxes imposed by a Governmental Authority (including any interest, fines, assessments, penalties or additions
to tax, in each case, imposed by a Governmental Authority in connection therewith or with respect thereto) including (x) taxes
imposed on, or measured by, income, franchise, profits or gross receipts, and (y) <I>ad valorem</I>, value added, capital gains,
sales, goods and services, use, real or personal property, capital stock, license, branch, payroll, estimated withholding, employment,
social security, unemployment, compensation, utility, severance, production, excise, stamp, occupation, premium, windfall profits,
transfer and gains taxes, abandoned and unclaimed property, escheat, and customs duties.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Tax Authority</U>&rdquo; means, with
respect to any Tax, the Governmental Authority charged with the administration, determination and collection of such Tax.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Tax Return</U>&rdquo; means any return,
report, information return, declaration, claim for refund, election or other document, together with all schedules, attachments,
amendments and supplements thereto, supplied to or required to be supplied to any Tax Authority.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Termination Date</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;9.01(a)(i)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Third-Party Claim</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;10.03</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Trade Secret</U>&rdquo; has the meaning
given to that term in the definition of Intellectual Property Rights.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 100; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Trademarks</U>&rdquo; has the meaning
given to that term in the definition of Intellectual Property Rights.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Transaction Documents</U>&rdquo; means
this Agreement, the Payments Administrator Agreement and the other documents, agreements, certificates and other instruments to
be executed, delivered and performed by the parties in connection with the transactions contemplated by this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Transaction Expenses</U>&rdquo; means:
(i) any and all third-party advisory fees, costs and expenses (including expenses of brokers, financial advisors, consultants,
accountants, commission agents, service providers and legal counsel) or other fees (including regulatory, consent fees and fees
of the Payments Administrator if any) and expenses incurred by the Company in connection with the transactions contemplated hereby,
(ii) any accrued or payable transaction, management, monitoring or similar fees payable to any Affiliate of the Company, (iii)
the fees and expenses of the Stockholder Representative as of the Closing, (iv) one hundred (100%) of any documented premium and
expenses payable with respect to the R&amp;W Policy in an amount not to exceed $[&hellip;], (v) all Severance Costs, (vi) all Change
in Control Payments and, (vii) all Transaction Payroll Taxes (other than Post-Closing Option Payroll Taxes Offsets).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Transaction Payroll Taxes</U>&rdquo;
means any employer-level employment or payroll Taxes payable as a result of the payment of the Severance Costs or other Change
in Control Payments, whether payable (or attributable to amounts payable) before, on or after the Closing as a result of the transactions
contemplated by this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Transfer Taxes</U>&rdquo; has the meaning
given to that term in <U>Section&nbsp;6.10(d)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Unresolved Matters</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;3.07(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>U.S. Dollars</U>&rdquo; means the lawful
currency of the United States.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Working Capital Difference</U>&rdquo;
means (i) the sum of all current assets reflected on <U>Schedule E-1</U> (excluding Cash on Hand, Restricted Cash, income Tax assets
and employee receivables); <I>minus</I> (ii) the sum of the current liabilities reflected on <U>Schedule E-1</U> (excluding Indebtedness,
Transaction Expenses and any income Tax liabilities), in each case as of 12:01 am Eastern Standard Time on the Closing Date and
calculated in accordance with GAAP, and only to the extent in accordance with GAAP, using the accounting methods, policies, practices
and procedures, as were used in the preparation of the balance sheet of the Company in the Audited Financial Statements as of December
31, 2018, <I>minus </I>(iii) $[&hellip;], expressed as a positive or negative value as appropriate. <U>Schedule E-1</U> attached
hereto sets forth an illustrative calculation of the Working Capital Difference.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>Written Consent</U>&rdquo; has the meaning
given to that term in the Recitals to this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&ldquo;<U>YTD Financial Statements</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;4.06(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 101; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0; text-align: center"><U>Schedule A</U></P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>Part 1 &ndash; Key Employees</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>[&hellip;]</TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">Schedule A-1</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 102; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0; text-align: center"><U>Schedule A</U></P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>Part 2 &ndash; Key Individuals</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>[&hellip;]</TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">Schedule A-2</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 103; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0; text-align: center"><U>Schedule A</U></P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>Part 3 &ndash; Key Stockholders</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>[&hellip;]</TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">Schedule A-3</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 104; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0; text-align: center"><U>Schedule B</U></P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>List of Stockholders to Sign Support Agreements by Midnight on
January 5, 2020</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.25in">[&hellip;]</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">Schedule B</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 105; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B><U>Schedule C</U></B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>Preliminary Schedule of Consideration to be Paid to Each Equityholder</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">Schedule C</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 106; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0; text-align: center"><U>Schedule D</U></P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>Knowledge Parties</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>[&hellip;]</TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">Schedule D</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 107; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0; text-align: center"><U>Schedule E-1</U></P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>Illustrative Calculation of Working Capital</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center">Schedule E-1</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center"></P>

<!-- Field: Page; Sequence: 108; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0; text-align: center"><U>Schedule E-2</U></P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>Illustrative Calculation of Indebtedness</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">Schedule E-2</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 109; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0; text-align: center"><U>Schedule E-3</U></P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>Illustrative Calculation of Cash</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center">Schedule E-3</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center"></P>

<!-- Field: Page; Sequence: 110; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"></P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0; text-align: center"><U>Schedule F</U></P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>Part 1 &ndash; Regulatory Milestones</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="white-space: nowrap; width: 53%"><FONT STYLE="font-size: 10pt"><B><U>[&hellip;]</U></B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 27%; text-align: center"><FONT STYLE="font-size: 10pt"><B><U>[&hellip;]</U></B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 20%; text-align: center"><FONT STYLE="font-size: 10pt"><B><U>[&hellip;]</U></B></FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 10pt">[&hellip;]</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">[&hellip;]</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">[&hellip;]</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 10pt">[&hellip;]</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">[&hellip;]</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">[&hellip;]</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 10pt">[&hellip;]</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">December 31, 2021</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">[&hellip;]</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 10pt"><B>Total</B>&#9;</FONT></TD>
    <TD>
        <P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>
        <P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>$25,000,000</B></FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">Schedule F-1</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 111; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0; text-align: center"><U>Schedule F</U></P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>Part 2 &ndash; Sales Milestones</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: left">The Net Sales Earn-Out Consideration for each of Calendar Year 2020 or 2021 will be an amount equal
to (i) the Net Sales in such Calendar Year <I>less</I> (ii) the Net Sales Earn-Out Target for such Calendar Year (<I>see Illustration
B below for illustration purposes only</I>); <U>provided that</U> the total aggregate Net Sales Earn-Out Consideration for Calendar
Years 2020 and 2021 pursuant to this paragraph 1 shall be a maximum of $10,000,000 (<I>see Illustration C below for illustration
purposes only</I>). In the event that the amount of Net Sales for a Calendar Year is less than the Net Sales Earn-Out Target for
that Calendar Year, such difference shall not affect the Net Sales Earn-Out Consideration, if any, payable with respect to the
other Calendar Year (<I>see Illustration A below for illustration purposes only</I>). The &ldquo;Net Sales Earn-Out Target&rdquo;
for Calendar Year 2020 will be $[&hellip;] and the &ldquo;Net Sales Earn-Out Target&rdquo; for Calendar Year 2021 will be the greater
of (i) [&hellip;] and (ii) $[&hellip;].</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: -2in; margin: 0pt 0 0pt 2in"></P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: -2in; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"> [&hellip;]</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: -2in; margin: 0pt 0 0pt 2in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: left">In addition to any Net Sales Earn-Out Consideration payable under paragraph 1, if Net Sales in Calendar
Year 2020 are at least [&hellip;]% greater in value than the greater of (i) [&hellip;] and (ii) $[&hellip;], an additional Net
Sales Earn-Out Consideration in an amount equal to $5,000,000 will be payable.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">Schedule F-2</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 112; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0; text-align: center"><U>Schedule G</U></P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: -2in; margin: 0pt 0 0pt 2in"><B>Related Parties</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: -2in; margin: 0pt 0 0pt 2in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>[&hellip;]</TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-indent: -2in; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: -2in; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: center">Schedule G</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center"></P>

<!-- Field: Page; Sequence: 113; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0; text-align: center"><U>Schedule H</U></P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: -2in; margin: 0pt 0 0pt 2in"><B>Illustrative Parent Earn-Out Statement</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: -2in; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: -2in; margin: 0pt 0 0pt 2in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; border: Black 1pt solid; text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="width: 16%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>[&hellip;]</B></FONT></TD>
    <TD STYLE="width: 16%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>[&hellip;]</B></FONT></TD>
    <TD STYLE="width: 16%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>[&hellip;]</B></FONT></TD>
    <TD STYLE="width: 16%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>[&hellip;]</B></FONT></TD>
    <TD STYLE="width: 16%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>[&hellip;]</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: left; text-indent: 0in"><FONT STYLE="font-size: 10pt">[&hellip;]</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left; text-indent: 0in">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: left; text-indent: -2in; margin: 0pt 0 0pt 2in"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: -2in; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: -2in; margin: 0pt 0 0pt 2in"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: -2in; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 2in; font-size: 10pt; text-align: center; text-indent: -2in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 2in; font-size: 10pt; text-align: center; text-indent: -2in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 2in; font-size: 10pt; text-align: center; text-indent: -2in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 2in; font-size: 10pt; text-align: center; text-indent: -2in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 2in; font-size: 10pt; text-align: center; text-indent: -2in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 2in; font-size: 10pt; text-align: center; text-indent: -2in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 2in; font-size: 10pt; text-align: center; text-indent: -2in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 2in; font-size: 10pt; text-align: center; text-indent: -2in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 2in; font-size: 10pt; text-align: center; text-indent: -2in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 2in; font-size: 10pt; text-align: center; text-indent: -2in">&nbsp;</P>

<P STYLE="margin: 0pt 0 0pt 2in; font-size: 10pt; text-align: center; text-indent: -2in">Schedule H</P>

<P STYLE="margin: 0pt 0 0pt 2in; font-size: 10pt; text-align: center; text-indent: -2in">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.2
<SEQUENCE>3
<FILENAME>exh_22.htm
<DESCRIPTION>EXHIBIT 2.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 2.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 12pt 0pt; border: Black 1pt solid">Portions of this agreement have been redacted
in compliance with Regulation S-K Item 601(b)(2). The omitted information is not material and would likely cause competitive harm
to the Company if publicly disclosed.</P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0">EXECUTION VERSION</P>

<P STYLE="font-size: 10pt; text-align: right; margin: 0">PRIVATE AND CONFIDENTIAL</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt">AGREEMENT AND PLAN OF MERGER</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt">by and among</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt">ANIKA THERAPEUTICS, INC.,</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt">SUNSHINE MERGER SUB, LLC,</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt">PARCUS MEDICAL, LLC</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt">AND</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt">PHILIP MUNDY,<BR>
as the Unitholder Representative</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt">Dated as of January 4, 2020</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt">TABLE OF CONTENTS</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: right"><U>Page</U></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="width: 90%; text-align: left; text-indent: -0.8in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.8in">Article I DEFINITIONS</TD>
    <TD STYLE="width: 10%; text-align: right; padding-top: 12pt; padding-bottom: 0pt">2</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">1.01&nbsp;&nbsp;&nbsp;Definitions</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">2</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">1.02&nbsp;&nbsp;&nbsp;Rules of Construction</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">2</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -0.8in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.8in">Article II THE MERGER</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">3</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.01&nbsp;&nbsp;&nbsp;The Merger</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">3</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.02&nbsp;&nbsp;&nbsp;Closing</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">3</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.03&nbsp;&nbsp;&nbsp;Effective Time</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">3</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.04&nbsp;&nbsp;&nbsp;Effects</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">3</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.05&nbsp;&nbsp;&nbsp;Governing Documents; Directors and Officers</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">3</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">2.06&nbsp;&nbsp;&nbsp;Additional Action</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">3</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -0.8in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.8in">Article III PURCHASE PRICE; EFFECT ON UNITS</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">4</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.01&nbsp;&nbsp;&nbsp;Effects of Merger</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">4</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.02&nbsp;&nbsp;&nbsp;Treatment of Company RSUs</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">4</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.03&nbsp;&nbsp;&nbsp;Intentionally omitted.</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">5</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.04&nbsp;&nbsp;&nbsp;Payment Procedures</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">5</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.05&nbsp;&nbsp;&nbsp;Holdback</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">7</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.06&nbsp;&nbsp;&nbsp;Aggregate Closing Payment Schedule</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">8</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.07&nbsp;&nbsp;&nbsp;Post-Closing Determination of the Closing Statement</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">8</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.08&nbsp;&nbsp;&nbsp;Earn-Out Consideration</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">11</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.09&nbsp;&nbsp;&nbsp;No Interest</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">14</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.10&nbsp;&nbsp;&nbsp;Withholding Rights</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">14</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">3.11&nbsp;&nbsp;&nbsp;Purchase Price Allocation</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">14</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -0.8in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.8in">Article IV REPRESENTATIONS AND WARRANTIES REGARDING THE COMPANY</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">15</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.01&nbsp;&nbsp;&nbsp;Organization; Qualification</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">15</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.02&nbsp;&nbsp;&nbsp;Capitalization</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">15</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.03&nbsp;&nbsp;&nbsp;Authority; Enforceability</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">16</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.04&nbsp;&nbsp;&nbsp;No Conflicts; Consents and Approvals</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">17</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.05&nbsp;&nbsp;&nbsp;No Subsidiaries; No Repurchase Obligations</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">17</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.06&nbsp;&nbsp;&nbsp;Financial Statements</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">17</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.07&nbsp;&nbsp;&nbsp;Liabilities</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">18</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.08&nbsp;&nbsp;&nbsp;Inventory</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">18</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.09&nbsp;&nbsp;&nbsp;Accounts Receivable</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">19</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.10&nbsp;&nbsp;&nbsp;Absence of Certain Changes</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">19</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.11&nbsp;&nbsp;&nbsp;Legal Proceedings</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">20</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.12&nbsp;&nbsp;&nbsp;Compliance with Applicable Laws</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">20</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.13&nbsp;&nbsp;&nbsp;Material Contracts</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">21</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.14&nbsp;&nbsp;&nbsp;Taxes</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">24</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.15&nbsp;&nbsp;&nbsp;Employee Matters</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">25</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in; width: 90%">4.16&nbsp;&nbsp;&nbsp;Labor Matters</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; width: 10%">27</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.17&nbsp;&nbsp;&nbsp;Insurance</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">28</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.18&nbsp;&nbsp;&nbsp;Intellectual Property</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">29</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.19&nbsp;&nbsp;&nbsp;Privacy and Data Security</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">31</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.20&nbsp;&nbsp;&nbsp;Real Property</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">32</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.21&nbsp;&nbsp;&nbsp;Personal Property</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">32</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.22&nbsp;&nbsp;&nbsp;Related-Party Transactions</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">32</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.23&nbsp;&nbsp;&nbsp;Bank Accounts</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">33</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.24&nbsp;&nbsp;&nbsp;Customers, Distributors and Suppliers</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">33</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.25&nbsp;&nbsp;&nbsp;Key Revenue Agreements</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">34</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.26&nbsp;&nbsp;&nbsp;Condition and Sufficiency of Assets</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">34</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.27&nbsp;&nbsp;&nbsp;Compliance with Healthcare Laws</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">34</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.28&nbsp;&nbsp;&nbsp;Medical Device Compliance</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">35</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.29&nbsp;&nbsp;&nbsp;Brokers</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">37</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.30&nbsp;&nbsp;&nbsp;Environmental Matters.</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">37</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">4.31&nbsp;&nbsp;&nbsp;No Other Representations or Warranties</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">38</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -0.8in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.8in">Article V REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">38</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.01&nbsp;&nbsp;&nbsp;Organization; Qualification</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">38</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.02&nbsp;&nbsp;&nbsp;Authority; Enforceability</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">38</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.03&nbsp;&nbsp;&nbsp;No Conflicts; Consents and Approvals</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">39</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.04&nbsp;&nbsp;&nbsp;Litigation</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">39</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.05&nbsp;&nbsp;&nbsp;Availability of Funds</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">39</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.06&nbsp;&nbsp;&nbsp;Merger Sub</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">39</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.07&nbsp;&nbsp;&nbsp;No Other Representations or Warranties</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">40</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">5.08&nbsp;&nbsp;&nbsp;Parent&rsquo;s Investigation and Reliance</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">40</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -0.8in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.8in">Article VI COVENANTS OF THE PARTIES</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">40</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.01&nbsp;&nbsp;&nbsp;Access by Parent</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">40</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.02&nbsp;&nbsp;&nbsp;Certain Restrictions</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">41</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.03&nbsp;&nbsp;&nbsp;Reasonable Best Efforts; Regulatory and Other Approvals</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">43</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.04&nbsp;&nbsp;&nbsp;No Solicitation or Negotiation of Alternative Proposals</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">44</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.05&nbsp;&nbsp;&nbsp;Required Unitholder Approval</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">45</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.06&nbsp;&nbsp;&nbsp;Additional Unitholder Consents</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">46</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.07&nbsp;&nbsp;&nbsp;Information Statement</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">46</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.08&nbsp;&nbsp;&nbsp;Employees; Employee Benefits</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">46</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.09&nbsp;&nbsp;&nbsp;Third-Party Consents</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">48</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.10&nbsp;&nbsp;&nbsp;Tax Matters</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">48</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.11&nbsp;&nbsp;&nbsp;Further Assurances; Post-Closing Cooperation</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">50</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.12&nbsp;&nbsp;&nbsp;Indemnification of Managers and Officers; Managers&rsquo; and Officers&rsquo; Insurance, etc.</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">51</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.13&nbsp;&nbsp;&nbsp;R&amp;W Insurance</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">51</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.14&nbsp;&nbsp;&nbsp;Notification</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">52</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">6.15&nbsp;&nbsp;&nbsp;Parent Filings</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">52</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -0.8in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.8in"></TD></TR></TABLE>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -0.8in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.8in; width: 90%">Article VII CONDITIONS TO OBLIGATIONS OF PARENT AND MERGER SUB</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt; width: 10%">52</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.01&nbsp;&nbsp;&nbsp;Representations and Warranties</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">52</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.02&nbsp;&nbsp;&nbsp;Performance</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">52</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.03&nbsp;&nbsp;&nbsp;Payment of Transaction Expenses</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">53</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.04&nbsp;&nbsp;&nbsp;Officer&rsquo;s Certificates</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">53</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.05&nbsp;&nbsp;&nbsp;Orders and Applicable Laws</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">53</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.06&nbsp;&nbsp;&nbsp;No Material Adverse Effect</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">53</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.07&nbsp;&nbsp;&nbsp;Unitholder Approval</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">53</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.08&nbsp;&nbsp;&nbsp;Payments Administrator Agreement</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">53</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.09&nbsp;&nbsp;&nbsp;Letter Agreements</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">53</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.10&nbsp;&nbsp;&nbsp;Continued Employment</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">53</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.11&nbsp;&nbsp;&nbsp;Consents</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">53</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">7.12&nbsp;&nbsp;&nbsp;FIRPTA</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">53</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -0.8in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.8in">Article VIII CONDITIONS TO OBLIGATIONS OF THE COMPANY</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">54</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">8.01&nbsp;&nbsp;&nbsp;Representations and Warranties</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">54</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">8.02&nbsp;&nbsp;&nbsp;Performance</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">54</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">8.03&nbsp;&nbsp;&nbsp;Officer&rsquo;s Certificate</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">54</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">8.04&nbsp;&nbsp;&nbsp;Orders and Applicable Laws</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">54</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">8.05&nbsp;&nbsp;&nbsp;Unitholder Approval</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">54</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">8.06&nbsp;&nbsp;&nbsp;Payments Administrator Agreement</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">54</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -0.8in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.8in">Article IX TERMINATION</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">54</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">9.01&nbsp;&nbsp;&nbsp;Termination</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">54</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">9.02&nbsp;&nbsp;&nbsp;Effect of Termination</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">55</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -0.8in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.8in">Article X INDEMNIFICATION</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">55</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">10.01&nbsp;&nbsp;&nbsp;Survival</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">55</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">10.02&nbsp;&nbsp;&nbsp;Indemnification</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">56</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">10.03&nbsp;&nbsp;&nbsp;Third-Party Claims</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">57</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">10.04&nbsp;&nbsp;&nbsp;Limitations on Indemnification</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">58</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">10.05&nbsp;&nbsp;&nbsp;No Contribution</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">60</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">10.06&nbsp;&nbsp;&nbsp;Remedies Exclusive</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">61</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">10.07&nbsp;&nbsp;&nbsp;Adjustment Characterization</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">61</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">10.08&nbsp;&nbsp;&nbsp;Damage Limitations</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">61</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; text-indent: -0.8in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.8in">Article XI MISCELLANEOUS</TD>
    <TD STYLE="text-align: right; padding-top: 12pt; padding-bottom: 0pt">61</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.01&nbsp;&nbsp;&nbsp;Unitholder Representative</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">61</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.02&nbsp;&nbsp;&nbsp;Actions of the Unitholder Representative</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">63</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.03&nbsp;&nbsp;&nbsp;Entire Agreement</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">63</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.04&nbsp;&nbsp;&nbsp;Expenses</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">63</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.05&nbsp;&nbsp;&nbsp;Announcements</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">63</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.06&nbsp;&nbsp;&nbsp;No Waiver</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">63</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.07&nbsp;&nbsp;&nbsp;Amendments</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">64</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.08&nbsp;&nbsp;&nbsp;Addresses for Notices</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">64</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.09&nbsp;&nbsp;&nbsp;Captions</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">65</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in; width: 90%">11.10&nbsp;&nbsp;&nbsp;Severability</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt; width: 10%">65</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.11&nbsp;&nbsp;&nbsp;Assignment</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">65</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.12&nbsp;&nbsp;&nbsp;Counterparts</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">65</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.13&nbsp;&nbsp;&nbsp;Disclosure</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">65</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.14&nbsp;&nbsp;&nbsp;Specific Performance</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">66</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.15&nbsp;&nbsp;&nbsp;Governing Applicable Law</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">66</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.16&nbsp;&nbsp;&nbsp;Consent to Jurisdiction</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">66</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.17&nbsp;&nbsp;&nbsp;Waiver of Jury Trial</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">66</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.18&nbsp;&nbsp;&nbsp;Obligations of Merger Sub</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">66</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.19&nbsp;&nbsp;&nbsp;No Third-Party Beneficiaries</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">67</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; text-indent: -0.5in; padding-top: 0in; padding-bottom: 0pt; padding-left: 1in">11.20&nbsp;&nbsp;&nbsp;Legal Representation</TD>
    <TD STYLE="text-align: right; padding-top: 0in; padding-bottom: 0pt">67</TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt">ANNEXES AND SCHEDULES</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: left; margin: 0 0 12pt"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-decoration: underline; width: 15%">Annexes</TD>
    <TD STYLE="width: 85%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>Annex A</TD>
    <TD>Definitions</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>Annex B</TD>
    <TD>Form of Support Agreement</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>Annex C</TD>
    <TD>Form of FIRPTA Certificate</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>Annex D</TD>
    <TD>Unitholder Representative NDA</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="font-weight: bold; text-decoration: underline; vertical-align: middle">Schedules</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>Schedule&nbsp;A</TD>
    <TD>Key Employees, Key Individuals and Key Unitholders</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>Schedule&nbsp;B</TD>
    <TD>List of Unitholders to Sign Support Agreement by Midnight on January 5, 2020</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>Schedule&nbsp;C</TD>
    <TD>Preliminary Schedule&nbsp;of Consideration to be Paid to Each Equityholder</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>Schedule&nbsp;D</TD>
    <TD>Knowledge Parties</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>Schedule&nbsp;E</TD>
    <TD>Illustrative Calculation of Working Capital, Indebtedness and Cash</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>Schedule&nbsp;F</TD>
    <TD>Sales Growth and Sales Milestones</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; font-weight: bold; text-align: left; margin: 0 0 12pt"></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt"></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt">AGREEMENT AND PLAN OF MERGER</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">This AGREEMENT AND PLAN OF MERGER is made as
of January 4, 2020 (this &ldquo;<U>Agreement</U>&rdquo;) by and among (i) Anika Therapeutics, Inc., a Delaware corporation (&ldquo;<U>Parent</U>&rdquo;),
(ii) Sunshine Merger Sub, LLC, a Wisconsin limited liability company and wholly owned subsidiary of Parent (&ldquo;<U>Merger Sub</U>&rdquo;),
(iii) Parcus Medial, LLC, a Wisconsin limited liability company (the &ldquo;<U>Company</U>&rdquo;), and (iv) Philip Mundy, solely
in his capacity as the representative, agent and attorney-in-fact of the Equityholders (the &ldquo;<U>Unitholder Representative</U>&rdquo;).
Parent, Merger Sub, the Company and the Unitholder Representative are each referred to herein as a &ldquo;<U>Party</U>&rdquo; or,
collectively, as the &ldquo;<U>Parties</U>&rdquo;.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt">WITNESSETH:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">WHEREAS, each of the board of managers of the
Company, the board of directors of Parent and the board of managers and the sole member of Merger Sub have determined that this
Agreement is advisable and have approved this Agreement and the merger of Merger Sub with and into the Company upon the terms and
subject to the conditions set forth in this Agreement (the &ldquo;<U>Merger</U>&rdquo;);</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">WHEREAS, concurrent with the execution of this
Agreement, and as a condition and inducement to Parent&rsquo;s willingness to enter into this Agreement, the Key Individuals and
Key Unitholders have entered into letter agreements (collectively, the &ldquo;<U>Letter Agreements</U>&rdquo;) dated as of the
date hereof and which shall be effective as of the Effective Time;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">WHEREAS, as an inducement to Parent&rsquo;s
and Merger Sub&rsquo;s willingness to enter into this Agreement, (i) promptly after the execution and delivery of this Agreement
and in any event by midnight on January 5, 2020, the Unitholders of the Company listed on <U>Schedule&nbsp;B</U> will have executed
and delivered support agreements in the form attached hereto as <U>Annex B</U> (the &ldquo;<U>Support Agreements</U>&rdquo;) and
(ii) prior to the Closing Date, and as a condition to the obligations of Parent and Merger Sub hereunder, Unitholders holding at
least ninety percent (90%) of the issued and outstanding Company Units shall have executed and delivered Support Agreements;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">WHEREAS, the Support Agreements will constitute
the applicable Unitholder&rsquo;s consent to, and vote to approve and adopt, this Agreement and the Merger and appointment of the
Unitholder Representative to act on its behalf pursuant to <U>Section&nbsp;11.01</U>; and</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">WHEREAS, concurrently with the execution and
delivery of this Agreement, and as a condition of, and inducement to, the Company&rsquo;s willingness to enter into this agreement,
Parent has delivered to the Company a binder (the &ldquo;<U>Binder Agreement</U>&rdquo;), evidencing a commitment to issue and
bind the R&amp;W Policy at or prior to the Closing.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">NOW, THEREFORE, in consideration of the mutual
representations, warranties, covenants and agreements in this Agreement, and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:</P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0 0 12pt"><FONT STYLE="color: #010000">Article
I</FONT><BR>
DEFINITIONS</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">1.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Definitions</U>. As used in this Agreement, certain terms have the meanings set forth in Annex A.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">1.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Rules of Construction</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>All article, section, subsection, schedule and annex references used in this Agreement are to articles, sections,
subsections, schedules and annexes to this Agreement unless otherwise specified. The annexes and schedules attached to this Agreement
constitute a part of this Agreement and are incorporated into this Agreement for all purposes.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>If a term is defined as one part of speech (such as a noun), it shall have a corresponding meaning when used as another
part of speech (such as a verb). Unless the context of this Agreement clearly requires otherwise, words importing one gender shall
include all other genders. The words &ldquo;includes&rdquo; or &ldquo;including&rdquo; shall mean &ldquo;including without limitation,&rdquo;
and the words &ldquo;hereof,&rdquo; &ldquo;hereby,&rdquo; &ldquo;herein,&rdquo; &ldquo;hereunder&rdquo; and similar terms in this
Agreement shall refer to this Agreement as a whole and not any particular section or article in which such words appear. Any reference
to a Law shall include any amendment thereof or any successor thereto and any rules and regulations promulgated thereunder; <U>provided</U>
that for purposes of any representations and warranties contained in this Agreement that are made as of a specific date, references
to any Law shall be deemed to refer to such Law as amended as of such date. References to &ldquo;written&rdquo; or &ldquo;in writing&rdquo;
include documents in electronic form or transmission by email. A reference to any Person includes such Person&rsquo;s successors
and permitted assigns. Currency amounts referenced in this Agreement are in U.S. Dollars.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Whenever this Agreement refers to a number of days, such number shall refer to calendar days unless Business Days
are specified. Whenever any action must be taken hereunder on or by a day that is not a Business Day, then such action may be validly
taken on or by the next day that is a Business Day.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each Party acknowledges that it and its attorneys have been given an equal opportunity to negotiate the terms and
conditions of this Agreement and that any rule of construction to the effect that ambiguities are to be resolved against the drafting
Party or any similar rule operating against the drafter of an agreement shall not be applicable to the construction or interpretation
of this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Except as otherwise specifically provided herein, all accounting terms used herein and not expressly defined herein
shall have the respective meanings given to such terms under GAAP.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0 0 12pt"><FONT STYLE="color: #010000">Article
II</FONT><BR>
THE MERGER</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>The Merger</U>. On the terms and subject to the conditions set forth in this Agreement, and in accordance with
the relevant provisions of Wisconsin Law, Merger Sub shall be merged with and into the Company at the Effective Time, and at the
Effective Time the separate existence of Merger Sub shall cease and the Company shall continue as the surviving limited liability
company and a wholly owned subsidiary of Parent. The entity that survives the Merger is sometimes referred to in this Agreement
as the &ldquo;<U>Surviving Company</U>&rdquo;.</P>

<!-- Field: Page; Sequence: 8; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Closing</U>. The closing of the transactions contemplated by this Agreement (the &ldquo;<U>Closing</U>&rdquo;)
will take place at 10:00 a.m. prevailing Eastern Time on the Closing Date at the offices of Sullivan&nbsp;&amp; Cromwell LLP, at
125 Broad Street, New York, New York 10004, or at such other place, time and/or date as Parent and the Company shall mutually agree
in writing; <U>provided</U>, <U>however</U>, that in no event shall the Closing take place fewer than two (2) days after the receipt
of the Notice by the Unitholders. On the Closing Date, the Parties will cause the transactions described in <U>Section&nbsp;2.01</U>,
<U>Section&nbsp;2.03</U>, <U>Section&nbsp;3.01</U> and <U>Section&nbsp;3.04</U> to occur and will, as applicable, deliver the other
documents and instruments to be delivered under <U>Article VII</U> and <U>Article VIII</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Effective Time</U>. As soon as practicable following the Closing, the Parties (other than the Unitholder Representative)
shall file with the Wisconsin Department of Financial Institutions of the State of Wisconsin Articles of Merger executed in accordance
with the relevant provisions of Wisconsin Law and shall make all other filings or recordings required under the Wisconsin Law.
The Merger shall become effective at such time as the Articles of Merger have been duly filed with such Department of Financial
Institutions, or at such other time as Parent and the Company shall agree and specify in the Articles of Merger (the time the Merger
becomes effective being the &ldquo;<U>Effective Time</U>&rdquo;).</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.04<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Effects</U>. The Merger shall have the effects set forth in the Wisconsin Law.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.05<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Governing Documents; Directors and Officers</U>. At the Effective Time, the articles of organization and the operating
agreement of the Surviving Company shall be amended to be those of Merger Sub immediately prior to the Effective Time, except that
and the name of the Surviving Company shall be &ldquo;Parcus Medical, LLC&rdquo;. The Parties (other than the Unitholder Representative)
shall take all actions necessary so that the managers and officers of Merger Sub immediately prior to the Effective Time shall
be, respectively, the managers and officers of the Surviving Company from and after the Effective Time, until their successors
have been duly elected or appointed and qualified or until their earlier death, removal or resignation in accordance with the articles
of organization and the operating agreement of the Surviving Company.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.06<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Additional Action</U>. The Surviving Company may, at any time after the Effective Time, take any action, including
executing and delivering any document, in the name and on behalf of either the Company or Merger Sub, in order to consummate the
transactions contemplated by this Agreement.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0 0 12pt"><FONT STYLE="color: #010000">Article
III</FONT><BR>
PURCHASE PRICE; EFFECT ON UNITS</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Effects of Merger</U>. At the Effective Time, as a result of the Merger and without any action on the part of
any of Parent, Merger Sub, the Company or any holder of Company Units:</P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Merger Sub</U>. Each limited liability company interest of Merger Sub issued and outstanding immediately prior
to the Effective Time shall be converted into and become one (1) fully paid and non-assessable unit of limited liability company
interest of the Surviving Company.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Conversion of Company Units</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The amounts payable hereunder in respect of the Company Units shall be allocated among the holders of the Company
Units in accordance with the Operating Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Without limiting <U>Section&nbsp;3.01(b)(i)</U>, as of the Effective Time, all of the Company Units issued and outstanding
immediately prior to the Effective Time (other than Excluded Units) shall no longer be outstanding and shall automatically be
cancelled and retired and shall cease to exist, and each holder thereof shall cease to have any rights with respect thereto, except
the right to receive the Per Unit Merger Consideration.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Cancellation of Excluded Units</U>. Any Excluded Unit shall, by virtue of the Merger and without any action on
the part of the holder of such Excluded Unit, cease to be outstanding, be cancelled without payment of any consideration therefor
and shall cease to exist.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Treatment of Company RSUs</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>At the Effective Time, (i) any vesting conditions applicable to each outstanding right to receive a Company Unit
granted to Mark Hazelwood pursuant to his offer letter with the Company (a &ldquo;<U>Company RSU</U>&rdquo;), shall, automatically
and without any required action on the part of the holder thereof, accelerate in full, and (ii) each Company RSU shall, automatically
and without any required action on the part of the holder thereof, be cancelled, retired and cease to exist and each holder thereof
shall cease to have any rights with respect thereto, except the right to receive (without interest) the Per Unit Merger Consideration.
The portion of the Aggregate Closing Amount payable in respect of the Company RSUs <I>less</I> applicable Taxes required to be
withheld with respect to such payment shall be paid by the Company through special payroll immediately prior to the Effective Time.
Any portion of the Indemnity Holdback, Special Indemnity Holdback, Purchase Price Holdback or Earn-Out Consideration that is payable
in respect of the Company RSUs in accordance with this <U>Article III</U> shall be paid by the Surviving Company through its payroll
no later than the first regularly scheduled payroll that is at least four (4) Business Days after such amounts become payable to
the Unitholder Representative pursuant to this <U>Article III</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>At or prior to the Effective Time, the Company shall take all actions that are necessary to effect the treatment
of Company RSUs pursuant to this <U>Section&nbsp;3.02</U> and to ensure that, from and after the Effective Time, neither Parent
nor the Surviving Company shall be required to deliver Company Units or other capital stock of the Company or any consideration
other than the Per Unit Merger Consideration pursuant to any Company RSUs.</P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Intentionally Omitted.</U></P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.04<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Payment Procedures</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>No later than seven (7) Business Days before the Closing Date and no more than ten (10) Business Days prior to the
Closing Date, the Company shall deliver to Parent (or, with respect to the reasonable supporting detail, have Made Available to
Parent) the Company&rsquo;s good faith calculation of, and reasonable supporting detail relating to, both the estimated Aggregate
Purchase Price (the &ldquo;<U>Estimated Aggregate Purchase Price</U>&rdquo;), each component thereof (the &ldquo;<U>Estimated Closing
Statement</U>&rdquo;) and reasonable supporting detail relating to such component, (including bank statements dated as of the date
that the Estimated Closing Statement is provided, a reconciliation between any differences in the Company&rsquo;s cash position
and the bank statement, debt payoff letters and invoices). The Estimated Closing Statement shall be prepared in accordance with
the terms (including the definitions) of this Agreement. Parent shall have the right to object to the amounts contained in the
Estimated Closing Statement no later than the third (3<SUP>rd</SUP>) Business Day immediately prior to the Closing Date. The Company
shall in good faith consider the objections, if any, of Parent to the Estimated Closing Statement and, if Parent has made any objections,
shall reissue the Estimated Closing Statement containing the Estimated Aggregate Purchase Price and each component thereof no later
than the second (2<SUP>nd</SUP>) Business Day immediately prior to the Closing Date with any such revisions that the Company has
determined in good faith are appropriate.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>On or prior to the Closing Date, Parent, the Unitholder Representative and the Payments Administrator shall enter
into the Payments Administrator Agreement, which agreement shall have customary terms and shall provide that on the Closing Date,
Parent shall deposit with the Payments Administrator, for the benefit of the applicable Equityholders, an amount in cash equal
to the Aggregate Closing Amount <I>less</I> the portion of such amount payable in respect of the Company RSUs by wire transfer
of immediately available funds to an account specified by the Payments Administrator in writing no later than four (4) Business
Days prior to the Closing Date. The Payments Administrator Agreement also shall provide that the amounts paid to the Payments
Administrator pursuant to this <U>Section&nbsp;3.04(b)</U> (the &ldquo;<U>Payments Administrator Fund</U>&rdquo;) shall be held
and disbursed by the Payments Administrator, and Parent shall cause the Payments Administrator to hold and disburse the Payments
Administrator Fund, in accordance with this <U>Section&nbsp;3.04</U>. Any portion of the amount deposited by Parent (or caused
to be deposited by Parent) that remains unclaimed by the applicable Equityholders six (6) months after the Effective Time will,
to the extent permitted by Applicable Law, be returned to Parent upon demand.</P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>As promptly as practicable on or after the date hereof and in accordance with the Payments Administrator Agreement,
the Payments Administrator shall provide to each Unitholder (i) a letter of transmittal (which shall include a waiver and release
pursuant to which each Unitholder executes a full and unconditional release regarding any and all claims as an Unitholder, including
the calculation of the Per Unit Merger Consideration, as a condition to receiving the Per Unit Merger Consideration, in favor of
the Company, Parent, Merger Sub and the Surviving Company and its subsidiaries and each of their directors, officers, managers,
employees and Affiliates, and which shall be in such form and have such other provisions as Parent and the Company may reasonably
agree). Upon delivery of such letter of transmittal to the Payments Administrator, the holder shall be entitled to receive, upon
the later to occur of the Closing or the date such holder delivers such documents to the Payments Administrator (subject to the
terms of the Payments Administrator Agreement), in exchange for each of their Company Units an amount of cash equal to the Per
Unit Closing Payment and the Company Units so surrendered shall forthwith be cancelled. Until surrendered as contemplated by this
<U>Section&nbsp;3.04(c)</U>, each such Company Unit shall be deemed at all times after the Effective Time to represent only the
right to receive upon such surrender the Per Unit Merger Consideration as contemplated by this <U>Article III,</U> and no cash
shall be paid to the holder of any such unit in respect thereof. No interest shall be paid or accrue on any cash payable upon surrender
of any Company Units.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The consideration to be paid in accordance with the terms of this <U>Article III</U> upon effectiveness of the Merger
shall constitute satisfaction in full of all rights pertaining to the Company Units, and after the Effective Time there shall be
no further registration of transfers on the transfer books of the Surviving Company of Company Units that were outstanding immediately
prior to the Effective Time.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>For the avoidance of doubt, and notwithstanding anything to the contrary herein, in no event shall the aggregate
amount of consideration payable by Parent to any Equityholder or any other holders of any equity or debt securities of the Company
pursuant to this <U>Section&nbsp;3.04</U> exceed the Aggregate Purchase Price.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.05<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Holdback</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>At the Effective Time, Parent shall holdback (i) [&hellip;] of the Aggregate Purchase Price, which shall constitute
a holdback used to satisfy any indemnification amounts owed to Parent from the Equityholders under <U>Article X</U> but excluding
any amounts owed to Parent from the Equityholders pursuant to <U>Section&nbsp;3.07</U> (the &ldquo;<U>Indemnity Holdback</U>&rdquo;),
(ii) [&hellip;] of the Aggregate Purchase Price, which shall constitute a holdback used to satisfy any indemnification amounts
owed Parent from the Company pursuant to <U>Section&nbsp;10.02(a)(v)</U> (the &ldquo;<U>Special Indemnity Holdback</U>&rdquo;)
and (iii) [&hellip;] of the Aggregate Purchase Price, which shall constitute a specific holdback used to satisfy amounts owed to
Parent from the Equityholders pursuant to <U>Section&nbsp;3.07</U> (the &ldquo;<U>Purchase Price Holdback</U>&rdquo;). The Indemnity
Holdback, Special Indemnity Holdback, the Purchase Price Holdback shall each be disbursed solely for the purposes and in accordance
with the terms of this Agreement. The Company and Parent agree that [&hellip;] of the Special Indemnity Holdback relates to [&hellip;]
liabilities of the Surviving Company (the [&hellip;] <U>Holdback</U>&rdquo;).</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>From and after the Closing, Parent and the Unitholder Representative agree to work in good faith to determine the
[&hellip;] liabilities of the Surviving Company. To the extent that Parent establishes, based on reasonable evidence, that there
is an [&hellip;] liability (all such amounts &ldquo;[&hellip;]&rdquo;), Parent shall be entitled to take all actions to remediate
such [&hellip;] (including any of the actions that would otherwise be prohibited under <U>Section 6.10(g)(ii)</U>) and the [&hellip;]
Holdback shall be reduced by the aggregate amount of the Losses incurred by the Parent in respect of such [&hellip;].</P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>To the extent that Parent and the Unitholder Representative are unable to agree on whether there is an [&hellip;]
of the Surviving Company, either of Parent or the Unitholder Representative may, upon written notice to the other, refer all matters
that remain in dispute for resolution to the Independent Accountant who shall, acting as an expert in accounting and not as a valuation
expert or arbitrator, render its decision as to what amounts should be retained in or released from the [&hellip;] Holdback (the
&ldquo;[<U>&hellip;] Matters</U>&rdquo;) (and not on any other matter or calculation set forth in the Closing Statement) in a manner
consistent with the terms (including the definitions) of this Agreement. In resolving any [&hellip;] Matter, the Independent Accountant
may not assign a value to any [&hellip;] Matter greater than the maximum value for such matter claimed by either party or less
than the minimum value for such matter claimed by either party. The Independent Accountant&rsquo;s determination as to each [&hellip;]
Matter shall be set forth in a written statement delivered to each of Parent and the Unitholder Representative within ten (10)
Business Days after such items are submitted for determination, with such written statement including (i) the Independent Accountant&rsquo;s
determination as to the calculation of each of the Unresolved Matters and (ii) the corresponding releases or retention that is
due to the [&hellip;] Holdback from its determination as to the calculations of the [&hellip;] Matters, all of which shall be conclusive,
final and binding on all Parties absent manifest error. The Independent Accountant shall also determine the proportion of its fees
and expenses to be paid by each of Parent and the Unitholder Representative (solely on behalf of the Equityholders) based on the
degree (as determined in good faith by the Independent Accountant) to which the Independent Accountant has accepted the positions
of Parent and the Unitholder Representative. The Independent Accountant&rsquo;s fees and expenses payable by Parent (if any) shall
be paid to the Independent Accountant directly by Parent, and the Independent Accountant&rsquo;s fees and expenses payable by the
Unitholder Representative (if any, solely on behalf of the Equityholders) shall be paid from the Expense Fund and the Purchase
Price Holdback. By way of example only, should the aggregate Sales Tax Matters sum to $1,000, and the Independent Accountant awards
$600 in favor of the Unitholder Representative&rsquo;s position, sixty percent (60%) of the Independent Accountant&rsquo;s fees
and expenses would be borne by Parent and forty percent (40%) would be borne by the Unitholder Representative. The Independent
Accountant&rsquo;s fees and expenses payable by Parent (if any) shall be paid to the Independent Accountant directly by Parent,
and the Independent Accountant&rsquo;s fees and expenses payable by the Unitholder Representative (if any, solely on behalf of
the Equityholders) shall be paid from the Expense Fund, Purchase Price Holdback and Special Indemnity Holdback. To the extent the
Expense Fund, Purchase Price Holdback and Special Indemnity Holdback are insufficient or unavailable to cover all of the Independent
Accountant&rsquo;s fees and expenses payable by the Unitholder Representative, Parent shall pay any such remaining fees and expenses
and Parent shall be entitled to deduct such amounts from any amounts payable to the applicable Equityholders (or to the Payments
Administrator on their behalf) pursuant to this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>On the nine (9) month anniversary of the Closing Date, the amount remaining in the [&hellip;] Holdback shall be
released to the Payments Administrator and, with respect to Company RSUs, to the Surviving Company, no later than [&hellip;],
in such proportions as required in accordance with the terms of this Agreement; <U>provided</U> that if (i) there are any claims
for Losses under <U>Section 10.02(a)(v)</U> that are pending on such dates or (ii) there are [&hellip;] Matter, the applicable
portion (and only the applicable portion) of the [&hellip;] Holdback that is subject to any such Losses shall not be so released
until such applicable Losses are finally resolved and satisfied.</P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The amount remaining in (i) the Indemnity Holdback, as of the date that is twelve (12) months after the Closing Date
(the &ldquo;<U>Indemnity Release Date</U>&rdquo;), and (ii) the Special Indemnity Holdback, as of the date that is three (3) years
after the Closing Date (the &ldquo;<U>Special Indemnity Release Date</U>&rdquo; and together with the Indemnity Release Date, the
&ldquo;<U>Release Dates</U>&rdquo;), shall be released to the Payments Administrator and, with respect to Company RSUs, to the
Surviving Company no later than ten (10) Business Days following the relevant Release Date in such proportions as required in accordance
with the terms of this Agreement; <U>provided</U> that if there are any claims for Losses under <U>Article X</U> (other than under
<U>Section 10.02(a)(v)</U>) that are pending on the Indemnity Release Date, the applicable portion (and only the applicable portion)
of the Indemnity Holdback that is subject to any such Losses shall not be so released until such applicable Losses are finally
resolved and satisfied and <U>provided further</U> that if there are any claims for Losses under <U>Section 10.02(a)(v)</U> that
are pending on the Special Indemnity Release Date, the applicable portion (and only the applicable portion) of the Special Indemnity
Holdback that is subject to any such Losses shall not be so released until such applicable Losses are finally resolved and satisfied.
The Payments Administrator shall distribute the portion of the Per Unit Holdback Consideration that is distributable to the Equityholders
in accordance with the terms of this Agreement and the Payments Administrator Agreement promptly after its release from the Indemnity
Holdback or Special Indemnity Holdback, as applicable, and the Surviving Company shall process the portion of the Per Unit Holdback
Consideration that is payable in respect of Company RSUs through its payroll. To the extent amounts of the Indemnity Holdback or
Special Indemnity Holdback are distributed to the Equityholders, the Unitholder Representative shall be entitled to be reimbursed
from such distributed amounts from the Indemnity Holdback or Special Indemnity Holdback, respectively, for any out-of-pocket costs
(including attorney fees) for administering claims relating to Losses, to the extent there are not adequate funds available in
the Expense Fund to cover the reimbursement of such out-of-pocket costs.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.06<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Aggregate Closing Payment Schedule</U>. <U>Schedule&nbsp;C</U> attached hereto sets forth the Company&rsquo;s
preliminary calculation of the allocation of the Aggregate Closing Amount and the allocation of the Aggregate Cash Amount entitled
to be received in accordance with this Agreement by each Equityholder. No later than four (4) Business Days prior to the Closing
Date (but subject to updates based on revisions, if any, to the Estimated Closing Statement pursuant to <U>Section&nbsp;3.04(a)</U>),
the Company shall deliver to Parent a schedule (the &ldquo;<U>Aggregate Closing Payment Schedule</U>&rdquo;) setting forth (a)
the final allocation of the Aggregate Closing Amount to be paid in accordance with this Agreement to each Equityholder and (b)
the final allocation of the Aggregate Cash Amount to be paid in accordance with this Agreement to each Equityholder. Parent shall
be entitled to rely exclusively upon the Aggregate Closing Payment Schedule&nbsp;in paying the Aggregate Cash Amount pursuant to
<U>Section&nbsp;3.04</U> and shall have no obligation to investigate the entitlements of any Person to any portion of the Aggregate
Cash Amount payable at Closing.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.07<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Post-Closing Determination of the Closing Statement</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Within sixty (60) days after the Closing Date, Parent shall prepare and deliver to the Unitholder Representative
a good faith calculation of the Aggregate Purchase Price and each component thereof (the &ldquo;<U>Closing Statement</U>&rdquo;).
The Parties acknowledge and agree that the Closing Statement, and the component items and calculations therein, shall be prepared
in a manner consistent with the terms (including the definitions) of this Agreement. If Parent fails to deliver the Closing Statement
in accordance with the immediately preceding sentence, then, at the Unitholder Representative's election, the Estimated Closing
Statement delivered by the Company to Parent pursuant to <U>Section&nbsp;3.04(a)</U> shall be deemed to be the Final Closing Statement.
The Closing Statement shall be conclusive, final and binding on all Parties absent manifest error unless the Unitholder Representative
gives Parent written notice (the &ldquo;<U>Dispute Notice</U>&rdquo;) of any disputes or objections thereto (collectively, the
&ldquo;<U>Disputed Items</U>&rdquo;), with its good faith calculation of, and reasonable supporting detail relating to, such Disputed
Items, within thirty (30) Business Days of receipt of the Closing Statement (such period, the &ldquo;<U>Review Period</U>&rdquo;).
In the event the Unitholder Representative fails to deliver to Parent a Dispute Notice prior to the expiration of the Review Period
or otherwise earlier notifies Parent in writing that the Unitholder Representative has no disputes or objections to the Closing
Statement, the amounts set forth in the Closing Statement shall be conclusive, final and binding on all Parties absent manifest
error.</P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Parent and the Unitholder Representative shall, for a period of ten (10) Business Days (or such longer period as
Parent and the Unitholder Representative may agree in writing) following delivery of a Dispute Notice to Parent (the &ldquo;<U>Resolution
Period</U>&rdquo;), attempt in good faith to resolve their differences, and any such resolution by them as to any Disputed Items
shall be conclusive, final and binding on all Parties absent manifest error. Any Disputed Items agreed to by Parent and the Unitholder
Representative in writing, together with any items or calculations set forth in the Closing Statement not disputed or objected
to by the Unitholder Representative in the Dispute Notice, are collectively referred to herein as the &ldquo;<U>Resolved Matters</U>&rdquo;.
Any Resolved Matters shall be conclusive, final and binding on all Parties absent manifest error, except to the extent such component
could be affected by other components of the calculations set forth in the Closing Statement that are the subject of a Dispute
Notice.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>If at the end of the Resolution Period, Parent and the Unitholder Representative have been unable to resolve any
differences that they may have with respect to the matters specified in the Dispute Notice, either of Parent or the Unitholder
Representative may, upon written notice to the other, refer all matters that remain in dispute with respect to the Dispute Notice
(the &ldquo;<U>Unresolved Matters</U>&rdquo;) for resolution to the Independent Accountant who shall, acting as an expert in accounting
and not as a valuation expert or arbitrator, render its decision on the Unresolved Matters (and not on any other matter or calculation
set forth in the Closing Statement) in a manner consistent with the terms (including the definitions) of this Agreement. For the
avoidance of doubt, the Independent Accountant shall apply the Accounting Methodologies and the other principles set forth in
this Agreement for purposes of the disputed calculations, even if the Accounting Methodologies or such other principles deviate
from GAAP, and the engagement letter for the Independent Accountant shall include the agreement of the Independent Accountant
to apply the Accounting Methodologies. In resolving any Unresolved Matter, the Independent Accountant may not assign a value to
any Unresolved Matter greater than the maximum value for such matter claimed by either party or less than the minimum value for
such matter claimed by either party. The Independent Accountant&rsquo;s determination as to each Unresolved Matter shall be set
forth in a written statement delivered to each of Parent and the Unitholder Representative within ten (10) Business Days after
such items are submitted for determination, with such written statement including (i) the Independent Accountant&rsquo;s determination
as to the calculation of each of the Unresolved Matters and (ii) the corresponding corrective calculations set forth in the Closing
Statement that are derived from its determination as to the calculations of the Unresolved Matters, all of which shall be conclusive,
final and binding on all Parties absent manifest error. The Independent Accountant shall also determine the proportion of its
fees and expenses to be paid by each of Parent and the Unitholder Representative (solely on behalf of the Equityholders) based
on the degree (as determined in good faith by the Independent Accountant) to which the Independent Accountant has accepted the
positions of Parent and the Unitholder Representative. The Independent Accountant&rsquo;s fees and expenses payable by Parent
(if any) shall be paid to the Independent Accountant directly by Parent, and the Independent Accountant&rsquo;s fees and expenses
payable by the Unitholder Representative (if any, solely on behalf of the Equityholders) shall be paid from the Expense Fund and
the Purchase Price Holdback. By way of example only, should the aggregate Unresolved Matters sum to $1,000, and the Independent
Accountant awards $600 in favor of the Unitholder Representative&rsquo;s position, sixty percent (60%) of the Independent Accountant&rsquo;s
fees and expenses would be borne by Parent and forty percent (40%) would be borne by the Unitholder Representative. The Independent
Accountant&rsquo;s fees and expenses payable by Parent (if any) shall be paid to the Independent Accountant directly by Parent,
and the Independent Accountant&rsquo;s fees and expenses payable by the Unitholder Representative (if any, solely on behalf of
the Equityholders) shall be paid from the Expense Fund. To the extent the Expense Fund and Purchase Price Holdback are insufficient
or unavailable to cover all of the Independent Accountant&rsquo;s fees and expenses payable by the Unitholder Representative,
Parent shall pay any such remaining fees and expenses and Parent shall be entitled to deduct such amounts from any amounts payable
to the applicable Equityholders (or to the Payments Administrator on their behalf) pursuant to this Agreement.</P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>For purposes of this Agreement, the &ldquo;<U>Final Closing Statement</U>&rdquo; shall be (i)&nbsp;in the event that
no Closing Statement is delivered by Parent to the Unitholder Representative within thirty (30) days after the Closing Date, the
Estimated Closing Statement, (ii) in the event that no Dispute Notice is delivered by the Unitholder Representative to Parent prior
to the expiration of the Review Period, the Closing Statement delivered by Parent to the Unitholder Representative pursuant to
<U>Section&nbsp;3.07(a)</U>, (iii) in the event that a Dispute Notice is delivered by the Unitholder Representative to Parent prior
to the expiration of the Review Period, the Closing Statement delivered by Parent to the Unitholder Representative pursuant to
<U>Section&nbsp;3.07(a)</U>, as adjusted pursuant to the agreement of Parent and the Unitholder Representative in writing, or (iv)
in the event that a Dispute Notice is delivered by the Unitholder Representative to Parent prior to the expiration of the Review
Period and Parent and the Unitholder Representative are unable to agree on all matters set forth in such Dispute Notice, the Closing
Statement delivered by Parent to the Unitholder Representative pursuant to <U>Section&nbsp;3.07(a)</U>, as adjusted by the Independent
Accountant to be consistent with (A) the Resolved Matters and (B) the Independent Accountant&rsquo;s determination as to the calculation
of the Unresolved Matters in accordance with <U>Section&nbsp;3.07(a)</U> and <U>Section&nbsp;3.07(c)</U>. The &ldquo;<U>Final Aggregate
Purchase Price</U>&rdquo; shall mean the Aggregate Purchase Price as derived from the Final Closing Statement.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>From and after the delivery of the Closing Statement by Parent until the determination of the Final Closing Statement
pursuant to this <U>Section&nbsp;3.07</U>, Parent and the Surviving Company shall, and shall cause their respective subsidiaries
to, permit the Unitholder Representative and its Representatives reasonable access to the personnel, accountants and properties
of the Surviving Company and its subsidiaries, and provide reasonable access (with the right to make copies), during business
hours upon reasonable advance notice, to all of the books, records, contracts and other documents (including auditor&rsquo;s work
papers) of the Surviving Company or its subsidiaries only to the extent necessary to evaluate the calculations set forth in the
Closing Statement.</P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Payment in Respect of Final Aggregate Purchase Price</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>If the Final Aggregate Purchase Price exceeds or is equal to the Estimated Aggregate Purchase Price, then within
five (5) Business Days after the final determination of the Final Closing Statement, Parent or the Surviving Company shall deposit,
or cause to be deposited, in immediately available funds, with the Payments Administrator an amount in cash equal to the sum of
(i) the full amount, if any, by which the Final Aggregate Purchase Price exceeds the Estimated Aggregate Purchase Price (<I>less</I>
the portion of such amount payable in respect of the Company RSUs, which the Surviving Company shall process through its payroll)
<I>plus </I>(ii) the Purchase Price Holdback (<I>less</I> the portion of such amount payable in respect of the Company RSUs, which
the Surviving Company shall process through its payroll), and, immediately thereafter, Parent and the Unitholder Representative
shall provide a joint written instruction to the Payments Administrator to deliver such amounts promptly to the Equityholders in
accordance with this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>If the Estimated Aggregate Purchase Price exceeds the Final Aggregate Purchase Price (such excess the &ldquo;<U>Overstatement</U>&rdquo;)
and the Purchase Price Holdback exceeds the Overstatement (such excess the &ldquo;<U>Payable Holdback Portion</U>&rdquo;), then
within five (5) Business Days after the final determination of the Final Closing Statement, Parent or the Surviving Company shall
deposit, or cause to be deposited, in immediately available funds, with the Payments Administrator the Payable Holdback Portion
(<I>less</I> the portion of such amount payable in respect of the Company RSUs, which the Surviving Company shall process through
its payroll) and, immediately thereafter, Parent and the Unitholder Representative shall provide a joint written instruction to
the Payments Administrator to deliver such amounts promptly to the Equityholders in accordance with this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>If the Overstatement exceeds the Purchase Price Holdback (such excess the &ldquo;<U>Payable Overstatement</U>&rdquo;),
the Purchase Price Holdback shall be for Parent&rsquo;s account.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>All payments pursuant to this <U>Section&nbsp;3.07</U> shall be treated as an adjustment to the Final Aggregate Purchase
Price for all foreign, federal, state and local income Tax purposes unless otherwise required by Law.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.08<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Earn-Out Consideration</U>. As additional consideration for the Merger, upon the achievement of certain milestones
as further described below, Parent shall, subject to the terms of this <U>Section&nbsp;3.08</U>, pay the Earn-Out Consideration
to Equityholders in full as set forth on <U>Schedule&nbsp;C</U> under the heading &ldquo;Earn-Out Consideration&rdquo; <U>provided</U>,
<U>however</U>, that any amounts payable by Parent pursuant to this <U>Section 3.08</U> shall be offset and reduced by any amounts
(i) deductible from payments to Equityholders (or to the Payments Administrator on their behalf) pursuant to this Agreement (including
pursuant to Article X) or (ii) owed by the Equityholders to the Parent Indemnified Parties (including pursuant to Article X).</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Within five (5) Business Days of the amount of any Net Sales Growth Earn-Out Consideration or Net Sales Earn-Out
Consideration becoming conclusive, final and binding on all Parties, in accordance with this <U>Section&nbsp;3.08</U>, Parent or
the Surviving Company shall deposit, or cause to be deposited, in immediately available funds, with the Payment Administrator the
applicable amount (<I>less</I> the portion of such amount payable in respect of the Company RSUs, which the Surviving Company shall
process through its payroll), if any, and, immediately thereafter, Parent and the Unitholder Representative shall provide a joint
written instruction to the Payments Administrator to deliver such amounts promptly to the Equityholders in accordance with this
Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Subject to Unitholder Representative&rsquo;s ongoing compliance with the Unitholder Representative NDA attached hereto
as Annex D, until filing by Parent of its Form 10-K for the year ended December&nbsp;31, 2022, Parent shall, within thirty (30)
days following the filing of its Form 10-Q or Form 10-K with the Securities and Exchange Commission (the &ldquo;<U>SEC</U>&rdquo;)
(as applicable), but not later than thirty (30) days following the normal filing deadline for such Form, prepare and deliver a
good faith calculation of the total Net Sales from the Company Products in the applicable calendar quarter (a &ldquo;<U>Parent
Earn-Out Statement</U>&rdquo;), together with, for the Parent Earn-Out Statements delivered immediately following the filing of
its Form 10-K in fiscal years 2020, 2021 and 2022 only, a statement as to whether any Net Sales Growth Earn-Out Consideration or
Net Sales Earn-Out Consideration is payable in connection therewith and if so, the amount thereof. The Parties acknowledge and
agree that the Parent Earn-Out Statement, and the component items and calculations therein, shall be prepared in a manner consistent
with the terms (including the definitions) of this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>If the Unitholder Representative disputes the calculation of Net Sales set forth in any Parent Earn-Out Statement
the Unitholder Representative shall deliver to Parent a written notice (an &ldquo;<U>Earn-Out Dispute Notice</U>&rdquo;) of any
disputes or objections thereto (collectively, the &ldquo;<U>Earn-Out Disputed Items</U>&rdquo;) with reasonable supporting detail
as to such Disputed Items, within thirty (30) Business Days of receipt of the Parent Earn-Out Statement (such period, the &ldquo;<U>Earn-Out
Review Period</U>&rdquo;); <U>provided that</U> the Unitholder Representative may only deliver an Earn-Out Dispute Notice in respect
of the Parent Earn-Out Statement delivered with respect to its Form 10-K for years 2020, 2021 and 2022.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>If the Unitholder Representative fails to deliver to Parent an Earn-Out Dispute Notice prior to the expiration of
the Earn-Out Review Period or otherwise earlier notifies Parent in writing that the Unitholder Representative has no disputes or
objections to the Parent Earn-Out Statement, the amount of Net Sales set forth in the Parent Earn-Out Statement shall be conclusive,
final and binding on all Parties absent manifest error and payments shall be made by Parent in accordance with <U>Section&nbsp;3.04</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Parent and the Unitholder Representative shall, for a period of ten (10) Business Days (or such longer period as
Parent and the Unitholder Representative may agree in writing) following delivery of an Earn-Out Dispute Notice to Parent (the
&ldquo;<U>Earn-Out Resolution Period</U>&rdquo;), attempt in good faith to resolve their differences, and any such resolution by
them as to any Earn-Out Disputed Items shall be conclusive, final and binding on all Parties absent manifest error. Any Earn-Out
Disputed Items agreed to by Parent and the Unitholder Representative in writing, together with any items or calculations set forth
in the Parent Earn-Out Statement not disputed or objected to by the Unitholder Representative in the Earn-Out Dispute Notice, are
collectively referred to herein as the &ldquo;<U>Earn-Out Resolved Matters</U>&rdquo;. Any Earn-Out Resolved Matters shall be conclusive,
final and binding on all Parties absent manifest error, except to the extent such component could be affected by other components
of the calculations set forth in the Parent Earn-Out Statement that are the subject of an Earn-Out Dispute Notice. If at the end
of the Earn-Out Resolution Period, Parent and the Unitholder Representative have been unable to resolve any differences that they
may have with respect to the matters specified in the Earn-Out Dispute Notice, either of Parent or the Unitholder Representative
may, upon written notice to the other, refer all matters that remain in dispute with respect to the Dispute Notice to be exclusively
and definitively resolved, without any recourse to appeal, by final and binding arbitration pursuant to <U>Section&nbsp;3.08(f)</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Any Earn-Out Arbitration shall be instituted and conducted in, and its seat shall be, the city of Chicago, Illinois,
where the arbitration award shall be rendered. The arbitration shall be administered by the International Court of Arbitration
of the International Chamber of Commerce (&ldquo;<U>ICC</U>&rdquo;) in accordance with the Rules of Arbitration of the ICC (&ldquo;<U>Arbitration
Rules</U>&rdquo;), as in effect as of the date of commencement of the arbitration, as modified by this Agreement or mutual agreement
of the Parties. The law of this arbitration clause shall be the law of the State of Delaware. The arbitration shall be conducted
in the English language, though documents or testimony may be submitted in other languages if a translation is provided. The arbitration
panel shall be composed of three (3) arbitrators. The first (1st) arbitrator shall be appointed by the claimant. The second (2nd)
arbitrator shall be appointed by the respondent. The third (3rd) arbitrator (who shall act as chairman) shall be appointed by the
two (2) party-appointed arbitrators, within fifteen (15) calendar days from the date of confirmation of the second (2nd) party-appointed
arbitrator. If any party fails to appoint an arbitrator within the required period, or if the two (2) arbitrators cannot reach
an agreement with respect to the third (3rd) arbitrator within the applicable periods, the appointment shall be made by the ICC
International Court of Arbitration pursuant to the Arbitration Rules. To the extent that an Earn-Out Arbitration involves more
than one (1) party as claimant, such claimants shall jointly appoint the first (1st) arbitrator. To the extent that an Earn-Out
Arbitration involves more than one (1) respondent, such respondents shall jointly appoint the second (2nd) arbitrator. The Parties
consent to the consolidation of arbitrations commenced hereunder pursuant to the Arbitration Rules. Any award of the arbitration
panel must be in writing and state the grounds upon which it is based (in each case, a &ldquo;<U>Final Award</U>&rdquo;). The Final
Award shall be conclusive, final and binding on the Parties and their successors, and a judgment upon the Final Award may be recognized
and enforced in any court of competent jurisdiction. The fees and expenses of the arbitration and other reasonable and documented
costs of the party which has prevailed in such arbitration (the &ldquo;<U>Arbitration Fees</U>&rdquo;), including reasonable attorney&rsquo;s
fees, shall be borne as established by the arbitration panel. The Arbitration Fees payable by Parent (if any) shall be paid directly
by Parent, and the Arbitration Fees payable by the Unitholder Representative (if any, solely on behalf of the Equityholders) shall
be paid from the Expense Fund and the Purchase Price Holdback. To the extent the Expense Fund and the Purchase Price Holdback are
insufficient or unavailable to cover all of the Arbitration Fees payable by the Unitholder Representative, Parent shall pay any
such remaining Arbitration Fees and Parent shall be entitled to deduct such amounts from any amounts payable to the Payments Administrator
on behalf of the Equityholders.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Parent Actions</U>. Until December 31, 2022, Parent agrees to use commercially reasonable efforts (including in
respect of amount and timing of capital allocation) to achieve sales of the Company Products that will enable the Equityholders
to achieve the maximum Earn-out Consideration. In no event shall Parent take any action primarily intended to avoid the payment
of any Net Sales Growth Earn-Out Consideration or Net Sales Earn-Out Consideration becoming payable. Any dispute arising out of,
resulting from or in connection with this <U>Section 3.08(g)</U> shall be exclusively and definitively resolved, without any recourse
to appeal, by final and binding arbitration pursuant to <U>Section 3.08(f)</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(h)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Enforcement of Earn-Out Covenant</U>. The right and power to enforce this <U>Section&nbsp;3.08</U> against Parent
shall reside entirely with the Unitholder Representative (on behalf of the Equityholders), and none of the Equityholders shall
be entitled to bring, commence, continue or prosecute any claim, legal action or proceeding under, in relation to, arising out
of or in connection with a breach of this <U>Section&nbsp;3.08</U> or otherwise claiming that after the Effective Time Parent has
not complied with this <U>Section&nbsp;3.08</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>No Equityholder shall assign its interest in the Earn-Out Consideration to any Person without first notifying Parent
and the Unitholder Representative of such transfer and the Aggregate Closing Payment Schedule&nbsp;shall be revised to reflect
such permitted transfer and shall record the name of the transferee. No holder of Company RSUs shall assign its interest in Earn-Out
Consideration to any Person other than by will or the laws of descent and distribution.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.09<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>No Interest</U>. Notwithstanding anything to the contrary contained herein, no interest shall accumulate on any
Per Unit Merger Consideration.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.10<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Withholding Rights</U>. Parent shall be entitled to deduct and withhold from any amounts payable to the applicable
Equityholder under this Agreement such amounts as Parent is required to deduct and withhold with respect to the making of such
payment under the Code or any provision of applicable Tax Law. The Parties shall cooperate in good faith to reduce or eliminate
any such deduction or withholding. If Parent determines that withholding is required pursuant to this <U>Section 3.10</U>, Parent
shall provide notice thereof to Unitholder Representative promptly following such determination. To the extent that such amounts
are so withheld and timely paid over to or deposited with the relevant Tax Authority by Parent in accordance with the foregoing,
such withheld amounts shall be treated for all purposes of this Agreement as having been paid to the applicable Equityholder in
respect to which such deduction and withholding was made.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.11<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Purchase Price Allocation</U>. Within ninety (90) days after the Closing, Parent shall deliver to the Unitholder
Representative a statement allocating the &quot;fair market value&quot; of the assets of the Company for all Tax purposes in accordance
with Section&nbsp;1060 of the Code and the Treasury Regulations thereunder and the allocation methodology set forth on <U>Schedule
3.11</U> attached hereto (the &ldquo;<U>Purchase Price Allocation</U>&rdquo;). Such Purchase Price Allocation will be final if
Parent does not receive an objection described in the following sentence. If, within fifteen (15) Business Days after delivery
of the Purchase Price Allocation, the Unitholder Representative notifies Parent in writing that the Equityholders object to the
allocation set forth in the Purchase Price Allocation together with the reasons, set forth in reasonable particularity, for such
objection, Parent and the Unitholder Representative shall, within twenty (20) days of receiving such written notice, discuss possible
resolutions of such dispute, and if they are able to do so, shall make such revisions to the Purchase Price Allocation to reflect
such resolution, which shall be final and binding. In the event Parent and the Equityholders are unable to resolve such dispute
within twenty (20) days, Parent and the Equityholders shall refer the matter to the Independent Accountant in accordance with the
procedural principles of <U>Section 3.07(c)</U>. Parent and the Equityholders agree (a) to be bound by the Purchase Price Allocation
as ultimately determined hereunder, (b) to prepare and file their Tax Returns on a basis consistent with such Purchase Price Allocation
as ultimately determined hereunder and (c) not to take any position inconsistent with the Purchase Price Allocation Schedule as
ultimately determined hereunder on any applicable Tax Return or in any proceeding before any Tax Authority, in each case except
as required under applicable Tax Law. The payment of any Earn-Out Consideration and any other adjustments to the Final Aggregate
Purchase Price after the Closing Date should be reflected in the Purchase Price Allocation in accordance with this <U>Section&nbsp;3.11</U>.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0 0 12pt"><FONT STYLE="color: #010000">Article
IV</FONT><BR>
REPRESENTATIONS AND WARRANTIES REGARDING THE COMPANY</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">The Company hereby represents and warrants
to Parent and Merger Sub as of the date hereof and, at Closing, as of the Closing Date (except for any representation or warranty
that is expressly made as of a specified date, in which case the Company hereby represents and warrants to Parent and Merger Sub
as of such specified date), except as disclosed in the corresponding sections or subsections of the Company Disclosure Schedule,
as follows:</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Organization; Qualification</U>. The Company (a) is a limited liability company duly organized, validly existing
and in good standing under the Applicable Laws of the State of Wisconsin and (b) has all requisite limited liability company power
and authority to conduct its respective business as now being conducted and to own, lease and operate its respective Properties.
The Company is duly qualified or licensed to do business in each jurisdiction listed in <U>Section&nbsp;4.01</U> of the Company
Disclosure Schedule, which constitute all jurisdictions in which the ownership or operation of its Properties make such qualification
or licensing necessary, except where the failure to be so qualified or licensed, individually or in the aggregate, has not had,
and would not be reasonably likely to have, a Material Adverse Effect. The Company has Made Available to Parent true and complete
copies of the Organizational Documents of the Company, each of which are in full force and effect.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Capitalization</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>As of January 4, 2020, the Company Units consists solely of 6283.1 Company Units that are issued and outstanding.
All of the issued and outstanding Company Units are duly authorized, validly issued, fully paid and non-assessable and are not
subject to preemptive or similar rights of any kind. As of January 4, 2020, other than 20 Company Units issuable in respect of
Company RSUs, the Company has no Company Units reserved for issuance. As of the date of this Agreement, the Company Units are held
by the Persons with the addresses and in the amounts set forth in <U>Section&nbsp;4.02(a)(i)</U> of the Company Disclosure Schedule.
Except as permitted by <U>Section&nbsp;6.02</U> or as provided in the Company&rsquo;s Organizational Documents, no Person has as
of the date of this Agreement or will have as of or following the Effective Time any right to acquire from the Company any Company
Units, or other Equity Interests of the Company or any right valued by reference to a Company Unit. The Aggregate Closing Payment
Schedule, when delivered in accordance with <U>Section&nbsp;3.06</U>, will contain a true and correct calculation of the respective
amounts of the Aggregate Closing Amount to be paid in accordance with this Agreement to each holder of the Company&rsquo;s outstanding
Company Units and any other equity securities of the Company and will set forth the amounts required to be paid to each such holder
in accordance with the Company&rsquo;s Organizational Documents (as applicable) and the Company Plans. Except as set forth in the
Aggregate Closing Payment Schedule, no Person is entitled to receive any portion of the Aggregate Closing Amount.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000"></FONT></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Except as described in <U>Section&nbsp;4.02(a)</U>, as of the date of this Agreement, there are no other issued and
outstanding Company Units and no outstanding subscriptions, options, warrants, calls, rights, convertible securities, proxy or
Unitholder agreements or other Contracts or other understandings of any character obligating the Company to issue, transfer, sell,
repurchase or redeem any Company Units. The Company has no treasury units. All of the Company Units were offered and sold in compliance
with Applicable Laws and the Organizational Documents of the Company. The Company has no outstanding bonds, debentures, notes or
other obligations the holders of which have the right to vote (or which are convertible into or exercisable for securities having
the right to vote) with the Unitholders on any matter submitted to the Unitholders or as a separate class of holders of units.
There are no declared but unpaid distributions in respect of the Company Units.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company is not a party or subject to any agreement or understanding which affects or relates to the ownership,
voting, dividend rights or giving of support agreements with respect to any Equity Interest in the Company or by a manager of the
Company.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company does not own any Equity Interests in any Person.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Authority; Enforceability</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has all requisite limited liability company power and authority to execute and deliver this Agreement
and the other Transaction Documents to which the Company is a party, to perform its obligations hereunder and thereunder and to
consummate the transactions contemplated hereby and thereby. The execution and delivery by the Company of this Agreement and the
other Transaction Documents to which the Company is a party, and the performance by the Company of its obligations hereunder and
thereunder, have been duly and validly authorized by all necessary limited liability company action, subject only to obtaining
the affirmative vote of 50% of the outstanding Company Units to approve this Agreement, including the satisfaction or waiver of
any applicable notice provisions under Wisconsin Law and the Operating Agreement (the &ldquo;<U>Required Unitholder Approval</U>&rdquo;).
This Agreement has been (and each other Transaction Document to be executed by the Company at or prior to Closing will be) duly
and validly executed and delivered by the Company and, assuming the Required Unitholder Approval is obtained, constitutes (and
each other Transaction Document to be executed by the Company at or prior to Closing will constitute) the legal, valid and binding
obligation of the Company enforceable against the Company in accordance with its terms, except as the same may be limited by bankruptcy,
insolvency, reorganization, arrangement, moratorium or other similar Applicable Laws relating to or affecting the rights of creditors
generally, or by general equitable principles (the &ldquo;<U>Enforceability Exceptions</U>&rdquo;).</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Required Unitholder Approval is the only approval of the holders of Company Units required to approve this Agreement
and the Merger under the Company&rsquo;s Organizational Documents and Applicable Laws, and no other limited liability company proceedings
by the Company are necessary to authorize this Agreement or the transactions contemplated hereby, other than the filing of the
Articles of Merger. No &ldquo;fair price,&rdquo; &ldquo;moratorium,&rdquo; &ldquo;control share acquisition&rdquo; or other anti-takeover
statute or regulation or any provision in the Company&rsquo;s Organizational Documents is, or at the Effective Time will be, applicable
to the Company, the Merger or the other transactions contemplated by this Agreement. No objection or dissociation rights shall
be available to the holders of Company Units in connection with the Merger pursuant to the Company&rsquo;s Organizational Documents
and Wisconsin Law.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company&rsquo;s board of managers has (i) determined that the Merger, upon the terms and subject to the conditions
set forth herein, is in the best interests of the holders of the Company Units, (ii) approved this Agreement and the transactions
contemplated hereby, and declared their advisability and (iii) recommended the approval of this Agreement to the Unitholders entitled
to vote thereon (the &ldquo;<U>Board Recommendation</U>&rdquo;) in accordance in all respects with the Company&rsquo;s Organizational
Documents, Applicable Law and its fiduciary duties.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.04<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>No Conflicts; Consents and Approvals</U>. The execution and delivery by the Company of this Agreement and the
other Transaction Documents to which the Company is a party do not, and the performance by the Company of its obligations under
this Agreement and the other Transaction Documents to which the Company is a party will not:</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>conflict with or result in a violation or breach of any of the terms, conditions or provisions of the Organizational
Documents of the Company;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>require the consent, notice or other action by any Person under, or result in a violation of or result in a breach
of or default (or give rise to any right of termination, cancellation or acceleration) under (with or without the giving of notice,
the lapse of time or both) any Contract or other understandings to which the Company is a party, except for (i) any such violations
or defaults (or rights of termination, cancellation or acceleration) which would not reasonably be expected to be material to the
Company, individually or taken as a whole and (ii) approvals required as a result of the business activities of Parent and its
Affiliates;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>(i) conflict with, violate or breach any term or provision of any Applicable Laws applicable to the Company, except
as would not reasonably be expected to be material to the Company, taken as a whole, or (ii) require any consent or approval of
any Governmental Authority, or notice to, or declaration, filing or registration with, any Governmental Authority, under any Applicable
Laws, the Required Unitholder Approval and the filing of the Articles of Merger; or</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>result in the creation or imposition of any material Lien other than Permitted Liens on any asset of the Company.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.05<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>No Subsidiaries; No Repurchase Obligations</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company does not have any Subsidiaries and does not, directly or indirectly, own any interest in any other Person.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Except as provided herein, there are no (i) outstanding obligations of the Company to repurchase, redeem or otherwise
acquire any securities of the Company or (ii) outstanding obligations of the Company to provide funds to or make any investment
(in the form of a loan, capital contribution or otherwise) in the Company or any other Person.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.06<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Financial Statements</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Set forth in <U>Section 4.06(a)(i)</U> of the Company Disclosure Schedule are true and complete copies of the following
financial statements: balance sheets and statements of operations and cash flows of the Company as at September&nbsp;30, 2019 on
an audited basis (the &ldquo;<U>YTD Financial Statements</U>&rdquo;), for the two years ended December&nbsp;31, 2017 on an unaudited
basis (the &ldquo;<U>Unaudited Financial Statements</U>&rdquo;, and for the year ended December 31, 2018 on an audited basis (the
&quot;<U>Audited Financial Statements</U>&quot;, and, together with the Unaudited Financial Statements and YTD Financial Statements,
the &ldquo;<U>Financial Statements</U>&rdquo;). Except as described in <U>Section&nbsp;4.06(a)</U> of the Company Disclosure Schedule,
the Financial Statements are correct and complete in all material respects, were prepared in accordance with GAAP applied on a
consistent basis throughout the periods presented and fairly present in all material respects the financial condition, results
of operations and cash flows of the Company as at the respective dates thereof and for the respective periods covered thereby.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>All accounts, books, ledgers and records of the Company are complete and correct in all material respects, have been
maintained in a consistent manner and have recorded therein the results of operations and the assets and liabilities of the Company
in all material respects. The Company maintains a system of accounting and internal controls that provides reasonable assurance
that financial transactions are executed in accordance with the authorization of management. There are no significant deficiencies
or material weaknesses in the design or operation of the internal controls over financial reporting of the Company that would reasonably
be expected to affect their ability to record, process, summarize and report financial information in all material respects, and
there has been no written, or, to the Knowledge of the Company, other complaint, allegation or claim with respect to the accounting
or auditing practices, procedures, methodologies or methods of internal controls over financial reporting of the Company.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Section&nbsp;4.06(c)</U> of the Company Disclosure Schedule&nbsp;sets forth, in reasonable detail, the Indebtedness
of the Company as of the date hereof, including, for each item of Indebtedness, the agreement governing the Indebtedness and the
interest rate, maturity date, any assets securing such Indebtedness and any prepayment or other penalties payable in connection
with the repayment of such Indebtedness at the Closing.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.07<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Liabilities</U>. Except for (a) liabilities specifically reflected and adequately reserved against in the YTD
Financial Statements, (b) liabilities incurred since the date of the YTD Financial Statements in the Ordinary Course of Business
(none of which is a liability resulting from breach of contract, breach of warranty, tort, infringement or misappropriation), (c)
Transaction Expenses, (d) liabilities reflected in the calculation of the Indebtedness or Working Capital Difference or (e) liabilities
that are not required to be disclosed or reflected on financial statements prepared in accordance with GAAP, there are no liabilities
or obligations of the Company of any kind whatsoever, whether accrued, contingent, absolute, asserted or unasserted, known or unknown,
contingent, determined, determinable or otherwise.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.08<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Inventory</U>. Except as would not, individually or in the aggregate, reasonably be expected to be material to
the Company, and except for obsolete materials and materials of below standard quality, which have been written down in the Financial
Statements to realizable market value or for which adequate reserves have been provided therein, (a) the inventory of the Company
is of a quality and quantity useable and, in the case of finished goods, saleable in the ordinary course of business and (b) no
inventory of the Company is being held on consignment by third parties. Except as would not, individually or in the aggregate,
reasonably be expected to be material to the Company, the Company does not have any obligation, contingent or otherwise, to repurchase
or accept returns of any Company Products, or otherwise compensate or reimburse any distributor in connection with any unsold goods,
whether at the expiration of the applicable shelf-life or otherwise.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.09<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Accounts Receivable</U>. Each account receivable that has been billed is and each unbilled account receivable
will be when billed (a) valid and existing and represents monies due (or believed in good faith to be due) for goods sold and delivered
and services performed in the ordinary course and (b) a legally binding obligation of the account debtor enforceable in accordance
with its terms not subject to refunds, discounts (other than trade discounts provided in the ordinary course of business), setoffs,
adverse claims, counterclaims, assessments, defaults, prepayments, defenses or conditions precedent, subject to the effect of any
Laws relating to bankruptcy, reorganization, insolvency, moratorium, fraudulent conveyance or preferential transfers, or similar
Laws relating to or affecting creditors&rsquo; rights generally.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.10<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Absence of Certain Changes</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Since September 30, 2019, there has not been:</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any resignation or termination of any managing member or officer of the Company, and to the Company&rsquo;s Knowledge
there are no impending resignations or terminations of employment of any managing member, officer or Key Employee;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any labor organization activity related to the Company;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any sale, assignment, transfer, exclusive license or other exclusive grant of any Intellectual Property Rights or
other intangible assets;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any non-exclusive license or other non-exclusive grant of any Intellectual Property Rights or other intangible assets,
other than in the Ordinary Course of Business to the Company&rsquo;s customers, suppliers, distributors and contractors;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(v)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any modification to any Material Contract outside of the Ordinary Course of Business;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(vi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any material change, except in the Ordinary Course of Business or otherwise not reflected in the YTD Financial Statements,
in the contingent obligations of the Company by way of guaranty, endorsement, indemnity or warranty;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(vii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any waiver by the Company of a material right or of a debt owed to it;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000"></FONT></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(viii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any change in any compensation arrangement or agreement with any employee, officer or manager, other than normal
adjustments in connection with the Company&rsquo;s annual reviews or otherwise in the Ordinary Course of Business;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ix)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any incurrence of any material indebtedness for borrowed money by the Company and the Company has not guaranteed
such indebtedness of another Person or issued or sold any debt securities or warrants or other rights to acquire any debt security
of the Company;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(x)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any change in any method of accounting or accounting practices by the Company;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any making, changing or rescinding of any material election in respect of Taxes by the Company or changing of any
method of Tax accounting by the Company, or any event, development or circumstance as a result of which the Company incurred a
material Tax liability (or material decrease in a material Tax asset or attribute) not in the Ordinary Course of Business; or</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any arrangement or commitment by the Company regarding any of the matters described in subsections (i) through (xi)
above that is not disclosed in response to subsections (i) through (xi).</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Since September 30, 2019, there has not been any state of facts, changes, development, event, effect, condition or
occurrence that, individually or in the aggregate with all other facts, changes, developments, events, effects, conditions and
occurrences, has resulted in or would reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.11<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Legal Proceedings</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>As of the date hereof, (i) there is no Action or Order pending or threatened in writing against the Company that
would affect or bind the Company or any of its assets or Properties, and (ii) to the Company&rsquo;s Knowledge, there is no investigation
or review pending or threatened by a Governmental Authority with respect to the Company.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>To the Company&rsquo;s Knowledge, there is no material Action of any nature pending or threatened in writing against
any current or former manager of the Company (in their capacities as such or relating to their employment, services or relationship
with the Company).</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.12<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Compliance with Applicable Laws</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company is, and the business of the Company is being conducted, and has been, in compliance in all material respects
with all Applicable Laws. The Company holds all material Governmental Approvals necessary for the Company to own, lease and operate
its Properties and to carry on its business as currently conducted in each of the jurisdictions where such business is conducted,
and all such Governmental Approvals are in full force and effect. There has not occurred any breach of or default under (with or
without notice, lapse of time or both) any such material Governmental Approval, and the Company has not received any written notice
(including through any Action) of any such breach or default.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000"></FONT></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has not, and no manager, officer, employee or, to the Knowledge of the Company, agents or other Persons,
acting for or on behalf of the Company, has (i) used any funds for unlawful contributions, gifts, entertainment or other unlawful
expenses relating to political activity, (ii)&nbsp;made any unlawful payment to foreign or domestic government officials or employees
or to foreign or domestic political parties or campaigns, or violated any provision of applicable Anti-Corruption Laws or (iii)
taken any action that would constitute a violation of applicable Anti-Corruption Laws. No manager, officer, employee or, to the
Knowledge of the Company, agents or other Persons, acting for or on behalf of the Company has established or maintained any fund
or asset that has not been recorded in the books and records of the Company.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company does not maintain or conduct, and has not maintained or conducted, any business, investment, operation
or other activity in or with: (i)&nbsp;any country or person targeted by any of the economic sanctions of the United States of
America administered by the United States Treasury Department&rsquo;s Office of Foreign Assets Control; (ii)&nbsp;any person appearing
on the list of Specially Designated Nationals and Blocked Persons issued by the United States Treasury Department&rsquo;s Office
of Foreign Assets Control; or (iii)&nbsp;any country or person designated by the United States Secretary of the Treasury pursuant
to the USA PATRIOT Act as being of &ldquo;primary money laundering concern&rdquo;.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.13<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Material Contracts</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Section&nbsp;4.13(a)</U> of the Company Disclosure Schedule&nbsp;sets forth a true, complete and accurate list
of all Material Contracts in effect as of the date hereof. &ldquo;<U>Material Contracts</U>&rdquo; means:</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Contract pursuant to which the Company is liable for any Indebtedness, except for Company Plans;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Contract pursuant to which the Company is a lessor or lessee of any real property or any machinery, equipment,
motor vehicles, office furniture, fixtures or other personal property involving expenditures in excess of $10,000 per annum;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any partnership, joint venture or similar Contract to which the Company is a party or by which the Company is bound
relating to any Person that is not wholly owned by the Company;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Contract that involves a sharing of revenues, profits, cash flows, expenses or losses with other Persons or any
Contract that involves the payment of royalties to any other Person, in each case that involve payments by the Company in excess
of $10,000 in any twelve (12)-month period;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(v)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Contract for the purchase or sale of real property or any option to purchase or sell real property by the Company;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(vi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Contract relating to the acquisition or disposition by the Company of any business or all or substantially all
of the assets of any Person or business (whether by merger, sale of stock, sale of assets, license or otherwise) or any Contract
pursuant to which it has any material ownership interest in another Person;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000"></FONT></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(vii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Contract which requires payments by the Company in excess of $15,000 in any twelve (12)-month period, other than
purchase orders, Company Plans or other Contracts that are terminable by the Company on thirty (30) days&rsquo; notice or less
without obligation to make any material payment;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(viii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Contract to which the Company is a party or by which the Company is bound that contains any (A) &ldquo;most favored
nation&rdquo; or similar provision in favor of a Person other than the Company, (B) provision expressly requiring the Company to
purchase goods or services exclusively from, or distribute or resell goods or services exclusively through, another Person, or
(C) express restriction on the ability of the Company or any of its Affiliates (whether before or after the Closing) to compete
in any business market or geographic area;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ix)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any employment agreement binding on the Company that is not terminable at will or that contains any severance or
termination pay or other compensatory obligations in connection with a termination of employment other than (A) accrued payment
obligations for services rendered prior to the Termination Date and (B) relocation expense reimbursement in amounts less than $15,000,
except as mandated by local law;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(x)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any contract, letter or other agreement providing for payment by the Company of more than $25,000 annually which
provides for any consulting or advising role of any Person in respect of the business of the Company;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Contract between the Company, on the one hand, and any of its Affiliates, on the other hand, that is material
to the operation of the business of the Company, as applicable, and is not listed in response to another item of this <U>Section&nbsp;4.13</U>
or as a Company Plan;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Contract that results in any Person holding a power of attorney from the Company (other than those granted to
payroll providers, tax filing professionals, lawyers or law firms for administrative matters in the Ordinary Course of Business);</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xiii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Contract to which the Company is a party or by which the Company is bound that provides for the indemnification
of any Person other than Contracts entered into in the Ordinary Course of Business and Contracts the primary purpose of which do
not relate to taxes or environmental liabilities of any Person;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xiv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Contract that relates principally to the advertising or promotion of the business or operations of the Company;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Contract that requires the consent of a Governmental Authority as a result of the transactions contemplated by
this Agreement;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xvi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any agreement, other than Ordinary Course Purchase Orders, with any Key International Distributor, any Key Domestic
Distributor, any Key Customer or Key Supplier (for the avoidance of doubt, excluding any Contracts with Key International Distributors,
Key Domestic Distributors, Key Customers and Key Suppliers for which the primary purchase or sale obligations have been completed
but which may contain ongoing warranty, indemnification or other similar obligations);</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xvii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any dealer, distributor, referral or similar agreement, or any Contract providing for the grant of rights to market,
refer or sell the Company&rsquo;s products or services to any other Person providing for, likely to result in, or have actually
resulted in during the twelve (12) month period ended September 30, 2019, on an individual basis, more than $100,000 in total
recognized revenue (the &ldquo;<U>Key Revenue Agreements</U>&rdquo;);</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xviii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;
</FONT></FONT>any standstill or similar agreement containing provisions prohibiting a third party from purchasing Equity Interests
of the Company or assets of the Company or otherwise seeking to influence or exercise control over the Company;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xix)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any settlement agreement under which the Company has any ongoing obligations (other than customary non-disclosure
or confidentiality covenants);</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xx)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Contract to which the Company is a party or by which the Company is bound, which is primarily related to privacy
and data protection and is material to the business of the Company, including any Contract for the collection, use, disclosure,
storage, transfer or disposal of third party Personal Data; and</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xxi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Contract pursuant to which the Company has (A) granted to any Person a license, covenant not to sue, option or
other right with respect to or under any Company IP, other than non-exclusive licenses granted in the Ordinary Course of Business
to the Company&rsquo;s customers, suppliers, distributors and contractors; or (B) been granted by any Person a license, covenant
not to sue, option or other right with respect to any Intellectual Property Rights (other than non-exclusive licenses to off-the-shelf,
unmodified, commercially available software with annual payments no greater than $15,000).</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has Made Available to Parent true, complete and accurate copies of all Material Contracts.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each of the Material Contracts constitutes a legal, valid and binding obligation of the Company and, to the Company&rsquo;s
Knowledge, of the other parties thereto, except as limited by the Enforceability Exceptions. The Company is not in material breach
of or in material default under any Material Contract, and no event or circumstance has occurred which, with notice, lapse of time
or both, would constitute a material default or material breach by the Company under any Material Contract. Prior to the date of
this Agreement, the Company has not received any written notice of any such material default or material breach (other than notices
of matters that have been resolved prior to the date hereof without material liability to the Company), and, to the Company&rsquo;s
Knowledge, there does not exist any material default or material breach, and no event or circumstance has occurred which, with
notice, lapse of time or both, would constitute a material default or material breach under any Material Contract by any party
thereto other than the Company.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000"></FONT></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company's [&hellip;] with [&hellip;] and [&hellip;] are expired and terminated in all respects, and and all rights
of [&hellip;] and [&hellip;] to receive Company Units upon a change in control under such agreements have been terminated in all
respects.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.14<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Taxes</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company (A) has duly and timely filed (taking into account any valid extension of time within which to file)
all Tax Returns required to be filed with the appropriate Tax Authority and all such filed Tax Returns are complete and accurate
in all material respects; (B) has duly and timely paid all material Taxes that were required to be paid by the Company (whether
or not shown on any Tax Returns) and, with respect to material Taxes not yet due, such Taxes have been accrued as current liabilities
on the balance sheet included in the YTD Financial Statements if required by GAAP; and (C) has withheld and timely paid to the
appropriate Tax Authorities all material Taxes required to have been withheld and complied with related reporting requirements.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>No issues that have been raised by the relevant Tax Authority in connection with any examination of any Tax Return
referred to in clause&nbsp;(a) above are currently pending. No Tax Return of the Company is currently being examined by any Tax
Authority, nor has the Company received any written notice from a Tax Authority that it intends to conduct any such examinations.
All deficiencies asserted or assessments made, if any, as a result of any such Tax examinations have been paid in full, settled
or withdrawn. There are no Liens for Taxes (other than Permitted Liens) upon any of the assets of the Company. No written power
of attorney has been granted with respect to any matter relating to the Taxes of the Company which will be in force for any taxable
period beginning after the Closing Date or for any Straddle Period.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has Made Available to Parent true and complete copies of (A)&nbsp;all income Tax Returns filed by the
Company with respect to taxable periods ending on and after December&nbsp;31, 2016, and (B) all private letter ruling requests,
closing agreements or gain recognition agreements with a Tax Authority with respect to Taxes requested or executed.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company is not a party to any Contract providing for allocation, sharing or indemnification with respect to Taxes
(other than a Contract not primarily related to Taxes which was entered into in the Ordinary Course of Business, including without
limitation credit or loan agreements, vendor agreements, purchase and sale agreements and leases).</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>No written claim has been made within the last three (3) years by a Tax Authority in a jurisdiction where the Company
does not file Tax Returns such that it is subject to taxation by, or required to file any Tax Return in, that jurisdiction.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company (A) has not engaged in any &ldquo;reportable transaction&rdquo; as defined in Treasury Regulations Section&nbsp;1.6011-4(b)
or any other transaction requiring disclosure under any similar provision of state, local or foreign Law, (B) has not ever been
a member of any consolidated, combined, unitary or similar Tax group, (C) has not been granted any extension, or waived the statute
of limitations, for the assessment or collection of Taxes (other than pursuant to extensions of time to file Tax Returns obtained
in the Ordinary Course of Business), which extension or waiver is still in force, or (D) is not subject to any private letter ruling
of the IRS or comparable rulings of other Tax Authorities.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company will not be required to include any material item of income in, or to exclude any material item of deduction
from, taxable income in any taxable period (or portion thereof) ending after the Closing as a result of any closing agreement entered
into prior to the Closing with any Tax Authority, installment sale or open transaction entered into prior to the Closing, any accounting
method change made prior to the Closing, any prepaid amount received on or prior to the Closing Date, the application of Section&nbsp;965
of the Code, any election pursuant to Section&nbsp;108(i) of the Code (or any similar provision of state, local or foreign Law)
made prior to the Closing with respect to any taxable period ending on or prior to the Closing Date, or any transferee or successor
liability for the Taxes of any other Person (other than the Company) under Treasury Regulations Section&nbsp;1.1502-6 (or any similar
provision of state, local or foreign Law), or otherwise.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(h)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company is not and has never been treated as an association taxable as a corporation for U.S. federal income
tax purposes. The Company is (and at all times until the Closing will be) treated as a partnership for U.S. federal income tax
purposes. The Company does not and has never owned any interest in any entity that is treated as an association taxable as a corporation
for U.S. federal income tax purposes.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.15<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Employee Matters</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Section&nbsp;4.15(a)</U> of the Company Disclosure Schedule&nbsp;sets forth an accurate and complete list of each
Company Plan. For purposes of this Agreement, &ldquo;<U>Company Plan</U>&rdquo; means any benefit or compensation plan, program,
policy, practice, agreement, contract, arrangement or other obligation, whether or not in writing and whether or not funded, in
each case, which is sponsored or maintained by, or required to be contributed to, or with respect to which any potential liability
is borne by the Company. Company Plans include, but are not limited to, &ldquo;employee benefit plans&rdquo; within the meaning
of Section&nbsp;3(3) of ERISA (&ldquo;<U>ERISA Plans</U>&rdquo;), employment, consulting, retirement, severance, termination or
change in control agreements, deferred compensation, equity-based, incentive, bonus, supplemental retirement, profit sharing, insurance,
medical, welfare, fringe or other benefits or remuneration of any kind. No Company Plan is maintained outside the jurisdiction
of the United States or covers any employees or other service providers of the Company who reside or work outside of the United
States.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>With respect to each Company Plan, the Company has Made Available to Parent, to the extent applicable, accurate and
complete copies of (i) the Company Plan document, including any amendments thereto, and all related trust documents, insurance
contracts or other funding vehicles, (ii) a written description of such Company Plan if such plan is not set forth in a written
document, (iii) the most recently prepared actuarial report, and (iv) all material correspondence to or from any Governmental Authority
received in the last three (3) years with respect to any Company Plan. With respect to each ERISA Plan, the Company has Made Available
to Parent, to the extent applicable, accurate and complete copies of (i) the most recent summary plan description together with
any summaries of all material modifications thereto, (ii) the most recent IRS determination or opinion letter, and (iii) the two
most recent annual reports (Form 5500 or 990 series and all schedules and financial statements attached thereto).</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>(i) Each Company Plan (including any related trusts), other than &ldquo;multiemployer plans&rdquo; within the meaning
of Section&nbsp;3(37) of ERISA (each, a &ldquo;<U>Multiemployer Plan</U>&rdquo;), has been established, operated and administered
in material compliance with its terms and Applicable Laws, including, without limitation, ERISA and the Code, (ii) all contributions
or other amounts payable by the Company with respect to each Company Plan in respect of current or prior plan years have been paid
or accrued in accordance with GAAP, and (iii) there are no pending or served, or, to the Company&rsquo;s Knowledge, threatened
claims (other than routine claims for benefits) or proceedings by a Governmental Authority by, on behalf of or against any Company
Plan or any trust related thereto which could reasonably be expected to result in any material liability to the Company.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each ERISA Plan that is intended to be qualified under Section&nbsp;401(a) of the Code has been determined by the
IRS to be qualified under Section&nbsp;401(a) of the Code and, to the Company&rsquo;s Knowledge, nothing has occurred that would
adversely affect the qualification or tax exemption of any such Company Plan. With respect to any ERISA Plan, the Company has not
engaged in a transaction in connection with which the Company reasonably could be subject to either a civil penalty assessed pursuant
to Section&nbsp;409 or Section&nbsp;502(i) of ERISA or a tax imposed pursuant to Section&nbsp;4975 or 4976 of the Code.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Neither the Company nor any ERISA Affiliate has contributed (or had any obligation of any sort) in the last six (6)
years to a plan that is subject to Section&nbsp;412 of the Code or Section&nbsp;302 or Title IV of ERISA. Neither the Company nor
any ERISA Affiliate has maintained, established, participated in or contributed to, or is or has been obligated to contribute to,
or has otherwise incurred any obligation or liability (including any contingent liability) under, any Multiemployer Plan within
the last six (6) years. No Company Plan is a &ldquo;multiple employer welfare arrangement&rdquo; (as defined in Section&nbsp;3(40)
of ERISA). For purposes of this Agreement, &ldquo;<U>ERISA Affiliate</U>&rdquo; means all employers (whether or not incorporated)
that would be treated together with the Company as a &ldquo;single employer&rdquo; within the meaning of Section&nbsp;414 of the
Code.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Except as required by Applicable Laws, no Company Plan provides retiree or post-employment medical, disability, life
insurance or other welfare benefits to any Person, and the Company has no obligation to provide such benefits. To the extent that
the Company sponsors such plans, the Company has reserved the right to amend, terminate or modify at any time each Company Plan
that provides retiree or post-employment disability, life insurance or other welfare benefits to any Person.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each Company Plan that is a &ldquo;nonqualified deferred compensation plan&rdquo; (within the meaning of Section&nbsp;409A
of the Code) is in documentary compliance with, and has been operated and administered in all respects in compliance with, Section&nbsp;409A
of the Code and the guidance issued by the IRS provided thereunder.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(h)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Neither the execution and delivery of this Agreement, approval of this Agreement nor the consummation of the transactions
contemplated by this Agreement could, either alone or in combination with another event, (i) entitle any current or former employee,
manager, officer or independent contractor of the Company to severance pay or any material increase in severance pay, (ii) accelerate
the time of payment or vesting, or materially increase the amount of compensation due to any such employee, manager, officer or
independent contractor, (iii) directly or indirectly cause the Company to transfer or set aside any assets to fund any material
benefits under any Company Plan, (iv) otherwise give rise to any material liability under any Company Plan, or (5)&nbsp;limit or
restrict the right to merge, materially amend, terminate or transfer the assets of any Company Plan on or following the Effective
Time.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000"></FONT></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Neither the execution and delivery of this Agreement, approval of this Agreement nor the consummation of the transactions
contemplated by this Agreement could, either alone or in combination with another event, result in the payment of any amount that
could, individually or in combination with any other such payment, constitute an &ldquo;excess parachute payment&rdquo; as defined
in Section&nbsp;280G(b)(1) of the Code.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(j)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has no obligation to provide, and no Company Plan or other agreement provides any individual with the
right to, a gross up, indemnification, reimbursement or other payment for any excise or additional taxes, interest or penalties
incurred pursuant to Section&nbsp;409A or Section&nbsp;4999 of the Code or due to the failure of any payment to be deductible under
Section&nbsp;280G of the Code.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.16<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Labor Matters</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Section&nbsp;4.16(a)</U> of the Company Disclosure Schedule&nbsp;sets forth, with respect to each current employee
of the Company, including any employee who is on a leave of absence of any nature, paid or unpaid, authorized or unauthorized,
including disability, family or other leave, sick leave or on layoff status subject to recall, (i) the name of such employee and
the date as of which such employee was originally hired by the Company, and whether the employee is on an active or inactive status,
(ii) such employee&rsquo;s title, (iii) such employee&rsquo;s annualized compensation as of the date of this Agreement, including
base salary, vacation and paid time off accrual amounts, target bonus and commission amounts (if any), and any other compensation
forms, if applicable, (iv)&nbsp;such employee&rsquo;s severance entitlement (if any), (v) whether such employee is not fully available
to perform work because of a qualified disability or other leave and, if applicable, the type of leave (e.g., disability, workers&rsquo;
compensation, family or other leave protected by Applicable Laws) and the anticipated date of return to full service, (vi) the
facility at which such employee is located and (vii) whether such employee is classified as exempt or non-exempt (as applicable).</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>As of the date hereof the Company is not a party to any collective bargaining agreement or other agreement with a
labor union or like organization, and, to the Company&rsquo;s Knowledge, there are no activities or proceedings by any individual
or group of individuals, including representatives of any labor unions or like organizations, to organize any employees of the
Company. As of the date hereof, (i) there is no strike, lockout, slowdown, work stoppage, job action, picketing, unfair labor practice
or other labor dispute pending or, to the Company&rsquo;s Knowledge, threatened, (ii) there is no unfair labor practice charge
against the Company pending before the National Labor Relations Board or comparable labor relations authority, and (iii) there
is no pending or, to the Company&rsquo;s Knowledge, threatened arbitration or grievance, charge, complaint, audit or investigation
by or before any Governmental Authority with respect to any current or former employees of the Company.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company is in compliance in all material respects with all Applicable Laws respecting labor, employment, fair
employment practices (including equal employment opportunity laws), terms and conditions of employment, workers&rsquo; compensation,
occupational safety and health, affirmative action, employee privacy, sexual harassment, plant closings, and wages and hours. The
Company has not incurred any liability or obligation under the Worker Adjustment and Retraining Notification Act and the regulations
promulgated thereunder or any similar state or local Law that remains unsatisfied.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>There are no proceedings pending or, to the Company&rsquo;s Knowledge, threatened against the Company in any forum
by or on behalf of any present or former employee of the Company, any applicant for employment or classes of employees or applicants
for employment alleging breach of any express or implied employment contract, violation of any Applicable Laws governing employment
or the termination thereof, or any other discriminatory, wrongful or tortious conduct on the part of the Company in connection
with the employment relationship.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has no direct or indirect liability, whether actual or contingent, with respect to any misclassification
of any person as an independent contractor rather than as an employee, with respect to any misclassification of any employee as
exempt versus non-exempt, or with respect to any employee leased from another employer, except as would not, when taken as a whole,
reasonably be expected to be material to the Company, and the Company has no notice or Knowledge of any pending or threatened claim
by any Person who is performing or has performed services for the Company that he/she is or was misclassified for such purposes.
The Company has no direct or indirect liability, whether actual or contingent, with respect to the failure to give meal/rest periods
to any eligible current or former employee, except as would not, when taken as a whole, reasonably be expected to be material to
the Company, and the Company has no notice or Knowledge of any pending or threatened claim by any current employee or former employee
that he/she has not been given the meal/rest periods to which he/she is or was entitled.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>No Manager Guaranteed Payments or Manager Deferred Compensation Payments have been accrued in respect of any employee
of the Company, other than a current or former manager of the Company.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.17<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Insurance</U>. <U>Section&nbsp;4.17(i)</U> of the Company Disclosure Schedule&nbsp;contains a true and complete
list of all material insurance policies (other than any insurance policies that are Company Plans) currently in effect as of the
date hereof that insure the business, operations, employees and Properties of the Company with coverage customary for companies
similarly situated to the Company. Each such material insurance policy is in full force and effect and is valid and binding, and
no premiums due under any such insurance policies have not been paid. The Company has not received any written notice of cancellation
or termination in respect of any such policy or is in default under any such policy in any material respect. <U>Section&nbsp;4.17(ii)</U>
of the Company Disclosure Schedule&nbsp;sets forth a true and complete description of (a) all current and open or known claims
relating to the Company under such policies and (b) all claims made under such policies with respect to any claims, individually,
in excess of $25,000 relating to the Company with respect to its business during the preceding three (3) years. During the preceding
three (3) years, the Company has not settled any Action for an amount in excess of insured limits.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.18<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Intellectual Property</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Section&nbsp;4.18(a)</U> of the Company Disclosure Schedule&nbsp;sets forth a true and complete list of all Company
IP that is issued by, registered with, or the subject of a pending application before any Governmental Authority or Internet domain
name registrar, as applicable (the &ldquo;<U>Scheduled Company IP</U>&rdquo;), indicating for each such item the record owner or
registrant, registration or application number, registration or application date and the applicable filing jurisdiction (or in
the case of an Internet domain name, the applicable domain name registrar). The Company IP is subsisting and the issued patents,
registered Copyrights and registered Trademarks that are Company IP are valid and enforceable.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>There are no inventorship challenges, opposition or nullity proceedings or interferences declared, commenced or,
to the Knowledge of the Company, threatened with respect to any Company IP. The Company has complied with its duty of candor and
disclosure to the United States Patent and Trademark Office and any relevant foreign patent office with respect to all applications
and other filings with respect to any Company IP, as applicable, filed by or on behalf of the Company, and has made no material
misrepresentation in such applications. The Company has no Knowledge of any information that would preclude it from having clear
title to the Scheduled Company IP owned or purported to be owned by the Company or affecting the scope, patentability, validity
or enforceability of any Scheduled Company IP, as applicable.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company is the sole and exclusive owner of all Company IP owned by or purported to be owned by the Company, free
and clear of all Liens other than Permitted Liens. The Company owns, or has valid and sufficient rights pursuant to a written and
enforceable agreement to use, all Intellectual Property Rights used in or necessary for the conduct of the business of the Company,
as currently conducted and as proposed to be conducted, all of which rights shall continue in effect unchanged immediately after
the consummation of the transactions contemplated by this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>None of (i) the conduct of the business of the Company or (ii) the development, use, import, sale, offer for sale,
commercialization or other exploitation of any Company Products Infringes or has Infringed the Intellectual Property Rights of
any Person in the prior six (6) years. To the Knowledge of the Company, no Person is Infringing, or has within the prior six (6)
years Infringed, any Company IP. The Company has not, within the prior six (6) years, asserted any claim, notice, invitation to
license or similar communication against any Person alleging any Infringement of any Company IP.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has not received in the prior six (6) years any claim, notice, invitation to license or similar communication
(i)&nbsp;contesting or challenging the use of any Intellectual Property Rights, or the scope, validity, enforceability or ownership
of any Company IP, or (ii) relating to the actual or alleged Infringement of any Intellectual Property Rights of any third Person.
The Company IP is not subject to any Order or any Contract adversely affecting, as applicable, the ownership, scope, validity or
enforceability of, or the Company&rsquo;s use of or rights to, such Company IP. There is no Action pending or, to the Company&rsquo;s
Knowledge, threatened that seeks to cancel, limit or challenge, as applicable, the ownership, use, scope, validity or enforceability
of any Company IP.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000"></FONT></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Neither the execution of this Agreement nor the consummation of the transactions contemplated by this Agreement will,
under any Contract to which the Company is a party or by which the Company is bound, result in (i) Parent or the Company being
bound by or subject to any obligation to grant any license, covenant not to assert, or other right with respect to its respective
Intellectual Property Rights that Parent or the Company, as applicable, would not have been bound by or subject to but for the
execution of this Agreement or the consummation of the transactions contemplated by this Agreement, or (ii) the Company being obligated
to pay any royalties, honoraria, fees or other payments to any Person, with respect to Intellectual Property Rights, at a rate
in excess of the rate at which the Company is obligated to pay such amounts prior to the Closing.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has obtained, from all Persons (including each current or former employee, officer, manager, consultant
and contractor) that have contributed to the creation or development of any Intellectual Property Rights for or on behalf of the
Company, valid and enforceable written agreements containing irrevocable present assignments to the Company of all such Intellectual
Property Rights, and no such Person retains any right, title or interest in or to any such Intellectual Property Rights. No current
or former employee, consultant, contractor, officer or manager of the Company has excluded any Intellectual Property Rights from
any written assignment executed by any such Person in connection with work performed for or on behalf of the Company.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(h)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has taken reasonable measures (including executing written and enforceable non-disclosure agreements
with all Persons who have (i) created or developed any subject matter that would be considered a Trade Secret of the Company if
the Company had taken all reasonable measures to protect the confidentiality of the subject matter or (ii) had access to any material
Trade Secrets used by the Company) to protect the confidentiality and value of all Trade Secrets used or held for use by the Company
(including all Trade Secrets included in the Company IP).</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The IT Assets (i) are sufficient for and operate and perform in all material respects as required by the Company
to conduct the business of the Company as currently conducted and as proposed to be conducted; (ii) have not materially malfunctioned
or failed within the prior six (6) years, and (iii) are free from material bugs and other defects and do not contain any &ldquo;virus,&rdquo;
&ldquo;worm,&rdquo; &ldquo;spyware&rdquo; or other malicious software. No Person has gained unauthorized access to or use of any
IT Assets or any data or other information stored on or processed by any IT Asset.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: left; text-indent: 1in"><FONT STYLE="color: #010000">(j)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>No funding, facilities or personnel of any Governmental Authority or any university, college, research institute
or other educational institution has been used to create or otherwise develop any Company IP, except for any such funding or use
of facilities or personnel that has not resulted in such Governmental Authority or institution obtaining ownership rights in (or
options to obtain ownership rights in), licenses to (or options to receive licenses to) or other rights to use or exploit any Company
IP.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000"></FONT></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.19<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Privacy and Data Security</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company&rsquo;s data, privacy and security practices comply, and at all times have complied, in all material respects,
with applicable Data Protection and Security Requirements. The Company has provided all notices and obtained all consents required
by Data Protection and Security Requirements and satisfied all other requirements under Data Protection and Security Requirements
for its Processing of Personal Data and that are necessary for the conduct of business as currently conducted, as proposed to be
conducted, and in connection with the consummation of the transaction contemplated hereunder. The transactions to be consummated
hereunder as of the Closing Date will comply with all Data Protection and Security Requirements applicable to the Company.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company has implemented and at all times has maintained reasonable and appropriate organizational, physical, administrative
and technical measures consistent with the state of the art for the industry in which the Company operates to protect the operation,
confidentiality, integrity and security of all of the Company&rsquo;s confidential and other data and information, in any format,
generated or used in the conduct of the business of the Company (&ldquo;<U>Business Data</U>&rdquo;) and the IT Assets, against
unauthorized access, acquisition, interruption, alteration, modification or use (collectively, &ldquo;<U>Misuse</U>&rdquo;). Without
limiting the generality of the foregoing, the Company has implemented a comprehensive written information security program that
complies with 45 C.F.R. Part 164, Subpart C and (i) identifies internal and external risks to the security of the Business Data
or IT Assets and (ii) implements, monitors and improves adequate and effective safeguards to control those risks. The Company has
not experienced (nor have any Persons acting on the Company&rsquo;s behalf experienced) any actual or alleged Security Incident,
including, without limitation, any &ldquo;breach&rdquo; (as defined in 45 C.F.R. Part 164, Subpart D) of unsecured Protected Health
Information or of EU Personal Data. The Company has not (nor have any Persons acting on the Company&rsquo;s behalf) notified, and
the Company has not experienced any event resulting in any requirement that the Company notify, any Person or Data Protection Authority
of any Security Incident, including any loss or unauthorized access, use or disclosure, of EU Personal Data or of Protected Health
Information that would constitute a breach for which notification to individuals, the media, or the United States Department of
Health and Human Services (&ldquo;<U>HHS</U>&rdquo;) is required under 45 C.F.R. Part 164, Subpart D. In addition, the Company
does not have any material data security, information security or other technological vulnerabilities that could adversely impact
the operation of relevant IT Assets or cause a Security Incident.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company has obligated all third party service providers, outsourcers, and processors of confidential information on
their behalf and all third parties managing IT Assets on their behalf to appropriate contractual terms relating to the Processing
of Business Data (as applicable and as required by Data Protection and Security Requirements) and information security and have
taken reasonable measures to ensure that such third parties have complied with their contractual obligations. Without limiting
the generality of the foregoing, the Company has entered into business associate agreements with vendors and customers in all situations
where required by 45 C.F.R. &sect;&sect;&nbsp;164.502(e) and 164.504(e) or Article 28 of the GDPR. The Company has taken reasonable
measures to ensure that all third parties acting on its behalf have complied with their contractual obligations.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company has not received any notice of any claims, investigations (including investigations by any Governmental Authority,
including the HHS Office for Civil Rights and any other Data Protection Authority), for alleged violations of Data Protection and
Security Requirements with respect to Personal Data Processed by, or under the control of, Company, and, to the Company&rsquo;s
Knowledge, there are no facts or circumstances that are likely to form the basis for any such claims, investigations or allegations.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.20<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Real Property</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>As of the date hereof, the Company does not own any real property.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Section&nbsp;4.20(b)</U> of the Company Disclosure Schedule&nbsp;sets forth as of the date hereof a true and complete
list of all material lease and sublease agreements (&ldquo;<U>Lease Agreements</U>&rdquo;) for the leasing, use or occupancy of,
or otherwise granting a right in or relating to all real property currently leased or subleased by the Company or otherwise used
or occupied by the Company, including all amendments, terminations and modifications thereof (&ldquo;<U>Leased Real Property</U>&rdquo;).
The Company has Made Available to Parent true and complete copies of all Lease Agreements. Each of the Lease Agreements (other
than any Lease Agreement which will terminate or expire by its terms prior to the Closing) constitutes a legal, valid and binding
obligation of the Company party thereto and, to the Company&rsquo;s Knowledge, of the other parties thereto, except as limited
by the Enforceability Exceptions. There are no outstanding defaults or events of default under the Lease Agreements. Except for
Permitted Liens, there are no Liens on the Leased Real Property. The Company&rsquo;s occupancy, use and operation of the Leased
Real Property by the Company materially complies with all Applicable Laws. To the Company&rsquo;s Knowledge, there are no pending
or threatened appropriation, condemnation, eminent domain or similar proceedings by any Governmental Authority relating to the
Leased Real Property. The Company is the tenant, subtenant or licensee named under the Lease Agreement for the Leased Real Property
and is in possession of the properties purported to be leased, subleased or licensed thereunder.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.21<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Personal Property</U>. Except as would not reasonably be expected to be material, the Company (a) owns, leases
or licenses from third parties all tangible personal property required to conduct its business in the Ordinary Course of Business,
(b) has good and valid title to all tangible personal property owned by it, free and clear of all Liens except for Permitted Liens,
and (c) immediately upon consummation of the transactions contemplated by this Agreement, will be entitled to continue to use all
material tangible personal property which is currently employed by it in the conduct of its business as presently conducted. Except
as would not reasonably be expected to be material, such tangible personal property is in reasonable operating condition and reasonably
fit for the particular purposes for which it is used (subject only to normal maintenance requirements and reasonable wear and tear).
Other than with respect to any Intellectual Property Rights, the representations and warranties related to which are contained
solely in <U>Section&nbsp;4.18</U>, at the Closing, the Company will own, or has a valid and legal right to use, sufficient property,
assets and other rights (whether tangible or intangible) to be able to operate and conduct, and to continue to operate and conduct,
the business and operations of the Company in the Ordinary Course of Business, without the need for Parent or the Surviving Company
to acquire or license any other property, assets or other rights, and the Company will have good and valid title to such property,
assets and other rights, free and clear of any Liens except Permitted Liens.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.22<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Related-Party Transactions</U>. (a) No Affiliate of the Company (other than the Company) has any Indebtedness
for borrowed money owed by it to the Company and (b) the Company has no Indebtedness for borrowed money owed by it to any such
Affiliate. Except as expressly required by this Agreement, no Affiliate of the Company is a party to any Contract or other understanding
with the Company. Each Contract required to be listed in <U>Section&nbsp;4.22</U> of the Company Disclosure Schedule&nbsp;was entered
into upon fair and reasonable terms no less favorable to the Company, as the case may be, than it would obtain in a comparable
arm&rsquo;s-length transaction with a Person not an Affiliate.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.23<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Bank Accounts</U>. <U>Section&nbsp;4.23</U> of the Company Disclosure Schedule&nbsp;sets forth a true, complete
and correct list of each of the bank accounts in the name of the Company, including the title and number of the account, the individuals
with signatory authority over such account and the financial institution at which such account is located.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.24<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Customers, Distributors and Suppliers</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Section&nbsp;4.24(a)</U> of the Company Disclosure Schedule&nbsp;sets forth the top seven (7) international distributors
of the Company (in terms of total transfer pricing), during the last twelve (12) months (each, a &ldquo;<U>Key International Distributor</U>&rdquo;)
along with the amount of transfer pricing attributable to each Key International Distributor within such period. None of the other
international distributors of the Company individually represented more than $100,000 in total recognized revenue during the last
twelve (12) months.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Section&nbsp;4.24(b)</U> of the Company Disclosure Schedule&nbsp;sets forth the top ten (10) domestic distributors
of the Company (in terms of total commission), during the last twelve (12) months (each, a &ldquo;<U>Key Domestic Distributor</U>&rdquo;)
along with the amount of commission attributable to each Key Domestic Distributor within such period. None of the other domestic
distributors of the Company individually represented more than $100,000 in total recognized revenue during the last twelve (12)
months.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Section&nbsp;4.24(c)</U> of the Company Disclosure Schedule&nbsp;sets forth the fifteen (15) domestic customers
of the Company (excluding Key International Distributors and Key Domestic Distributors) (in terms of total recognized revenue),
during the last twelve (12) months (each, a &ldquo;<U>Key Customer</U>&rdquo;) along with the amount of recognized revenue attributable
to each Key Customer within such period. None of the other customers of the Company individually represented more than $100,000
in total recognized revenue during the last twelve (12) months.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Section&nbsp;4.24(d)</U> of the Company Disclosure Schedule&nbsp;sets forth the top ten (10) suppliers of the
Company (in terms of total dollars spent), during the last twelve (12) months (each, a &ldquo;<U>Key Supplier</U>&rdquo;) along
with the amount of dollars spent with each Key Supplier within such period.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>As of the date of this Agreement, no Key International Distributor, Key Domestic Distributor, Key Customer or Key
Supplier has canceled or otherwise terminated, or, to the Knowledge of the Company, threatened to cancel or otherwise terminate,
its relationship with the Company. As of the date of this Agreement, the Company has not received notice that any Key International
Distributor, Key Domestic Distributor, Key Customer or Key Supplier is considering or intends to cancel or otherwise materially
and adversely modify its relationship (including, without limitation, by seeking to renegotiate contractual terms) with the Company
or limit its purchases from or reduce its sales to, as applicable, the Company.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.25<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Key Revenue Agreements</U>. The amount of total revenue recognized pursuant to the Key Revenue Agreements during
the twelve (12) month period ended September&nbsp;30, 2019 was greater than eighty percent (80%) of the amount of total revenue
recognized by the Company during such period.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.26<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Condition and Sufficiency of Assets</U>. The Company owns or has the valid right to use under a lease or license
of, all the material assets and rights used in the operation of the Company&rsquo;s business as currently conducted. Such assets
and rights constitute all of the material assets, tangible and intangible, of any nature whatsoever, used in the operation of such
businesses as currently conducted.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.27<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Compliance with Healthcare Laws</U></P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>For the past five (5) years, the Company and to the Company&rsquo;s Knowledge, its officers, managers, employees,
or independent contractors, in their capacity as such, are and have been, in material compliance with all Applicable Laws relating
to healthcare regulatory matters (collectively, the &ldquo;<U>Healthcare Laws</U>&rdquo;), including, to the extent applicable:
(i) Laws governing participation in Medicare (Title XVIII of the Social Security Act), Medicaid (Title XIX of the Social Security
Act), and other federal and state healthcare programs defined in 42&nbsp;U.S.C.&nbsp;&sect;&nbsp;1320a-7b(f) (collectively, &ldquo;<U>Federal
Healthcare Programs</U>&rdquo;); (ii) HIPAA; (iii) Laws governing the corporate practice of medicine; (iv) Laws relating to kickbacks
and self-referrals, including (A) the federal Anti-Kickback Statute (42 U.S.C. &sect;&nbsp;1320a-7b(b)), (B) the civil False Claims
Act (31&nbsp;U.S.C.&nbsp;&sect;&sect;&nbsp;3729 et seq.), (C) the Beneficiary Inducement Law (42 U.S.C. &sect;&nbsp;1320a-7a(a)(5)),
(D) the administrative False Claims Law (42 U.S.C. &sect;&nbsp;1320a-7b(a)), (E) the exclusion Laws (42 U.S.C.&nbsp;&sect;&nbsp;1320a-7),
(F) the civil monetary penalty Laws (42 U.S.C. &sect;&nbsp;1320a-7a), (G) the Stark Law (42&nbsp;U.S.C.&nbsp;&sect;&nbsp;1395nn),
(H) the federal Sunshine Act (42 U.S.C. &sect;&nbsp;1320a-7h) and (I) any other Applicable Laws imposed or enforced by HHS; and
(v) any similar federal, state or local Laws.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Without limiting the generality of the foregoing, for the past five (5) years, none of the Company, or, to the Knowledge
of the Company, any managing employee, agent (as those terms are defined in 42&nbsp;C.F.R.&nbsp;&sect;&nbsp;1001.1001), officer,
manager or healthcare professional of the Company: (i)&nbsp;is or has been a party to a corporate integrity agreement or Certificate
of Compliance Agreement with the Office of Inspector General (&ldquo;<U>OIG</U>&rdquo;) or similar government-mandated compliance
program; (ii)&nbsp;has any continuing material reporting obligations pursuant to a settlement agreement or other remedial measure
entered into with any Governmental Authority; (iii)&nbsp;has been served with or received any search warrants, subpoenas or civil
investigative demands of which the Company is the subject of such search warrants, subpoenas or civil investigative demands from
any Governmental Authority; (iv)&nbsp;has been debarred, excluded or suspended from participation, has received a written notice
of their exclusion, suspension or debarment from participation or has been threatened with exclusion, suspension or debarment from
participation in any federal or state healthcare program or subject to a formal disciplinary action by any payor or Governmental
Authority; (v)&nbsp;has had a civil monetary penalty assessed against it, him or her under Section&nbsp;1128A of the Social Security
Act; (vi)&nbsp;is currently or has been listed on the United States General Services Administration published list of parties excluded
from federal procurement programs and non-procurement programs; or (vii)&nbsp;has been convicted of, or entered into any settlement
or reformation agreement with any Governmental Authority to avoid conviction of, any criminal offense relating to the delivery
of any item or service under a Federal Healthcare Program or had a civil monetary penalty assessed against them under Section&nbsp;1128A
of the Social Security Act or any regulations promulgated thereunder.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has adopted a code of ethics and has an operational healthcare compliance program, materially covering
and implementing the seven elements of an effective compliance program described in the Compliance Program Guidance for the Durable
Medical Equipment, Prosthetics, Orthotics, and Supply Industry published by the HHS OIG, which governs all employees and contractors,
including sales representatives and their interactions with healthcare providers.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>To the extent required by applicable Healthcare Laws, the Company has (i)&nbsp;verified that all employees providing
clinical services, if any, have valid and current licenses, permits and credentials, (ii)&nbsp;conducted criminal background checks
on all applicable employees and independent contractors and&nbsp;(iii) screened all officers, managers, employees and independent
contractors using the HHS/OIG List of Excluded Individuals/Entities.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.28<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Medical Device Compliance</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company is currently conducting, and has conducted, its business and operations in compliance in all material
respects with all applicable requirements of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. &sect;&sect;&nbsp;301 et seq.,
all applicable regulations promulgated by the United States Food and Drug Administration (&ldquo;<U>FDA</U>&rdquo;) and all similar
laws and regulations issued by any other similar Governmental Authority including those relating to nonclinical research, clinical
research, good clinical practices, good laboratory practices, investigational use, premarket notification, premarket approval,
establishment registration, device listing, clinical trial registration and reporting, Quality System Regulation, record keeping,
labeling, advertising, device importation and exportation, adverse event reporting, recalls, and reporting of corrections and removals,
as applicable (collectively, &ldquo;<U>Medical Device Laws</U>&rdquo;).</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has not received in the past five (5) years any written notice, Form FDA-483, FDA warning letters or
&ldquo;untitled letters,&rdquo; from the FDA or any similar notice or letter from any other Governmental Authority alleging or
asserting non-compliance with Medical Device Law or any other communication alleging actual or potential violations of Medical
Device Law. The Company has not entered into any consent decree or order pursuant to any Medical Device Law and the Company is
not a party to any judgment, decree or judicial or administrative order pursuant to any Medical Device Law. There is no civil,
criminal or administrative action, suit, demand, claim, complaint, hearing, investigation, demand letter, proceeding or request
for information pending against the Company and the Company has no material liability (whether actual or contingent) for failure
to comply with any Medical Device Law. To the Company's Knowledge, there is no act, omission, event or circumstance that would
reasonably be expected to give rise to or lead to any such action, suit, demand, claim, complaint, hearing, investigation, notice,
demand letter, warning letter, proceeding or request for information or any such liability.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000"></FONT></P>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each of the Company Products has been and is being designed, researched, developed, investigated, manufactured, tested,
packaged, labeled, stored, distributed, promoted, marketed, imported, exported and/or sold in compliance in all material respects
with all applicable requirements under Medical Device Laws. Each of the Company Products is the subject of an appropriate Regulatory
Authorization, as required, and duly held by the Company. The Company has obtained and maintained in full force and effect, all
necessary Regulatory Authorizations needed for the continuing operation of the Company, as listed in <U>Section&nbsp;4.28(c)</U>
of the Company Disclosure Schedule.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company is and has been for the past five (5) years, in material compliance with, and each Company Product has
been designed, manufactured, prepared, assembled, packaged, labeled, stored, and processed in material compliance with applicable
Quality System Regulation.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has made all notifications, submissions and reports to the FDA and other Governmental Authorities required
by Medical Device Laws, and all such notifications, submissions and reports were true, complete and correct as of the date of submission
to the FDA or other Governmental Authority (or were corrected or supplemented by a subsequent notification, submission or report).
The Company has not made any untrue statement or fraudulent statement to the FDA or other Governmental Authority; failed to disclose
a fact required to be disclosed to the FDA or other Governmental Authority; or committed an act, made a statement, or failed to
make a statement that, at the time such disclosure was made, would reasonably be expected to provide a basis for the FDA to invoke
its policy respecting &ldquo;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities,&rdquo; set forth in 56
Fed. Reg. 46191 (September&nbsp;10, 1991) or any other Governmental Authority to invoke any similar policy.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>None of the Company, or, to the Company&rsquo;s Knowledge, any of its customers, has undertaken a recall, field correction,
removal or withdrawal of any Company Products, nor have any such products been seized, detained, subject to suspension of manufacturing
or termination or suspension of marketing. To the Company&rsquo;s Knowledge, there are no facts or circumstances reasonably likely
to cause such recall, field correction, removal, withdrawal, seizure, detention, suspension of manufacturing or termination or
suspension of marketing of any Company Product.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The studies, non-clinical laboratory studies, animal studies, tests, preclinical trials, and clinical trials, if
any, conducted by or on behalf of, or (if applicable) sponsored by, the Company were and, to the extent still pending, are being
conducted in accordance with experimental protocols, procedures and controls pursuant to, where applicable, standard medical and
accepted professional scientific research procedures and standards, and Medical Device Laws (including the applicable requirements
of good laboratory practices or good clinical practices, International Conference on Harmonization E6-Good Clinical Practices Consolidated
Guideline, FDA regulations, including 21 C.F.R. Parts 50, 54, 56, 58 and 812, and equivalent regulations of other Governmental
Authorities). The Company has not received any oral or written notices or correspondence or other communication from an institutional
review board, an ethics committee, a data monitoring committee, similar organization overseeing the conduct of clinical or other
studies, the FDA or any other Governmental Authority exercising comparable authority, that has ordered or commenced any action
to place a clinical hold order on, or otherwise terminate, materially delay, limit, modify or suspend, any proposed or ongoing
clinical trial conducted or proposed to be conducted by or on behalf of the Company, or, to the Company&rsquo;s Knowledge, alleged
any violation of any Medical Device Laws in connection with any preclinical or clinical studies, trials or tests.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000"></FONT></P>

<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(h)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has made available to Parent complete and accurate copies of (i)&nbsp;all material filings, commitments
and agreements with the FDA, any EU competent authority or equivalent Governmental Authority relating to any Company Product, (ii)&nbsp;all
material correspondence and minutes, notes or other documentation of any meetings, teleconferences, or other verbal discussions
or agreements with the FDA, any EU competent authority or equivalent Governmental Authority relating to any Company Product and
(iii)&nbsp; all design history files and material technical documentation relating to each Company Product, (iv) all material data,
information, results, analyses, publications, and written reports relating to any Company Product, including all material information
as to the safety and efficacy of the Company Products and all clinical trial protocols, trial statistical analysis plans and published
trial results (collectively, the &ldquo;<U>Material Product and Trial Information</U>&rdquo;).&nbsp; The Material Product and Trial
Information is a true and correct representation in all material respects of the matters reflected therein. The registration and
regulatory files, Regulatory Authorizations, and supporting materials of the Company with respect to the Company Products have
been maintained in all material respects in accordance with all Applicable Laws, guidelines and guidances issued or relied on by
FDA and other similar Governmental Authorities, and the standard operating procedures of the Company.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.29<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Brokers</U>. The Company does not have any liability to pay fees or commissions to any broker, finder or agent
with respect to the transactions contemplated by this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.30<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Environmental Matters</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company is, and at all times has been in compliance, in all material respects, with all applicable Environmental
and Safety Requirements.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Without limiting the generality of the foregoing, to the Company&rsquo;s Knowledge, no facts, circumstances or other
conditions exist that will hinder the Company&rsquo;s ability to comply with Environmental and Safety Requirements or require capital
expenditures to comply with Environmental and Safety Requirements after the Effective Time.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has obtained and is in compliance in all material aspects with all permits, licenses, certificates, registrations
and other authorizations that are required pursuant to applicable Environmental and Safety Requirements for the occupation of its
facilities and the operation of its business, provided on <U>Section&nbsp;4.30(c)</U> of the Disclosure Schedule, all of which
are valid and in full force and effect.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has not received any written claim, complaint, citation, report or other written notice, or to the Knowledge
of the Company any other notice, regarding any liabilities, including any investigatory, remedial or corrective obligations or
violations, arising under applicable Environmental and Safety Requirements.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000"></FONT></P>

<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has not stored, disposed of, arranged for or permitted the disposal of, transported, handled or released
Hazardous Materials at the Real Property, or at any property or facility formerly owned, leased, operated or otherwise used by
the Company. The Real Property is not, and, to Company&rsquo;s Knowledge, each such other facility or property is not contaminated
by any such material above any regulatory level that is reasonably likely to give rise to a violation of or liability under Environmental
and Safety Requirements.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has not received any request for information from any Governmental Authority pursuant to any Environmental
and Safety Requirements.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has not expressly, by operation of law, or otherwise, assumed any liability of any other Person under
Environmental and Safety Requirements.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(h)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has made available true and accurate copies of all material environmental reports, assessments, audits,
correspondence and other environmental information within the possession or control of the Company with respect to the Real Property,
the operations of the Company or the Company&rsquo;s compliance with Environmental and Safety Requirements and all such reports
are provided on <U>Schedule&nbsp;4.30(h)</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.31<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>No Other Representations or Warranties</U>. Except for the representations and warranties of the Company expressly
set forth in this <U>Article IV</U>, neither the Company nor any other Person makes any other express or implied representation
or warranty on behalf of the Company with respect to the Company or the transactions contemplated by this Agreement, and the Company
hereby disclaims any such other representations or warranties.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0 0 12pt"><FONT STYLE="color: #010000">Article
V</FONT><BR>
REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">Parent and Merger Sub hereby jointly and severally,
represent and warrant to the Company as of the date hereof and, at Closing, as of the Closing Date (except for any representation
or warranty that is expressly made as of a specified date, in which case Parent and Merger Sub hereby represent and warrant to
the Company as of such specified date), as follows:</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">5.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Organization; Qualification</U>. Parent (a) is a corporation duly formed, validly existing and in good standing
under the Applicable Laws of its jurisdiction of organization, (b) has all requisite corporate power and authority to conduct its
business as it is now being conducted and to own, lease and operate its Properties and (c) holds all material Governmental Approvals
required to carry on its business as now being conducted. Merger Sub (i) is a limited liability company duly organized, validly
existing and in good standing under the Applicable Laws of Wisconsin, (ii) has all requisite corporate power and authority to conduct
its business as it is now being conducted and to own, lease and operate its Properties and (iii) holds all material Governmental
Approvals required to carry on its business as now being conducted.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">5.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Authority; Enforceability</U>. Each of Parent and Merger Sub has all requisite corporate or limited liability
company power and authority to execute and deliver this Agreement and the other Transaction Documents to which they are a party,
to perform their obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby. The execution
and delivery by Parent and Merger Sub of this Agreement and the other Transaction Documents to which they are a party, and the
performance by Parent and Merger Sub of their obligations hereunder and thereunder, have been duly and validly authorized by all
necessary corporate or limited liability company action by each such party, except for approval of this Agreement by Parent, as
the sole member of Merger Sub, which will be effected by written consent immediately following the execution of this Agreement.
This Agreement and each other Transaction Document to which Parent or Merger Sub is a party has been duly and validly executed
and delivered by Parent and Merger Sub and constitutes the legal, valid and binding obligation of Parent and Merger Sub enforceable
against Parent and Merger Sub in accordance with its terms, except as the same may be limited by the Enforceability Exceptions.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">5.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>No Conflicts; Consents and Approvals</U>. The execution and delivery by Parent and Merger Sub of this Agreement
and the other Transaction Documents to which Parent and Merger Sub are a party do not, and the performance by Parent and Merger
Sub of their obligations under this Agreement and the other Transaction Documents to which Parent or Merger Sub are a party will
not:</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>conflict with or result in a violation or breach of (i) any of the terms, conditions or provisions of the Organizational
Documents of Parent and Merger Sub or (ii) any Order to which Parent or Merger Sub is subject;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>require the consent, notice or other action by any Person under, or result in a violation of or result in a breach
of or default (or give rise to any right of termination, cancellation or acceleration) under (with or without the giving of notice,
the lapse of time or both) any Material Contract to which Parent or Merger Sub is a party; or</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>(i) conflict with, violate or breach any term or provision of any Applicable Law applicable to Parent or Merger Sub,
or (ii) require any consent or approval of any Governmental Authority, or notice to, or declaration, filing or registration with,
any Governmental Authority, under any Applicable Law, and the filing of the Articles of Merger.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">5.04<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Litigation</U>. As of the date hereof, there are no Actions pending or, to the knowledge of Parent or Merger Sub,
threatened in writing against Parent or Merger Sub, nor are there any outstanding Orders that affect or bind Parent, Merger Sub
or any of their Properties, that would reasonably be expected to result in the issuance of an Order restraining, enjoining or otherwise
prohibiting or making illegal the Merger or the performance by Parent or Merger Sub of their obligations under this Agreement and
the other Transaction Documents to which Parent or Merger Sub is a party.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">5.05<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Availability of Funds</U>. Parent will have at Closing sufficient funds available for Parent and Merger Sub to
consummate the Closing and Parent will, at the applicable times, have sufficient funds available to consummate the other transactions
and make the other payments contemplated by this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">5.06<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Merger Sub</U>. Merger Sub is a wholly owned subsidiary of Parent. Merger Sub was formed specifically to consummate
the transactions contemplated by this Agreement and has conducted no operations and incurred no obligation or liabilities other
than in connection with its formation and the transactions contemplated hereby.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">5.07<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>No Other Representations or Warranties</U>. Except for the representations and warranties of Parent and Merger
Sub expressly set forth in this <U>Article V</U>, neither Parent, Merger Sub or any other Person makes any other express or implied
representation or warranty on behalf of Parent or Merger Sub with respect to Parent or Merger Sub or the transactions contemplated
by this Agreement, and Parent and Merger Sub each hereby disclaims any such other representations or warranties.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">5.08<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Parent&rsquo;s Investigation and Reliance</U>. Parent is a sophisticated purchaser and has made its own independent
investigation, review and analysis regarding the Company and the transactions contemplated hereby, which investigation, review
and analysis were conducted by Parent together with expert advisors, including legal counsel, that it has engaged for such purpose.
Parent acknowledges that neither the Company nor any other Person has made any representation or warranty, express or implied,
with respect to the Company or the transactions contemplated by this Agreement, or as to the accuracy or completeness of any information
concerning the Company contained herein or made available in connection with Parent&rsquo;s investigation of the Company (including
any information, documents or materials Made Available to Parent, whether orally or in writing, in any confidential information
memoranda, &ldquo;data rooms,&rdquo; management presentations, due diligence discussions or in any other form in expectation of,
or in connection with, the transactions contemplated by this Agreement), except as expressly set forth in <U>Article IV</U>, and
the Company and its Affiliates and Representatives expressly disclaim any and all liability that may be based on such information
or errors therein or omissions therefrom. Parent has not relied and is not relying on any statement, representation or warranty,
oral or written, express or implied, made by the Company or any other Person, except as expressly set forth in <U>Article IV</U>
and the Company Disclosure Schedule. Parent acknowledges and agrees that the representations and warranties in <U>Article IV</U>
are the result of arm&rsquo;s length negotiations between sophisticated parties. Nothing in this <U>Section&nbsp;5.08</U> is intended
to modify or limit any of the representations or warranties of the Company set forth in <U>Article IV</U>.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0 0 12pt"><FONT STYLE="color: #010000">Article
VI</FONT><BR>
COVENANTS OF THE PARTIES</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Access by Parent</U>. From and after the date hereof until the earlier of the Closing Date and the termination
of this Agreement (the &ldquo;<U>Interim Period</U>&rdquo;), the Company will provide Parent and its Representatives with reasonable
access, upon reasonable prior notice and during normal business hours, to all managers, officers, employees, agents and accountants
of the Company and its Properties, books, Contracts and records relating to the Company, but, in each case, only to the extent
that such access does not unreasonably interfere with the business and operations of the Company; <U>provided</U>, <U>however</U>,
the Company shall not be required to provide any of the foregoing (a) with respect to any information that is subject to attorney-client
privilege, to the extent doing so would reasonably be expected to cause such privilege to be waived, or (b) if the Company reasonably
determines, after consulting with outside counsel, that such cooperation or access is prohibited by any federal, state or local
Applicable Laws. All such access and information obtained as a result of such access shall be subject to the terms and conditions
of the Non-Disclosure Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Certain Restrictions</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>During the Interim Period, except as set forth in <U>Section&nbsp;6.02(a)</U> of the Company Disclosure Schedule&nbsp;or
unless otherwise contemplated by this Agreement, the Company (w) will operate and maintain its business in the Ordinary Course
of Business, (x) will use commercially reasonable efforts to maintain the ordinary and customary relationships of the Company with
its suppliers, customers, key employees and others having material business relationships with it, and (y) except as required by
Applicable Law, will not take any of the following actions unless either (i) expressly required by this Agreement or (ii) as set
forth in <U>Section&nbsp;6.02(a)</U> of the Company Disclosure Schedule, without Parent&rsquo;s consent (which consent shall not
be unreasonably withheld, conditioned or delayed):</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>declare, set aside, make or pay any distribution in respect of the Equity Interest of the Company or repurchase,
redeem or otherwise acquire any outstanding Units or other securities of, or other ownership interests in, the Company;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>transfer, issue, sell or dispose of any Units or other Equity Interests of the Company or grant Equity Interests
of the Company;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>amend its Organizational Documents or undertake, declare or effect any recapitalization, reclassification, reorganization,
stock split, liquidation, dissolution or winding up;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>take any action that would result in the Company having any Subsidiaries;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(v)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>acquire, dispose, exchange or lease to any other Person any real property or other material Properties of the Company
or incur any Liens or permit any Liens to be imposed on any Property of the Company other than Permitted Liens, other than in the
Ordinary Course of Business;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(vi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>enter into, amend, modify or terminate (partially or completely) any (A) Material Contract, (B) Contract that would
constitute a Material Contract if entered into prior to the date of this Agreement, or (C) Contract with a Key Customer or material
supplier, except, in each case of (A), (B) and (C), in the Ordinary Course of Business;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(vii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>incur any Indebtedness other than Company Tax Liability;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(viii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>make any loans or advances to, or any investments in or capital contributions to, any Person, or forgive or discharge
in whole or in part any outstanding loans or advances, or prepay any indebtedness for borrowed money (other than routine advancement
of expenses or commissions to managers, officers, consultants or employees in the Ordinary Course of Business);</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ix)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>merge, fail to maintain its legal existence or consolidate with any other Person, or acquire capital stock or assets
of any other Person or enter into any Contract with respect to a joint venture, strategic alliance or partnership;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(x)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>change the Company&rsquo;s methods of accounting, except to the extent required by changes in GAAP;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>(A) make (outside the Ordinary Course of Business), change or rescind any material Tax election; (B) settle or compromise
any claim, audit, assessment or dispute relating to Taxes in excess of the amount reserved with respect thereto in the YTD Financial
Statements; (C) file any material amended Tax Return; (D) make any change in any material method of Tax accounting or material
Tax accounting periods; (E)&nbsp;knowingly surrender any claim for a refund of Taxes; (F) enter into any closing agreement with
a Governmental Authority relating to any Tax; (G) file any material Tax Return except as in accordance with past practice or in
the Ordinary Course of Business; or (H) consent to any extension or waiver of the limitation period applicable to any material
Tax claim or assessment (other than pursuant to extensions of time to file Tax Returns obtained in the Ordinary Course of Business);</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>make or enter into any commitment for any capital expenditures outside the Ordinary Course of Business;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xiii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>commence any lawsuit or legal proceedings or pay or agree to pay in settlement or compromise of any suits or claims
of liability against the Company;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xiv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>grant, extend, waive or modify any material rights in or to, or sell, assign, lease, license, transfer, let lapse,
abandon or otherwise dispose of, any material Properties of the Company (including any Company IP), other than grant non-exclusive
licenses in the Ordinary Course of Business to customers, suppliers, distributors and contractors;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>disclose to any third party any Trade Secrets included in the Company IP in a way that results in the loss of protection
for such Trade Secrets;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xvi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>except as required pursuant to the terms of any Company Plan in effect as of the date hereof, or as required under
Applicable Laws, (A) increase the compensation or consulting fees, bonus opportunity, pension, welfare, fringe or other benefits,
severance or termination pay of any of the current or former managers, officers, employees or consultants of the Company, (B)&nbsp;become
a party to, establish, adopt, amend, commence participation in or terminate any Company Plan or any arrangement that would have
been a Company Plan had it been entered into prior to this Agreement, (C) hire any employee or engage any independent contractor
(who is a natural person), except to fill a vacant position with an annual salary or wage rate or consulting fees and target cash
bonus opportunity in not excess of $100,000, (D) terminate the employment of any executive officer or manager other than for cause,
(E) grant any new equity awards, or amend or modify the terms of any outstanding equity awards under any Company Plans, (F) take
any action to accelerate the vesting or lapsing of restrictions or payment, or fund or in any other way secure the payment of,
compensation or benefits under any Company Plan or (G) forgive any loans or issue any loans (other than routine advances of expenses
or commissions issued in the Ordinary Course of Business) to any of its managers, officers, consultants or employees;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xvii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>become a party to, establish, adopt, amend, commence participation in or terminate any collective bargaining agreement
or other agreement with a labor union, works council or similar organization;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xviii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;
</FONT></FONT>cancel or terminate any material insurance policy or cause any of the coverage thereunder to lapse (unless simultaneously
with such termination, cancellation or lapse, replacement policies providing coverage equal to or greater than the coverage under
the canceled, terminated or lapsed policies, for premiums at not more than current market rates, are in full force and effect);</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xix)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>accelerate the collection of receivables or delay the payment of payables of the Company in a manner inconsistent
with the Ordinary Course of Business; or</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(xx)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>agree or commit to do or engage in any of the foregoing.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Nothing contained in this Agreement shall give Parent, directly or indirectly, the right to control or direct the
Company&rsquo;s operations prior to the Closing. Prior to the Closing, the management of the Company shall exercise, consistent
with and in accordance with the terms and conditions of this Agreement, complete control and supervision over the operations of
the Company.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Reasonable Best Efforts; Regulatory and Other Approvals</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each of Parent, Merger Sub and the Company will, in order to consummate the Merger and the transactions contemplated
hereby, (i) take all steps reasonably necessary, and proceed diligently and in good faith and use its reasonable best efforts,
as promptly as practicable, to make all required filings required to be made by it with, and to give all required notices to, all
applicable Governmental Authorities, (ii) provide such other information and communications to such Governmental Authorities or
other Persons as such Governmental Authorities or other Persons may reasonably request in connection therewith and (iii) use its
reasonable best efforts and cooperate with each other Party, to take, or cause to be taken, all actions, and to do, or cause to
be done, all things reasonably necessary, appropriate or desirable to consummate and make effective, as promptly as practicable,
the Merger and the other transactions contemplated by this Agreement, including the satisfaction of the respective conditions set
forth in <U>Article VII</U> and <U>Article VIII,</U> and including to execute and deliver such other instruments and to do and
perform such other acts and things as may be reasonably necessary or reasonably desirable for effecting completely the consummation
of the Merger and the other transactions contemplated hereby.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Parent and the Company will provide prompt notification to each other when any such approval referred to in <U>Section&nbsp;6.03(a)</U>
is obtained, taken, made, given or denied, as applicable, and will advise each other of any material communications with any Governmental
Authority or other Person regarding any of the transactions contemplated by this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>In furtherance of the foregoing covenants in this <U>Section&nbsp;6.03</U>:</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000"></FONT></P>

<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each of Parent, Merger Sub and the Company shall prepare, as soon as is practical following the execution of this
Agreement, any necessary filings in connection with the transactions contemplated by this Agreement that may be required to be
filed by such Party under any federal, state or local Applicable Laws. Each such Party shall submit such filings as soon as practicable,
but in no event later than ten (10)&nbsp;days (subject to extension by mutual agreement)&nbsp;after the date hereof. The Parties
shall request expedited treatment of any such filings, shall promptly furnish each other with copies of any notices, correspondence
or other written communication from the relevant Governmental Authority, shall promptly make any appropriate or necessary subsequent
or supplemental filings and shall cooperate in the preparation of such filings.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>In connection with their obligations pursuant to this <U>Section&nbsp;6.03(c)</U>, Parent and the Company shall,
to the extent permitted by Applicable Laws, (w)&nbsp;keep each other informed in all material respects and on a reasonably timely
basis of any material communication received by such party from, or given by such party to, any Governmental Authority and of any
material communication received or given in connection with any proceeding by a private party, in each case with respect to this
Agreement or the transactions contemplated hereby, (x)&nbsp;notify each other of all documents filed with, submitted to or received
from any Governmental Authority with respect to this Agreement or the transactions contemplated hereby, (y)&nbsp;furnish each other
with such information and assistance as the other may reasonably request in connection with their preparation of any such governmental
filing or submission hereunder and (z)&nbsp;reasonably cooperate with each other in connection with and in advance of any such
filing or submission with a Governmental Authority in connection with the transactions contemplated by this Agreement and in connection
with any investigation or other inquiry by or before any Governmental Authority relating to this Agreement or the transactions
contemplated hereby, including any Action initiated by a private party. To the extent permitted by Applicable Law, the Company
will not, nor will it permit any of its Representatives to, make any material communications with, or proposals relating to, or
enter into, any material understanding, undertaking or agreement with, any Governmental Authority relating to the transactions
contemplated by this Agreement without Parent&rsquo;s prior review and approval.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each Party shall cooperate in good faith with all Governmental Authorities, and undertake promptly any and all actions,
consistent with its obligation under this <U>Section&nbsp;6.03</U>, that are required to complete lawfully the transactions contemplated
by this Agreement prior to the Termination Date. Notwithstanding the foregoing, nothing in this Agreement shall require, or be
construed to require, either Party or any of its Affiliates, before or after the Closing Date, to agree to (x) sell, hold, divest,
license, discontinue or limit any of its or its Affiliates&rsquo; assets, businesses, contracts or interests; (y) subject to <U>Section&nbsp;3.07(h),</U>
any conditions relating to, changes in, or restrictions on the operation of any of its or its Affiliates&rsquo; assets, businesses,
contracts or interests; or (z) any material modification or waiver of the terms and conditions of this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.04<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>No Solicitation or Negotiation of Alternative Proposals</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000"></FONT></P>

<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company agrees that, unless and until this Agreement is terminated, neither it nor any of the officers and managers
of it shall, and that none of its Representatives shall, directly or indirectly: (i) initiate, solicit or knowingly encourage any
inquiries or the making of any proposal or offer that constitutes, or could reasonably be expected to lead to, any Acquisition
Proposal; (ii) engage in, continue or otherwise participate in any discussions or negotiations regarding, or provide any non-public
information or data to any Person relating to, any Acquisition Proposal; (iii) agree to, approve, endorse, recommend or consummate
any Acquisition Proposal; (iv) enter into any letter of intent, memorandum of understanding, agreement in principle, merger agreement,
acquisition agreement or other agreement (an &ldquo;<U>Alternative Acquisition Agreement</U>&rdquo;); or (v) otherwise knowingly
facilitate any effort or attempt to make an Acquisition Proposal.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>No Change in Recommendation or Alternative Acquisition Agreement</U>. Except to the extent required by the managers&rsquo;
fiduciary duties prior to the time support agreements constituting the Required Unitholder Approval have been delivered to Parent,
the Company&rsquo;s managers shall not withhold, withdraw, qualify or modify (or propose or resolve to withhold, withdraw, qualify
or modify), in a manner adverse to Parent, the Board Recommendation.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Existing Discussions</U>. The Company agrees that it will immediately cease and cause to be terminated any existing
activities, discussions or negotiations with any parties conducted heretofore with respect to any Acquisition Proposal or any fundraising
effort, including exploration of or preparation for an initial public offering. The Company also agrees that it will promptly after
announcement of this Agreement request each Person that has heretofore executed a confidentiality agreement in connection with
its consideration of an existing Acquisition Proposal or any fundraising effort to return or destroy all confidential information
heretofore furnished to such Person by or on behalf of the Company.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Notice</U>. The Company agrees that it will promptly (and, in any event, within twenty-four (24) hours) notify
Parent if any inquiries, proposals or offers with respect to an Acquisition Proposal are received by, or any such information is
requested from, or any such discussions or negotiation are sought to be initiated or continued with, it or any of its Representatives
indicating, in connection with such notice, the material financial terms and conditions of any proposals or offers (including,
if applicable, copies of any written requests, proposals or offers, including proposed agreements) and thereafter shall keep Parent
informed, on a current basis, of the status and material financial terms of any such proposals or offers (including any amendments
thereto) and the status of any such discussions or negotiations, including any change in the Company&rsquo;s intentions as previously
notified.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.05<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Required Unitholder Approval</U>. In accordance with Applicable Laws, including Sections 183.1202 and 183.0404(1)(a)
of Wisconsin Law, and the Company&rsquo;s Organizational Documents, immediately following the execution of this Agreement, the
Company shall seek and shall use its reasonable best efforts to obtain as promptly as practicable, and in any event, by midnight
on January 5, 2020 (the &ldquo;<U>Initial Unitholder Consent Delivery Period</U>&rdquo;), a support agreement in the form attached
to this Agreement as <U>Annex B</U> from the Unitholders holding a number of Company Units sufficient to satisfy the Required Unitholder
Approval in lieu of a meeting pursuant to Sections 182.1202 and 183.0404(1)(a) of Wisconsin Law for the purposes of approving this
Agreement. As promptly as practicable and, in any event, prior to the expiration of the Initial Unitholder Consent Delivery Period,
if Support Agreements constituting the Required Unitholder Approval are duly executed and delivered to the Company, the Company
shall deliver to Parent a copy thereof (including by facsimile or other electronic image scan transmission), certified as correct
and complete by a an executive officer of the Company.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 51; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.06<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Additional Unitholder Consents</U>. After the date of this Agreement and prior to the Effective Time the Company
shall use reasonable best efforts to have Support Agreements, to the extent not executed and delivered during the Initial Unitholder
Consent Delivery Period, executed and delivered by all remaining Unitholders such that, together with the Required Unitholder Approval,
Unitholders holding at least ninety percent (90%) of the issued and outstanding Company Units shall have executed and delivered
Support Agreements prior to the Closing Date.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.07<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Information Statement</U>. Within ten (10) Business Days of the date of this Agreement, the Company shall prepare
(with the cooperation of Parent) and mail to each holder of Company Units that does not execute a Support Agreement during the
Initial Unitholder Consent Delivery Period, an information statement regarding the transactions contemplated by this Agreement,
which shall be in a form reasonably acceptable to Parent (as it may be amended or supplemented from time to time, the &ldquo;<U>Information
Statement</U>&rdquo;). The Information Statement shall constitute an information statement for the Company&rsquo;s solicitation
of consent of the holders of Company Units with respect to the adoption of this Agreement and the approval of the Merger and shall
include (a) a statement to the effect that the Company&rsquo;s board of managers had unanimously recommended that the holders of
Company Units vote in favor of the adoption of this Agreement and the approval of the Merger, (b) a statement that adoption of
this Agreement shall constitute, among other things, approval by the holders of Company Units of the Expense Fund and the withholding
of the Indemnity Holdback, Special Indemnity Holdback and Purchase Price Holdback by Parent and the Expense Fund by the Unitholder
Representative and (c) such other information as Parent and the Company reasonably agree is required or advisable under Applicable
Laws to be included therein. The Company shall, with the cooperation of Parent (to the extent reasonably required), prepare any
other necessary documentation required or advisable to be provided to holders of Company Units pursuant to Wisconsin Law. None
of the information supplied or to be supplied by Parent or the Company for inclusion in the Information Statement or any amendment
or supplement thereto will contain, as of the date of the delivery of such document, any untrue statement of a material fact, or
will omit to state any material fact necessary in order to make the statements therein, in light of the circumstances under which
they are made, not misleading.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.08<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Employees; Employee Benefits</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>For a period of one (1) year following the Effective Time (the &ldquo;<U>Continuation Period</U>&rdquo;), Parent
will, or will cause an Affiliate to, provide to each Continuing Employee for so long as such Continuing Employee remains an employee
of Parent or its Affiliates during the Continuation Period (i) base salary or regular hourly wage and target annual cash bonus
opportunities that are, in the aggregate, substantially comparable to the base salary or regular hourly wage and target annual
cash bonus opportunities provided to such Continuing Employee as of immediately prior to the Effective Time and (ii) retirement
and welfare benefits (excluding any defined benefit plan benefits) that are, in the aggregate, substantially comparable to those
provided to either (x) such Continuing Employees as of immediately prior to the Effective Time or (y) similarly situated employees
of Parent.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 52; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Parent shall use commercially reasonable efforts to (i) cause any pre-existing conditions or limitations and eligibility
waiting periods under any group health plans of Parent or its Affiliates to be waived with respect to the Continuing Employees
and their eligible dependents, and (ii) give each Continuing Employee credit for the plan year in which the Effective Time occurs
towards applicable deductibles and annual out-of-pocket limits for medical expenses incurred prior to the Effective Time for which
payment has been made. Parent shall give each Continuing Employee service credit for such Continuing Employee&rsquo;s employment
with the Company for purposes of vesting, benefit accrual, level of benefits and eligibility to participate under each applicable
Parent benefit plan (which, for the avoidance of doubt, does not include any equity incentive plan), as if such service had been
performed with Parent, except for benefit accrual under defined benefit pension plans, for purposes of qualifying for subsidized
early retirement benefits or to the extent it would result in a duplication of benefits.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Prior to delivering or making any written or oral communications to the managers, officers or employees of the Company
pertaining to compensation or benefit matters that are affected by the transactions contemplated by this Agreement, the Company
shall provide Parent with a copy summarizing the intended communications for Parent&rsquo;s approval (which shall not be unreasonably
withheld, conditioned or delayed).</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company shall take the actions set forth on <U>Section&nbsp;6.08(d)</U> of the Company Disclosure Schedule.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Nothing contained in this Agreement is intended to (i) be treated as an amendment of any particular Company Plan,
(ii) prevent Parent, the Surviving Company or any of their Affiliates from amending or terminating any of their benefit plans or,
after the Effective Time, any Company Plan in accordance with its terms, (iii) prevent Parent, the Surviving Company or any of
their Affiliates, after the Effective Time, from terminating the employment of any Continuing Employee, or (iv) create any third-party
beneficiary rights in any employee of the Company, any beneficiary or dependent thereof, with respect to the compensation, terms
and conditions of employment and/or benefits that may be provided to any Continuing Employee by Parent, the Surviving Company or
any of their Affiliates or under any benefit plan which Parent, the Surviving Company or any of their Affiliates may maintain.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.09<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Third-Party Consents</U>. The Company shall use commercially reasonable efforts to (i) obtain prior to the Closing,
and (ii) deliver to Parent at or prior to the Closing, all consents, waivers and approvals under each Contract listed or described
in Section&nbsp;6.09 of the Company Disclosure Schedule.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.10<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Tax Matters</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 53; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Tax Returns</U>. The Unitholder Representative shall prepare and file, or cause to be prepared and filed, all
Tax Returns of the Company with respect to any period ending on or prior to the Closing Date that are due on or prior to the Closing
Date and all income Tax Returns of the Company with respect to any period ending on or prior to the Closing Date (each, a &ldquo;<U>Pre-Closing
Tax Return</U>&rdquo;). Such Pre-Closing Tax Returns shall be prepared in a manner consistent with past practices of the Company
unless otherwise required by Applicable Laws. Parent shall prepare and timely file, or cause to be prepared and timely filed, all
Tax Returns of the Company that are not Pre-Closing Tax Returns and that are due after the Closing Date. With respect to any such
Tax Return for which the Equityholders bear responsibility to pay a portion of the Tax reflected on such Tax Return, or to the
extent taken into account in determining the Final Aggregate Purchase Price as finally determined pursuant to <U>Section&nbsp;3.07</U>
(&quot;<U>Parent Returns</U>&quot;), Parent will prepare such Tax Returns consistent with the past practices of the Company unless
otherwise required by Applicable Laws. At least ten (10) Business Days prior to the date on which each such Parent Return is required
to be filed, Parent shall submit any such Buyer Return to the Unitholder Representative for the Unitholder Representative's review
and comment, and Parent shall accept any reasonable comments provided by the Unitholder Representative.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Audits and Contests Regarding Taxes</U>. Any Party who receives, or whose Affiliate receives, any notice of a
pending or threatened Tax audit, assessment or adjustment or other proceeding related to Taxes against or with respect to the Company
that relates to any Tax Return or Taxes with respect to a Pre-Closing Tax Period shall promptly notify the other Parties within
five (5) Business Days after receipt of such notice. Parent and the Unitholder Representative each agree to consult with and to
keep the other informed on a regular basis regarding the status of any such proceeding. The Unitholder Representative shall have
the right to conduct and control any such proceeding and to employ counsel of its choice at the Equityholders&rsquo; sole expense
in such proceeding, and to control the disposition of any issue involved in such proceeding to the extent such proceeding relates
to or affects a Pre-Closing Tax Return; provided that Parent shall have the right to participate in such proceeding through counsel
of its choice at its own expense. To the extent inconsistent therewith, the provisions of this <U>Section&nbsp;6.10(b)</U> shall
supersede the provisions of <U>Section&nbsp; 10.03</U>. The Equityholders agree if the IRS (or applicable state taxing authority)
issues a notice of final partnership adjustment assessing an &ldquo;imputed underpayment&rdquo; against the Company with respect
to a Tax period ending prior to or including the Closing Date, to cause the Company to make the election described in Section&nbsp;6226(a)
of the Code.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Tax Cooperation</U>. Each of Parent, on the one hand, and Equityholders and the Unitholder Representative, on
the other hand, shall cooperate, as and to the extent reasonably requested by such other Party, in connection with preparing and
filing any Tax Return and any inquiry, investigation, claim assessment, audit, litigation or other proceeding regarding Taxes with
respect to the Company or Surviving Company for any Pre-Closing Tax Period. Such cooperation shall include, upon such other Party&rsquo;s
request, signing any Tax Return prepared consistent with this Agreement, amended Tax Returns, claims or other documents necessary
to settle any Tax controversy, the provision of records and information that are reasonably relevant to any such inquiry, investigation,
claim assessment, audit, litigation or other proceeding and making employees available on a mutually convenient basis to provide
additional information and explanation of any material provided hereunder. Parent and the Equityholders agree to retain for seven
(7) years all books and records with respect to Tax matters pertinent to the Company relating to any Pre-Closing Tax Period, and
to abide by all record retention agreements entered into with any Governmental Authority.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000"></FONT></P>

<!-- Field: Page; Sequence: 54; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Transfer Taxes</U>. Notwithstanding anything herein to the contrary, all transfer, documentary, sales, use, stamp,
registration and other similar Taxes (including penalties and interest) incurred solely as a result of the Merger (&ldquo;<U>Transfer
Taxes</U>&rdquo;) shall be borne 50% by the Equityholders and 50% by Parent. Such Transfer Taxes shall be paid by the party legally
responsible to pay such Taxes (with the other party paying the party that is legally responsible to pay its share of such Tax at
least five (5) Business Days before the Tax payment due date). The parties agree to cooperate in the preparation and filing of
any returns with respect to the Transfer Taxes, including by promptly supplying any information in its possession that is reasonably
necessary to complete such returns.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Tax Sharing Agreements</U>. All Contracts providing for allocation, sharing or indemnification with respect to
Taxes (other than Contracts not primarily related to Taxes which were entered into in the Ordinary Course of Business, including
without limitation credit or loan agreements, vendor agreements, purchase and sale agreements and leases) to which the Company
is a party and pursuant to which the Company may have any obligations or responsibilities with respect to Taxes shall be terminated
prior to the Closing, and the Company shall have no further obligations or responsibilities thereunder following the Closing.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Tax Refunds</U>. Any refund of Taxes of the Company, or any amounts credited against such Taxes in lieu of a refund
(including any interest actually received or credited with respect thereof) attributable to any Pre-Closing Tax Period, to the
extent not included in the Working Capital Difference, shall be the property of Equityholders, shall be paid promptly to Equityholders
and, if received by, or credited to, Parent, the Company, the Surviving Company, or any other affiliated entity of Parent shall
be payable promptly to Equityholders.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Other Tax Matters</U>. Subject to <U>Section 3.05</U>, with respect to certain Tax matters, Parent and the Equityholders
agree as follows:</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>To treat (and have the Company treat) any Transaction Expenses and Company RSUs paid, payable or accrued on or before
the Closing Date as deductible in a Pre-Closing Tax Period to the extent allowable under Applicable Law.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>To the extent it could increase the Tax liability of the Company or the Equityholders for a Pre-Closing Tax Period
or otherwise result in a claim for Indemnified Taxes under this Agreement, without the written prior consent of Unitholder Representative,
such consent not to be unreasonably withheld, conditioned, or delayed, Parent shall not, and shall cause the Company and Surviving
Company not to, except where required by Applicable Law on a &quot;more likely than not&quot; basis and with notification of such
basis to the Unitholder Representative or a final determination of a Tax Authority, (i) amend or cause the amendment of a Tax Return
of the Company for a Pre-Closing Tax Period or a Straddle Period; (ii)&nbsp;change an annual accounting period, adopt or change
any accounting method, file or amend any Tax election concerning the Company for a Pre-Closing Tax Period or a Straddle Period;
(iii) extend or waive the applicable statute of limitations with respect to a Tax of the Company for a Pre-Closing Tax Period;
(iv) file any ruling request with any Governmental Authority that relates to Taxes or Tax Returns of the Company for a Pre-Closing
Tax Period or a Straddle Period; or (v) initiate or participate in any voluntary disclosure program with any Governmental Authority
regarding any Tax (or potential Taxes) or Tax Returns of the Company, or initiate the filing of any Tax Return(s) in any jurisdiction(s)
in which the Company has not historically filed such Tax Returns(s), in each case, for a Pre-Closing Tax Period.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 55; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Parent shall not, and shall not allow the Company to, engage in any transaction after the Closing, but on the Closing
Date, that is outside the ordinary course of business and is not contemplated by this Agreement and that will increase the amount
of Taxes of the Company or the Equityholders for a Pre-Closing Tax Period.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(h)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Treatment</U>. The Parties intend for Parent&rsquo;s acquisition of Company Units to be treated for Tax purposes
in the same manner as the transaction described in Revenue Ruling 99-6, Situation 2 with Parent treated as acquiring assets of
the Company (following a deemed liquidating distribution of the Company&rsquo;s assets to the Unitholders) and the Unitholders
treated as selling their interests in the Company to Parent. The Parties shall file or cause to be filed all Tax Returns in a manner
consistent with such treatment and shall not make any inconsistent statement or adjustment on any Tax Return or during the course
of any Tax-related matter, or otherwise take any Tax position inconsistent with such treatment unless otherwise required by Applicable
Law. The Parties intend for the Earn-Out Consideration payable to the Unitholders to be treated for Tax purposes as additional
Per Unit Merger Consideration for the exchange of Company Units unless otherwise required by applicable Tax Law. In pursuance of
the immediately preceding sentence, payments of the Earn-Out Consideration to the Unitholders shall, in accordance with Sections
483 and 1274 of the Code and the Treasury Regulations thereunder, be treated for Tax purposes as part principal and part interest.
The principal component of any payment shall be determined by discounting the payment by the lowest applicable federal rate in
effect for any month in the three (3) month period ending on the Closing Date from the date the payment is made to the Closing
Date, and the interest component of any payment shall be equal to the amount by which such payment exceeds the amount determined
to be principal.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.11<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Further Assurances; Post-Closing Cooperation</U>. Upon the terms and subject to the conditions of this Agreement,
at any time or from time to time after the Closing, each of the Parties hereto shall execute and deliver such other documents and
instruments, provide such materials and information and take such other actions as may reasonably be necessary, proper or advisable,
to the extent permitted by Applicable Law, to fulfill its obligations under this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.12<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Indemnification of Managers and Officers; Managers&rsquo; and Officers&rsquo; Insurance, etc</U>.Parent agrees
that, subject to Applicable Laws, all rights to indemnification and all limitations of liability existing in favor of the Indemnified
Managers and Officers (as provided in (i) the Company&rsquo;s Organizational Documents and (ii) any other indemnification agreements
(as applicable) as in effect as of the date of this Agreement) with respect to matters occurring on or prior to the Effective Time
shall survive the Merger and shall continue in full force and effect thereafter, without any amendment thereto.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>If Parent or the Surviving Company or any of its successors or assigns shall (i) consolidate with or merge into any
other Person and shall not be the continuing or surviving Person of such consolidation or merger or (ii) transfer all or substantially
all of its properties and assets to any Person, then, in each such case, proper provisions shall be made so that the successors
and assigns of Parent and the Surviving Company, as the case may be, assume all of the obligations of Parent and the Surviving
Company set forth in this <U>Section&nbsp;6.12</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000"></FONT></P>

<!-- Field: Page; Sequence: 56; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Prior to, but effective as of, the Closing, the Company shall, at Company&rsquo;s expense, obtain a managers&rsquo;
and officers&rsquo; liability, employment practices liability and fiduciary liability insurance policy providing each individual
currently covered by the Company&rsquo;s managers&rsquo; and officers&rsquo; liability, employment practices liability and fiduciary
liability insurance coverage for events occurring at or prior to the Effective Time (including acts or omissions relating to the
approval of this Agreement and consummation of the transactions contemplated hereby) that is no less favorable than the Company&rsquo;s
existing policy and has a claims period of six (6) years after the Closing Date.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The provisions of this <U>Section&nbsp;6.12</U> shall survive the consummation of the Merger and are intended to
be for the benefit of, and shall be enforceable by, each individual who served as a manager or officer of the Company prior to
the Effective Time (each, an &ldquo;<U>Indemnified Manager or Officer</U>&rdquo;), each of whom is an express third-party beneficiary
of this <U>Section&nbsp;6.12</U>. The obligations of the Company under this <U>Section&nbsp;6.12</U> shall not be terminated or
modified in such a manner as to adversely affect the rights of any Indemnified Manager or Officer under this <U>Section&nbsp;6.12</U>
without the consent of such affected Indemnified Manager or Officer.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.13<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>R&amp;W Insurance</U>. Prior to the Closing, Parent may in its discretion obtain and bind the R&amp;W Policy.
The Company shall cooperate with Parent&rsquo;s efforts at Parent&rsquo;s request and provide such assistance as may be reasonably
necessary or appropriate in order to enable Parent to obtain and bind the R&amp;W Policy. The Parties acknowledge and agree that,
other than in the case of Fraud by any Equityholder, neither the Equityholders, the Unitholder Representative nor any of their
respective Representatives shall be liable to the insurer under the R&amp;W Policy for subrogation claims pursuant to the R&amp;W
Policy, and Parent covenants and agrees that the R&amp;W Policy will include a waiver of such subrogation claims (other than in
the case of Fraud by any Equityholder) for the benefit of the Equityholders, the Unitholder Representative and their respective
Representatives.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.14<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Notification</U>. During the Interim Period, the Company shall give prompt notice to Parent, and Parent shall
give prompt notice to the Company, (a) of any notice or other communication received by such party from any Governmental Authority
in connection with the transactions contemplated by this Agreement or from any Person alleging that the consent of such Person
is or may be required in connection with the transactions contemplated by this Agreement, and (b) any material communications (written
or oral) received from any Person relating to the Company IP and (c) any matter (including a breach of any representation, warranty,
covenant or agreement contained in this Agreement) that would reasonably be expected to lead to the failure to satisfy any of the
conditions to Closing in <U>Article VII</U> or <U>Article VIII</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.15<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Parent Filings</U>. The Company will use its reasonable best efforts to cooperate with Parent to (i) prepare pro
forma financial statements that comply with the rules and regulations of the SEC to the extent required for any SEC filings to
be made by Parent, including the requirements of Regulation S-X; and (ii) provide and make reasonably available upon reasonable
notice the senior management employees of the Company to discuss the materials prepared and delivered pursuant to this <U>Section&nbsp;6.15</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.16<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Company Audit</U>. At Parent or Merger Sub's sole cost and expense, the Company will use its reasonable best efforts
to engage and cause an independent registered auditor to conduct and complete an audit of its respective financial statements for
the year ended December 31, 2019.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000"></FONT></P>

<!-- Field: Page; Sequence: 57; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.17<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Personal Guarantees</U>. Parent agrees to use commercially reasonable efforts to cause each of [&hellip;] personal
guarantees of the Company's Indebtedness to be released on or after Closing.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0 0 12pt"><FONT STYLE="color: #010000">Article
VII</FONT><BR>
CONDITIONS TO OBLIGATIONS OF PARENT AND MERGER SUB</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">The obligations of Parent and Merger Sub to
consummate the Closing are subject to the satisfaction, at or before the Closing, of each of the following conditions (all or any
of which may be waived in whole or in part by Parent in its sole discretion):</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Representations and Warranties</U>. (a) The representations and warranties made by the Company set forth in <U>Article
IV</U>, other than the Company Fundamental Representations, shall be true and correct in all respects as of the date hereof and
on and as of and as though made on the Closing Date (except for any such representation or warranty that is expressly made as of
a specified date, which need only be true and correct as of such specified date), disregarding in each case any qualifications
regarding materiality or Material Adverse Effect, except for any failures in such representations and warranties to be so true
and correct that, individually or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse
Effect, and (b) the Company Fundamental Representations shall be true and correct in all respects as of the date hereof and as
of and as though made on the Closing Date (except for any such representation or warranty that is expressly made as of a specified
date, which need only be so true and correct as of such specified date, and with respect to the representations and warranties
made by the Company in <U>Section&nbsp;4.02(a)</U>, the first sentence of <U>Section&nbsp;4.02(b)</U>, and <U>Section&nbsp;4.02(c)</U>,
except where the failure to be so true and correct is to a <I>de minimis</I> extent).</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Performance</U>. The Company shall have performed and complied in all material respects with the agreements, covenants
and obligations required by this Agreement to be so performed or complied with by it at or before the Closing.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Payment of Transaction Expenses</U>. The Company shall have provided copies of customary payoff letters in connection
with the repayment of Transaction Expenses from the Persons listed on <U>Schedule&nbsp;7.03</U> hereto.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.04<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Officer&rsquo;s Certificates</U>. The Company shall have delivered to Parent and Merger Sub at the Closing a certificate
of the president of the Company, dated as of the Closing Date, certifying that the conditions in <U>Section&nbsp;7.01</U>, <U>Section&nbsp;7.02</U>
and <U>Section&nbsp;7.03</U> have been satisfied and setting forth all Transaction Expenses incurred by the Company.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.05<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Orders and Applicable Laws</U>. There shall not be in effect on the Closing Date any Order or Applicable Law restraining,
enjoining or otherwise prohibiting or making illegal the consummation of any of the transactions contemplated by this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.06<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>No Material Adverse Effect</U>. Since the date of this Agreement, there shall not have occurred and be continuing
a Material Adverse Effect.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.07<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Unitholder Approval</U>. The Company shall have obtained the Required Unitholder Approval, Unitholders holding
at least the required number of units to approve the merger pursuant to the Company&rsquo;s Organizational Documents and Wisconsin
Law shall have been provided to Parent.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000"></FONT></P>

<!-- Field: Page; Sequence: 58; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.08<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>No Objection/Dissociation</U>. No holder of Company Units shall have exercised objection or dissociation rights
under Wisconsin Law.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.09<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Payments Administrator Agreement</U>. Parent shall have received the Payments Administrator Agreement duly executed
by the Unitholder Representative and the Payments Administrator.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.10<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Letter Agreements</U>. The Key Individuals and Key Unitholders shall have executed Letter Agreements, which shall
remain in full force and effect.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.11<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Continued Employment</U>. The Key Employees shall be employed by the Company (except to the extent such employment
is terminated by death of a Key Employee) and shall not have served any resignations or be subject to pending termination.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.12<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Consents</U>. The consents listed on <U>Section&nbsp;4.04(b)</U> of the Company Disclosure Schedule&nbsp;shall
have been obtained in form and substance reasonably satisfactory to Parent.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.13<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>FIRPTA</U>. The Company shall have delivered a duly executed certificate substantially in the form attached hereto
as Annex C (the &ldquo;<U>FIRPTA Certificate</U>&rdquo;), dated as of the Closing Date, satisfying the requirements of Temporary
Treasury Regulation Section&nbsp;1.1445-11T, to the effect that fifty percent (50%) or more of the value of the gross assets of
the Company does not consist of U.S. real property interests, or that ninety percent (90%) or more of the value of the gross assets
of the Company does not consist of U.S. real property interests plus cash or cash equivalents.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.14<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Certain Agreements</U>. Prior to the Effective Time, the Company shall take the actions set forth on <U>Section
7.13</U> of the Company Disclosure Schedule.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">7.15<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Audit</U> . The Company shall have delivered to Parent a copy of an executed engagement letter(s) (including the
audit plan) with the Company&rsquo;s independent registered auditor.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0 0 12pt"><FONT STYLE="color: #010000">Article
VIII</FONT><BR>
CONDITIONS TO OBLIGATIONS OF THE COMPANY</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">The obligation of the Company to consummate
the Closing is subject to the satisfaction, at or before the Closing, of each of the following conditions (all or any of which
may be waived in whole or in part by the Company in its sole discretion):</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">8.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Representations and Warranties</U>. (a) The representations and warranties made by Parent and Merger Sub set forth
in <U>Article V</U>, other than the Parent Fundamental Representations, shall be true and correct in all respects as of the date
hereof and on and as of and as though made on the Closing Date (except for any such representation or warranty that is expressly
made as of a specified date, which need only be true and correct as of such specified date), disregarding in each case any qualifications
regarding materiality, except for any failures in such representations and warranties to be so true and correct that, individually
or in the aggregate, have not had and would not reasonably be expected to have a material adverse effect on the ability of Parent
and Merger Sub to consummate the transactions contemplated hereby, and (b) the Parent Fundamental Representations shall be true
and correct in all respects as of the date hereof and as of and as though made on the Closing Date (except for any such representation
or warranty that is expressly made as of a specified date, which need only be so true and correct as of such specified date).</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000"></FONT></P>

<!-- Field: Page; Sequence: 59; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">8.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Performance</U>. Parent and Merger Sub shall have performed and complied in all material respects with the agreements,
covenants and obligations required by this Agreement to be so performed or complied with by them at or before the Closing.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">8.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Officer&rsquo;s Certificate</U>. Parent and Merger Sub shall have delivered to the Company at the Closing a certificate
of an executive officer of Parent and Merger Sub, dated as of the Closing Date, certifying that the conditions in <U>Section&nbsp;8.01</U>
and <U>Section&nbsp;8.02</U> have been satisfied.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">8.04<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Orders and Applicable Laws</U>. There shall not be in effect on the Closing Date any Order or Applicable Law restraining,
enjoining or otherwise prohibiting or making illegal the consummation of any of the transactions contemplated by this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">8.05<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Unitholder Approval</U>. The Company shall have obtained the Required Unitholder Approval.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">8.06<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Payments Administrator Agreement</U>. The Company shall have received the Payments Administrator Agreement duly
executed by the Unitholder Representative and Parent.</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0 0 12pt"><FONT STYLE="color: #010000">Article
IX</FONT><BR>
TERMINATION</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">9.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Termination</U>. This Agreement may be terminated, and the transactions contemplated by this Agreement may be
abandoned, at any time prior to the Closing by mutual written consent of Parent and the Company or by notice from Parent or the
Company, as applicable, to such other Party:</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>by either Parent or the Company:</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>if the Closing has not occurred on or before April 3, 2020 (the &ldquo;<U>Termination Date</U>&rdquo;) and the failure
to consummate is not caused by a breach of this Agreement by the terminating Party; or</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>if any Governmental Authority shall have issued an Order permanently restraining or enjoining or otherwise prohibiting
the consummation of the transactions contemplated by this Agreement and such Order or other action is or shall have become final
and nonappealable; or</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000"></FONT></P>

<!-- Field: Page; Sequence: 60; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>by Parent if the Required Unitholder Approval has not been obtained and certified by the chief executive officer
of the Company prior to the end of the Initial Unitholder Consent Delivery Period;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>by Parent if there has been a breach by the Company of any representation, warranty, covenant or agreement contained
in this Agreement that (x) would result in a failure of a condition set forth in <U>Section&nbsp;7.01</U> or <U>Section&nbsp;7.02</U>
and (y) if curable, is not cured prior to the earlier of (A) the Termination Date and (B) the date that is thirty (30) days after
written notice thereof is given by Parent to the Company; or</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>by the Company if there has been a breach by Parent or Merger Sub of any representation, warranty, covenant or agreement
contained in this Agreement that (x) would result in a failure of a condition set forth in <U>Section&nbsp;8.01</U> or <U>Section&nbsp;8.02</U>
and (y) if curable, is not cured prior to the earlier of (A) the Termination Date and (B) the date that is thirty (30) days after
written notice thereof is given by the Company to Parent.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">9.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Effect of Termination</U>. If this Agreement is terminated pursuant to <U>Section&nbsp;9.01</U>, this Agreement
will forthwith become null and void, and there will be no liability on the part of any Party (or any of their respective Representatives
or Affiliates) in respect of this Agreement, except as provided in this <U>Section&nbsp;9.02</U>, and except that the provisions
with respect to indemnification of the Unitholder Representative in <U>Section&nbsp;11.01(c)</U>, expenses in <U>Section&nbsp;11.04</U>
and confidentiality in <U>Section&nbsp;6.01</U> and <U>Section&nbsp;11.05</U> will continue to apply following any termination;
<U>provided</U>, <U>however</U>, that nothing in this <U>Section&nbsp;9.02</U> shall release any Party from liability for any willful
and material breach of this Agreement by such Party prior to the termination of this Agreement.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0 0 12pt"><FONT STYLE="color: #010000">Article
X</FONT><BR>
INDEMNIFICATION</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">10.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Survival</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The representations and warranties of the Parties contained in or made pursuant to this Agreement shall survive in
full force and effect until the date that is twelve&nbsp;(12) months from the Closing Date; <U>provided</U>, <U>however</U>, that
the Company Fundamental Representations and the Parent Fundamental Representations and the representations and warranties contained
in or made pursuant to <U>Section&nbsp;4.14</U> and <U>Section&nbsp;4.18</U> shall survive in full force and effect until the expiration
of the applicable statute of limitations, taking into account any tolling periods and other extensions; <U>provided</U>, <U>further</U>,
that Parent shall not, nor shall it permit any of its Affiliates (including the Company) to waive or extend any such statute of
limitations without the consent of the Unitholder Representative (each such survival period, a &ldquo;<U>Representations Survival
Period</U>&rdquo;). All covenants of the Parties shall survive until performed. For the avoidance of doubt, the Parties hereby
agree and acknowledge that a Representations Survival Period is a contractual statute of limitations that may be shorter than the
statute of limitations otherwise available under Applicable Law and any claim brought by any Indemnified Party pursuant to this
<U>Article X</U> must be brought or filed prior to the expiration of the applicable Representations Survival Period. Notwithstanding
the foregoing, if written notice of a claim has been given pursuant to this <U>Article X</U> prior to the applicable Representations
Survival Period by the Person seeking indemnification for such claim, then the representations, warranties, covenants or agreements
with respect to which such claim alleges a breach shall survive solely as and to the extent of such claim until such claim has
been finally resolved pursuant to this <U>Article X</U>. Nothing contained in this <U>Section&nbsp;10.01</U> shall affect the rights
of Parent under the R&amp;W Policy.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 61; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>This <U>Article X</U> shall survive the Closing and shall remain in effect (i) with respect to <U>Section&nbsp;10.02(a)(i)</U>
and <U>Section&nbsp;10.02(b)(i)</U>, so long as the relevant representations and warranties survive, (ii) with respect to <U>Section&nbsp;10.02(a)(ii)</U>
and <U>Section&nbsp;10.02(b)(ii)</U>, until such covenants are fully performed, (iii) with respect to <U>Section&nbsp;10.02(a)(iv)</U>,
until twelve (12) months after the Closing, and (iv) with respect to <U>Section&nbsp;10.02(a)(iii)</U> until sixty (60) days after
the expiration of the statute of limitations (including all applicable periods of extension) with respect to any claim arising
thereunder.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Notice of any assertion by any Indemnified Party that the Indemnifying Party is liable to it pursuant to <U>Section&nbsp;10.02</U>
must be given to the Indemnifying Party in writing on or prior to the time of expiration of the relevant representation, warranty
or covenant as set forth in this <U>Section&nbsp;10.01</U> or such claim will be forever barred. Any Indemnified Party seeking
indemnification hereunder shall state the facts known to the asserting Indemnified Party that give rise to such notice in sufficient
detail to allow the Indemnifying Party to evaluate the assertion.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">10.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Indemnification</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Subject to the limitations set forth in this <U>Article X</U>, subsequent to the Closing Date, the Unitholders shall
(severally but not jointly, from the Indemnity Holdback and Special Indemnity Holdback and thereafter according to their Indemnification
Pro Rata Share) indemnify and hold harmless Parent, Merger Sub and their Affiliates and Representatives, successors and permitted
assigns (the &ldquo;<U>Parent Indemnified Parties</U>&rdquo;) against any liabilities, losses, Claims, Actions, judgments, orders,
damages, expenses or costs, including reasonable out of pocket attorneys&rsquo; fees and expenses (collectively, &ldquo;<U>Losses</U>&rdquo;
and, individually, a &ldquo;<U>Loss</U>&rdquo;), that any of the foregoing suffers as a result of:</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any breach of the representations and warranties of the Company set forth in <U>Article IV</U> of this Agreement
or any failure of any such representation or warranty to be true and correct as of and as though made on the Closing Date (other
than those expressly given as of a specified date prior to the date of this Agreement, for which the breach shall be determined
as of such specified date);</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any breach by the Company of any of the covenants or agreements of the Company set forth in this Agreement required
by this Agreement to be performed or complied with by the Company at or before the Closing;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Indemnified Taxes;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any Payable Overstatement;</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(v)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>the matters set forth on <U>Section 10.02(a)(v)</U> of the Company Disclosure Schedule (the &ldquo;<U>Special Indemnity
Matters</U>&rdquo;); and</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 62; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(vi)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>the matters set forth on <U>Section 10.02(a)(vi)</U> of the Company Disclosure Schedule (the &ldquo;<U>Special Indemnity
Regulatory Matters</U>&rdquo;).</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Subject to the limitations set forth in this <U>Article X</U>, subsequent to the Closing Date, Parent shall indemnify
and hold harmless each Unitholder and their respective estate, heirs, Affiliates, Representatives, successors and permitted assigns
against any Loss that any of the foregoing suffers as a result of:</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any breach of the representations and warranties of Parent and Merger Sub set forth in <U>Article V</U> of this Agreement
or any failure of any such representation or warranty to be true and correct as of and as though made on the Closing Date (other
than those expressly given as of a specified date prior to the date of this Agreement, for which the breach shall be determined
as of such specified date); and</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>any breach by Parent, Merger Sub or the Surviving Company of any of the covenants or agreements of Parent, Merger
Sub or the Surviving Company set forth in this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">10.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Third-Party Claims</U>. Except as provided otherwise in <U>Section&nbsp;6.10(b)</U>, the obligations and liabilities
of an Indemnifying Party with respect to Losses resulting from the assertion of liability by third parties (each, a &ldquo;<U>Third-Party
Claim</U>&rdquo;) shall be subject to the following terms and conditions:</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Indemnified Parties shall promptly give written notice to the Indemnifying Parties of any Third-Party Claim that
might give rise to any Loss by the Indemnified Parties, stating the nature and basis of such Third-Party Claim, and the amount
thereof to the extent known, or a good-faith reasonable estimate of the Losses, and the method of computation of such Losses; <U>provided</U>,
<U>however</U>, that so long as such written notice is given on or prior to the time of expiration of the relevant representation,
warranty or covenant as set forth in <U>Section&nbsp;10.01</U>, no delay on the part of the Indemnified Party in so notifying the
Indemnifying Party shall relieve the Indemnifying Party from any obligation hereunder unless the Indemnifying Party is materially
prejudiced thereby. Such notice shall be accompanied by copies of all relevant documentation with respect to such Third-Party Claim,
including any summons, complaint or other pleading that may have been served, any written demand or any other document or instrument.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>From and after receipt of notice of a Third-Party Claim pursuant to <U>Section&nbsp;10.03(a)</U>, the Indemnifying
Parties shall have the right to assume and conduct, at their own expense, the defense against the Third-Party Claim in their own
names or in the names of the Indemnified Parties. Any Indemnified Parties shall have the right to employ separate counsel in any
such Third-Party Claim and/or to participate in the defense thereof, but the fees and expenses of such counsel shall not be included
as part of any Loss incurred by the Indemnified Party and shall not be payable by the Indemnifying Parties. The Party or Parties
conducting the defense of any Third-Party Claim shall keep the other Parties apprised of all significant developments with respect
thereto and shall not enter into any settlement, compromise or consent to judgment with respect to such Third-Party Claim without
the prior written consent of the other Parties hereto, such consent not to be unreasonably withheld, conditioned or delayed; <U>provided</U>,
<U>however</U>, that the Indemnifying Party shall be entitled to settle, compromise or consent to a judgment without the consent
of the Indemnified Party with respect to a Third-Party Claim that only imposes monetary obligations that are paid by the Indemnifying
Party and contains a release of the Indemnified Party from all liability thereunder. The Indemnified Party shall make available
all information and assistance reasonably available and necessary for the defense of the Third-Party Claim as the Indemnifying
Party may reasonably request and shall cooperate with the Indemnifying Party in such defense. The Unitholder Representative shall
be the sole party entitled to exercise any rights of the Unitholders with respect to Third-Party Claims under this <U>Section&nbsp;10.03</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 63; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">10.04<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Limitations on Indemnification</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Other than in the case of any claims for breaches of Company Fundamental Representations, breaches of the representations
and warranties of the Company set forth in <U>Section&nbsp;4.14</U>, claims resulting from Fraud by or on behalf of the Company,
claims pursuant to <U>Section&nbsp;10.02(a)(iii)</U> (collectively, the &ldquo;<U>Special Losses</U>&rdquo;) or claims resulting
from Special Indemnity Matters, as set forth in <U>Section 10.04(e)</U>, the sole and exclusive source of recovery for indemnification
available to any Parent Indemnified Parties shall be (i) first, the then-remaining balance of the Indemnity Holdback, and (ii)
second, the R&amp;W Policy to the extent covered thereby. Other than in the case of Special Losses, in no event will the Unitholders
be liable hereunder for any indemnification claim for any amount in excess of the Indemnity Holdback. Parent, on behalf of itself
and each other Parent Indemnified Party, hereby acknowledges and agrees that the provisions of this <U>Section&nbsp;10.04(a)</U>
shall apply and shall remain in full force and effect regardless of whether (a) Parent obtains at or following the Closing, or
maintains following the Closing, the R&amp;W Policy; (b) Parent amends, modifies, supplements, waives or terminates any provision
of the R&amp;W Policy; or (c) any claims are made by a Parent Indemnified Party under the R&amp;W Policy and such claim is denied
by the insurer.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>In connection with any indemnifiable claim arising out of, resulting from or in connection with any Special Losses,
after Parent Indemnified Parties have exhausted or made claims upon all amounts held in the Indemnity Holdback (after taking into
account all other claims for indemnification from the Indemnity Holdback made by Indemnified Parties), the sole and exclusive source
of recovery for indemnification shall be (i) first, the R&amp;W Policy to the extent covered thereby, and (ii) second (for the
avoidance of doubt, only after there are no amounts available pursuant to (i) of this sentence), from each Unitholder for their
Indemnification Pro Rata Share of the Special Losses; <U>provided</U> that in no event shall such Unitholder be liable for any
amount in excess of the Per Unit Merger Consideration actually received by such Unitholder as of the time of such indemnifiable
claim; <U>provided</U>, <U>further</U>, that any limitation of liability in this <U>Section&nbsp;10.04(b)</U> with respect to an
Unitholder shall not apply in the case of Fraud committed by such Unitholder.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>In connection with any indemnifiable claim arising out of, resulting from or in connection with any Payable Overstatement,
after Parent Indemnified Parties have exhausted or made claims upon all amounts held in the Purchase Price Holdback, the sole and
exclusive source of recovery for indemnification shall be from (i) first, the then-remaining balance of the Indemnity Holdback
and (ii) second, the then-remaining balance of the Special Indemnity Holdback and (iii) third, each Unitholder for their Indemnification
Pro Rata Share of the Payable Overstatement; <U>provided</U>, that in no event shall such Unitholder be liable for any amount in
excess of the Per Unit Merger Consideration actually received by such Unitholder as of the time of such indemnifiable claim.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 64; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Notwithstanding anything to the contrary in this Agreement, (i) in no event will the Unitholders be liable for any
amounts taken into account in the calculation of Final Aggregate Purchase Price (including any amounts included in Closing Indebtedness)
and (ii) in no event will any Unitholder be liable hereunder for any amount in excess of the Per Unit Merger Consideration actually
received by such Unitholders, except with respect to Fraud committed by such Unitholder.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Notwithstanding anything to the contrary in this Agreement, other than in the case of any claims resulting from Fraud
by or on behalf of the Company (which shall be considered Special Losses for purposes of this <U>Section 10.04</U>), with respect
to any Losses resulting from the Special Indemnity Matters, the sole and exclusive source of recovery for indemnification shall
be from (i) first, the then-remaining balance of the Special Indemnity Holdback and (ii) second (for the avoidance of doubt, only
after there are no amounts available pursuant to (i) of this sentence), from each Unitholder for their Indemnification Pro Rata
Share of any Losses resulting from the Special Indemnity Matters<FONT STYLE="font-size: 10pt">.</FONT></P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Notwithstanding anything to the contrary in this Agreement, other than in the case of any claims resulting from Fraud
by or on behalf of the Company (which shall be considered Special Losses for purposes of this <U>Section 10.04</U>), with respect
to any Losses resulting from the Special Indemnity Regulatory Matters, the sole and exclusive source of recovery for indemnification
shall be <FONT STYLE="font-size: 10pt">by making deductions from any amounts payable to Unitholders (or to the Payments Administrator
on their behalf) pursuant to Section 3.08 of this Agreement, with such deductions not being greater, in the aggregate, than $750,000.</FONT></P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(g)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each Person entitled to indemnification hereunder or otherwise to reimbursement for Losses in connection with the
transactions contemplated by this Agreement shall use all reasonable efforts to mitigate all Losses upon becoming aware of any
event or circumstance that would reasonably be expected to give rise to any Losses that are indemnifiable or recoverable hereunder
or in connection herewith; <U>provided</U>, <U>however</U>, any and all such direct and indirect reasonable costs and expenses
related to such mitigation may be included with the Losses for which indemnification may be sought under this <U>Article X</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(h)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The right to indemnification, payment of Losses or other remedies based on any representations, warranties, covenants
or agreements set forth in this Agreement or in any certificate delivered with respect hereto will not be affected by any investigation
conducted with respect to, or any knowledge or information acquired (or capable of being acquired) by any Party at any time (other
than, for the avoidance of doubt, any disclosures set forth in the Company Disclosure Schedule), whether before or after the execution
and delivery of this Agreement or the Closing Date, with respect to the accuracy or inaccuracy of or compliance with, any such
representation, warranty, covenant or agreement.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Basket</U>. A Parent Indemnified Party shall not be entitled to indemnification from the Equityholders under this
<U>Article X</U> for breaches of Non-Fundamental Representations unless the aggregate amount of the indemnification obligations
of the Equityholders under this <U>Article X</U> for breaches of Non-Fundamental Representations (but for this <U>Section 10.04(h)</U>)
exceeds $175,000 (the &ldquo;<U>Basket</U>&rdquo;), in which event the Parent Indemnified Parties shall, subject to the other limitations
set forth in this <U>Article X</U>, be entitled to indemnification for all such Losses from the first dollar. Notwithstanding the
foregoing, the Basket shall not apply to any indemnification obligations for Losses to the extent resulting from Fraud.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000"></FONT></P>

<!-- Field: Page; Sequence: 65; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(j)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>For purposes of this <U>Article X</U>, any breach of any representation, warranty, covenant or agreement shall be
determined, and the resulting determination of any Losses shall be calculated, without regard to any &ldquo;materiality,&rdquo;
&ldquo;material,&rdquo; &ldquo;Material Adverse Effect&rdquo; or similar materiality qualification with respect thereto; provided
that the foregoing shall not apply to <U>Section&nbsp;4.10(b)</U> or the terms &ldquo;Material Contract&rdquo;, &ldquo;Material
Contracts&rdquo;, and &ldquo;Material Product and Trial Information&rdquo;.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(k)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The amount of any and all Losses under this <U>Article X</U> will be determined net of any amounts actually recovered
by the Indemnified Party under indemnification agreements or arrangements with third parties or under insurance policies with respect
to such Losses. If any Indemnified Party shall recover any duplicate Losses pursuant to indemnification agreements or arrangements
with third parties or under insurance policies or otherwise subsequent to recovering corresponding Losses from the Equityholders
pursuant to this <U>Article X</U>, such Indemnified Party shall promptly reimburse and deliver the amount of such duplicate recovery
to the Payments Administrator, and, immediately thereafter, Parent and the Unitholder Representative shall provide a joint written
instruction to the Payments Administrator to deliver such amount promptly to the applicable Equityholders in accordance with this
Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">10.05<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>No Contribution</U>. No Indemnifying Party or any of its employees or agents shall have any right of contribution,
right of indemnity or other right or remedy against the Company in connection with any indemnification obligation or any other
liability to which they may become subject under or in connection with this Agreement in their capacity as an Unitholder.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">10.06<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Remedies Exclusive</U>. The indemnification rights of the Indemnified Parties under this <U>Article X</U> are
the sole and exclusive remedies after the Closing available to the Indemnified Parties with respect to any claims or disputes arising
between the Indemnified Parties and Indemnifying Parties with respect to the transactions contemplated by this Agreement or the
business of the Company, except as specified in this <U>Article X</U> with respect to Fraud; <U>provided</U>, <U>however</U>, that
nothing contained herein shall affect the rights of the Parties under (a) <U>Section&nbsp;11.14</U> with respect to any covenants
to be performed by the Parties, (b) <U>Section&nbsp;3.06</U> or (c) <U>Section&nbsp;3.07</U>; <U>provided</U>, <U>further</U>,
that nothing contained in this <U>Section&nbsp;10.06</U> shall affect the rights of Parent under the R&amp;W Policy.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">10.07<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Adjustment Characterization</U>. The Parties agree to treat any payment made pursuant to this <U>Article X</U>
after the Closing as an adjustment to the Final Aggregate Purchase Price for all Tax purposes, unless otherwise required by Applicable
Laws.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">10.08<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Damage Limitations</U>. Notwithstanding anything to the contrary contained in this Agreement, no Person shall
be liable under this <U>Article X</U> for any punitive or exemplary damages other than any such damages that are recovered by a
third party that is not an Affiliate of the applicable Indemnified Party in connection with a Third-Party Claim.</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0 0 12pt"><FONT STYLE="color: #010000"></FONT></P>

<!-- Field: Page; Sequence: 66; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; text-align: center; text-indent: 0in; margin: 0 0 12pt"><FONT STYLE="color: #010000">Article
XI</FONT><BR>
MISCELLANEOUS</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.01<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Unitholder Representative</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The adoption of this Agreement by the Required Unitholder Approval, and the receipt of the benefits hereof, including
the right to receive consideration payable in connection with the Merger, shall automatically and without any further action on
the part of any Equityholder constitute the irrevocable appointment of Philip Mundy as the representative, agent, proxy and attorney-in-fact
for each of the Equityholders with respect to matters arising after the effectiveness of the Merger and for all purposes in connection
with this Agreement and the agreements ancillary hereto to be performed by the Unitholder Representative.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Without limiting <U>Section&nbsp;11.01(a)</U>, the Unitholder Representative is hereby irrevocably appointed the
representative, agent, proxy and attorney-in-fact for each of the Equityholders for all purposes of this Agreement and the Payments
Administrator Agreement, including full and sole power and authority on such Equityholders&rsquo; behalf, and in lieu of each Equityholders
having the ability to take any of the following actions directly, to, after the Closing, (i)&nbsp;give and receive notices and
communications, (ii) object to such deliveries, (iii) make claims on behalf of the Unitholders pursuant to <U>Article X</U>, (iv)
agree to, negotiate, enter into settlements and compromises of, and demand arbitration and comply with orders of, courts and awards
of arbitrators with respect to such claims, (v) take all actions necessary under <U>Section&nbsp;6.10</U>, (vi)&nbsp;execute any
instrument or document that the Unitholder Representative may determine is necessary or desirable in the exercise of its authority
under this <U>Section&nbsp;11.01</U> and the Payments Administrator Agreement, and (vii) take all actions necessary or appropriate
in the judgment of the Unitholder Representative for the accomplishment of the foregoing. The Unitholder Representative may resign
at any time with ten (10) days&rsquo; prior written notice. A vacancy in the position of Unitholder Representative shall be filled
in the following order:</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>By Les Matthews, if he is able and willing to serve; and</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>By a successor designated by the holders of a majority in interest of the Indemnity Holdback (a &rdquo;<U>Unitholder
Majority</U>&rdquo;); <U>provided</U> that such person was not an employee of the Company or Parent or any of its subsidiaries
at the Effective Time (unless consented to in writing by Parent).</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Promptly following any change in the Unitholder
Representative as provided above, the successor Unitholder Representative shall notify Parent of the change and the successor's
address and other contact information. No bond shall be required of the Unitholder Representative. Notices or communications to
or from the Unitholder Representative after the Closing shall constitute notice to or from each of the Equityholders.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000"></FONT></P>

<!-- Field: Page; Sequence: 67; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Unitholder Representative will incur no liability of any kind with respect to any action or omission by the Unitholder
Representative in connection with the Unitholder Representative&rsquo;s services pursuant to this Agreement and any agreements
ancillary hereto, except in the event of liability directly resulting from the Unitholder Representative&rsquo;s gross negligence
or willful misconduct. The Unitholder Representative shall not be liable for any action or omission pursuant to the advice of counsel.
The Equityholders will indemnify, defend and hold harmless the Unitholder Representative from and against any and all losses, liabilities,
damages, claims, penalties, fines, forfeitures, actions, fees, costs and expenses (including the fees and expenses of counsel and
experts and their staffs and all expense of document location, duplication and shipment) (collectively, &ldquo;<U>Representative
Losses</U>&rdquo;) arising out of or in connection with the Unitholder Representative&rsquo;s execution and performance of this
Agreement and any agreements ancillary hereto, in each case as such Representative Loss is suffered or incurred; <U>provided</U>
that in the event that any such Representative Loss is finally adjudicated to have been directly caused by the gross negligence
or willful misconduct of the Unitholder Representative, the Unitholder Representative will reimburse the Equityholders the amount
of such indemnified Representative Loss to the extent attributable to such gross negligence or willful misconduct. The Unitholder
Representative will be entitled to reasonable compensation for his services (the &quot;Unitholder Representative Fee&quot;), which
is initially established at a rate of $150 per hour, but not exceeding $7,500 per calendar quarter unless approved by a Unitholder
Majority. If not paid directly to the Unitholder Representative by the Equityholders, any such Representative Losses or Unitholder
Representative Fee may be recovered by the Unitholder Representative from (i) the funds in the Expense Fund, (ii) the amounts in
the Indemnity Holdback and (iii) the amounts in the Special Indemnity Holdback at such time as remaining amounts would otherwise
be distributable to the Equityholders; <U>provided</U> that while this Section&nbsp;allows the Unitholder Representative to be
paid from the aforementioned sources of funds, this does not relieve the Equityholders from their obligation to promptly pay such
Representative Losses or Unitholder Representative Fee as they are suffered or incurred, nor does it prevent the Unitholder Representative
from seeking any remedies available to it at Law or otherwise. In no event will the Unitholder Representative be required to advance
its own funds on behalf of the Equityholders or otherwise. Notwithstanding anything in this Agreement to the contrary, any restrictions
or limitations on liability or indemnification obligations of, or provisions limiting the recourse against non-parties otherwise
applicable to, the Equityholders set forth elsewhere in this Agreement are not intended to be applicable to the indemnities provided
to the Unitholder Representative under this Section. The foregoing indemnities will survive the Closing, the resignation or removal
of the Unitholder Representative or the termination of this Agreement. Upon the Closing, Parent will wire to the Unitholder Representative
an aggregate cash amount of $200,000 (the &ldquo;<U>Expense Fund Amount</U>&rdquo;), such amount to constitute an expense fund
(the &ldquo;<U>Expense Fund</U>&rdquo;), which will be used for the purposes of paying directly, or reimbursing the Unitholder
Representative for, the Unitholder Representative Fee and any third-party expenses pursuant to this Agreement and the Payments
Administrator Agreement. The Equityholders will not receive any interest or earnings on the Expense Fund and irrevocably transfer
and assign to the Unitholder Representative any ownership right that they may otherwise have had in any such interest or earnings.
The Unitholder Representative will not be liable for any loss of principal of the Expense Fund other than as a result of its gross
negligence or willful misconduct. The Unitholder Representative will hold these funds separate from his personal funds, will not
use these funds for any personal purposes (except with respect to the Unitholder Representative Fee) and will not voluntarily make
these funds available to his creditors in the event of bankruptcy. Contemporaneous with or as soon as practicable following the
completion of the Unitholder Representative&rsquo;s responsibilities, the Unitholder Representative will deliver any remaining
balance of the Expense Fund to the Payments Administrator, for further payment of the Per Unit Expense Fund Consideration in such
proportions as required in accordance with the terms of this Agreement. For tax purposes, the Expense Fund will be treated as having
been received and voluntarily set aside by the Equityholders at the time of Closing.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000"></FONT></P>

<!-- Field: Page; Sequence: 68; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.02<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Actions of the Unitholder Representative</U>. A decision, act, consent or instruction of the Unitholder Representative
shall constitute a decision of all Equityholders and shall be final, binding and conclusive upon each such Equityholders, and Parent
may rely upon any decision, act, consent or instruction of the Unitholder Representative as being the decision, act, consent or
instruction of each and every such Equityholders. Parent is hereby relieved from any liability to any Person for any acts done
by them in accordance with such decision, act, consent or instruction of the Unitholder Representative.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.03<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Entire Agreement</U>. This Agreement supersedes all prior discussions and agreements among the Parties with respect
to the subject matter hereof, excluding the Non-Disclosure Agreement, and, together with the Non-Disclosure Agreement, contains
the sole and entire agreement among the Parties hereto with respect to the subject matter hereof. The Non-Disclosure Agreement
shall survive any termination of this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.04<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Expenses</U>. Except as otherwise provided in this Agreement, whether or not the transactions contemplated by
this Agreement are consummated, each Party will pay its own costs and expenses incurred in connection with the negotiation, execution
and consummation of the transactions contemplated by this Agreement, including the Merger.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.05<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Announcements</U>. No press or other public announcement, or public statement or comment in response to any inquiry,
relating to the transactions contemplated by this Agreement or the terms hereof shall be issued or made by any Party without the
joint approval of the other Parties (other than the Unitholder Representative); <U>provided</U> that a press release or other public
announcement, regulatory filing, statement or comment made without such joint approval shall not be in violation of this <U>Section&nbsp;11.05</U>
if it is made in order for the disclosing Party or any of its Affiliates to comply with Applicable Laws or stock exchange rules
and in the reasonable judgment of the Party making such release or announcement, based upon advice of outside counsel, prior review
and joint approval, despite reasonable efforts to obtain the same, would prevent dissemination of such release or announcement
in a sufficiently timely fashion to comply with such Applicable Laws or rules; and <U>provided</U>, <U>further</U>, that in all
instances prompt notice from one Party to the others shall be given with respect to any such release, announcement, statement or
comment. Each Party shall inform its Affiliates that may be involved in the transactions contemplated by this Agreement of the
requirements set forth in this <U>Section&nbsp;11.05</U> and shall make reasonable efforts to obtain compliance with the provisions
of this <U>Section&nbsp;11.05</U> from such Affiliates.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.06<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>No Waiver</U>. No failure on the part of any Party to exercise and no delay in exercising, and no course of dealing
with respect to, any right, remedy, power or privilege under this Agreement shall operate as a waiver of such right, remedy, power
or privilege, nor shall any single or partial exercise of any right, remedy, power or privilege under this Agreement preclude any
other or further exercise of any such right, remedy, power or privilege or the exercise of any other right, remedy, power or privilege.
The rights, remedies, powers and privileges provided in this Agreement are cumulative and not exclusive of any rights, remedies,
powers and privileges provided by Applicable Law.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000"></FONT></P>

<!-- Field: Page; Sequence: 69; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.07<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Amendments</U>. Any provision of this Agreement may be amended, modified, supplemented or waived only by an instrument
in writing duly executed by, if executed prior to the Effective Time, Parent, the Company, Merger Sub and the Unitholder Representative,
and if executed after the Effective Time, Parent and the Unitholder Representative. Any such amendment, modification, supplement
or waiver shall be for such period and subject to such conditions as shall be specified in the instrument effecting the same and
shall be binding upon the Parties, and any such waiver shall be effective only in the specific instance and for the purposes for
which given.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.08<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Addresses for Notices</U>. All notices and other communications given or made pursuant hereto shall be in writing
and shall be deemed to have been duly given or made as of the date delivered or sent if delivered personally, on the next Business
Day if sent by prepaid overnight carrier (providing proof of delivery), on the fifth (5<SUP>th</SUP>) Business Day following the
date of mailing if delivered by registered or certified mail (postage prepaid, return receipt requested) or on the date delivered
if sent by email (providing confirmation of receipt) to the Parties at the following addresses, facsimile numbers or email addresses
(or at such other addresses, facsimile numbers or email addresses as shall be specified by the Parties by like notice):</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 1in">if to the Company (prior to the Closing):</P>

<P STYLE="font-size: 10pt; margin: 0 0 0 1.5in">Parcus Medical , LLC<BR>
6423 Parkland Dr.</P>

<P STYLE="font-size: 10pt; margin: 0 0 0 1.5in">Sarasota, FL 34243</P>

<P STYLE="font-size: 10pt; margin: 0 0 0 1.5in">Attn: Mark Brunsvold, President</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 1.5in">Email: mbrunsvold@parcusmedical.com</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 1in">with a copy to (which shall not constitute notice):</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 1.5in">Reinhart Boerner Van Deuren s.c.<BR>
1000 North Water Street, Suite 1700<BR>
Milwaukee, WI 53202<BR>
Attn: Robert F. Henkle, Jr.; Melissa Zabkowicz<BR>
Email: RHENKLE@reinhartlaw.com; MZabkowicz@reinhartlaw.com</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 1in">if to Parent, Merger Sub or the Surviving Company:</P>

<P STYLE="font-size: 10pt; margin: 0 0 0 1.5in">Anika Therapeutics, Inc.</P>

<P STYLE="font-size: 10pt; margin: 0 0 0 1.5in">32 Wiggins Ave</P>

<P STYLE="font-size: 10pt; margin: 0 0 0 1.5in">Bedford, MA 01730</P>

<P STYLE="font-size: 10pt; margin: 0 0 0 1.5in">Attn: Charles Sherwood III</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 1.5in">Email: ChSherwoodIII@AnikaTherapeutics.com</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 1in">with a copy to (which shall not constitute notice):</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 1.5in">Sullivan&nbsp;&amp; Cromwell LLP<BR>
125 Broad Street<BR>
New York, New York 10004<BR>
Attn: Keith Pagnani; Melissa Sawyer<BR>
Email: pagnanik@sullcrom.com; sawyerm@sullcrom.com</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 1in"></P>

<!-- Field: Page; Sequence: 70; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt 1in">if to the Unitholder Representative, or to the Equityholders after the Closing:</P>

<P STYLE="font-size: 10pt; margin: 0 0 0 1.5in">Philip Mundy<BR>
[&hellip;]</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt 1.5in">Email: phil@mundymed.com</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.09<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Captions</U>. The captions and Section&nbsp;headings appearing in this Agreement are included solely for convenience
of reference and are not intended to affect the interpretation of any provision of this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.10<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Severability</U>. Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall,
as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining
provisions of this Agreement, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable
such provision in any other jurisdiction, and in lieu of such prohibited or unenforceable provision, there will be added automatically
as a part of this Agreement a legal, valid and enforceable provision as similar in terms to such prohibited or unenforceable provision
as may be possible.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.11<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Assignment</U>. The obligations of the Parties under this Agreement are not assignable without the prior written
consent of the other Parties, which such Parties may withhold in their discretion.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.12<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Counterparts</U>. This Agreement may be executed in any number of counterparts, all of which taken together shall
constitute one and the same instrument and any of the Parties may execute this Agreement by signing any such counterpart. Delivery
of an executed counterpart of a signature page&nbsp;to this agreement may be made by electronic or digital delivery such as in
Adobe Portable Document Format or using generally recognized e-signature technology (e.g., DocuSign or Adobe Sign).</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.13<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Disclosure</U>. The Company may, at its option, include in the Company Disclosure Schedule, any items that are
not material in order to avoid any misunderstanding, and any such inclusion, or any references to dollar amounts, shall not be
deemed to be an acknowledgment or representation that such items are material to establish any standard of materiality or to define
further the meaning of such terms for purposes of this Agreement. In no event shall the inclusion of any matter in the Company
Disclosure Schedule&nbsp;be deemed or interpreted to broaden the Company&rsquo;s representations, warranties, covenants or agreements
contained in this Agreement. The mere inclusion of an item in the Company Disclosure Schedule&nbsp;shall not be deemed an admission
by the Company that such item represents a material exception or fact, event, or circumstance or that such item would be reasonably
likely to result in a Material Adverse Effect. The information contained in the Company Disclosure Schedule&nbsp;is disclosed solely
for the purposes of this Agreement, and no information contained therein shall be deemed to be an admission by any Party hereto
to any third party of any matter whatsoever, including of any violation of Law or breach of any agreement.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 71; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.14<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Specific Performance</U>. The Parties agree that if any of the provisions of this Agreement were not performed
in accordance with their specific terms or were otherwise breached, irreparable damage would occur, money damages may not be a
sufficient remedy and that the Parties shall be entitled to specific performance of the terms of this Agreement and immediate injunctive
relief, without the necessity of proving the inadequacy of money damages as a remedy, in addition to any other remedy at Law or
in equity.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.15<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Governing Applicable Law</U>. THIS AGREEMENT SHALL BE DEEMED TO BE MADE IN AND IN ALL RESPECTS SHALL BE INTERPRETED,
CONSTRUED AND GOVERNED BY AND IN ACCORDANCE WITH THE LAW OF THE STATE OF DELAWARE WITHOUT REGARD TO THE CONFLICTS OF LAW PRINCIPLES
THEREOF TO THE EXTENT THAT SUCH PRINCIPLES WOULD DIRECT A MATTER TO ANOTHER JURISDICTION. Subject to <U>Sections 3.07(c) and 3.07(e)
to 3.07(g)</U>, the Parties hereby irrevocably submit to the personal jurisdiction of the Chancery Court of the State of Delaware
(and, if the Chancery Court of the State of Delaware declines to accept jurisdiction over a particular matter, the state courts
or the Federal courts of the United States of America located in the State of Delaware) solely in respect of the interpretation
and enforcement of the provisions of this Agreement and of the documents referred to in this Agreement, and in respect of the transactions
contemplated by this Agreement, and hereby waive, and agree not to assert, as a defense in any action, suit or proceeding for the
interpretation or enforcement hereof or of any such document, that it is not subject thereto or that such action, suit or proceeding
may not be brought or is not maintainable in said courts or that the venue thereof may not be appropriate or that this Agreement
or any such document may not be enforced in or by such courts, and the parties hereto irrevocably agree that all claims with respect
to such shall be heard and determined in such a Delaware State or Federal court.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.16<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Consent to Jurisdiction</U>. Each Party irrevocably consents to service of process by registered mail, return
receipt requested, as provided in <U>Section&nbsp;11.08</U>. Nothing in this Agreement will affect the right of any Party to serve
process in any other manner permitted by Applicable Law.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.17<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Waiver of Jury Trial</U>. TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, EACH PARTY HEREBY WAIVES ALL RIGHTS
TO A TRIAL BY JURY IN ANY LEGAL ACTION TO ENFORCE OR INTERPRET THE PROVISIONS OF THIS AGREEMENT OR THAT OTHERWISE RELATES TO THIS
AGREEMENT.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.18<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Obligations of Merger Sub</U>. Parent hereby guarantees the due and punctual performance and payment (not merely
collection) in full of all obligations and liabilities of Merger Sub under this Agreement, as and when due and payable or required
to be performed pursuant to any provision of this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.19<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>No Third-Party Beneficiaries</U>. Nothing in this Agreement, express or implied, is intended to confer upon any
Person (other than the Parties, an Indemnified Party, an Indemnified Manager or Officer (solely with respect to <U>Section&nbsp;6.12</U>)
or Company Counsel (solely with respect to <U>Section&nbsp;11.20</U>)) any rights or remedies under or by reason of this Agreement.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 72; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">11.20<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Legal Representation</U>.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Parent, on behalf of itself and its Affiliates (including, after the Closing, the Surviving Company), acknowledges
and agrees that Reinhart Boerner Van Deuren s.c. (&ldquo;<U>Company Counsel</U>&rdquo;) has acted as counsel for the Company in
connection with this Agreement and the transactions contemplated hereby (the &ldquo;<U>Acquisition Engagement</U>&rdquo;), and
in connection with this Agreement and the transactions contemplated hereby, Company Counsel has not acted as counsel for any other
Person, including Parent.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Only the Company and its Affiliates shall be considered clients of Company Counsel in the Acquisition Engagement.
Parent, on behalf of itself and its Affiliates (including, after the Closing, the Surviving Company), acknowledges and agrees that,
upon and after the Closing, all confidential communications between the Company and its Affiliates, on the one hand, and Company
Counsel, on the other hand, in the course of the Acquisition Engagement, and any attendant attorney-client privilege, attorney
work product protection, and expectation of client confidentiality applicable thereto, shall be deemed to belong solely to the
Equityholders and their respective Affiliates (other than the Company), and not the Company, and shall not pass to or be claimed,
held, or used by Parent or the Company (or, after the Closing, the Surviving Company) upon or after the Closing. Accordingly, Parent
shall not have access to any such communications, or to the files of Company Counsel relating to the Acquisition Engagement, whether
or not the Closing occurs. Without limiting the generality of the foregoing, upon and after the Closing, (i)&nbsp;to the extent
that files of Company Counsel in respect of the Acquisition Engagement constitute property of the client, only the Equityholders
and their respective Affiliates shall hold such property rights and (ii) Company Counsel shall have no duty whatsoever to reveal
or disclose any such attorney-client communications or files to the Company (or, after the Closing, the Surviving Company) or Parent
by reason of any attorney-client relationship between Company Counsel and the Company or otherwise; <U>provided</U>, <U>however</U>,
that notwithstanding the foregoing, Company Counsel shall not disclose any such attorney-client communications or files to any
third parties (other than representatives, accountants and advisors of the Equityholders and their respective Affiliates; <U>provided</U>
that such representatives, accounts and advisors are instructed to maintain the confidence of such attorney-client communications).
Parent, on behalf of itself and its Affiliates (including, after the Closing, the Surviving Company) irrevocably waives any right
it may have arising out of its ownership of the Company (including, after Closing, the Surviving Company) or the Merger to discover
or obtain (or use, if discovered or obtained) information or documentation relating to the Acquisition Engagement, to the extent
that such information or documentation was subject to an attorney-client privilege, work product protection or other expectation
of confidentiality owed to the Company and/or its Affiliates. If and to the extent that, at any time subsequent to Closing, Parent
or any of its Affiliates (including, after the Closing, the Surviving Company) shall have the right to assert or waive any attorney-client
privilege with respect to any communication between the Company or its Affiliates and any Person representing them that occurred
at any time prior to the Closing, Parent, on behalf of itself and its Affiliates (including, after the Closing, the Surviving Company)
shall be entitled to waive such privilege only with the prior written consent of the Equityholders (such consent not to be unreasonably
withheld). Parent, on behalf of itself and its Affiliates (including, after the Closing, the Surviving Company), acknowledges and
agrees that Company Counsel has acted as counsel for the Company and its respective Affiliates and that Company Counsel may represent
the Unitholders, the Unitholder Representative and/or their respective Affiliates in future matters. Accordingly, Parent, on behalf
of itself and its Affiliates (including, after the Closing, the Surviving Company), expressly consents to Company Counsel&rsquo;s
representation of the Equityholders, the Unitholder Representative and/or their respective Affiliates and/or any of their respective
agents (if any of the foregoing Persons so desire) in any matter, including, without limitation, any post-Closing matter in which
the interests of Parent and the Surviving Company, on the one hand, and the Equityholders, the Unitholder Representative or any
of their respective Affiliates, on the other hand, are adverse, including any matter relating to the transactions contemplated
by this Agreement, and whether or not such matter is one in which Company Counsel may have previously advised the Company or its
Affiliates.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 73; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>From and after the Closing, the Surviving Company shall cease to have any attorney-client relationship with Company
Counsel, unless and to the extent Company Counsel is expressly engaged in writing by the Surviving Company to represent the Surviving
Company after the Closing. Any such representation of the Surviving Company by Company Counsel after the Closing shall not affect
the foregoing provisions hereof. Furthermore, Company Counsel, in its sole discretion, shall be permitted to withdraw from representing
the Surviving Company in order to represent the Equityholders.</P>

<P STYLE="font-size: 10pt; margin: 0 0 12pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Each of the Parties to this Agreement consents to the arrangements in this <U>Section&nbsp;11.20</U> and waives any
actual or potential conflict of interest that may be involved in connection with any representation by Company Counsel permitted
hereunder.</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0 0 12pt">[THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK]</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 74; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">IN WITNESS WHEREOF, this Agreement has been
duly executed and delivered by the duly authorized officer of each Party as of the date first above written.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: middle">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: left">PARCUS MEDICAL, LLC</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">By:</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; border-bottom: Black 0.5pt solid; text-align: left">/s/ Mark Brunsvold</TD></TR>
<TR>
    <TD STYLE="width: 33%">&nbsp;</TD>
    <TD STYLE="width: 34%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; vertical-align: bottom; width: 5%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; vertical-align: middle; width: 5%">Name:</TD>
    <TD STYLE="font-size: 10pt; vertical-align: middle; width: 23%">Mark Brunsvold</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; vertical-align: middle">Title:</TD>
    <TD STYLE="font-size: 10pt; vertical-align: bottom">President</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-indent: -0.3in; margin: 24pt 0 24pt 3.3in"></P>

<P STYLE="font-size: 10pt; margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin-top: 0; text-align: center; margin-bottom: 0">[<I>Signature Page to Agreement and Plan of Merger</I>]</P>

<P STYLE="font-size: 10pt; margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>



<P STYLE="font-size: 10pt; margin: 0"></P>

<!-- Field: Page; Sequence: 75; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-indent: -0.3in; margin: 24pt 0 24pt 3.3in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: middle">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: left">ANIKA THERAPEUTICS, INC.&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">By:</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; border-bottom: Black 0.5pt solid; text-align: left">/s/ Joseph G. Darling</TD></TR>
<TR>
    <TD STYLE="width: 33%">&nbsp;</TD>
    <TD STYLE="width: 34%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; vertical-align: bottom; width: 5%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; vertical-align: middle; width: 5%">Name:</TD>
    <TD STYLE="font-size: 10pt; vertical-align: middle; width: 23%">Joseph G. Darling</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; vertical-align: middle">Title:</TD>
    <TD STYLE="font-size: 10pt; vertical-align: middle">President and CEO</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; text-indent: -0.3in; margin: 24pt 0 24pt 3.3in"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 0; text-align: center">[<I>Signature Page to Agreement and Plan of Merger</I>]</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 76; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; font-weight: bold; margin: 24pt 0 12pt 3in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: middle">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: left">SUNSHINE MERGER SUB, LLC</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">By:</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; border-bottom: Black 0.5pt solid; text-align: left">/s/ Charles Sherwood III</TD></TR>
<TR>
    <TD STYLE="width: 33%">&nbsp;</TD>
    <TD STYLE="width: 34%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; vertical-align: bottom; width: 5%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; vertical-align: middle; width: 5%">Name:</TD>
    <TD STYLE="font-size: 10pt; vertical-align: middle; width: 23%">Charles Sherwood III</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; font-weight: bold; margin: 24pt 0 12pt 3in"></P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin-top: 0; text-align: center; margin-bottom: 0">[<I>Signature Page to Agreement and Plan of Merger</I>]<B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 77; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; font-weight: bold; margin: 24pt 0 12pt 3in"></P>

<P STYLE="font-size: 10pt; margin: 0"></P>

<P STYLE="font-size: 10pt; margin: 0"></P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: middle">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; width: 40%"><P STYLE="margin-top: 0; margin-bottom: 0">Philip Mundy, <FONT STYLE="font-size: 10pt; font-style: normal; font-weight: 400">solely
in his capacity as Unitholder Representative</FONT></P></TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 0.5pt solid">/s/ Philip Mundy</TD></TR>
<TR STYLE="vertical-align: middle">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Philip Mundy</TD></TR>
</TABLE>


<P STYLE="font-size: 10pt; margin: 0"></P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin-top: 0; text-align: center; margin-bottom: 0">[<I>Signature Page to Agreement and Plan of Merger</I>]&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 78; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; margin: 0 0 12pt">Annex A</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">Unless otherwise defined in this Agreement,
the following terms have the meanings specified in this <U>Annex A</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Acquisition Engagement</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;11.20(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Acquisition Proposal</U>&rdquo; means
(i) any proposal or offer with respect to a merger, joint venture, partnership, consolidation, dissolution, liquidation, tender
offer, recapitalization, reorganization, share exchange, business combination or similar transaction involving the Company pursuant
to which the Unitholders immediately preceding such transaction would hold, directly or indirectly, less than eighty percent (80%)
of the Equity Interests in the surviving or resulting entity of such transaction and (ii) any acquisition by any Person resulting
in, or proposal or offer, which if consummated would result in, any Person becoming the beneficial owner of, directly or indirectly,
in one or a series of related transactions, twenty percent (20%) or more of the total voting power or of any class of equity securities
of the Company, or twenty percent (20%) or more of the consolidated total assets of the Company, in each case other than the transactions
contemplated by this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Action</U>&rdquo; means any action,
demand, claim, suit, proceeding, investigation or arbitration by or before any Governmental Authority or arbitration tribunal.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Affiliate</U>&rdquo; means any Person
that directly or indirectly through one or more intermediaries, controls, is controlled by or is under common control with, the
Person specified. For purposes of this definition, &ldquo;<U>control</U>&rdquo; of a Person means the power to direct or cause
the direction of the management and policies of such Person whether through the ownership of voting securities or ownership interests,
by Contract or otherwise.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Aggregate Cash Amount</U>&rdquo;
means the aggregate amount of the Per Unit Closing Payment payable at Closing pursuant to <U>Section&nbsp;3.01</U> and <U>Section&nbsp;3.02</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Aggregate Closing Amount</U>&rdquo;
means an amount equal to (i) the Estimated Aggregate Purchase Price, <I>minus</I> (ii) the Indemnity Holdback, <I>minus</I> (iii)
the Special Indemnity Holdback, <I>minus</I> (iv) the Purchase Price Holdback, <I>minus</I> (v) the Expense Fund Amount.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Aggregate Closing Payment Schedule</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;3.06</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Aggregate Purchase Price</U>&rdquo;
means (i) $35,000,000, <I>plus </I>(ii) Cash on Hand, <I>minus </I>(iii) Closing Indebtedness, <I>plus </I>(iv) the Working Capital
Difference, <I>minus</I> (v) Transaction Expenses.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Agreed Sales and Use Taxes</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;3.05(b)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Agreement</U>&rdquo; has the meaning
given to that term in the Preamble to this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 79; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Alternative Acquisition Agreement</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;6.04(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Anti-Corruption Law</U>&rdquo; means
any Law governing financial recordkeeping and reporting requirements or for the prevention or punishment of public or commercial
corruption and bribery, including the U.S. Currency and Foreign Transactions Reporting Act of 1970, the U.S. Money Laundering Control
Act of 1986, the U.S. Foreign Corrupt Practices Act of 1977, the UK Bribery Act 2010 and any applicable money laundering-related,
anti-corruption or anti-bribery Laws of any other jurisdiction.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Applicable Laws</U>&rdquo; means
all laws (including common law), statutes, codes, rules, regulations, ordinances, orders, writs, judgments, injunctions, decrees
and other pronouncements having the effect of law of the United States, any foreign country or any state, county, city or other
political subdivision thereof or of any Governmental Authority, in each case as applicable to the Company, Parent, Merger Sub,
or the Unitholder Representative, as the case may be.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Arbitration Fees</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;3.07(g)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Arbitration Rules</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;3.08(f)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Articles of Merger</U>&rdquo; has
the meaning given to that term in <U>Section 2.03</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Audited Financial Statements</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;4.06(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Binder Agreement</U>&rdquo; has the
meaning given to that term in the Recitals to this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Board Recommendation</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;4.03(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Business Data</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;4.19(b)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Business Day</U>&rdquo; means a day
other than Saturday, Sunday or any day on which (a)&nbsp;banks located in New York, New York or (b) solely for purposes of determining
the Closing Date, the Wisconsin Department of Financial Institutions, is authorized or required by Law to close.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Calendar Year</U>&rdquo; means a
period of twelve (12) consecutive months commencing on January 1 and ending on the following December 31.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Cash on Hand</U>&rdquo; means, with
respect to the Company, all cash, cash equivalents and marketable securities (convertible to cash within 30 days) other than Restricted
Cash as of 12:01 a.m. Eastern Standard Time on the Closing Date. For the avoidance of doubt, Cash on Hand shall (i) be calculated
net of uncleared checks and drafts issued by the Company and (ii) include uncleared checks and drafts received or deposited for
the account of the Company, including deposits in transit.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 80; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Change in Control Payments</U>&rdquo;
means any change in control, transaction, retention, or bonus payments to any Person (which for the avoidance of doubt shall include,
but not be limited to, any payments under the Company CIC Bonus Units) and any fees, costs or expenses related thereto, which are
or may become payable by or on behalf of the Company in connection with the execution and delivery of this Agreement or the consummation
of the Merger or any of the other transactions contemplated by this Agreement, either alone or in combination with another event
that occurs on or prior to the Closing, whether payable hereunder, under any Contract or Company Plan, or under any other plan,
policy, agreement or arrangement, and whether payable prior to or following the Closing, and, for the avoidance of doubt, excluding
any payments made to any Equityholder pursuant to <U>Article III</U> of this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Claim</U>&rdquo; means any demand,
claim, action, investigation, legal proceeding (whether at law or in equity) or arbitration.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Closing</U>&rdquo; has the meaning
given to that term in <U>Section&nbsp;2.02</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Closing Date</U>&rdquo; means (i)
the first (1<SUP>st</SUP>) Business Day following the date on which the last of the conditions set forth in <U>Article VII</U>
and <U>Article VIII</U> (other than those that by their nature are intended to be satisfied at the Closing, but subject to the
satisfaction or waiver thereof at the Closing) are satisfied or waived by the applicable Parties or (ii) such other date as Parent
and the Company mutually agree upon in writing, in each case, subject to the proviso in the first sentence of <U>Section&nbsp;2.02</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Closing Indebtedness</U>&rdquo; means
the Indebtedness of the Company (excluding any such Indebtedness that is owed to the Company) as of 12:01 a.m. Eastern Standard
Time on the Closing Date. For the avoidance of doubt, Closing Indebtedness shall not include any Transaction Expenses or any amounts
included in the Working Capital Difference.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Closing Statement</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;3.07(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Code</U>&rdquo; means the Internal
Revenue Code of 1986, as amended.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Company</U>&rdquo; has the meaning
given to that term in the Preamble to this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Company CIC Bonus Units</U>&rdquo;
means the change in control bonus agreements.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Company Counsel</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;11.20(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Company Disclosure Schedule</U>&rdquo;
means the disclosure schedule dated the date hereof regarding this Agreement that has been prepared by the Company and delivered
to Parent with this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Company Fundamental Representations</U>&rdquo;
means the representations and warranties made pursuant to <U>Section&nbsp;4.01</U>, <U>Section&nbsp;4.02</U> (except with respect
to addresses of Equityholders), <U>Section&nbsp;4.03</U>, <U>Section&nbsp;4.04(a)</U>, <U>Section&nbsp;4.14(h)</U>, <U>Section
4.16(f)</U> and <U>Section&nbsp;4.29</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Company IP</U>&rdquo; means all Intellectual
Property Rights that are owned by, purported to be owned by, exclusively licensed or purported to be exclusively licensed to the
Company.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Company Plan</U>&rdquo; has the meaning
given to that term in <U>Section&nbsp;4.15(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 81; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Company Products</U>&rdquo; means
all products, services or other offerings currently provided or under development (including, without limitation, the products,
services and offerings under development listed on <U>Schedule G)</U> by the Company.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Company RSU</U>&rdquo; has the meaning
given to that term in <U>Section&nbsp;3.02</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Company Tax Liability</U>&rdquo;
means any unpaid liability of the Company for Taxes other than income Taxes.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Company Units</U>&rdquo; means the
membership interests in the Company pursuant to the Operating Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Continuation Period</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;6.08(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Continuing Employees</U>&rdquo; means
the employees who continue to be employed with the Company at the Effective Time.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Contract</U>&rdquo; means any contract,
agreement, instrument, lease, license, evidence of indebtedness, mortgage, indenture, security agreement or other legally binding
arrangement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Copyrights</U>&rdquo; has the meaning
given to that term in the definition of Intellectual Property Rights.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Data Protection and Security Requirements</U>&rdquo;
means (i) all Laws relating to the Processing of Personal Data, data privacy, data or cyber security, breach notification, or data
localization, including but not limited to HIPAA and the GDPR; (ii) all regulatory and self-regulatory guidelines and published
interpretations by Governmental Authorities of such Laws; (ii) all provisions of Contracts to which the Company is a party or by
which the Company is bound that relate to the Processing of Personal Data; and (iii) all policies and notices of the Company relating
to the Processing of Personal Data.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Data Protection Authority</U>&rdquo;
means the Governmental Authority charged with supervising and enforcing compliance with Data Protection and Security Requirements.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Dispute Notice</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;3.07(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Disputed Items</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;3.07(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Earn-Out Arbitration</U>&rdquo; means
any arbitration commenced pursuant to <U>Section&nbsp;3.07(f)</U> or <U>Section&nbsp;3.07(h)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Earn-Out Consideration</U>&rdquo;
means the Net Sales Earn-Out Consideration and the Net Sales Growth Earn-Out Consideration.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Earn-Out Dispute Notice</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;3.08(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Earn-Out Disputed Items</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;3.08(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Earn-Out Resolution Period</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;3.08(e)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 82; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Earn-Out Resolved Matters</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;3.08(e)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Earn-Out Review Period</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;3.08(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Effective Time</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;2.03</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Enforceability Exceptions</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;4.03(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Environmental and Safety Requirements</U>&rdquo;
means all Law concerning public health and safety, worker health and safety, or pollution and protection of the environment, including
all those relating to the presence, use, production, generation, handling, transport, treatment, storage, disposal, distribution,
labeling, testing, processing, release, threatened release, control, or cleanup of any Hazardous Materials, substances or wastes,
chemical substances or mixtures, pesticides, pollutants, contaminants, toxic chemicals, petroleum products or byproducts, asbestos,
or polychlorinated biphenyls. This includes, without limitation, Laws referenced in the definition of Hazardous Materials herein
and any other Laws relating to releases or threatened releases of Hazardous Materials or otherwise relating to the manufacture,
generation, processing, distribution, use, advertising, packaging, labeling, sale, treatment, storage, management, disposal, cleanup,
transportation or handling of Hazardous Materials.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Equityholder</U>&rdquo; means a holder
of any Company Units or any Company RSUs immediately prior to the Effective Time.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Equity Interests</U>&rdquo; means
capital stock, partnership or membership interests or units (whether general or limited), options, warrants, calls, phantom stock,
profit participation (other than any cash bonus tied to Company profit or performance and not to the value of the Company Units),
restricted stock, stock appreciation rights and any other interest or participation that confers on a Person the right to receive
a share of the profits and losses of the issuing entity.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>ERISA</U>&rdquo; means the Employee
Retirement Income Security Act of 1974, as amended.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>ERISA Affiliate</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;4.15(e)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>ERISA Plans</U>&rdquo; has the meaning
given to that term in <U>Section&nbsp;4.15(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Estimated Aggregate Purchase Price</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;3.04(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Estimated Closing Statement</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;3.04(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Excluded Units</U>&rdquo; means Company
Units owned by Parent, Merger Sub or any other direct or indirect wholly owned subsidiary of Parent and Company Units owned by
the Company or any direct or indirect wholly owned subsidiary of the Company, and in each case not held on behalf of third parties.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Expense Fund</U>&rdquo; has the meaning
given to that term in <U>Section&nbsp;11.01(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 83; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Expense Fund Amount</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;11.01(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>FDA</U>&rdquo; has the meaning given
to that term in <U>Section&nbsp;4.28(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Federal Healthcare Programs</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;4.27(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Final Aggregate Purchase Price</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;3.07(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Final Closing Statement</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;3.07(d)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Financial Statements</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;4.06(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Fraud</U>&rdquo; means any fraud
causes of action that require as an element an intent to deceive, malice, recklessness, scienter or similar intent, but not any
type of fraud cause of action based solely on negligence or any similar constructive knowledge element with respect to the making
of a representation or warranty set forth in <U>Article IV</U> or <U>Article V</U> of this Agreement (as qualified by the corresponding
section(s) of the Company Disclosure Schedule by any of the individuals named in the definition of &ldquo;Knowledge&rdquo;) or
by a Unitholder with respect to the making of the representations and warranties set forth in such Unitholder&rsquo;s letter of
transmittal or Support Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Fully Diluted Company Units</U>&rdquo;
means the total number of Company Units <U>plus</U> the number of Company Units issuable pursuant to Company RSUs.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>GAAP</U>&rdquo; means Generally Accepted
Accounting Principles in the United States.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>GDPR</U>&rdquo; means Regulation
(EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to
the processing of personal data and on the free movement of such data.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Good Manufacturing Practices</U>&rdquo;
means with respect to the Company, the standards for the manufacture, processing, packaging, testing, transportation, handling
and holding of Company Products, as set forth in Applicable Law, FDA and other Governmental Authority guidance documents.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Governmental Approval</U>&rdquo;
means any authorization, consent, approval, license, permit, franchise, tariff, rate, certification, agreement, directive, waiver,
exemption, variance or Order of any Governmental Authority.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Governmental Authority</U>&rdquo;
means any entity exercising executive, legislative, judicial, regulatory or administrative functions of or pertaining to government,
including any governmental authority, agency, department, board, commission or instrumentality of the United States or any foreign
country, any state or local body of the United States or any foreign country or any political subdivision of any of the foregoing,
and any tribunal, court or arbitrator, including any Notified Body.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 84; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Hazardous Materials</U>&rdquo; means
any chemicals, materials, wastes or substances that are defined, regulated, determined or identified as toxic or hazardous under
any Environmental and Safety Requirements including, without limitation, substances defined as &ldquo;hazardous substances,&rdquo;
&ldquo;hazardous materials,&rdquo; &ldquo;hazardous waste,&rdquo; &ldquo;pollutant or contaminant,&rdquo; &ldquo;petroleum&rdquo;
or &ldquo;natural gas liquids&rdquo; in CERCLA, the Hazardous Materials Transportation Act, the Resource Conservation and Recovery
Act, or comparable state or local Laws or in the regulations pursuant to said Laws.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Healthcare Laws</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;4.27(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>HHS</U>&rdquo; has the meaning given
to that term in <U>Section&nbsp;4.19(b)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>HIPAA</U>&rdquo; means, collectively,
the Health Insurance Portability and Accountability Act of 1996, Public Law 104-191, as amended by the Health Information Technology
for Economic and Clinical Health Act, enacted as Title XIII of the American Recovery and Reinvestment Act of 2009, Public Law 111-5,
and their implementing regulations, including but not limited to, the Standards for Privacy of Individually Identifiable Health
Information at 45 C.F.R. Parts 160 and 164, Subparts A and E, the Security Standards for the Protection of Electronic Protected
Health Information at 45 C.F.R. Parts 160 and 164, Subparts A and C, and the Notification of Breach of Unsecured Protected Health
Information requirements at 45 C.F.R. Part 164, Subpart D.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>ICC</U>&rdquo; has the meaning given
to that term in <U>Section&nbsp;3.08(f)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Indebtedness</U>&rdquo; means all
obligations, contingent or otherwise, of the Company, including accrued and unpaid interest, and any prepayment fees, breakage
costs, premiums, expenses or penalties in respect of (i) borrowed money, other than intercompany loans (to the extent settled or
eliminated prior to Closing) and including related party loans and payables; (ii)&nbsp;bonds, debentures, notes (including, for
the avoidance of doubt, any convertible notes) or similar instruments; (iii)&nbsp;capitalized leases on the Financial Statements
or required to be capitalized in accordance with GAAP; (iv)&nbsp;all Indebtedness of others secured by a Lien on Property of the
Company, whether or not the Indebtedness secured thereby has been assumed; (v)&nbsp;interest rate, currency or commodity derivatives
or hedging transactions or similar arrangements (valued at the termination thereof); (vi)&nbsp;all letters of credit or performance
bonds not collateralized by cash issued for the account of the Company, only to the extent drawn upon; (vii)&nbsp;all guarantees
of the Company of any Indebtedness of any Person other than a wholly owned Subsidiary of the Company; (viii) deferred purchase
price with respect to the acquisition of any business, asset, or securities, whether contingent or otherwise, including all Tax-related
payments and amounts owed under any earn-out or similar performance payment, at the maximum value, whether contingent or not, or
any seller notes or post-closing true-up obligations; (ix)&nbsp;Company Tax Liabilities, if any; (x) all accrued, deferred and
unpaid salary or other compensation amounts due to any current or former managers of the Company which have been designated as
&quot;Guaranteed Payments&quot; in the Financial Statements (the &ldquo;Manager <U>Guaranteed Payments</U>&rdquo;), to the extent
not paid at Closing; and (xi) any other deferred compensation amounts due to any current or former managers of the Company included
in Accounts Payable (the &ldquo;<U>Manager Deferred Compensation Amounts</U>&rdquo;), to the extent not paid at Closing.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 85; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Indemnification Pro Rata Share</U>&rdquo;
means, with respect to any Unitholder and expressed as a percentage, the quotient obtained by <I>dividing</I> (i) the aggregate
amount of the Per Unit Merger Consideration payable to such Unitholder pursuant to <U>Article III</U> (assuming release in full
of the Indemnity Holdback, Special Indemnity Holdback, Purchase Price Holdback, Expense Fund and Earn-Out Consideration) <I>by</I>
(ii) the sum of the Per Unit Merger Consideration paid to all Unitholders pursuant to <U>Article III</U> (assuming release in full
of the Indemnity Holdback, Special Indemnity Holdback, Purchase Price Holdback and Expense Fund).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Indemnified Manager or Officer</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;6.12(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Indemnified Party</U>&rdquo; means,
in the case of an indemnification claim pursuant to <U>Section&nbsp;10.02(a)</U>, Parent, the Surviving Company, Merger Sub and
their Affiliates and Representatives, successors and permitted assignees and in the case of an indemnification claim pursuant to
<U>Section&nbsp;10.02(b)</U>, each Unitholder and their estate, heirs, Affiliates, Representatives, successors and permitted assignees.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Indemnified Taxes</U>&rdquo; means,
except to the extent taken into account in determining the Final Aggregate Purchase Price as finally determined pursuant to <U>Section&nbsp;3.07</U>
or as described in the immediately succeeding sentence, (a) any and all Taxes imposed on or with respect to the Company attributable
to a Pre-Closing Tax Period, (b) Taxes of any member of an affiliated, consolidated, combined or unitary group of which the Company
is or was a member on or prior to the Closing Date, including pursuant to Treasury Regulations Section&nbsp;1.1502-6 or any analogous
or similar state, local or non-U.S. Law, (c) Taxes of any Person imposed on the Company as a transferee or successor, by contract,
indemnification agreement or pursuant to any Applicable Law, which Taxes relate to an event, agreement or transaction occurring
before the Closing Date and (d) Transfer Taxes borne by the Unitholders under Section 6.10(d). Indemnified Taxes do not include
any increase in Taxes of the Company for a Pre-Closing Tax Period resulting from Parent engaging, or allowing the Company to engage,
in a transaction after the Closing but on the Closing Date that is outside the ordinary course of business and not contemplated
by this Agreement. With respect to any Straddle Period, in the case of a Tax based or measured by income, receipts, profits, wages,
capital or net worth or is imposed in connection with any sale or other transfer or assignment of property or any other specifically
identifiable transaction or event, the amount of Taxes attributable to a Pre-Closing Tax Period shall be determined on an interim
closing of the books basis as if the tax period ending on the Closing Date, and, in the case of all other Taxes, the amount of
Taxes attributable to a Pre-Closing Tax Period shall be the amount of Taxes for the entire period multiplied by a fraction, the
numerator of which is the number of days in the period ending on the Closing Date and the denominator of which is the number of
days in the entire period.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Indemnifying Party</U>&rdquo; means,
in the case of an indemnification claim pursuant to <U>Section&nbsp;10.02(a)</U>, the Unitholders and their respective successors
and permitted assigns and in the case of an indemnification claim pursuant to <U>Section&nbsp;10.02(b)</U>, Parent and its successors
and permitted assigns.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Indemnity Holdback</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;3.05(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Indemnity Release Date</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;3.05(b)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 86; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Independent Accountant</U>&rdquo;
means a certified public firm of independent accountants of national standing satisfactory to Parent and the Unitholder Representative.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Information Statement</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;6.07</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Infringe</U>&rdquo; means, with respect
to any Intellectual Property Rights, to directly or indirectly infringe, misappropriate, make unauthorized use of or otherwise
violate such Intellectual Property Rights.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Initial Unitholder Consent Delivery
Period</U>&rdquo; has the meaning given to that term in <U>Section&nbsp;6.05</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Intellectual Property Rights</U>&rdquo;
means all intellectual property and the rights appurtenant thereto, in any and all jurisdictions worldwide, including the following:
(i) patents, patent applications, inventions, and utility models, whether or not patented or patentable, including provisionals,
statutory invention registrations, invention disclosures, registrations, design patents, divisions, continuations and continuations-in-part,
and any reexaminations, substitutions, renewals, extensions, reexaminations and reissues thereof; (ii) copyrights in works of authorship,
including software, firmware, applications, files, databases and compilations, the registrations and applications therefor, and
all renewals, extensions, restorations and reversions thereof, together with all moral rights and common law rights thereto (collectively,
&ldquo;<U>Copyrights</U>&rdquo;); (iii) trademarks, service marks, trade names, brand names, corporate names, logos, trade dress,
slogans, and other source indicators, applications and registrations for the foregoing, including all renewals of the same, and
the common law rights and goodwill associated therewith and symbolized thereby (collectively, &ldquo;<U>Trademarks</U>&rdquo;);
(iv) Internet domain names, all applications and registrations for the foregoing, including all renewals of same; (v) trade secrets,
know-how, and all non-public, confidential or proprietary information, documents and materials (collectively, &ldquo;<U>Trade Secrets</U>&rdquo;);
and (vi) all other intellectual property, industrial or proprietary rights.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Interim Period</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;6.01</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>IRS</U>&rdquo; means the Internal
Revenue Service.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>IT Assets</U>&rdquo; means all information
technology and computer systems (including the computers, computer software, databases, firmware, middleware, servers, workstations,
routers, hubs, switches, data communications lines and all other information technology equipment, and all associated documentation)
used by or on behalf of the Company.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Key Customer</U>&rdquo; has the meaning
given to that term in <U>Section&nbsp;4.24(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Key Domestic Distributor</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;4.24(b)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Key Employees</U>&rdquo; means those
employees of the Company listed on Part 1 of <U>Schedule&nbsp;A</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Key International Distributor</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;4.24(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 87; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Key Revenue Agreements</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;4.13(a)(xvii)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Key Supplier</U>&rdquo; has the meaning
given to that term in <U>Section&nbsp;4.24(d)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Key Unitholders</U>&rdquo; means
those Unitholders of the Company listed on Part 3 of <U>Schedule&nbsp;A</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Knowledge</U>&rdquo; means, when
used with respect to the Company, the actual knowledge after reasonable inquiry, of the individuals listed on <U>Schedule&nbsp;D</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Law</U>&rdquo; means any U.S. or
non-U.S. federal, state or local law, statute, treaty, ordinance, rule, regulation, judgment, order, injunction or decree of any
Governmental Authority.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Lease Agreements</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;4.20(b)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Leased Real Property</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;4.20(b)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Letter Agreements</U>&rdquo; has
the meaning given to that term in the Recitals to this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Liens</U>&rdquo; means any lien,
charge, pledge, security interest, claim or other encumbrance.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Loss</U>&rdquo; or &ldquo;<U>Losses</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;10.02(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Made Available to Parent</U>&rdquo;
means made available in the virtual data room supported by Anika Therapeutics with respect to &ldquo;Project Sunshine&rdquo; no
later than 5:00 p.m. (prevailing Eastern Standard Time) on the second (2<SUP>nd</SUP>) Business Day prior to the date of this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Material Adverse Effect</U>&rdquo;
means any state of facts, change, development, event, effect, condition or occurrence that, individually or in the aggregate with
all other facts, changes, developments, events, effects, conditions and occurrences, (i) would reasonably be expected to prevent,
materially delay, materially impair or have a material adverse effect on the ability of the Company to perform its obligations
under this Agreement or the other Transaction Documents to which it is a party or to otherwise consummate the transactions contemplated
by this Agreement, or (ii) is or would reasonably be expected to be materially adverse to the assets, business, condition (financial
or otherwise), results of operations or prospects of the Company, taken as a whole; <U>provided</U>, <U>however</U>, that none
of the following, either alone or in combination, shall be considered or taken into account in determining whether a Material Adverse
Effect has occurred or would reasonably be expected to occur, except to the extent that the adverse effect on the Company arising
therefrom is disproportionate as compared to other similarly situated companies in the industry in which the Company operate: (a)
any change in Applicable Law after the date of this Agreement; (b) any change in general regulatory, economic, or political conditions,
or in the economy or financial markets generally or in the particular industry or industries in which the Company participate;
(c) any engagement of hostilities, act of war (whether or not declared) or terrorist activity; (d) any effect of weather, geological
or meteorological events; (e) any change in GAAP (including the rules and principles related to accelerated depreciation) after
the date of this Agreement; (f) any change or development in any financial, banking or securities market in the U.S. in general;
(g) any effect of the announcement or pendency of this Agreement and the transactions contemplated hereby; (h)&nbsp;any failure
to meet financial projections, estimates or forecasts (except that the underlying causes of such failure may be taken into account
in determining whether there has been a Material Adverse Effect); or (i)&nbsp;any actions taken (or omitted to be taken) at the
request of Parent or Merger Sub or required to be taken or omitted, as applicable, by the express terms of this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 88; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Material Contracts</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;4.13(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Material Product and Trial Information</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;4.28(h)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Medical Device Laws</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;4.28(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Merger</U>&rdquo; has the meaning
given to that term in the Recitals to this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Merger Sub</U>&rdquo; has the meaning
given to that term in the Preamble to this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Misuse</U>&rdquo; has the meaning
given to that term in <U>Section 1.1(b)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Multiemployer Plan</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;4.15(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Net Sales</U>&rdquo; means total
revenue attributable to the Company Products, minus the aggregate amount of sales returns, allowances, and discounts attributable
to the Company Products, calculated in accordance with GAAP, and only to the extent in accordance with GAAP, using the accounting
methods, policies, practices and procedures as were used in the preparation of the Audited Financial Statements for the period
ended December&nbsp;31, 2018. As used herein, &ldquo;total revenue&rdquo; includes, without limitation, all invoiced sales and
unbilled earned revenue that is supported by a completed Delivered Order Form indicating: the part number and lot number of each
Company Product implanted along with disposables consumed (if any), quantity, pricing (subject to review of the applicable Contract),
the date of the applicable surgery, and the name and address of the applicable hospital or surgical center. If any Company Product
is combined or bundled with any product, the revenue attributable to such Company Product in respect of such combination or bundle
will be equal to: (1) the standalone MSRP (or equivalent) of the Company Products in the bundle <I>divided by</I> the standalone
MSRP (or equivalent) of all products in the bundle; <I>multiplied by</I> (2) the revenue generated by the bundle; multiplied by
(3) 0.90.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Net Sales Earn-Out Consideration</U>&rdquo;
means the additional consideration as set forth on Part 2 of <U>Schedule&nbsp;F</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Net Sales Growth Earn-Out Consideration</U>&rdquo;
means the additional consideration as set forth on Part 1 of <U>Schedule&nbsp;F</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Non-Disclosure Agreement</U>&rdquo;
means the Mutual Confidential Information Disclosure Agreement between the Company and Parent, dated May&nbsp;10, 2019.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 89; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Notified Body</U>&rdquo; means an
entity licensed, authorized or approved by the applicable government agency, department or other authority to assess and certify
the conformity of a medical device with the requirements of the EU legislation governing medical devices and with applicable harmonized
standards.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Operating Agreement</U>&rdquo; means
the Company&rsquo;s Third Amended and Restated Operating Agreement, dated October&nbsp;1, 2011.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Order</U>&rdquo; means any writ,
judgment, decree, injunction or similar order of any Governmental Authority (in each such case whether preliminary or final).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Ordinary Course of Business</U>&rdquo;
means the conduct of the business of the Company in all material respects in accordance with its customary and normal practices,
policies and procedures prior to the date of this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Ordinary Course Purchase Orders</U>&rdquo;
means purchase orders entered into in the Ordinary Course of Business that do not vary any terms set forth on the applicable Contract
between the Company and the Key International Distributors, Key Domestic Distributors, Key Customers and Key Suppliers.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Organizational Documents</U>&rdquo;
means, with respect to any Person, the articles or certificate of incorporation or organization and by-laws or operating agreement,
or such other organizational documents of such Person, including those that are required to be registered or kept in the place
of incorporation, organization or formation of such Person and which establish the legal existence of such Person.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Overstatement</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;3.07(f)(ii)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Parent</U>&rdquo; has the meaning
given to that term in the Preamble to this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Parent Earn-Out Statement</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;3.08(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Parent Fundamental Representations</U>&rdquo;
means the representations and warranties made pursuant to <U>Section&nbsp;5.01</U>, <U>Section&nbsp;5.02</U>, <U>Section&nbsp;5.03(a)</U>
and <U>Section&nbsp;5.05</U> of this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Parent Indemnified Parties</U>&rdquo;
has the meaning given in <U>Section&nbsp;10.02(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Party</U>&rdquo; and &ldquo;<U>Parties</U>&rdquo;
have the meanings given to those terms in the Preamble to this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Payable Holdback Portion</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;3.07(f)(ii)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Payable Overstatement</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;3.07(f)(iii)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Payments Administrator</U>&rdquo;
means Acquiom Financial LLC.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 90; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Payments Administrator Agreement</U>&rdquo;
means the agreement among the Unitholder Representative, Parent and the Payments Administrator for purposes of distributing the
Per Unit Merger Consideration and other applicable amounts to the Equityholders pursuant to the terms of this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Payments Administrator Fund</U>&rdquo;
has the meaning given in <U>Section&nbsp;3.04(b)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Per Unit Closing Payment</U>&rdquo;
means an amount equal to the quotient of (i) the Aggregate Closing Amount <I>divided by </I>(ii) the total number of Fully Diluted
Company Units.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Per Unit Earn-Out Consideration</U>&rdquo;
means an amount equal to the quotient of the sum of the Earn-Out Consideration <I>divided by</I> the total number of Fully Diluted
Company Units.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Per Unit Expense Fund Consideration</U>&rdquo;
means an amount equal to (i) any amount released (whether in one or more releases) from the Expense Fund as provided for in <U>Section&nbsp;11.01(c)</U>
<I>divided by</I> (ii) the total number of Fully Diluted Company Units.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Per Unit Holdback Consideration</U>&rdquo;
means an amount equal to (i) any amount released (whether in one or more releases) from the Indemnity Holdback or Special Indemnity
Holdback as provided for in <U>Section&nbsp;3.05(b)</U> <I>divided by</I> (ii) the total number of Fully Diluted Company Units.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Per Unit Merger Consideration</U>&rdquo;
means, with respect to each Company Unit and each Company RSU, an amount equal to the Per Unit Closing Payment, <I>plus</I>, subject
to <U>Article X</U> and <U>Section&nbsp;3.05(b)</U>, the Per Unit Holdback Consideration, <I>plus</I>, subject to <U>Section&nbsp;3.07</U>,
any Per Unit Purchase Price Adjustment Consideration, <I>plus</I>, subject to <U>Section&nbsp;11.01</U>, the Per Unit Expense Fund
Consideration, plus the Per Unit Earn-Out Consideration.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Per Unit Purchase Price Adjustment
Consideration</U>&rdquo; means an amount equal to the amount equal to the payment owed by Parent pursuant to <U>Section&nbsp;3.07(f)</U>
<I>divided by</I> the total number of Fully Diluted Company Units.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Permitted Lien</U>&rdquo; means any
of the following: (i) any Lien (x) for Taxes not yet due or delinquent or (y) for Taxes being contested in good faith by appropriate
proceedings for which adequate reserves have been maintained to the extent required by GAAP and which are not material in amount
or effect on the Company; (ii) zoning, planning and similar limitations and restrictions on, and all rights of any Governmental
Authority to regulate any real property that would not reasonably be expected to impair the continued use and operation of the
assets to which they relate in the conduct of the business of the Company as presently conducted; (iii) statutory or common law
Liens in favor of carriers, warehousemen, mechanics and materialmen, and statutory or common law Liens to secure claims for labor,
materials or supplies for amounts not yet due or that are being contested in good faith by appropriate proceedings for which adequate
reserves have been maintained in accordance with GAAP; (iv) pledges and deposits made in the Ordinary Course of Business in compliance
with workers&rsquo; compensation, unemployment insurance and other Applicable Laws regarding social security; (v) any Lien that
is released on or prior to the Closing; (vi) any Lien arising in the Ordinary Course of Business by operation of Applicable Law
with respect to a liability that is not yet due or delinquent or that is being contested in good faith by the Company; (vii) any
Lien reflected in the Financial Statements; and (viii) any purchase money Lien arising in the Ordinary Course of Business.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 91; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Person</U>&rdquo; means any individual,
corporation, company, voluntary association, partnership, joint venture, trust, limited liability company, unincorporated organization,
Governmental Authority or other entity.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Personal Data</U>&rdquo; means any
data or information in any medium relating to an identified or identifiable individual, browser, or device and any other data or
information that constitutes personal information or personally identifiable information under any Applicable Law, and includes,
but is not limited to, a natural person&rsquo;s first and last name, home or other physical address, telephone number, e-mail address,
photograph, social security number, driver&rsquo;s license number, passport number or other government-issued identification number,
biometric information, credit card or other financial information, or customer or account number, IP address, cookie information,
or other unique identifiers. An identifiable individual is one who can be identified, directly or indirectly, in particular by
reference to an identification number or to one or more factors specific to his/her physical, physiological, mental, economic,
cultural or social identity. Personal Data shall include Protected Health Information.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Pre-Closing Tax Period</U>&rdquo;
means any taxable year or other taxable period ending on or before the Closing Date, and that portion of any Straddle Period ending
on the Closing Date.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Process</U>&rdquo; or &ldquo;<U>Processing</U>&rdquo;
means the collection, use, storage, processing, recording, distribution, transfer, import, export, protection (including security
measures), disposal, disclosure or other activity regarding data (whether electronically or in any other form or medium).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Properties</U>&rdquo; means, as to
any Person, all assets and properties of every kind, nature, character and description (whether real, personal or mixed, whether
tangible or intangible, and wherever situated) operated, owned or leased by such Person.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Protected Health Information</U>&rdquo;
means protected health information as that term is defined at 45 C.F.R. &sect;&nbsp;160.103 for purposes of HIPAA.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Purchase Price Holdback</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;3.05(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Quality System Regulation</U>&rdquo;
means design control, Good Manufacturing Practice, and quality system management requirements governing the standards and methods
to be used in, and the facilities or controls to be used for, the design, manufacture, processing, packaging, testing or holding
of medical devices to assure their quality, safety, performance, and efficacy, including the FDA Quality System Regulation at 21
C.F.R. Part 820 and associated FDA guidance, international standards for quality management systems as adopted by the International
Organization for Standardization such as ISO 13485:2016, and similar requirements of any Governmental Authority.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>R&amp;W Policy</U>&rdquo; means the
general representations and warranties insurance policy that is being obtained by Parent relating to the transactions contemplated
by this Agreement with a face value of $[&hellip;].</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 92; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Regulatory Authorization</U>&rdquo;
means, with respect to a particular jurisdiction, any and all approvals, licenses, registrations, certificates, permits, consents,
notifications, clearances or authorizations of any Governmental Authority as are necessary to manufacture, commercially distribute,
import, export, sell and market a Company Product in such jurisdiction, which shall include where applicable: 510(k) or premarket
notification clearances, de novo classifications, pre-market approvals, investigational device exemptions, product recertifications,
manufacturing approvals and authorizations, CE Mark certifications, pricing and reimbursement approvals, labeling approvals, registration
notifications or their foreign equivalents.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Release Dates</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;3.05(b)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Representations Survival Period</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;10.01(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Representative Losses</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;11.01(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Representatives</U>&rdquo; means,
as to any Person, its officers, managers, directors, employees, partners, members, Unitholders, counsel, accountants, financial
advisors, engineers, agents and consultants (other than the Unitholder Representative).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Required Unitholder Approval</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;4.03(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Resolution Period</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;3.07(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Resolved Matters</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;3.07(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Restricted Cash</U>&rdquo; means
any cash which is not freely usable by Parent because it is subject to restrictions, limitations or Taxes on use or distribution
by Law, contract or otherwise, including without limitation, restrictions on dividends and repatriations or any other form of restriction.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Review Period</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;3.07(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;[<U>&hellip;] Holdback</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;3.05(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;[<U>&hellip;] Matters</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;3.05(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Sales Schedule</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;3.05(b)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Scheduled Company IP</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;4.18(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Security Incident</U>&rdquo; means
any unauthorized access, acquisition, use, disclosure, modification, deletion or destruction of information (including Personal
Data) or interference with system operations of IT Assets.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 93; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Severance Costs</U>&rdquo; means
the aggregate amount of severance due and payable in connection with any termination of employment prior to the Closing Date of
any employee of the Company that is outstanding as of the Closing Date.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Special Indemnity Holdback</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;3.05(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Special Indemnity Matters</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;10.02(a)(v)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Special Indemnity Regulatory Matters</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;10.02(a)(vi)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Special Losses</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;10.04(a)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Straddle Period</U>&rdquo; means
any taxable period that begins on or before and ends after the Closing Date.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Subsidiary</U>&rdquo; means, with
respect to any Person, any other Person of which such Person (either alone or through or together with any other subsidiary) owns,
directly or indirectly, fifty percent (50%) or more of the outstanding equity securities or securities carrying the voting power
in the election of the board of directors or other governing body of such Person.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Support Agreements</U>&rdquo; has
the meaning given to that term in the Recitals to this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Surviving Company</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;2.01</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Tax</U>&rdquo; means any and all
federal, state, local or foreign taxes imposed by a Governmental Authority (including any interest, fines, assessments, penalties
or additions to tax, in each case, imposed by a Governmental Authority in connection therewith or with respect thereto) including
(x) taxes imposed on, or measured by, income, franchise, profits or gross receipts, and (y) <I>ad valorem</I>, value added, capital
gains, sales, goods and services, use, real or personal property, capital stock, license, branch, payroll, estimated withholding,
employment, social security, unemployment, compensation, utility, severance, production, excise, stamp, occupation, premium, windfall
profits, transfer and gains taxes, abandoned and unclaimed property, escheat, and customs duties.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Tax Authority</U>&rdquo; means, with
respect to any Tax, the Governmental Authority that imposes such Tax, and the agency (if any) charged with the collection of such
Tax for such Governmental Authority.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Tax Return</U>&rdquo; means any return,
report, information return, declaration, claim for refund, election or other document, together with all schedules, attachments,
amendments and supplements thereto, supplied to or required to be supplied to any Tax Authority.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Termination Date</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;9.01(a)(i)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 94; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Third-Party Claim</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;10.03</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Trade Secret</U>&rdquo; has the meaning
given to that term in the definition of Intellectual Property Rights.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Trademarks</U>&rdquo; has the meaning
given to that term in the definition of Intellectual Property Rights.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Transaction Documents</U>&rdquo;
means this Agreement, the Payments Administrator Agreement and the other documents, agreements, certificates and other instruments
to be executed, delivered and performed by the parties in connection with the transactions contemplated by this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Transaction Expenses</U>&rdquo; means:
(i) any and all third-party advisory fees, costs and expenses (including expenses of brokers, financial advisors, consultants,
accountants, commission agents, service providers and legal counsel) or other fees (including regulatory and consent fees, if any)
and expenses incurred by the Company in connection with the transactions contemplated hereby, (ii) any accrued or payable transaction,
management, monitoring or similar fees payable to any Affiliate of the Company, (iii) the fees and expenses of the Unitholder Representative
as of the Closing, (iv) fifty percent (50%) of any documented premium and expenses payable with respect to the R&amp;W Policy,
(v) all Severance Costs, (vi) all Change in Control Payments, (vii) all Manager Guaranteed Payments, (viii) all Manager Deferred
Compensation Amounts and (ix) all Transaction Payroll Taxes.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Transaction Payroll Taxes</U>&rdquo;
means any employer level employment or payroll Taxes payable as a result of the payment of the Company RSUs, the Per Unit Holdback
Consideration, the Per Unit Purchase Price Adjustment Consideration, the Per Unit Expense Fund Consideration, the Per Unit Earn-Out
Consideration, Severance Costs or Change in Control Payments, solely to the extent payable (or attributable to amounts payable)
before, on or after the Closing as a result of the transactions contemplated by this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Transfer Taxes</U>&rdquo; has the
meaning given to that term in <U>Section&nbsp;6.10(d)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>U.S. Dollars</U>&rdquo; means the
lawful currency of the United States.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Unitholder</U>&rdquo; means any holder
of Company Units immediately prior to the Effective Time.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Unitholder Representative</U>&rdquo;
has the meaning given to that term in the Preamble to this Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Unresolved Matters</U>&rdquo; has
the meaning given to that term in <U>Section&nbsp;3.07(c)</U>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Wisconsin Law</U>&rdquo; means the
Wisconsin Limited Liability Company Law (Chapter 183 of the Wisconsin Statutes).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt"></P>

<!-- Field: Page; Sequence: 95; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>Working Capital Difference</U>&rdquo;
means (i) the sum of all current assets reflected on <U>Schedule&nbsp;E</U> (excluding Cash on Hand, Restricted Cash, income Tax
assets and employee receivables); <I>minus</I> (ii) the sum of the current liabilities reflected on <U>Schedule&nbsp;E</U> (excluding
Indebtedness, Transaction Expenses and any income Tax liabilities), in each case as of 12:01 am Eastern Standard Time on the Closing
Date and calculated in accordance with GAAP, and only to the extent in accordance with GAAP, using the accounting methods, policies,
practices and procedures, as were used in the preparation of the balance sheet of the Company in the audited Financial Statements
as of September 30, 2019 (the &quot;<U>Accounting Methodologies</U>&quot;), <I>minus </I>(iii) $[&hellip;], expressed as a positive
or negative value as appropriate. <U>Schedule&nbsp;E</U> attached hereto sets forth an illustrative calculation of the Working
Capital Difference.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0 0 12pt">&ldquo;<U>YTD Financial Statements</U>&rdquo;
has the meaning given to that term in <U>Section&nbsp;4.06(a)</U>.</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0 0 12pt; text-align: center">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0 0 12pt; text-align: center">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0 0 12pt; text-align: center">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0 0 12pt; text-align: center">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0 0 12pt; text-align: center"></P>

<!-- Field: Page; Sequence: 96; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0 0 12pt; text-align: center"><U>Schedule&nbsp;A</U></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0"><B>Part 1 &ndash; Key Employees</B></P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 8pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>[&hellip;]</TD></TR></TABLE>

<P STYLE="font-size: 10pt; text-align: center; margin: 0 0 8pt"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0 0 8pt"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0 0 8pt"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0 0 8pt"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0 0 8pt"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0 0 8pt">Schedule A-<FONT STYLE="font-size: 10pt">1</FONT><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0 0 8pt"></P>

<!-- Field: Page; Sequence: 97; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: center; margin: 0 0 8pt"><B><U>Schedule&nbsp;A</U></B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0"><B>Part 2 &ndash; Key Individuals</B></P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 8pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>[&hellip;]</TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin-top: 0; text-align: center; margin-bottom: 8pt">Schedule A-2</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0 0 12pt; text-align: center"></P>

<!-- Field: Page; Sequence: 98; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0 0 12pt; text-align: center"><U>Schedule&nbsp;A</U></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0"><B>Part 3 &ndash; Key Unitholders</B></P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 8pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>[&hellip;]</TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0"></P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin-top: 0; text-align: center; margin-bottom: 0">Schedule A-3</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0 0 12pt; text-align: center"><U></U></P>

<!-- Field: Page; Sequence: 99; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0 0 12pt; text-align: center"><U>Schedule&nbsp;B</U></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0"><B>List of Unitholders to Sign Support Agreement by Midnight on January
5, 2020</B></P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 8pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>[&hellip;]</TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0"></P>

<P STYLE="font-size: 10pt; margin-top: 0; text-align: center; margin-bottom: 0">Schedule B-1</P>



<P STYLE="font-size: 10pt; margin-top: 0; text-align: center; margin-bottom: 0"></P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0 0 12pt; text-align: center"></P>

<!-- Field: Page; Sequence: 100; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0 0 12pt; text-align: center"><U>Schedule&nbsp;D</U></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0 0 12pt"><B>Knowledge Parties</B></P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 8pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>[&hellip;]</TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin-top: 0; text-align: center; margin-bottom: 8pt">Schedule D-<FONT STYLE="font-size: 10pt">1</FONT></P>

<P STYLE="font-size: 10pt; margin: 0 0 8pt"></P>

<!-- Field: Page; Sequence: 101; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0 0 12pt; text-align: center"><U>Schedule&nbsp;E</U></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0 0 12pt"><B>Illustrative Calculation of Working Capital, Indebtedness and
Cash</B></P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0 0 12pt; text-align: center">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0 0 12pt; text-align: center">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0 0 12pt; text-align: center">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin-top: 0; text-align: center; margin-bottom: 0">Schedule E-1</P>

<P STYLE="font-size: 10pt; margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0"></P>

<!-- Field: Page; Sequence: 102; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0 0 12pt; text-align: center"><U>Schedule&nbsp;F</U></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0 0 12pt"><B>Part 1 &ndash; Sales Growth Milestones</B></P>

<P STYLE="font-size: 10pt; margin: 0 0 3pt">The Net Sales Growth Earn-Out Consideration for each of Calendar Year 2020 or 2021
will be an amount equal to (i) the annual Incremental Net Sales <I>multiplied by</I> (ii) the applicable Multiple (as set forth
below) (<I>see Illustration A on the following page&nbsp;for illustration purposes only</I>); <U>provided that</U> the total aggregate
Net Sales Growth Earn-Out Consideration for Calendar Years 2020 and 2021 pursuant to this paragraph 1 shall be a maximum of $50,000,000
(<I>see Illustration B on the following page&nbsp;for illustration purposes only</I>); <U>provided further</U> that the Net Sales
Growth Earn-Out Consideration shall only be payable in respect of a Calendar Year if the Net Sales in that Calendar Year equal
or exceed the Net Sales in the prior Calendar Year by at least [&hellip;]%.&nbsp; The &ldquo;Incremental Net Sales&rdquo; for Calendar
Year 2020 will be Net Sales in excess of $[&hellip;] and the &ldquo;Incremental Net Sales&rdquo; for Calendar Year 2021 will be
Net Sales in excess of the greater of (i) [&hellip;] and (ii) $[&hellip;].</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0 0 12pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 40%; border-collapse: collapse; font-size: 10pt">
<TR>
    <TD STYLE="white-space: nowrap; width: 58%; text-align: center"><FONT STYLE="font-size: 10pt"><B><U>&hellip;</U></B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 42%; text-align: center"><FONT STYLE="font-size: 10pt"><B><U>&hellip;</U></B></FONT></TD></TR>
<TR STYLE="background-color: #DEEAF6">
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">&hellip;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">&hellip;</FONT></TD></TR>
<TR>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">&hellip;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">&hellip;</FONT></TD></TR>
<TR STYLE="background-color: #DEEAF6">
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">&hellip;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 10pt">&hellip;</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin-top: 0; text-align: center; margin-bottom: 0">Schedule F-<FONT STYLE="font-size: 10pt">1</FONT></P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0"></P>

<!-- Field: Page; Sequence: 103; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; margin: 0"></P>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; margin: 0 0 12pt; text-align: center"><U>Schedule&nbsp;F</U></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0 0 12pt"><B>Part 2 &ndash; Sales Milestones</B></P>

<P STYLE="font-size: 10pt; margin: 0 0 3pt">The Net Sales Earn-Out Consideration in an amount equal to $10,000,000 will be payable
if Net Sales equal or exceed $[&hellip;] for any last twelve month period ending on or before December&nbsp;31, 2022;&nbsp;(<I>see
Illustrations A and B below for illustration purposes only</I>); <U>provided that</U> in no event will the Net Sales Earn-Out Consideration
be payable more than once.</P>

<P STYLE="font-size: 10pt; margin: 0 0 3pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0 0 3pt 0.5in">[&hellip;]</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0 0 3pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0 0 3pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0 0 3pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0 0 3pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin-top: 0; margin-bottom: 3pt">Schedule F-2</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0 0 3pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0 0 3pt 0.5in"></P>

<!-- Field: Page; Sequence: 104; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0 0 3pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: -2in; margin: 0 0 3pt 2in"><B><U>Schedule G</U></B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: -2in; margin: 0 0 3pt 2in"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: -2in; margin: 0 0 3pt 2in"><B>Products in Development</B></P>

<P STYLE="font-size: 10pt; text-align: center; text-indent: -2in; margin: 0 0 3pt 2in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 80%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="width: 43%; border: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Project</B></FONT></TD>
    <TD STYLE="width: 57%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">[&hellip;]</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">[&hellip;]</FONT></TD></TR>
</TABLE>
<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0 0 3pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0 0 3pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0 0 3pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0 0 3pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0 0 3pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: left; text-indent: 0in; margin: 0 0 3pt 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin-top: 0; margin-bottom: 3pt">Schedule G</P>

<P STYLE="font-size: 10pt; text-align: center; margin-top: 0; margin-bottom: 3pt; border-bottom: Black 4pt solid">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
